<SEC-DOCUMENT>0001628280-25-019659.txt : 20250424
<SEC-HEADER>0001628280-25-019659.hdr.sgml : 20250424
<ACCEPTANCE-DATETIME>20250424160312
ACCESSION NUMBER:		0001628280-25-019659
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20250612
FILED AS OF DATE:		20250424
DATE AS OF CHANGE:		20250424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOCRYST PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000882796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				621413174
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23186
		FILM NUMBER:		25867194

	BUSINESS ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-859-1302

	MAIL ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>bcrx-20250424.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:79f1b597-5081-40c7-8541-415568e3d0b8,g:ecdcf9bc-7ed2-4584-936b-1fac065a649a,d:08dd44edc832493d888aecb8122c7631-->
<html xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:bcrx="http://biocryst.com/20250424" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bcrx-20250424</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-2">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-3">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-4">0000882796</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bcrx-20250424.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i08dd44edc832493d888aecb8122c7631_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SCHEDULE 14A</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#8201;</span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary Proxy Statement</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitive Proxy Statement</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitive Additional Materials</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting Material under &#167;240.14a-12</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">BIOCRYST PHARMACEUTICALS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Name of Registrant as Specified In Its Charter)</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:91.931%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check all boxes that apply):</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fee required.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee paid previously with preliminary materials.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20250424_g1.jpg" alt="logo_biocryst2a.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"/></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BIOCRYST PHARMACEUTICALS, INC.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4505 Emperor Blvd., Suite 200</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Durham, North Carolina 27703</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> MEETING OF STOCKHOLDERS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To Be Held June&#160;12, 2025</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders of BioCryst Pharmaceuticals, Inc.:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the Annual Meeting of Stockholders of BioCryst Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;), will be held at our corporate headquarters at 4505 Emperor Blvd., Suite 200, Durham, NC 27703 on Thursday, June&#160;12, 2025 at 10:00 a.m., Eastern Daylight Time (t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he &#8220;Meeting&#8221;), for the following purposes:</span></div><div style="margin-top:6pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect the two directors nominated in this Proxy Statement to serve for a term ending at the 2028 annual meeting of stockholders and until a successor is duly elected and qualified;</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for 2025;</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To hold a non-binding, advisory vote regarding executive compensation;</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan; and</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Meeting or any adjournment thereof.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE IN FAVOR OF PROPOSALS 1, 2, 3 AND 4.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The proposals are further described in the accompanying Proxy Statement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors has fixed the close of business on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as the record date for the determination of stockholders entitled to receive notice of and to vote at the Meeting or any adjournment thereof. The Meeting may be adjourned from time to time without notice other than announcement at the Meeting, and any business for which notice of the Meeting is hereby given may be transacted at any such adjournment. A list of the stockholders entitled to vote at the Meeting will be open to examination by any stockholder, for any purpose germane to the Meeting, during ordinary business hours, for a period of at least 10 days prior to the Meeting at the principal executive offices of the Company, located at 4505 Emperor Blvd, Suite 200, Durham, NC 27703. Stockholders wishing to examine the list may make arrangements to do so by contacting our Corporate Secretary in writing at our principal executive offices or by telephone at (919) 859-1302.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve the right to implement any health and safety measures as we deem prudent or as may be required by applicable laws or government orders. In addition, if we determine that it is not possible or advisable to hold the Meeting in person at our corporate offices on the meeting date, we may make alternative arrangements to hold the Meeting at a different date or time, in a different location, and/or by means of remote communication. In the event we determine it is necessary or appropriate to make alternative arrangements for the Meeting, we will announce the decision to do so in advance, and details on how to participate will be issued by press release, posted on our website, and filed with the Securities and Exchange Commission as additional proxy soliciting material.</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please carefully review the Proxy Card and Proxy Statement.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BY ORDER OF THE BOARD OF DIRECTORS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes, Corporate Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Durham, North Carolina</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;24, 2025</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALL STOCK</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLDERS ARE INVITED TO ATTEND THE ANNUAL MEETING IN PERSON. WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE VOTE PROMPTLY. A PERSON GIVING A PROXY HAS THE POWER TO REVOKE IT. IF YOU ATTEND THE MEETING, YOUR PROXY WILL NOT BE COUNTED WITH RESPECT TO ANY MATTER UPON WHICH YOU VOTE IN PERSON.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:89.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_13">PROXY STATEMENT</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_13">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_16">ITEMS TO BE VOTED UPON</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_19">1. ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_22">2. RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_22">5</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_22">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_25">3. </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_25">NON-BINDING, </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_25">ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_25">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_28">4. APPROVAL OF AN AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLAN</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_28">11</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_31">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_31">20</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_34">EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_34">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_37">COMPENSATION DISCUSSION AND ANALYSIS</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_37">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_40">COMPENSATION COMMITTEE REPORT</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_40">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_43">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_43">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_46">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_46">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_46"> SUMMARY COMPENSATION TABLE</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_46">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_49">GRANTS OF PLAN-BASED AWARDS IN 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_49">4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_49">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_52">OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_52">4</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_52">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_55">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_55">4 </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_55">OPTION EXERCISES AND STOCK VESTED</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_55">40</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_58">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_58">40</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_61">CEO PAY RATIO</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_61">44</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_64">PAY VERSUS PERFORMANCE</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_64">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_67">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_67">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_67"> DIRECTOR COMPENSATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_67">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_70">AUDIT COMMITTEE REPORT</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_70">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_73">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_73">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_76">STOCKHOLDER PROPOSALS</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_76">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_79">NO INCORPORATION BY REFERENCE</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_79">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_82">OTHER MATTERS</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_82">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_85">GENERAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_85">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_88">ANNEX A</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">A-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_88">1</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BIOCRYST PHARMACEUTICALS, INC.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4505 Emperor Blvd., Suite 200</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Durham, North Carolina 27703</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors (the &#8220;Board&#8221; or the &#8220;Board of Directors&#8221;) of BioCryst Pharmaceuticals, Inc. (&#8220;BioCryst&#8221; or the &#8220;Company&#8221;) for the Annual Meeting of Stockholders of the Company to be held at our corporate headquarters at 4505 Emperor Blvd., Suite 200, Durham, NC 27703 o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n Thursday, June&#160;12, 2025 at 10:00 a.m., Eastern Daylight Time, and at any adjournment thereof (the &#8220;Meeting&#8221;), and for the purposes set forth in the accompanying Notice of Annual Meeting o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this document, the words &#8220;BioCryst,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; and &#8220;us&#8221; refer only to BioCryst Pharmaceuticals, Inc. and not to any other person or entity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are taking advantage of Securities and Exchange Commission (&#8220;SEC&#8221;) rules that allow us to deliver proxy materials to our stockholders via the Internet. Under these rules, we are sending our stockholders a one-page notice regarding the Internet availability of proxy materials instead of a full printed set of proxy materials. Our stockholders will not receive printed copies of the proxy materials unless specifically requested. Instead, the one-page notice that our stockholders receive will tell them how to ac</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cess and review on the Internet all of the important information contained in the proxy materials. This notice also tells our stockholders how to submit their proxy card on the Internet and how to request to receive a printed copy of our proxy materials. We expect to provide notice and electronic delivery of this Proxy Statement to such stockholders on or about April&#160;24, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve the right to implement any health and saf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ety measures as we deem prudent or as may be required by applicable laws or government orders. In addition, if we determine that it is not possible or advisable to hold the Meeting in person at our corporate offices on the meeting date, we may make alternative arrangements to hold the Meeting at a different date or time, in a different location, and/or by means of remote communication. In the event we determine it is necessary or appropriate to make alternative arrangements for the Meeting, we will announce the decision to do so in advance, and details on how to participate will be issued by press release, posted on our website, and filed with the SEC as additional proxy soliciting material.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purpose of the Meeting</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The matters to be considered at the Meeting are:</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect the two directors nominated in this Proxy Statement to serve for a term ending at the 2028 annual meeting of stockholders and until a successor is duly elected and qualified;</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for 2025;</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To hold a non-binding, advisory vote regarding executive compensation;</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan; and</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Meeting or any adjournment thereof.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revocation and Voting of Proxies</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time prior to the voting thereof, by giving written notice to our Corporate Secretary at our principal executive offices, 4505 Emperor Blvd., Suite 200, Durham, NC 27703 or by voting in person at the Meeting. Attendance at the Meeting will not, by itself, revoke a proxy. All valid, unrevoked proxies will be voted as directed. In the absence of any contrary directions, proxies received by the Board will be voted as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the election of each of the nominees named in this Proxy Statement for director of the Company;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR ratification of the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accountants for 2025;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR approval of the non-binding, advisory resolution regarding executive compensation; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR approval of the amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to such other matters as may properly come before the Meeting, votes will be cast in the discretion of the appointed proxies.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting and Quorum</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only holders of record (referred to in this section as the &#8220;Stockholders&#8221;) of our common stock (the &#8220;Common Stock&#8221;) as of the close of business on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;Record Date&#8221;) will be entitled to notice of and to vote at the Meeting. At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ther</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e were 209,207,928 shares of Com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mon Stock outstanding. Stockholders are entitled to vote in any one of the following ways:</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">In Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders who choose to attend the Meeting can vote in person at the Meeting by presenting a form of photo identification acceptable to the Company and casting a ballot. Registered holders may vote upon presentation of such identification. Beneficial owners who hold their shares through a nominee, such as a broker or a bank, must obtain a proxy from such nominee or other holder of record and present it to the inspector of election with their ballot.</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">By Internet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders can vote on the Internet by following the instructions provided in the one-page notice regarding the Internet availability of proxy materials.</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">By Mail</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders can vote by mail after requesting a paper copy of the proxy materials, including a proxy card, by following the instructions provided in the one-page notice regarding the Internet availability of proxy materials.</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">By Telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders can vote over the telephone using the toll-free telephone number obtained by accessing the website set forth in the instructions provided in the one-page notice regarding the Internet availability of proxy materials.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Common Stock is entitled to one vote on all matters on which Stockholders may vote. There is no cumulative voting in the election of directors. The presence, in person or by proxy, of holders of a majority of the outstanding shares of Common Stock entitled to vote at the Meeting is necessary to constitute a quorum at the Meeting. Shares of Common Stock represented by a properly executed and returned proxy will be treated as present at the Meeting for purposes of determining the presence of a quorum without regard to whether the proxy is marked as casting a vote for or against, or withholding authority or abstaining, with respect to a particular matter. In addition, shares of Common Stock represented by &#8220;broker non-votes&#8221; generally will be treated as present for purposes of determining the presence of a quorum. Broker non-votes are shares of Common Stock held in record name by brokers, banks or other nominees as to which a proxy is received and (i) instructions have not been received from the beneficial owners or persons entitled to vote, (ii) the broker or nominee does not have discretionary power, and (iii) the record holder had indicated that it does not have authority to vote such shares on that matter. Under current stock exchange rules, brokers who do not have instructions from their customers may in some cases vote the shares in their discretion but are not permitted to vote on certain proposals and may elect to not vote on any of the proposals unless the customer provides voting instructions. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Attending the Meeting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders as of the Record Date are invited to attend the Meeting. Stockholders must present a form of photo identification acceptable to the Company, such as a valid driver&#8217;s license or passport, to be admitted to the Meeting. Registered holders may vote upon presentation of such identification. Beneficial owners who hold their shares through a nominee, such as a broker or a bank, must obtain a proxy from such nominee or other holder of record and present it to the inspector of election with their ballot. Each Stockholder may appoint only one proxy holder or representative to attend the Meeting on his or her behalf. In addition, we reserve the right to implement any health and safety measures as we deem prudent or as may be required by applicable laws or government orders. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting will begin promptly at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10:00 a.m.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Eastern Daylight Time. Please allow ample time for the check-in procedures. Media may attend the Meeting by invitation only. No cameras, audio or video recording equipment, communication devices, or other similar equipment may be brought into the Meeting.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Votes, Abstentions, and Broker Non-Votes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors will be elected by a plurality of the votes cast. This means that the nominees with the most votes will be elected. Votes may be cast for or withheld from the nominee, but a withheld vote or a broker non-vote will not affect the outcome of the election of directors at the Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of the holders of a majority of the shares of Common Stock represented in person or by proxy at the Meeting and voting on the proposal is required for approval of (i) the ratification of our selection of Ernst &amp; Young LLP as our independent registered public accountants for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (ii) the non-binding, advisory resolution regarding executive compensation, and (iii) the amended and restated Stock Incentive Plan. Abstentions and broker non-votes will have no effect upon these proposals.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Solicitation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are making this proxy solicitation both through the mail and Internet, although proxies may be solicited by personal interview, telephone, facsimile, letter, e-mail or otherwise. Certain of our directors, officers and other employees, without additional compensation, may participate in the solicitation of proxies. We will pay the cost of this solicitation, including the reasonable charges and expenses of brokerage firms and others who forward solicitation materials to beneficial owners of Common Stoc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k. We may engage Georgeson LLC, 1290 Avenue of the Americas, 9th Floor, New York, NY 10104 as we deem necessary to assist us in soliciting proxies in conjunction with the Meeting, at an approximate cost of $16,500 plus reasonable out-of-pocket expenses for their services.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEMS TO BE VOTED UPON</span></div><div id="i08dd44edc832493d888aecb8122c7631_19"></div><div style="margin-top:6pt;padding-left:20pt;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ard of Directors currently consists of 10 directors and will be reduced to nine directors as of the Meeting. Three directors have terms expiring at the Meeting. Two of these directors are</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> named as director nominees in this Proxy Statement and have been nominated for reelection to the Board to serve for a term ending at the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> annual meeting of stockholders, and until their successors shall have been duly elected and qualified. Proxies cannot be voted for more than two nominees. Unless otherwise specified in the accompanying proxy card, the shares voted by proxy will be voted FOR the election of the two persons listed for terms expiring in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board expects that both nominees will be available for election, but if either of the nominees is not available or is</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> unwilling to accept election, it is expected that the proxies will vote for a substitute nominee to be designated by the Board or, if no such designation is made, that the proxies will vote for a lesser number of nominees. The Board has no reason to believe that the persons named will be unable to serve or will decline to serve if elected.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOMINEES FOR DIRECTOR WITH TERMS EXPIRING AT THE ANNUAL MEETING OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDERS IN 2028</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s) with the Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Served as <br/>Director Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td></tr></table></div><div style="margin-top:6pt;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following persons shall continue to serve as directors for the terms indicated:</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS WITH TERMS EXPIRING AT THE ANNUAL MEETING OF STOCKHOLDERS IN 2026</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s) with the Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Served as <br/>Director Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director, President, Chief Executive Officer, Interim Chief Financial Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2007</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS WITH TERMS EXPIRING AT THE ANNUAL MEETING OF STOCKHOLDERS IN 2027</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s) with the Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Served as <br/>Director Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director, Chair of the Board</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Age as of April&#160;14, 2025.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biographical Information of Directors and Director Nominees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below you can find information, including biographical information, about our nominees for director and directors whose terms continue after the Meeting, as well as a discussion of the specific experiences, qualifications, attributes, and skills considered by the Board in concluding that s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uch individuals should serve as directors. Mr. Stephen J. Aselage, 73, has served as a director since 2019, and his term will expire at the Meeting. We acknowledge and appreciate Mr. Aselage&#8217;s years of service and contributions to the Company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominees for Director with Terms Expiring in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2028</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in September 2021. From 2010 to 2021, Dr. Galson served as Senior Vice President, Research and Development, at Amgen Inc., a publicly-traded biotechnology company, where he also led regulatory affairs. Prior to joining Amgen Inc., Dr. Galson spent more than 20 years in public service roles across the U.S. Department of Health and Human Services, Department of Energy, Environmental Protection Agency, and Centers for Disease Control and Prevention. From 2001 to 2007, Dr. Galson progressed from deputy director, to acting director, to director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;FDA&#8221;). From 2007 to 2009, he served as acting surgeon general of the United States. Dr. Galson currently serves on the board of directors of Elephas Biosciences Corporation, a private biosciences company, and he serves as a senior advisor to Boston Consulting Group, Inc. He recently served as a member of the Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases in the United States and the European Union, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine. He previously served on the boards of directors of Vanda Pharmaceuticals Inc., a publicly-traded biopharmaceutical company, and Insilico Medicine, a private pharma-technology company. Dr. Galson received a B.S. in biochemistry from the State University of New York at Stony Brook, an M.D. from the Mount Sinai School of Medicine, and a master&#8217;s degree in public health from the Harvard School of Public Health. Dr. Galson&#8217;s industry background, research and development experience, and extensive regulatory experience provide valuable knowledge and insight to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alan G. Levin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in February 2020. Mr. Levin served as Chief Financial Officer of Endo Health Solutions Inc. (&#8220;Endo&#8221;), a global specialty healthcare company, from June 2009 until September 2013. Prior to joining Endo, Mr. Levin worked with Texas Pacific Group, a leading private equity firm, and one of its start-up investments. Before that, he was Chief Financial Officer of Pfizer, Inc. (&#8220;Pfizer&#8221;) where he worked for 20 years in a variety of executive positions of increasing responsibility, including Treasurer and Senior Vice President of Finance &amp; Strategic Management for the company&#8217;s research and development organization. He previously served as a member of the board of directors of Diffusion Pharmaceuticals Inc., a publicly-traded development stage oncology company, from 2015 until it was acquired by CervoMed, Inc. in August 2023, and was a member of the board of directors of Aceto Corporation, a former publicly-traded seller and distributor of generic drugs, pharmaceutical ingredients, and performance chemicals, from 2013 to 2019. In addition, Mr. Levin is a member of the board of directors of the Critical Path Institute, a non-profit collaboration between the FDA and the pharmaceutical industry, focused on accelerating development of and streamlining regulatory requirements for innovative medicines. He earned a bachelor&#8217;s degree from Princeton University and a master&#8217;s degree in accounting from New York University&#8217;s Stern School of Business. Mr. Levin is a certified public accountant. Mr. Levin&#8217;s extensive experience in strategic planning, capital markets, financial reporting, tax planning, and business development contribute valuable insight and experience to the Board. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors with Terms Expiring in 2026</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">George B. Abercrombie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in October 2011. Mr. Abercrombie has over 30 years of experience as a business leader in the pharmaceutical industry. Mr. Abercrombie held the position of Senior Vice President and Chief Commercial Officer at Innoviva, Inc., a publicly-traded bio-pharmaceutical asset management company, from 2014 to 2018. He served from 2001 to 2009 as the President and Chief Executive Officer of Hoffmann-La Roche Inc. (&#8220;Roche&#8221;), a pharmaceutical company, where he was responsible for leading operations in both the United States and Canada. During his tenure at Roche, Mr. Abercrombie also served as a member of the Roche Pharmaceutical Executive Committee, which was responsible for developing and implementing global strategy for the Pharmaceuticals Division. In 1993, Mr. Abercrombie joined Glaxo Wellcome Inc. (&#8220;Glaxo&#8221;) as Vice President and General Manager of the Glaxo Pharmaceuticals Division, and was later promoted to Senior Vice President, U.S. Commercial Operations. Prior to joining Glaxo, he spent over ten years at Merck &amp; Co., Inc., where he gained experience in sales and marketing, executive sales management and business development. Mr. Abercrombie began his career as a pharmacist after receiving a bachelor&#8217;s degree in pharmacy from the University of North Carolina at Chapel Hill, and later earned an MBA from Harvard University. He formerly served on the boards of directors of Fresh Tracks Therapeutics, Inc. (then Brickell Biotech, Inc.), Inspire Pharmaceuticals, Inc., Ziopharm Oncology, Inc., Tranzyme Pharma Inc. (now Ocera Therapeutics, Inc.), Aptus Health, Inc., and DemeRX IB, Inc. Additionally, he is an Adjunct Professor at Duke University&#8217;s Fuqua School of Business, the President of the Board of the North Carolina GlaxoSmithKline Foundation, an inaugural member of the Duke University Psychiatry and Behavioral Sciences Advisory Board, and the Chief Executive Officer of Abercrombie Advisors LLC, a pharmaceutical consulting firm. Mr. Abercrombie&#8217;s executive experience in the pharmaceutical industry and management positions with major pharmaceutical companies provide an excellent background for service on the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Theresa M. Heggie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in December 2018. Ms. Heggie most recently served as Chief Operating Officer of ProQR Therapeutics N.V. (&#8220;ProQR&#8221;), a publicly-traded biotechnology company developing RNA therapies using its proprietary Axiomer RNA-editing platform technology for severe, rare and common diseases, from February 2022 to October 2022, after joining ProQR as its Chief Commercial Officer in October 2021. She previously served as Chief Executive Officer of Freeline Therapeutics Holdings plc (&#8220;Freeline&#8221;), a publicly-traded gene therapy company, from June 2020 to August 2021 and, prior to that, as Senior Vice President, Head of Europe, Middle East, Africa &amp; Canada for Alnylam Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company, from May 2017 to May 2020. From June 2013 to March 2016, Ms. Heggie served as Chief Strategy and Marketing Officer for Bupa, an international healthcare group. Prior to June 2013, Ms. Heggie served in senior commercial and operating roles at Shire plc (&#8220;Shire&#8221;), a global specialty biopharmaceutical company, including Senior Vice President, Global Commercial Operations for the rare disease business. Prior to that, Ms. Heggie had responsibility over Europe, Middle East, and Africa rare disease </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and served as Chief Executive Officer of Jerini AG, a pharmaceutical company, following Shire&#8217;s acquisition of the company, and its lead asset, Firazyr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the treatment of hereditary angioedema. Prior to joining Shire, Ms. Heggie spent more than 20 years in a broad range of increasingly senior commercial positions at Janssen Pharmaceuticals and Baxter Healthcare. Ms. Heggie currently serves as a consultant on the Scientific Advisory Board for the Invivo Ventures III fund at Invivo Partners, a management company for early-stage investments in the healthcare sector. Since May 2023, she has also served as a member of the supervisory board of ProQR. Ms. Heggie previously served as a non-executive director of Swedish Orphan Biovitrum AB, an international specialty biopharmaceutical company dedicated to the treatment of rare diseases, from May 2016 to April 2017, as a member of the board of directors of Freeline from June 2020 to August 2021, and as a member of the supervisory board of ProQR from July 2019 to October 2021. Ms. Heggie holds a B.S. degree from Cornell University. Ms. Heggie&#8217;s extensive commercial experience in the industry, especially her rare disease commercial experience, provide valuable knowledge and insight to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in September 2021. Since September 2024, she has served as Senior Vice President of Oncology Regulatory Science, Strategy &amp; Excellence at AstraZeneca, a leading publicly-traded multinational pharmaceutical and biotechnology company. She previously served as Chief Medical Officer and Global Head, Oncology Center of Excellence at Parexel International Corporation (&#8220;Parexel&#8221;), a global clinical research organization, from September 2022 to September 2024, and as Vice President, Regulatory Consulting at Parexel from February 2019 to September 2022. Prior to joining Parexel, Dr. McKee served in several leadership roles of increasing responsibility at the FDA from 2008 to February 2019. While at the FDA, Dr. McKee served as a primary reviewer of new drug applications (&#8220;NDAs&#8221;) and biologics license applications (&#8220;BLAs&#8221;) across multiple divisions and served as both the acting deputy director and supervisory associate director of the Office of Hematology and Oncology products, where she managed four separate divisions performing NDA and BLA reviews. From January 2018 to February 2019, Dr. McKee was the deputy center director for the FDA&#8217;s Oncology Center of Excellence, which helps expedite development of innovative medical products of oncologic and hematologic malignancies and supports an integrated approach to their clinical evaluation. She holds an M.D. from Tulane University School of Medicine and a B.A. from Middlebury College. Dr. McKee&#8217;s extensive regulatory experience provides valuable knowledge and insight to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jon P. Stonehouse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in January 2007 as Chief Executive Officer and Director. He was also named President in July 2007. Additionally, Mr. Stonehouse has served as Interim Chief Financial Officer since April 2025. Prior to joining the Company, he served as Senior Vice President of Corporate Development for Merck KgaA, a pharmaceutical company, since July 2002. His responsibilities included corporate mergers and acquisitions, global licensing and business development, corporate strategy and alliance management. Prior to joining Merck KgaA, Mr. Stonehouse held a variety of roles at Astra Merck/AstraZeneca. Mr. Stonehouse began his career in the pharmaceutical industry as a sales representative and held increasing sales leadership positions at Merck &amp; Co., Inc. Mr. Stonehouse previously served on the board of directors of Bellicum Pharmaceuticals, Inc., a publicly-traded clinical stage biopharmaceutical company, from December 2014 to February 2024, on the advisory board of Precision Biosciences, Inc., a private biotechnology company, from 2008 to 2018, and on the advisory board for Genscript, a private bioservices company. He earned his B.S. in Microbiology at the University of Minnesota. As Chief Executive Officer and President of BioCryst, Mr. Stonehouse brings to the Board an intimate knowledge of our business, and his executive experience in a variety of capacities at major pharmaceutical companies provides industry-specific operational experience that is beneficial to the Board.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors with Terms Expiring in 2027</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was initially appointed to the Board in January 2012 and was elected as Chair of the Board in March 2023. Dr. Hutson brings over 30 years of experience as a seasoned professional and leader within the pharmaceutical industry. She retired from Pfizer in 2006 after spending 25 years in several research and leadership positions, most recently serving as Senior Vice President of Global Research &amp; Development (R&amp;D) as well as Director of Pfizer&#8217;s pharmaceutical R&amp;D site, Groton/New London Laboratories. Dr. Hutson received a B.A. degree from Illinois Wesleyan University and a Ph.D. in physiology from Vanderbilt University. Dr. Hutson currently serves on the board of directors for Clearside Biomedical, Inc., a publicly-traded biopharmaceutical company, and she serves as a member of the Scientific Advisory Board for Hatteras Venture Partners. She previously served on the board of directors of Endo International plc, a publicly-traded pharmaceutical company, Inspire Pharmaceuticals, Inc., Cubist Pharmaceuticals, Inc. and PhaseBio Pharmaceuticals, Inc. Dr. Hutson&#8217;s extensive experience in research and development in the pharmaceutical industry provides valuable insight to the Board. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vincent J. Milano</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in July 2021. Since November 2023, Mr. Milano has served as an advisor at Courier Health, Inc., a leading life sciences software company. He previously served as President and Chief Executive Officer of Idera Pharmaceuticals, Inc. (&#8220;Idera&#8221;) (now Aceragen, Inc.), a position he held from December 2014 until his resignation in September 2022 following Idera&#8217;s acquisition of Aceragen. Subsequent to Mr. Milano&#8217;s departure, Aceragen&#8217;s stockholders voted in August 2023 to approve a judicial insolvency procedure under Delaware law pursuant to which Aceragen&#8217;s assets were liquidated for the general benefit of all of its creditors. Prior to joining Idera, Mr. Milano </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">served in roles of increasing responsibility, including as Chairman, President and Chief Executive Officer, at ViroPharma Incorporated, which successfully developed and launched Cinryze for the treatment of hereditary angioedema (&#8220;HAE&#8221;) in the United States and Europe, prior to its acquisition by Shire Pharmaceuticals in January 2014. Prior to joining ViroPharma, Mr. Milano served as a senior manager at KPMG LLP, an independent registered public accounting firm. He currently serves as a member of the board of directors of Aclaris Therapeutics, a publicly-traded biopharmaceutical company, and he is the chairman of the board of Life Science Cares Philadelphia. He previously served on the boards of directors of Aceragen, Spark Therapeutics, Inc., VenatoRx Pharmaceuticals, Inc., and Vanda Pharmaceuticals Inc. Mr. Milano received his B.S. degree in accounting from Rider College. His rare disease and HAE experience, together with his extensive experience in the pharmaceutical industry, including both as an executive and director, provide valuable knowledge and experience to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A.Machelle Sanders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in February 2022. She served as the North Carolina Secretary of Commerce from February 2021 to January 2025. Prior to being appointed as North Carolina&#8217;s Secretary of Commerce, Ms. Sanders served as Secretary of the North Carolina Department of Administration from January 2017 to February 2021. Ms. Sanders has over 30 years of pharmaceutical and biotechnology experience with increasing levels of quality assurance and manufacturing operations responsibilities with Biogen, Inc. (&#8220;Biogen&#8221;), Purdue Pharmaceuticals, and AkzoNobel N.V. Most recently, she led product operations for Biogen&#8217;s multiple sclerosis franchise as its Vice President of Multiple Sclerosis Franchise Product Operations, and prior to that, she was Vice President of Manufacturing and General Manager for Biogen&#8217;s largest global manufacturing operation. Since May 2024, Ms. Sanders has served on the board of directors at Fortrea Holdings Inc., a publicly-traded leading global contract research organization. She previously served as a member of the boards of directors of Novan, Inc., until April 2024, and Radius Health, Inc., until her resignation in August 2022 following its acquisition by a leading healthcare fund. She received a B.S. in biochemistry from North Carolina State University and a master&#8217;s degree in health administration from Pfeiffer University. Ms. Sanders&#8217; extensive pharmaceutical and biotechnology experience provide valuable insight and expertise to the Board.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS A VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EACH OF THE TWO NOMINEES FOR DIRECTOR WITH TERMS EXPIRING IN </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2028</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NAMED ABOVE.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 2025</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board has appointed Ernst &amp; Young LLP as our independent registered public accountants for the fiscal year ending December 31, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Services provided to the Company by Ernst &amp; Young LLP in fiscal year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is asking its stockholders to ratify the selection of Ernst &amp; Young LLP as its independent registered public accountants for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although ratification is not required by the Company&#8217;s By-Laws or otherwise, the Board is submitting the selection of Ernst &amp; Young LLP to its stockholders for ratification as a matter of good corporate practice.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A representative of Ernst &amp; Young LLP will be present at the Meeting and will have an opportunity to make a statement and/or to respond to appropriate questions from our stockholders. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees Paid to Independent Registered Public Accountants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the audit of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consolidated financial statements, the Company entered into an engagement agreement with Ernst &amp; Young LLP, which set forth the terms by which Ernst &amp; Young LLP agreed to perform audit services for the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is information relating to the aggregate fees paid to Ernst &amp; Young LLP for professional services rendered for the fiscal years ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit fees</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,835,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,665,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-related fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Fees </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit fees represent the aggregate fees billed for professional services rendered by our independent registered public accounting firm for the audit of our annual financial statements and internal control over financial reporting, review of financial statements included in our quarterly reports on Form 10-Q, and services that are normally provided in connection with statutory and r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">egulatory filings or engagements, including the issuance of consents in connection with registration statement filings with the SEC. For 2024 and 2023, fees associated with registration statement filings were approximately $39,500 and $29,000, respectively. Fees reported in the 2024 proxy statement as associated with registration statement filings for 2023 actually related to filings made in both 2024 and 2023, and the amounts shown above have been revised to reflect the allocation of those fees in 2024 and 2023.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Fees</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax fees represent the aggregate fees billed for tax advisory services. </span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All Other Fees</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other fees are related to licensing fees paid to Ernst &amp; Young LLP for access to its proprietary accounting research database.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee Pre-Approval</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the policy of the Audit Committee, as set forth in the Audit Committee Charter, to pre-approve, consistent with the requirements of the federal securities laws, all auditing services and non-audit services provided to the Company by its independent registered public accounting firm, other than such non-audit services as are prohibited by law to be performed by the independent registered public accounting firm and other than as provided in the de minimis exception set forth in applicable provisions of the federal securities laws. The Audit Committee may delegate to one or more of its designated members the authority to grant the required pre-approvals, provided that the decisions of any member(s) to whom such authority is delegated to pre-approve an activity shall be presented to the full Audit Committee at each of its scheduled meetings. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> RATIFICATION OF THE APPOINTMENT OF ERNST &amp; YOUNG LLP AS THE COMPANY&#8217;S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Company&#8217;s stockholders do not ratify the appointment of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accountants for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the appointment will be reconsidered by the Audit Committee and the Board. Even if the selection is ratified, the Audit Committee in its discretion may select a different registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">NON-BINDING, ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank Act&#8221;) enables our stockholders to vote to approve, on an advisory or non-binding basis, a resolution on the compensation of our Named Executive Officers, as defined herein, as disclosed in this Proxy Statement in accordance with rules promulgated by the SEC. We currently hold a non-binding, advisory vote on the compensation of our Named Executive Officers every year, and we expect that the next such vote will occur at our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> annual meeting of stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company asks that you indicate your support for the compensation of our Named Executive Officers, as well as our executive compensation philosophy, policies and practices as described in &#8220;Compensation Discussion and Analysis&#8221; and the accompanying tables and related disclosures in this Proxy Statement. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our Named Executive Officers and the compensation philosophy, policies and practices described in this Proxy Statement. Your vote is advisory and so will not be binding on the Compensation Committee or the Board of Directors. However, the Compensation Committee and the Board of Directors will review the voting results and take them into consideration when structuring future executive compensation arrangements. The affirmative vote of the holders of a majority of the shares of Common Stock represented in person or by proxy at the Meeting and voting on the proposal will be required for approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designed our executive compensation program to attract, motivate, reward, and retain the senior management talent required to achieve our corporate objectives and to increase long-term stockholder value. We believe that the experience, abilities and commitment of our Named Executive Officers are unique in the biotechnology industry, and we recognize the need to fairly compensate and retain a senior management team that has produced excellent operating results over the past several years. Accordingly, the Compensation Committee makes compensation decisions for our executive officers after consideration of the following primary objectives: </span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to have a substantial portion of each officer&#8217;s compensation contingent upon the Company&#8217;s performance as well as upon his or her own level of performance and contribution toward the Company&#8217;s performance and long-term strategic goals;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to reward executives for actions that create short-term and long-term sustainable stockholder value, with a strong focus on Company results;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to align the interests of our executives with the Company&#8217;s corporate strategies, business objectives, and the long-term interests of our stockholders; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to attract, incentivize, and retain our executive talent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our executive compensation program is based on market best practices to ensure that it is appropriately risk-based and competitive with similar companies in our industry. We do not believe that our executive compensation program encourages our management to take excessive risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors encourages you to carefully review the information regarding our executive compensation program contained in this Proxy Statement, including the Compensation Discussion and Analysis beginning on page</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_37">27</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as the Summary Compensation Table and other related compensation tables and narrative discussion, appearing on page</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_46">36</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i830655254dc8407a904e56626902ed14_7756">48</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich provide detailed information on the compensation of our Named Executive Officers.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> THE FOLLOWING RESOLUTION:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RESOLVED, that the stockholders approve, on a non-binding, advisory basis, the compensation of the Company&#8217;s Named Executive Officers, as disclosed in this Proxy Statement, including the Compensation Discussion and Analysis, the Summary Compensation Table and the related compensation tables, notes and narrative discussion.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">APPROVAL OF AN AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLAN </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are asking our stockholders to approve an amendment and restatement of the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (as amended and restated, the &#8220;Stock Incentive Plan&#8221;). As amended and restated, the Stock Incentive Plan increases the number of shares available for issuance under the Stock Incentive Plan by 11,000,000 (the &#8220;Share Increase&#8221;). We believe that the Share Increase is necessary for the Stock Incentive Plan to support the Company&#8217;s goals in 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;14, 2025, the total number of shares reserved or available under the Stock Incentive Plan, without giving effect to the Share Increase, is 49,098,122. This amount consists of 47,007,187 shares reserved for awards already granted and 2,090,935 shares currently available for future issuance under the Stock Incentive Plan. The shares currently available for future issuance under the Stock Incentive Plan represent less than one-half of our projected needs for the next year, which provides limited availability and flexibility for our equity usage as part of our broad-based equity program.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The proposed increase would bring the total number of shares available under the Stock Incentive P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lan to 13,090,935 a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we currently expect to be sufficient under the Stock Incentive Plan through th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e 2026 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">annual meeting of stockholders (subject to a number of factors, including changes in stock price and the pace of the Company&#8217;s growth). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2025, our Board approved the Share Increase, subject to stockholder approval at this Meeting. The Stock Incentive Plan, as amended by the Share Increase, is attached as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Annex A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Proxy Statement. In addition to the Share Increase, the Stock Incentive Plan, as amended and restated o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n April 21, 2025, includes certain immaterial, administrative revisions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Share Increase is approved by our stockholders, we intend to file a Registration Statement on Form S-8 with the SEC following the Meeting during 2025.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Increase</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Usage and Needs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further explained below, our equity awards are intended to attract, incentivize, retain, and motivate participants in the Stock Incentive Plan and align the interests of our directors, employees, and consultants with those of our stockholders. The long period of retention of awards outlined below by our employees indicates the strong link between these incentives and the long-term success of stockholders and employees alike. Our Board and management believe that equity awards are necessary to remain competitive in our industry and are essential to recruiting and retaining the best talent. In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we expect to continue our successful commercialization of ORLADEYO&#174; (berotralstat), to advance our pipeline, and to become profitable. To achieve these goals, the Company must retain and attract top talent, and equity is critical to support continued revenue growth. Accordingly, we believe the increase in shares reserved for issuance under the Stock Incentive Plan pursuant to the Share Increase is necessary to allow the Company to provide customary levels of equity incentives to employees, including, without limitation, the long-term equity incentive awards that the Compensation Committee has historically granted to all employees on an annual basis. </span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.15pt">The Company has created a culture of ownership that aligns employees with stockholders by offering every employee equity as an incentive to join the Company and annually at the end of each year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Strategic use of a broad-based equity program is core to our compensation philosophy as the Compensation Committee has historically granted long-term equity incentive awards to all employees on an annual basis to, among other things, align our employees&#8217; interests with those of our stockholders by creating a culture of ownership. Pursuant to this philosophy, the Compensation Committee granted long-term equity incentive awards under the Stock Incentive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plan to 557 em</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ployees in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe that employees with a stake in the future success of our business are highly motivated to achieve long-term growth and are well-aligned with the interests of our other stockholders to increase stockholder value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the highly competitive biotechnology market, we have experienced lower than average turnover compared to the regional industry rate, and we believe this is in part due to the long-term retentive nature of equity awards and this ownership culture.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are in a highly competitive marketplace for biotechnology talent where equity compensation is used more broadly than other industries, and without the ability to offer competitive equity grants to incentivize and retain talent, we may lose key employees, which could impair our ability to execute on our business strategy and harm stockholder value. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">order to incentivize and retain our top talent, it is essential that we are able to grant equity awards that reflect the current value of the Company&#8217;s Common Stock. For the 38.0 million stock options outstanding and the 23.9 million stock options exercisable under the Stock Incentive Plan as of April&#160;14, 2025, the weighted-average exercise price is $7.93 and $7.96 per share, respectively. Both of these exercise prices are higher than our closing stock price of $7.04 on April&#160;14, 2025. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the 14.0 million stock options that have not yet vested, the weighted-average exercise price is $7.87 per share. Due to the high percentage of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">underwater stock options, which also contribute to the Company&#8217;s overhang, we believe it is critical that we are able to offer competitive equity awards at current market value to continue to incentivize a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd retain key talent.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Our ability to attract and retain top talent was critical to driving the strong launch of ORLADEYO and is vital to the continued success of the ORLADEYO global expansion.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ORLADEYO generated approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$438 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in net reve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nue. In 2025, the Company currently expects ORLADEYO net revenue to be between $535 million and $550 million, with global peak sales of $1 billion. To achieve these goals, the Company must retain and attract top talent to support the continued commercialization of ORLADEYO, and equity is critical to support this continued growth. </span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Outstanding equity awards have a positive impact on long-term employee ow</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">nership and alignment with stockholders.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s employee stock options have a 10-year term with vesting over four years, and the current average holding period for exercised stock options is approximate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly six years, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ith some of our officers and directors, inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">luding our CEO, holding many stock options for almost the full 10-year term. Although these longer holding periods increase overhang (which is considered by the Compensation Committee when making decisions with respect to the Stock Incentive Plan and is discussed further under &#8220;Potential Dilution and Burn Rate&#8221; below), this long-term employee ownership illustrates the positive impact of equity as a retention tool, which aligns wit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h stockholders. We believe retention of these options by employees provides the alignment with stockholders that our equity compensation philosophy seeks to achieve.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Equity is essential to talent acquisition and retention.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Board believes that the increase in the share reserve is necessary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to assure that a sufficient reserve of Common Stock is available for issuance to make competitive grants through 2026. For the reasons described above, we rely significantly on equity incentives in order to attract, incentivize, a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd retain employees, consultants, and non-employee directors, and we believe that such equity incentives are necessary for us to remain competitive in the marketplace for executive talent and for other key individuals. This high level of participation in our broad-based equity compensation program aligns the interests of all of our employees and directors with those of stockholders. However, such a participation rate can drive up overhang at the Company when compared to peers given that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vast majority </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of companies in our compensation peer group do not grant equity awards to every employee.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without the approval of the Share Increase, we will not be able to continue providing competitive equity incentives to existing employees or to attract new employees in our competitive market. This could ultimately result in the loss of critical talent and inhibit our ability to meet our future objectives. If approved by stockholders, we intend to use the additional shares under the Share Increase to recruit, incentivize, and retain employees.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Dilution and Burn Rate</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has demonstrated its focus on limiting potential dilution to current stockholders. Over the past five years, the Company has raised approxima</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tely $1.1 billion in cash through mechanisms such as royalty and debt financings as alternatives to equity financings that would have been</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> highly dilutive to stockholders. There were many factors that made these alternative financing approaches attractive, including the ability to bring this cash into the Company without additional equity dilution. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, when considering the number of shares to add to the Stock Incentive Plan, the Compensation Committee reviewed, among other things, the potential dilution to current stockholders as measured by overhang and burn rate, as well as projected future share usage in light of our growing employee population. We recognize the dilutive impact of our equity compensation programs on our stockholders and continuously aim to balance this concern with the competition for talent, competitive compensation practices, the need to attract and retain talent, and the long-term alignment of our employees with stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had a to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tal of 209,207,928 shares of Common Stock outstanding. The potential share dilution from the 11,000,000 additional shares to be reserved for issua</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nce under the Stock Incentive Plan, for which stockholder approval is being requested, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is 5.3% of th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e Company&#8217;s outstanding shares of Common Stock as of such date. Compared to the po</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tential share dilution associated with the most recent share requests of our peer companies, this percentage approximates the median of such requests, which is approximately 5.1% of the outstanding shares of common stock of the applicable peer companie</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. </span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overhang</span></div><div style="margin-top:6pt;padding-left:40pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Incentive Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a fully diluted basis, the approximately 49,098,122 shares reserved or currently available for issuance under the Stock Incentive Plan (without taking into account the Share Increase) represent an overhang of approximately 19% based on the number of outstanding shares of Common Stock and shares underlying outstanding awards under the Stock </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive Plan as of April&#160;14, 2025, and 68% of the shares underlying outstanding stock option awards under the Stock Incentive Plan are underwater (with an exercise price in excess of the closing price of our Common Stock on April&#160;14, 2025). If the underwater stock options were excluded, it would reduce our overhang as of April&#160;14, 2025 to 9%. The outstanding stock options under the Stock Incentive Plan that are underwater have a weighted-average exercise price of $9.55 per share and individual option exercise prices ranging up to $17.25 per share, as compared to the $7.04 per share closing price of our Common Stock on April&#160;14, 2025. If the Share Increase is approved, the additional 11,000,000 shares would increase the overhang of the Stock Incentive Plan to 22%. We calculate these overhang numbers as the total of (a) shares available for future grants under the Stock Incentive Plan plus (b) shares underlying any outst</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anding awards under the Stock Incentive Plan divided by (c) the total number of shares outstanding plus shares available for issuance under the Stock Incentive Plan plus shares underlying any outstanding awards under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:40pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentive Plans Generally</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section, including the table below, provides additional information about the aggregate outstanding equity awards under both of our equity incentive plans (i.e., the Stock Incentive Plan and our Inducement Equity Incentive Plan). </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of April 14, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares of Common Stock subject to outstanding stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,953,547</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average exercise price per share of outstanding stock options</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining term of outstanding stock options (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares of Common Stock subject to outstanding full value awards</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,926,802</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares of Common Stock available for grant under Company equity plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,890,317</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our dilution profile is elevated compared to our compensation peer group, certain factors have influenced our current overhang level. First, the Company has historically granted long-term equity incentive awards to all of its employees. We believe this high level of participation in our broad-based equity compensation program aligns the interests of employees and directors with those of stockholders. This strong employee ownership philosophy drives a higher level of overhang when compared with our peers, but we believe it is essential to the future success of the Company and our stockholders. Second, the Company&#8217;s employee stock options have a 10-year term with vesting occurring over a four-year period, and the current average holding period for exercised stock options is approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six years,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with some of our officers and directors, including our CEO, holding many stock options for almost the full 10-year term. The long vesting period of four years and the strong retention of in-the-money stock options can drive our overhang upwards despite positive outcomes for both employees and stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, our current executive officers held approximately 10,394,675 stock options as of April&#160;14, 2025. Of these outstanding stock options, approximately 2,793,641 stock options, or 27%, are exercisable and in-the-money and have an average age of approximately five years. In addition, if all exercisable, in-the-money stock options were exercised, our total overhang percentage as of April&#160;14, 2025 would be reduced by an approximate amount of at least four percentage points</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. However, because our executive officers and other employees continue to hold these options rather than exercising them and selling the underlying shares, which would reduce the overhang, they remain aligned with the long-term interests of our stockholders even though these stock options contribute to overhang. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the outstanding stock options th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at are underwater, or approximately 67% of all outstanding stock options, have a weighted-average exercise price of $9.78 per share and individual option exercise prices ranging up to $17.25 per share, as compared to the $7.04 per share closing price of our Common Stock on April&#160;14, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these factors in mind, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company is committed to continually incentivizing and retaining all employees through equity compensation while managing overhang and burn rate in order to drive long-term success. </span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Burn Rate</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our three-year average unadjusted burn rate is approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 6.2%. As</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there were approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,090,935</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares available for future grants under the Stock Incentive Plan. Depending on assumptions and various factors, such as stock price, employee population growth, and market conditions, should the Share Increase be approved, it is expected that there will be sufficient shares available under the Stock Incentive Plan to satisfy our equity compensation needs through o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ur 2026 ann</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ual meeting of stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Features that Protect Stockholder Interests</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stock Incentive Plan provides the following provisions that are favorable to our stockholders and protect stockholder interests:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Independent Plan Administration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee, comprised solely of non-employee, independent directors, administers the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No &#8220;Evergreen&#8221; Provision. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stock Incentive Plan does not include an &#8220;evergreen&#8221; feature pursuant to which the reserve of shares authorized for issuance would automatically be replenished periodically.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Limitation on Awards to Individuals.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan limits the number of shares of Common Stock subject to awards that an individual may receive during each calendar year to 1,500,000 shares.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Cap on Director Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan limits the value of the initial and annual awards and cash compensation to be granted to directors to $1,000,000 and $750,000, respectively.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Minimum One-Year Vesting Requirement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All awards granted under the Stock Incentive Plan are subject to a minimum one-year vesting period, provided that this limitation shall not apply to up to five percent of the total number of shares available for issuance under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Discounted Options or Stock Appreciation Rights.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Options and stock appreciation rights may not be granted with exercise prices below fair market value.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Dividends on Options and Stock Appreciation Rights Until Shares Are Issued and No Dividend Payments on Other Awards While Unvested.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan prohibits the payment of dividends on unvested awards.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Clawback.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Awards issued under the Stock Incentive Plan are subject to any clawback policy of the Company as in effect from time-to-time, including the clawback policy described under &#8220;Compensation Discussion and Analysis&#8212;Clawback Policy.&#8221;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Liberal Share Recycling.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Shares subject to an award will not be available for reuse if such shares are delivered or withheld to satisfy any tax withholding obligation, or not issued upon the settlement of an award or exercise of a stock option.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Gross Ups.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan does not provide for any tax gross-ups.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Repricings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&#8217;s capitalization as permitted under the Stock Incentive Plan) without the approval of the stockholders of the Company.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Double-Trigger on Change of Control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan includes a double-trigger provision for the vesting of any options, restricted stock, or restricted stock units (&#8220;RSUs&#8221;) upon a change of control; however, if awards are not assumed by the acquirer or successor in connection with such change of control, outstanding awards under the Stock Incentive Plan will be fully vested.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Transferability.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Awards generally may not be transferred, except by will or the laws of descent and distribution, unless approved by the Compensation Committee.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of the Stock Incentive Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal provisions of the Stock Incentive Plan, including (unless otherwise noted) the terms of the Share Increase, are summarized below. This summary is not complete and is qualified in its entirety by the terms of the Stock Incentive Plan attached as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Annex A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Proxy Statement.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Programs</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stock Incentive Plan consists of three separate equity incentive programs:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Discretionary Option Grant Program;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Stock Issuance Program; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Director Grant Program for non-employee Board members.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal features of each program are described below. The Compensation Committee or, in the absence of the Compensation Committee, another properly constituted committee of the Board, or the Board itself, has the authority to administer the equity incentive programs under the Stock Incentive Plan, and also has the authority to make grants under these programs to all eligible individuals. The Compensation Committee may by resolution authorize one or more officers of the Company to perform any or all things that the Compensation Committee is authorized and empowered to do or perform under the Stock Incentive Plan, and for all purposes under the Stock Incentive Plan, such officer or officers shall be treated as the Compensation Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;plan administrator,&#8221; as used in this summary, means, as applicable, the Compensation Committee, another properly constituted committee of the Board, the Board, or one or more officers of the Company, to the extent that any of them is acting within the scope of its administrative jurisdiction under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Reserve</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an aggregat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e of 70,090,000 shares of Common Stock have been reserved for issuance over the term of the Stock Incentive Plan, without giving effect to the Share Increase proposed under the terms of this proposal. The total number of shares reserved or available under the Stock Incentive Plan as of April&#160;14, 2025, without giving effect to the Share Increase proposed under the terms of this proposal, is 49,098,122. This amount consists of 47,007,187 shares reserved for awards already granted and 2,090,935 shares of C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ommon Stock currently available for future issuance under the Stock Incentive Plan. Approval of the Share Increase will increase the number of shares available for issuance under the Stock Incentive Plan b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y 11,000,000 s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of Common Stock issuable under the Stock Incentive Plan may be drawn from shares of our authorized but unissued Common Stock or from shares of Common Stock reacquired by us, including shares repurchased on the open market.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No individual may receive options or other awards under the Stock Incentive Plan exceedin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g 1,500,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares in the aggregate in any calendar year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event any change is made to the outstanding shares of Common Stock by reason of any recapitalization, stock dividend, stock split, combination of shares, exchange of shares or other change in corporate structure effected without our receipt of consideration, appropriate adjustments will be made to the securities issuable (in the aggregate and per participant) under the Stock Incentive Plan, the securities in effect under each outstanding option and stock issuance, and where applicable, the option exercise price per share.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eligibility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Officers and employees, non-employee Board members and independent consultants in our service or the service of our parents or subsidiaries, whether now existing or subsequently established, are eligible to participate in the Discretionary Option Grant Program and the Stock Issuance Program. Non-employee members of the Board are also eligible to participate in the Director Grant Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">four executive officers, approximately 576 other employees, and nine non</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-employee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Board members were eligible to participate in the Discretionary Option Grant Program and the Stock Issuance Program. Our nine non-employee Board members were also eligible to participate in the Director Grant Program. </span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;fair market value&#8221; per share of Common Stock on any relevant date under the Stock Incentive Plan will be deemed to be equal to the closing selling price per share on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that date on the Nasdaq Global Select Market. On April&#160;14, 2025, the closing selling price of our Common Stock per share was $7.04.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discretionary Option Grant Program</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Terms of Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator has complete discretion under the Discretionary Option Grant Program to determine which eligible individuals are to receive option grants, the time or times when those grants are to be made, the number of shares subject to each grant, the status of any granted option as either an incentive stock option or a non-statutory option under the federal tax laws, the vesting schedule, if any, for the option grant and the maximum term for which any granted option is to remain outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each granted option will have an exercise price per share no less than the fair market value of the option shares on the grant date. No granted option will have a term in excess of 10 years, and the option will generally become exercisable in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one or more installments over a specified period of service measured from the grant date. However, one or more options may be structured so that they will be immediately exercisable for any or all of the option shares; the shares acquired under those options will be unvested and subject to repurchase by us, at the exercise price paid per share, if the optionee ceases service with us prior to vesting in those shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon cessation of service, the optionee will have a limited period of time in which to exercise any outstanding options to the extent exercisable for vested shares. The Plan Administrator will have complete discretion to extend the period following the optionee&#8217;s cessation of service during which his or her outstanding options may be exercised and/or to accelerate the exercisability or vesting of such options in whole or in part. Such discretion may be exercised at any time while the options remain outstanding, whether before or after the optionee&#8217;s actual cessation of service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the optionee&#8217;s cessation of service as a result of death after at least five years of service, all of the optionee&#8217;s outstanding options will accelerate and become exercisable in full.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In no event may options (or stock appreciation rights) granted under the Stock Incentive Plan be directly or indirectly repriced without the approval of our stockholders.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Appreciation Rights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator is authorized to issue tandem stock appreciation rights in connection with option grants made under the Discretionary Option Grant Program. The grant price of a stock appreciation right may not be less than the fair market value of our Common Stock on the date of the grant.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tandem stock appreciation rights under the Discretionary Option Grant Program provide the holder with the right to surrender an option for an appreciation distribution from the Company. The amount of this distribution will be equal to the excess of:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">the fair market value of the vested shares of Common Stock subject to the surrendered option, over</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">the aggregate exercise price payable for such shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An appreciation distribution may, at the discretion of the Plan Administrator, be made in cash or in shares of Common Stock, or a combination thereof.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Issuance Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares may be issued under the Stock Issuance Program through direct and immediate issuance or with vesting upon the completion of a designated service period, the attainment of pre-established performance goals, or a specific period of time after issuance. To the extent a participant ceases service without completing the designated service period or performance goals, we have the right to repurchase the shares at the price paid, if any. However, the Plan Administrator has the discretionary authority at any time to accelerate the vesting of any and all unvested shares outstanding under the program. Share recipients will have full stockholder rights with respect to their shares, including the right to vote the shares and to receive regular cash dividends. Share recipients do not have rights with respect to unvested shares; however, the Plan Administrator may grant dividend equivalents entitling the holder of such unvested shares to regular cash dividends payable on such shares. Dividends and dividend equivalents are subject to the same vesting schedule and payable at the same time as the shares to which such dividends and dividend equivalents relate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Common Stock may also be issued under the program pursuant to RSUs that entitle the recipient to receive shares of Common Stock (or cash in lieu thereof) in the future following the satisfaction of vesting conditions imposed by the Plan Administrator. Outstanding RSUs under the program will automatically terminate, and no shares of Common Stock will be issued in satisfaction of those awards, if the vesting conditions established for the awards are not satisfied. RSU holders do not have stockholder rights with respect to the awards; however, the Plan Administrator may grant dividend equivalents entitling the holder of RSUs to regular cash dividends payable on the underlying shares. Dividend equivalents are subject to the same vesting schedule and payable at the same time as the shares underlying the RSU to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator has complete discretion under the program to determine which eligible individuals are to receive stock issuances or RSUs, the time or times when those issuances or awards are to be made, the number of shares subject to each issuance or award, the extent to which an RSU will have an accompanying dividend equivalent, and the vesting schedule to be in effect for the stock issuance or RSU.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director Grant Program</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Terms of Equity Grants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Director Grant Program, eligible non-employee Board members, including Board members who are our former employees, are eligible to receive equity grants in connection with their Board service. Each non-employee Board member may receive grants of stock options, RSUs, shares of Common Stock, other awards issuable under the Stock Incentive Plan, or a combination thereof. In no event will the aggregate grant date fair value calculated in accordance with FASB ASC Topic 718 of all awards granted during any calendar year to any non-employee Board member (excluding any awards granted at the election of a non-employee Board member in lieu of all or any portion of retainers or fees otherwise payable to non-employee Board members in cash), to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gether with the amount of any cash fees or retainers paid to such non-employee Board members during such calendar year with respect to such individual&#8217;s service as a non-employee Board member, exceed $750,000 or, for a non-employee Board member who first joins the Board, $1,000,000. In each case, the specific dollar amount of the grant will be as set forth in a Director Compensation Policy approved by the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each stock option grant, if any, will have an exercise price per share equal to no less than the fair market value per share of Common Stock on the grant date, and no stock option will have a term in excess of 10 years.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Provisions</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acceleration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we are acquired by merger or asset sale or otherwise undergo a change in control, including a change effected through the successful completion of a tender offer for more than 50% of our outstanding voting stock or a change in the majority of the Board effected through one or more contested elections for Board membership, except as set forth in the terms of the grant, all grants under the Stock Incentive Plan made on or after April 3, 2017 are subject to &#8220;double trigger&#8221; vesting if the grants are assumed. In such case, accelerated vesting will apply only if the grantee&#8217;s service is terminated by us without &#8220;cause&#8221; or the grantee due to a &#8220;constructive termination&#8221; within 90 days preceding or two years following the change in control. If the grants are not assumed in connection with the change in control, they will fully vest upon the change in control.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payment of Withholding Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator may provide one or more participants in the Discretionary Option Grant Program and Stock Issuance Program with the right to have us withhold a portion of the shares otherwise issuable to such participants in satisfaction of applicable withholding taxes that attach upon the exercise of options or the vesting of stock issuances or RSUs. Alternatively, the Plan Administrator may allow participants to deliver previously acquired shares of Common Stock in payment of such withholding tax liability.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amendment and Termination</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may amend or modify the Stock Incentive Plan at any time, subject to any required stockholder approval pursuant to applicable laws and regulations (including applicable Nasdaq Global Select Market rules). Unless sooner terminated by the Board, the Stock Incentive Plan will terminate on the earliest of:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">10 years following the date the Stock Incentive Plan is approved by the Board, which will be April 21, 2035 (but any options, stock issuances or other awards outstanding on such date shall remain in effect in accordance with their terms);</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">the date on which all shares available for issuance under the Stock Incentive Plan have been issued as fully vested shares; or</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">the termination of all outstanding options and stock issuances in connection with certain changes in control or ownership of the Company.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Plan Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, all future grants, including the identification of grant recipients and the sizes and types of grants, will be determined by the Plan Administrator in its discretion, and no arrangements have been made at this time with respect to the shares reserved for issuance under the Stock Incentive Plan. Therefore, the amount of future awards under the Stock Incentive Plan is not yet determinable, and it is not possible to predict the benefits or amounts that will be received by, or allocated to, particular individuals or groups of employees or participants.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an aggre</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gate of 70,090,000 shares of Common Stock have been reserved for issuance over the term of the Stock Incentive Plan, without giving effect to the Share Increase proposed under the terms of this proposal. The </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">total number of shares reserved or available under the Stock Incentive Plan as of April&#160;14, 2025, without giving effect to the Share Increase proposed under the terms of this proposal is 49,098,122. This amount consists of 47,007,187 shares reserved for awards already granted and 2,090,935 shares of Common Stock available for future issuance under the Stock Incentive Plan. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the securities authorized for issuance under our equity comp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ensation plans is presented as of December&#160;31, 2024, which does not give effect to the proposed Share Increase of 11,000,000 s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares of Common Stock under the Stock Incentive Plan.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(a)<br/>Number of<br/>Securities to be<br/>Issued Upon<br/>Exercise of<br/>Outstanding<br/>Options, Warrants<br/>and Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b)<br/>Weighted-<br/>Average<br/>Exercise Price<br/>of<br/>Outstanding<br/>Options,<br/>Warrants<br/>and Rights($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(c)<br/>Number of<br/>Securities<br/>Remaining Available<br/>for Future Issuance<br/>Under Equity<br/>Compensation Plans<br/>(Excluding<br/>Securities<br/>Reflected in Column<br/>(a))</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation plans approved by security holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48,371,006</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,107,386</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation plans not approved by security holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,980,503</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,698,932</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54,351,509</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,806,318</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents stock option awards and RSUs granted under the Stock Incentive Plan. The number of shares that may be issued pursuant to the Employee Stock Purchase Plan during a given period and the purchase price of such shares cannot be determined in advance of such purchases.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of 1,065,017 shares available for future issuance under the Stock Incentive Plan and 5,042,369 shares available for future issuance under the Employee Stock Purchase Plan.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents stock option awards and RSUs granted under the Inducement Equity Incentive Plan. For a narrative description of the terms of the Inducement Equity Incentive Plan, see Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December&#160;31, 2024, which is included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February&#160;25, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents shares available for issuance under the Inducement Equity Incentive Plan. For a narrative description of the terms of the Inducement Equity Incentive Plan, see Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December&#160;31, 2024, which is included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February&#160;25, 2025.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Income Tax Consequences</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the U.S. federal income tax treatment applicable to us and the participants who receive awards under the Stock Incentive Plan based on the federal income tax laws in effect on the date of this Proxy Statement. This summary is not intended to be exhaustive and does not address all matters relevant to a particular participant based on the participant&#8217;s specific circumstances. The summary expressly does not discuss the income tax laws of any state, municipality, or non-U.S. taxing jurisdiction, or the gift, estate, excise (including the rules applicable to deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)), or other tax laws other than U.S. federal income tax law. Because individual circumstances may vary, we recommend that all participants consult their own tax advisor concerning the tax implications of awards granted to them under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Grants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted under the Stock Incentive Plan may be either incentive stock options that satisfy the requirements of Section 422 of the Code or non-statutory options, which are not intended to meet such requirements. The federal income tax treatment for the two types of options differs as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Stock Options.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No taxable income is recognized by the optionee at the time of the option grant, and no taxable income is generally recognized at the time the option is exercised. The optionee will, however, recognize taxable income in the year in which the purchased shares are sold or otherwise transferred. For federal tax purposes, dispositions are divided into two categories: (i) qualifying and (ii) disqualifying. A qualifying disposition occurs if the sale or other disposition is made after the optionee has held the shares for more than two years after the option grant date and more than one year after the exercise date. If either of these two holding periods is not satisfied, then a disqualifying disposition will result. If the optionee makes a qualifying disposition, the taxable income recognized by the optionee will be treated as a long-term capital gain and we will not be entitled to an income tax deduction. If the optionee makes a disqualifying disposition of the purchased shares, then for the taxable year in which such disposition occurs, the optionee will recognize ordinary income, and we will be entitled to an income tax deduction, in an amount generally equal to the excess of (i) the fair market value of such shares on the option exercise date over (ii) the exercise price paid for the shares.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Statutory Options.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No taxable income is recognized by an optionee upon the grant of a non-statutory option. The optionee will in general recognize ordinary income in the year in which the option is exercised, in an amount equal to the excess of the fair market value of the purchased shares on the exercise date over the exercise price paid for the shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction equal to the amount of ordinary income recognized by the optionee with respect to the exercised non-statutory option. Any such deduction will in general be allowed for the taxable year of the Company in which such ordinary income is recognized by the optionee.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized upon receipt of a stock appreciation right. The holder will recognize ordinary income in the year in which the stock appreciation right is exercised, in an amount equal to the appreciation distribution. Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction equal to the appreciation distribution in the taxable year in which the ordinary income is recognized by the optionee.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Issuances</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the issuance of unvested stock will not result in taxable income to the employee. Instead, upon vesting, the fair market value of such shares, less cash or other consideration paid (if any), will be included in the participant&#8217;s ordinary income as compensation. Any cash dividends or other distributions paid with respect to the stock prior to vesting will also be included in the holder&#8217;s ordinary income as compensation when paid. The participant may, however, elect under Section 83(b) of the Code, to include in his or her ordinary income at the time the stock is issued the fair market value of such shares less any amount paid. Any cash dividends paid thereafter will be treated as dividend income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant with respect to the stock issuance. The deduction will in general be allowed for the taxable year of the Company in which such ordinary income is recognized by the participant.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized by a participant upon grant of an RSU. The participant will recognize ordinary income, in the year in which the RSU vests and the underlying stock is issued to the participant, in an amount equal to the fair market value of the shares on the date of issuance. Any cash or other property paid with respect to such shares on the vesting date will also be included in the participant&#8217;s ordinary income as compensation at the time of payment. A participant may not make an 83(b) election with respect to an RSU. Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction to the extent the participant recognizes ordinary income with respect to an RSU. The deduction will in general be allowed for the taxable year of the Company in which such ordinary income is recognized by the participant.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deductibility of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 162(m) of the Code imposes an annual deduction limit of $1 million on compensation paid by the Company to &#8220;covered employees&#8221; in any taxable year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This rule may limit the deductibility of awards granted pursuant to the Stock Incentive Plan.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS DEEMS THE APPROVAL OF THE AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, TO BE IN THE BEST INTERESTS OF THE COMPANY AND ITS STOCKHOLDERS AND RECOMMENDS A VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> APPROVAL OF THE AMENDED AND RESTATED STOCK INCENTIVE PLAN.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Business Conduct</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a code of business conduct that applies to all our employees as well as to each member of the Board. The code of business conduct is available on our website at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.biocryst.com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the Corporate Governance section. The Company intends to post on its website any amendments to, or waivers from, its code of business conduct. To date, there have not been any waivers by us under the code of business conduct.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is governed by a Board of Directors, which currently consists of 10 directors as determined by resolution of the Board in accordance with the Company&#8217;s Certificate of Incorporation. The Board will be reduced to nine directors as of the Meeting. The Board has determined that nine of the 10 current members of the Board (Mr. Abercrombie, Mr. Aselage, Dr. Galson, Ms. Heggie, Dr. Hutson, Mr. Levin, Dr. McKee, Mr. Milano, and Ms. Sanders) are independent as defined by the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of our directors or our executive officers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has established the Audit, Compensation, and Corporate Governance and Nominating committees to assist in the oversight of the Company. The Board has adopted charters for each of these committees, which are posted on the Company&#8217;s website at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.biocryst.com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company also makes available on its website its code of business conduct. Printed copies of these charters or the code of business conduct may be obtained, without charge, by contacting the Corporate Secretary, BioCryst Pharmaceuticals, Inc., 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Hutson currently serves as Chair of the Board. The Chair of the Board presides over the Board meetings and any executive session of the non-management directors. An executive session is held at every regularly scheduled Board meeting. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s CEO is responsible for setting the Company&#8217;s strategic direction and for the day-to-day leadership and performance of the Company, while the Company&#8217;s independent Chair assists and provides guidance to the CEO. The Company believes that having Dr. Hutson serve as Chair is the most appropriate leadership structure for the Company at this time, based on the current circumstances and direction of the Company and the membership of the Board, including Dr. Hutson&#8217;s vast experience in the pharmaceutical industry. This leadership structure permits the CEO to focus his attention on managing our business and allows the Chair to function as an important liaison between management and the Board, enhancing the ability of the Board to provide oversight of the Company&#8217;s management and affairs. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Oversight</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not view risk in isolation, but considers risk as part of its regular consideration of business strategy and business decisions. BioCryst approaches risk management by integrating its strategic planning, operational decision making and risk oversight through its internal Enterprise Risk Navigation committee, and by communicating risks and opportunities to the Board. The Board oversees the Company&#8217;s risk management function, directly and through its committees. The Board commits substantial time and effort every year to discussing and agreeing upon the Company&#8217;s strategic plan, and it reconsiders key elements of the strategic plan as warranted in response to significant events and opportunities. As part of the review of the strategic plan, as well as in evaluating events and opportunities that occur during the year, the Board and management also consider the risks relating to the strategic plan.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Board has primary responsibility for oversight of the Company&#8217;s risk management, the Board&#8217;s standing committees support the Board by regularly addressing various risks in their respective areas of oversight. Specifically, the Audit Committee assists the Board in fulfilling its oversight responsibilities with respect to risk management in the areas of financial reporting, internal controls, compliance with public reporting requirements, and cybersecurity. The Audit Committee also is responsible for reviewing, discussing and advising the Board with respect to our corporate compliance program and code of business conduct. The Compensation Committee assists the Board in fulfilling its risk management oversight responsibilities with respect to human capital management and risks arising from compensation policies and programs. The Corporate Governance and Nominating Committee assists the Board in fulfilling its risk management oversight responsibilities with respect to risks related to corporate governance matters, including as they relate to the Company&#8217;s corporate responsibility risk management, strategy, initiatives, and policies. For additional information related to the Compensation Committee&#8217;s role in evaluating risks related to our executive compensation program, see &#8220;Compensation Discussion and Analysis&#8221; below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Audit Committee currently consists of Mr. Levin, as its Chair, Mr. Abercrombie, Ms. Heggie, and Mr. Milano, and is responsible for the review of internal accounting controls, financial reporting, and related matters. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee&#8217;s responsibilities also include, among others, the preapproval of audit and non-audit services; reviewing the Company&#8217;s policies on enterprise risk assessment and risk management; reviewing the Company&#8217;s corporate compliance program; reviewing, preapproving and overseeing all related-party transactions; establishing and overseeing procedures for the receipt, retention, and treatment of complaints regarding accounting, internal accounting controls, or auditing matters; determining appropriate funding, to be provided by the Company, for payment of compensation to the independent accountants employed by the Company, any other advisors employed by the Audit Committee, and ordinary administrative expenses of the Audit Committee; reviewing and preapproving any non-GAAP financial disclosures and any pro forma financial disclosures; and reviewing and discussing accounting pronouncements, initiatives, and proposed rule changes relevant to the Company. The Audit Committee also recommends to the Board the independent accountants selected to be the Company&#8217;s auditors and reviews the audit plan, financial statements, and audit results, and it regularly reviews the independence, and evaluates the performance, of the selected independent accountants. In addition, the Audit Committee oversees the Company&#8217;s cybersecurity program and receives regular updates on the program from the Company&#8217;s cybersecurity steering committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted an Audit Committee Charter, available on the Company&#8217;s website, that meets all applicable rules of Nasdaq and the SEC. The Audit Committee me</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mbers </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are &#8220;independent&#8221; directors as defined by Nasdaq and the SEC, meet the heightened independence standards applicable to Audit Comm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ittee members under Nasdaq and SEC rules, and meet Nasdaq&#8217;s financial literacy requirements for audit committee members. The Board has determined that each of Mr. Levin and Mr. Milano qualifies as an &#8220;audit committee financial expert,&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as such term is defined by the SEC. The Audit Committee met eight times during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Compensation Committee currently consists of Dr. Hutson, as its Chair, Mr. Aselage, Dr. Galson (since March 2024) and Ms. Sanders, and is responsible for the annual review of officer compensation and other incentive programs. The Compensation Committee&#8217;s responsibilities also include, among others, the review and recommendation to the Board </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the compensation for directors serving on the Board and its committees; reviewing and approving the Company&#8217;s goals and objectives relevant to compensation of executive officers; overseeing the risk assessment of the Company&#8217;s compensation programs; reviewing compliance with any applicable Company stock ownership guidelines; assessing any conflicts of interest of the compensation consultant retained by the Compensation Committee; overseeing the administration of the Company&#8217;s clawback of incentive compensation; overseeing engagement with stockholders and proxy advisory firms on executive compensation matters; periodically reviewing the Company&#8217;s policies and strategies relating to human capital management and making recommendations to the Board with respect thereto; and reviewing and approving any compensatory contracts or similar transactions or arrangements with executive officers and certain other employees. Information describing the Compensation Committee&#8217;s processes and procedures for considering and determining executive compensation, including the role of consultants in determining or recommending the amount or form of director and executive compensation, is included under the heading &#8220;Compensation Discussion and Analysis&#8221; below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Compensation Committee Charter, available on the Company&#8217;s website, that meets all applicable rules of Nasdaq and the SEC. The Compensation Committee members are &#8220;independent&#8221; directors as defined by Nasdaq, meet the heightened independence standards applicable to Compensation Committee members under Nasdaq rules, and are &#8220;non-employee&#8221; directors as defined by SEC rules. The Compensation Committee m</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et five t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imes during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The directors who served as members of the Compensation Committee during 2024 are Dr. Hutson, Mr. Aselage, Dr. Galson and Ms. Sanders. None of these directors have ever served as an officer or employee of the Company, and none of these directors had any relationship with the Company during 2024 that would be required to be disclosed pursuant to Item 404 of Regulation S-K. No interlocking relationships exist between our current Board of Directors or Compensation Committee and the board of directors or compensation committee of any other company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Governance and Nominating Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Corporate Governance and Nominating Committee currently consists of Ms. Heggie, as its Chair, Mr. Abercrombie, Dr. Hutson, and Dr. McKee, and is responsible for selecting persons for election or re-election as directors </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and providing oversight of the corporate governance affairs and policies of the Board of Directors and the Company. The Corporate Governance and Nominating Committee&#8217;s responsibilities also include, among others, overseeing the evaluation of the Board and management of the Company; assessing the independence of incumbent directors and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> new director nominees; reviewing the Board&#8217;s committee structure and recommending to the Board for its approval directors to serve as members and chair of each committee; reviewing periodically the Board&#8217;s leadership structure, including the separation of the Chair of the Board and Chief Executive Officer roles and/or appointment of a lead independent director of the Board; overseeing the annual self-evaluation process of the Board and its committees; reviewing the adequacy of the Certificate of Incorporation and By-Laws of the Company and recommending appropriate amendments to the Board; overseeing the orientation process for new directors and ongoing education for directors; reviewing policies relating to meetings of the Board; and overseeing and reviewing the management continuity planning process, including the review and evaluation of succession plans relating to executive officers, including the Chief Executive Officer. The Corporate Governance and Nominating Committee also is responsible for general oversight of the Company&#8217;s corporate responsibility risk management, strategy, initiatives, and policies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Corporate Governance and Nominating Committee Charter, available on the Company&#8217;s websit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e, that meets all applicable rules of Nasdaq and the SEC. The Corporate Governance and Nominating Committee members are &#8220;independent&#8221; directors as defined by Nasdaq. The Corporate Governance and Nominating Committee met four t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imes during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Committees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a Commercialization Committee, a Science Committee, and a Finance Committee, each of which convenes from time to time, as needed, to assist the Company and the Board in strategic decision-making regarding product development and commercialization and significant scientific and financial matters. Information about these committees, including committee composition and copies of the committee charters, is available on the Company&#8217;s website.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selection of Board Nominees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate Governance and Nominating Committee (referred to in this section as the &#8220;Committee&#8221;) will consider candidates for Board membership suggested by its members and other Board members, as well as management and stockholders. The Committee has established a procedure for submission of suggestions by stockholders and will consider candidates recommended in writing, including biographical information and personal references. All submissions by stockholders should be sent directly to t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Chair of the Board, Nancy J. Hutson, Ph.D., at 4</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">505 Emperor Blvd., Suite 200, Durham, North Carolina 27703. The Chair will provide copies of all submissions to the Committee for its consideration.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee reviews all submissions and evaluates them based on predetermined selection criteria to identify prospective nominees. In reviewing candidates to become prospective nominees, the Committee makes an initial determination as to whether to conduct a full evaluation of the candidate based on the information provided to the Committee with the recommendation of the candidate, as well as the Committee&#8217;s own knowledge of the candidate, which may be supplemented by inquiries to the person making the recommendation or to others. The preliminary determination is based primarily on the need for additional Board members to fill vacancies or expand the size of the Board and the likelihood that the candidate can satisfy the director selection criteria described below. If the Committee determines, in consultation with the Chair of the Board and other Board members as appropriate, that additional consideration is warranted, it may request additional information about the candidate&#8217;s background and experience. The Committee then evaluates the candidate as a prospective nominee considering our director selection criteria, including:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the prospective nominee to represent the interests of the stockholders of the Company;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prospective nominee&#8217;s standards of integrity, commitment, and independence of thought and judgment;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prospective nominee&#8217;s ability to dedicate sufficient time, energy, and attention to the diligent performance of his or her duties, including the prospective nominee&#8217;s service on other public company boards; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the prospective nominee contributes to the range of talent, skill, and expertise appropriate for the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating prospective nominees for Board membership, consideration is given to obtaining a variety of experiences, backgrounds, skill sets, and perspectives within the Board. In considering the composition of the Board, we look at the entirety of the Board. Although we do not seek constituent or representational directors, the Committee does consider the composition of the Board whenever we are looking for a new director, including skill sets, backgrounds, experiences, perspectives, and personal characteristics. The Committee and the Board evaluate the Board&#8217;s composition on a periodic basis as part of their review of the Board as a whole. Our Board conducts annual self-evaluations, overseen by the Committee and designed to solicit directors&#8217; views on a variety of topics, including whether the Board, as a whole, has </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the appropriate mix of characteristics, business experience, background, and tenure. See &#8220;Annual Performance Evaluations&#8221; below for additional information about these evaluations. The Committee also regularly assesses the expertise and competencies of the directors by considering, among other things, whether the Board, as a whole, is sufficiently represented by directors with experience in the areas listed in the matrix below. In order to mor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e meaningfully assess Board strength, Board members are asked to only identify areas where they have deep, hands-on experience. Based on these evaluations, assessments, and self-disclosures, we believe the Board currently is comprised of directors who reflect an appropriate mix of backgrounds, experiences, perspectives, and personal characteristics that are aligned with the Company&#8217;s business strategy. The following matrix highlights the deep, hands-on experience and competencies of each director, as reviewed by the Committee, in the areas identified below. The absence of a mark does not necessarily indicate that the director does not possess any relevant expertise or competency in the area.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:30.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.836%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Expertise/Competency</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Abercrombie</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aselage</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Galson</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Heggie</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hutson</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Levin</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">McKee</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Milano</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sanders</span></div></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stonehouse</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Public Co. Board Experience</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CEO Experience</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CFO Experience</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Strategic/Transactional Expertise</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Financial Reporting/Capital Markets Expertise</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Manufacturing</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quality</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Rare Disease Commercial Expertise</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">International Rare Disease Expertise</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Regulatory</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Late-Stage Clinical Development</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Early-Stage Clinical and Discovery Research</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pharmaceutical Research &amp; Development Expertise</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IT Expertise</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Investor/Wall Street Experience</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also considers such other relevant factors as it deems appropriate, including the current composition of the Board, the relevance of the current expertise of the Board, stockholder communications, the balance of management and independent directors, the need for Audit Committee expertise and the evaluations of other prospective nominees. In connection with this evaluation, the Committee determines whether to interview the prospective nominee, and if warranted, one or more members of the Committee, and others as appropriate, interview prospective nominees in person or by telephone. After completing this evaluation and interview, the Committee selects the director nominees for the next annual meeting of stockholders.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee recommended the nomination of two incumbent directors whose terms are expiring at the Meeting for reelection to the Board of Directors. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also has authority to retain and approve the compensation of search firms to be used to identify director candidates. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Performance Evaluations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has a policy requiring an annual evaluation of the performance of the Board and the committees thereof, including individual assessments of each director&#8217;s performance and qualifications. The Board engages third-party evaluators to oversee the individual director assessments from time to time at the discretion of the Corporate Governance and Nominating Committee (referred to in this section as the &#8220;Committee&#8221;). Generally, as part of these individual director assessments, the third-party evaluators interview each director individually to discuss such director&#8217;s responses to a list of questions approved by the Committee and report the results of the interviews back to the Committee in the aggregate, protecting the anonymity of each director, which we believe facilitates open and honest responses to the interview questions. The Committee then reviews the results of these assessments in making recommendations to the Board, including with respect to director nominations and Board succession planning.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder or Other Interested Party Communications</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders or other parties interested in communicating directly with the Board, or specified individual directors, may do so by writing to the Corporate Secretary, 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703. The Secretary will review all such correspondence and will regularly forward to the Board copies of all such correspondence that, in the opinion of the Secretary, relates to the functions of the Board or its committees or that the Secretary otherwise </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determines requires their attention. Directors may at any time review a log of all correspondence received by the Company that is addressed to members of the Board and request copies of such correspondence. Concerns relating to accounting, internal controls or auditing matters will immediately be brought to the attention of the Chair of the Audit Committee and handled in accordance with procedures established by the Audit Committee with respect to such matters.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Ownership Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock ownership guidelines require our Leadership Team members and our non-employee directors (collectively, the &#8220;Covered Individuals&#8221; and each, a &#8220;Covered Individual&#8221;) to achieve a minimum ownership amount of Company securities within five years of the later of (i) June 2022, which was the effective date of our current stock ownership guidelines, and (ii) the date the Covered Individual becomes subject to the guidelines. We believe the stock ownership guidelines help ensure that our Leadership Team, which includes each executive officer, and each of our non-employee directors maintains an equity stake in the Company that appropriately links their interests with those of stockholders and employees. Covered Individuals are required to achieve the following minimum ownership amounts of Company securities, as applicable (the &#8220;Minimum Ownership Amount&#8221;): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Covered Individual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Minimum Ownership Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3x Base Salary</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Leadership Team Members</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1x Base Salary</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-Employee Directors</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3x Annual Cash Retainer</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Common Stock, unvested RSUs, and earned performance share units count toward achievement of the Minimum Ownership Amount. In addition, shares owned by the Covered Individual&#8217;s spouse or in trust for the benefit of the Covered Individual, the Covered Individual&#8217;s spouse and/or children count toward achievement of the Minimum Ownership Amount. Unexercised options (vested and unvested) and unearned performance share units do not count toward achievement of the Minimum Ownership Amount. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee of the Board reviews compliance with the stock ownership guidelines on an annual basis, with compliance to be measured as of December 31 each year, using an average stock price for the preceding 30-day period. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each Covered Individual was in compliance with the stock ownership guidelines.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Management Director Term Limits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Board adopted term limits for the non-management directors, which term limits may be waived by the Board upon recommendation by the Corporate Governance and Nominating Committee. Under the approved term limits, non-management directors shall serve for no more than four full three-year terms unless, upon consideration and recommendation of the Corporate Governance and Nominating Committee, the Board shall approve additional terms to be served by such non-management director. In 2024, the Board, upon recommendation of the Corporate Governance and Nominating Committee, determined to waive the term limits applicable to Dr. Hutson and approved her service on the Board for an additional three-year term, in light of her qualifications, extensive experience in research and development in the pharmaceutical industry, valuable pre-clinical experience, insight into the Company&#8217;s business, and her leadership of and contributions to the Board. Dr. Hutson abstained from the votes and discussions on these matters.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Board hel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d four m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eetings. Each member of the Board attended a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t least 75% of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the meetings of the Board and committees of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Board of which he or she was a member. We encourage all members of the Board to attend our annual meetings of stockholders. Our President and Chief Executive Officer, Jon P. Stonehouse, and the Chair of the Board, Dr. Hutson, were each in attendance in person at the 2024 annual meeting of stockholders.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Relationships and Related Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2024, there were no relationships or related transactions requiring disclosure between the Company and any of its directors, executive officers or five percent stockholders. The Audit Committee Charter requires all related party transactions to be pre-approved by the Audit Committee.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Hedging Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a policy that prohibits employees (including officers) or directors, or any of their family members, from engaging in any type of short sale or purchasing any financial instrument (including prepaid variable forward contracts, equity swaps, collars, and exchange-traded funds), or otherwise engaging in any transaction that, in either case, hedges or offsets, or is designed to hedge or offset, any decrease in the market value of our equity securities. Such persons may engage in other derivative transactions only if it is determined, to the satisfaction of our Insider Trading Compliance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Officer (currently, our Chief Legal Officer and Corporate Secretary), that such transactions are consistent with applicable rules, laws, and our Insider Trading Policy. </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider Trading Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-5">adopted</ix:nonNumeric> an Insider Trading Policy that governs the purchase, sale, and other dispositions of our securities by the Company and our directors, officers, employees, and certain other persons and entities. We believe this policy is reasonably designed to promote compliance with insider trading laws, rules and regulations and listing standards applicable to the Company. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers are listed below, followed by information, including biographical information, about our executive officers (other than Mr. Stonehouse, whose biographical information appears above under &#8220;Election of Directors&#8221;).</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President, Chief Executive Officer, Interim Chief Financial Officer, and Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D. </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Research and Development Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and Corporate Secretary</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Commercial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Age as of April&#160;14, 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, Anthony J. Doyle, the Company&#8217;s former Chief Financial Officer and Treasurer, resigned from his role as Chief Financial Officer of the Company, effective April 9, 2025. We acknowledge and appreciate Mr. Doyle&#8217;s dedicated service and contributions to the Company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biographical Information of Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in March 2021 as Chief Research and Development Officer. She previously served as Chief Medical Officer and Senior Vice President of clinical development at GlycoMimetics, Inc., a publicly-traded biotechnology company focused on serious and rare conditions, from 2006 to 2021. Prior to joining GlycoMimetics, Dr. Thackray was Vice President of Clinical Development at Biosynexus; concurrently served on the research ethics review board of the National Center for Healthcare Statistics, CDC; and was a member of the ICH E11A Expert Working Group for the development of a harmonized regulatory guideline for pediatric extrapolation in drug development. Dr. Thackray is a board-certified pediatrician and adjunct faculty of the Children&#8217;s National Medical Center and George Washington University School of Medicine and Health Sciences since 2000. She has authored more than 60 peer-reviewed articles and presentations. Dr. Thackray holds a B.S. degree in biological sciences from Stanford University and an M.D. from the George Washington University School of Medicine and Health Sciences. She completed her pediatric residency and chief residency at Children&#8217;s National Medical Center, trained in medical genetics at the National Human Genome Research Institute at the National Institutes of Health, and is a Fellow of the American Academy of Pediatrics. Dr. Thackray served on our Board from September 2019 to May 2021, and on the board of directors of Immunogen, Inc. from September 2021 until its acquisition by AbbVie Inc. in February 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alane P. Barnes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in September 2006 as its General Counsel. She was named Corporate Secretary in 2007, was named Vice President, General Counsel &amp; Corporate Secretary in 2011, and has served as our Chief Legal Officer and Corporate Secretary since 2018. She was named as an executive officer in 2013. Ms. Barnes is responsible for all legal affairs of the Company including SEC compliance, corporate governance, IP strategy and management, licensing transactions, government contract negotiations and management and dispute resolution. She graduated magna cum laude from Cumberland School of Law in 1997 and is a member of Curia Honoris, scholar of merit. Ms. Barnes received her B.S. in Natural Science with a concentration in biology and chemistry from the University of Alabama at Birmingham (&#8220;UAB&#8221;). Prior to joining the Company, Ms. Barnes worked for the UAB Research Foundation where she managed intellectual property, negotiated license transactions and facilitated the emergence of new companies based on university technology. Prior to employment at the UAB Research Foundation, Ms. Barnes practiced corporate law with a prominent law firm in Birmingham, Alabama. Ms. Barnes is currently a board member of the Research Triangle Area Association of Corporate Counsel and regularly speaks at national conferences regarding the pharmaceutical business and at women&#8217;s success conferences. She is a 2010 graduate of MOMENTUM, an organization geared toward building leadership in women.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charles K. Gayer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in August 2015 as its Vice President of Global Strategic Marketing and was promoted to Chief Commercial Officer in January 2020. Prior to joining BioCryst, Mr. Gayer held several U.S. and global commercial leadership roles in competitive rare disease categories at Talecris Biotherapeutics, Inc., a biopharmaceutical company that was acquired in 2011 by Grifols, S.A., a multinational pharmaceutical and chemical manufacturer. At Talecris, he led U.S. alpha-1 antitrypsin deficiency marketing and later European sales and marketing. At Grifols, he led the U.S. marketing team for the combined immune globulin portfolio of the two companies. Prior to joining Talecris, he served for six years at GSK plc, previously known as GlaxoSmithKline, in a range of professional marketing, consumer marketing and sales roles. Mr. Gayer began his career as a strategic consultant for biopharmaceutical companies and also spent three years as a business analyst at rare disease pioneer Genzyme Corporation. Mr. Gayer received his B.A. in Politics from Princeton University and his M.B.A. from the Fuqua School of Business at Duke University.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Philosophy and Overview of Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee (referred to in this section as the &#8220;Committee&#8221;) of the Board of Directors has the responsibility for establishing, implementing, and monitoring adherence with the Company&#8217;s compensation philosophy. Our goal is to provide a compensation package that attracts, incentivizes, and retains employees and is designed to align employees&#8217; interests with the Company&#8217;s corporate strategies and business objectives and the interests of the stockholders. We refer to the individuals identified below as our &#8220;Named Executive Officers&#8221; for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Named Executive Officers include our Chief Executive Officer (&#8220;CEO&#8221;), our former Chief Financial Officer (&#8220;CFO&#8221;), and our next three most highly compensated executive officers serving in such capacity at the end of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The compensation of our Named Executive Officers is discussed in this Compensation Discussion and Analysis and included in the Summary Compensation Table. Our Named Executive Officers for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President, Chief Executive Officer, Interim Chief Financial Officer, and Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former Chief Financial Officer and Treasurer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Research and Development Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and Corporate Secretary</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Commercial Officer</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mr. Doyle resigned as Chief Financial Officer of the Company, effective April 9, 2025. Following his resignation, he will continue to provide transition services to the Company as a consultant as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">discussed further in the &#8220;Potential Payments upon Termination or Change in Control&#8221; section below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Committee&#8217;s primary objectives for our executive compensation program are as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to have a substantial portion of each officer&#8217;s compensation contingent upon the Company&#8217;s performance as well as upon his or her own level of performance and contribution toward the Company&#8217;s performance and long-term strategic goals;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to reward executives for actions that create short-term and long-term sustainable stockholder value, with a strong focus on Company results;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to align the interests of our executives with the Company&#8217;s corporate strategies, business objectives, and the long-term interests of our stockholders; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to attract, incentivize, and retain our executive talent.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of the Compensation Committee and Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee has the authority to determine the Company&#8217;s compensation philosophy, assess overall corporate performance for the year and its impact on the cash bonus pool, equity award pool, and base salary adjustment pool, and to establish compensation for the Company&#8217;s executive officers. The Company does not conduct annual individual performance reviews; rather, compensation decisions for the Named Executive Officers have been determined by the Committee based on its assessment of the performance of the Company. The Committee believes this approach effectively aligns the incentives of the Named Executive Officers with those of the Company&#8217;s stockholders and reinforces the highly focused corporate strategy of the Company. The CEO makes recommendations to the Committee with respect to executive officer compensation (excluding himself). Neither the CEO nor any other Named Executive Officer participates in the Committee&#8217;s final determination of compensation for executive officers. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of Compensation Consultants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the practice of the Committee to use a compensation consultant to perform an annual competitive compensation analysis of the Company&#8217;s overall compensation practices. Since 2015, the Committee has engaged Aon&#8217;s Human Capital Solutions practice, a division of Aon plc (&#8220;Aon&#8221;), as the Company&#8217;s compensation consultant to conduct the overall analysis of the Company&#8217;s compensation practices and those of comparable companies in the biotechnology industry. The Committee has determined that there are no conflicts of interest with respect to the engagement of Aon by the Committee.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the direction of the Committee, Aon annually conducts an analysis of overall compensation practices, including benchmark comparisons of base salary, annual incentive targets, and long-term equity incentive compensation against a &#8220;peer group&#8221; of comparable companies discussed in more detail below. The results of this analysis are reviewed by the Committee in connection with its annual compensation decisions, including base salary determinations, annual incentive targets, and long-term equity grants.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Peer Group and the Use of Market Data</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company does not establish compensation levels based solely on benchmarking, pay practices at other companies are an important factor that the Committee considers in assessing the reasonableness of compensation and ensuring that our compensation practices are competitive in the marketplace. In order to evaluate the level of compensation for our Named Executive Officers, the Committee, using information provided by Aon, establishes a peer group of publicly-traded, national, and regional companies in the biopharmaceutical and biotechnology industries (the &#8220;Peer Group&#8221;) that generally:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">are similar to the Company in terms of one or more of the following: size (i.e., employee headcount, revenue, market capitalization, etc.), stage of development for primary products, cash runway, and research and development investment;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have named executive officer positions that are comparable to the Company&#8217;s in terms of breadth, complexity, and scope of responsibilities; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete with the Company for employee talent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Peer Group company participates in the Radford Biotechnology Survey, an Aon survey of executive total compensation for various corporate positions, which survey is widely used among biotechnology companies. Aon analyzes both survey data and compensation information reported in the public filings of the Peer Group companies for the comparative analysis and adjusts the data to reflect the age of the reported information. In August 2023, the Committee approved the 2023 Peer Group. The 2023 Peer Group, which the Committee used when making determinations for our December 2023 long-term equity incentive awards and 2024 base salary and Annual Incentive Plan (&#8220;AIP&#8221;) target adjustments, emphasized companies that have launched products within the last three years and are scaling. The 2023 Peer Group targeted growing commercial companies, with market capitalization and revenue ranges adjusted to reflect changes in the Company&#8217;s market capitalization and revenue during 2023, which resulted in the removal of G1 Therapeutics and Vir Biotechnology, and the addition of ADMA Biologics, SIGA Technologies, and Travere Therapeutics, as compared to the prior peer group. Biohaven Pharmaceutical was also not included in the 2023 Peer Group as a result of its acquisition by Pfizer in October 2022. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Peer Group consisted of the following 19 peer companies, which had market capitalization ranging from approximately $300 million to $5.8 billion and revenue ranging from approximately $10 million to $820 million:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ACADIA Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Arrowhead Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Dynavax Technologies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">PTC Therapeutics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ADMA Biologics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Blueprint Medicines</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Harmony Biosciences</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">SIGA Technologies</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Agenus</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Corcept Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Insmed</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Travere Therapeutics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Amicus Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Cytokinetics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Intra-Cellular Therapies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Ultragenyx Pharmaceutical</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Apellis Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Deciphera Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">MacroGenics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, the Committee approved the 2024 Peer Group. The 2024 Peer Group, which the Committee used when making determinations for our December 2024 long-term equity incentive awards and 2025 base salary and AIP target adjustments, continued to emphasize companies that have launched products within the last few years and are scaling. The 2024 Peer Group targeted growing commercial companies, with market capitalization and revenue ranges adjusted to reflect changes in the Company&#8217;s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics, and the addition of Ironwood Pharmaceuticals and Pacira BioSciences, as compared to the 2023 Peer Group. Deciphera Pharmaceuticals was also not included in the 2024 Peer Group as a result of its acquisition by Ono Pharmaceutical Co. in June 2024. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Peer Group consisted of the following 18 peer companies, which had market capitalization ranging from approximately $220 million to $12 billion and revenue ranging from approximately $35 million to $930 million:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ACADIA Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Arrowhead Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Insmed</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">SIGA Technologies</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ADMA Biologics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Blueprint Medicines</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Intra-Cellular Therapies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Travere Therapeutics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Agenus</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Corcept Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Ironwood Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Ultragenyx Pharmaceutical</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Amicus Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Dynavax Technologies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Pacira BioSciences</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Apellis Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Harmony Biosciences</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">PTC Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Advisory Vote on Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our annual meeting in June </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our stockholders approved our &#8220;say-on-pay&#8221; proposal with more th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an 95% of the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> votes cast (exclusive of abstentions and broker non-votes) approving our executive compensation policies as described in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proxy Statement filed with the SEC on April 25, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee believes that this vote reflected continued stockholder agreement with and support for the Committee&#8217;s overall executive compensation philosophy and actions, and therefore, the Committee continued to apply similar principles in determining the amounts and types of executive compensation for fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with specific compensation decisions to be made each year in consideration of these principles and the Company&#8217;s results and performance. In order to align incentives to stockholder interests, the performance of the Named Executive Officers is evaluated based on the Committee&#8217;s assessment of the overall performance of the Company. The Committee will continue to consider the outcome of stockholder say-on-pay votes in making future executive compensation decisions. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation program for executive officers was primarily comprised of the following elements:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">base salary;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">annual cash incentive compensation;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term equity incentive awards; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other employee benefits.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base Salary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides our employees with base salary to compensate them for services rendered during the fiscal year. In determining the base salary amount for each Named Executive Officer, the Committee primarily considers:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">industry experience, knowledge, and qualifications;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">salary levels in effect for comparable positions within the Company&#8217;s industry obtained from the Radford Biotechnology Survey; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">individual performance of the executive and the general performance of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee uses competitive compensation data from the annual total compensation study of peer companies provided by the Company&#8217;s compensation consultant to inform its decisions about overall compensation and specific compensation elements. Additionally, the Committee uses multiple reference points when establishing targeted compensation levels. The Committee does not make base salary or total compensation determinations based solely on benchmark comparisons or any specific percentile relative to the Peer Group or the broader United States market. Instead, the Committee applies judgment and discretion in establishing targeted pay levels, taking into account not only competitive market data, but also factors such as Company, business and individual performance, scope of responsibility, critical needs and skill sets, leadership potential and succession planning. The Committee also considers the compensation programs of other companies which, while not in the Peer Group, have similar characteristics of the Company&#8217;s business model, complexity and sophistication.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Base salary amounts are typically reviewed annually as part of the Company&#8217;s performance review process as well as upon a promotion or other change in responsibility. To assist the Committee in determining appropriate base salary increases, the Company&#8217;s compensation consultant provided competitive base salary levels by analyzing the competitive data described in more detail above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting 2024 salaries, consistent with its philosophy for 2023 salaries and given the highly focused strategy of the Company, the Committee did not conduct individual performance reviews but instead continued to assess the Named </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Officers based primarily on overall corporate performance while also giving consideration to individual contributions to corporate performance. The Committee also considered the market competitiveness of the Company&#8217;s current executive officer base salaries compared to the 2023 Peer Group based on the analysis prepared by Aon. This resulted in all of the Named Executive Officers receiving the increases in base salary for 2024 as set forth below, which generally reflect a 4% increase (the increase applicable to base salaries Company-wide), as well as adjustments to increase the competitive positioning in the marketplace of the base salaries for Mr. Stonehouse, Ms. Barnes, and Mr. Gayer:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate Percentage Increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024 Base Salary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">705,536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">549,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">599,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">525,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">544,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting 2025 salaries, consistent with its philosophy for 2024 salaries and given the highly focused strategy of the Company, the Committee did not conduct individual performance reviews but instead continued to assess the Named Executive Officers based primarily on overall corporate performance while also giving consideration to individual contributions to corporate performance. The Committee also considered the market competitiveness of the Company&#8217;s current executive officer base salaries compared to the 2024 Peer Group based on the analysis prepared by Aon. This resulted in all of the Named Executive Officers receiving the increases in base salary for 2025 as set forth below, which generally reflect a 3.25% increase (the increase applicable to base salaries Company-wide), as well as an adjustment to increase the competitive positioning in the marketplace of the base salary for Dr. Thackray. Mr. Doyle requested to forego a 3.25% base salary adjustment and to instead allocate his increase among members of his team.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate Percentage Increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025 Base Salary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">549,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">635,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">562,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Incentive Plan Compensation </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the Committee&#8217;s objective to have the entirety of each officer&#8217;s annual incentive program compensation contingent upon the Company&#8217;s performance based on the achievement of pre-established corporate performance objectives. Annual incentive payments are made pursuant to the AIP, which provides for a target amount of potential incentive awards for each participant thereunder, which is currently expressed as a percentage of annual base salary. In determining the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AIP targets for each of the Named Executive Officers, the Committee considered individual contributions to corporate performance and Peer Group market data provided by Aon.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee annually reviews with Aon the Peer Group data for non-equity incentive compensation and considers other factors intended to align the AIP with the Committee&#8217;s pay-for-performance philosophy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee maintained the existing targets set forth below for all Named Executive Officers for the 2024 plan year and for all continuing Named Executive Officers other than Mr. Gayer for the 2025 plan year. The </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025 AIP target for Mr. Gayer was increased to 70% of base salary to more appropriately reflect internal management positioning. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AIP targets for the Named Executive Officers of the Company were as follows:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024 AIP Target <br/>(percentage of base salary)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on overall corporate performance against pre-established corporate objectives, the actual payout under the AIP can range from zero to any amount relative to the target percentage of annual base salary. The overall amount of the AIP pool each performance year is determined by the Committee and is based on its assessment of Company performance against the current year corporate objectives multiplied by the sum of all participants at target performance. The AIP allows the Committee to use its discretion in setting the size of the AIP pool. The Committee may decide that the pool is as low as zero for a year of poor Company performance and may establish a pool that exceeds target for a year of exceptional Company performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AIP targets were set, the Committee believed that payout at the target performance level (100 points) was challenging but achievable and that payout above target represented a &#8220;stretch&#8221; performance goal, but was nevertheless achievable. In order to further tie individual compensation to Company performance, payout to individuals under the AIP is based on Company performance and awards under the AIP are typically settled in cash. All awards are reviewed and approved by the Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span id="id9ea9e013d6740e696bf1d820d021d58_26709"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-established corporate objectives for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Company performance are described in the table below. However, the table does not include the target levels with respect to the specific quantitative and qualitative objectives as we believe disclosure of such information would result in competitive harm to the Company. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Objective</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Points<br/>at<br/>Target</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ORLADEYO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate objectives for ORLADEYO included goals to increase the number of total and reimbursed patients on ORLADEYO, increase ORLADEYO net revenue, and advance ORLADEYO lifecycle management.</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complement-Mediated Diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate objectives for our complement-mediated diseases program included goals to advance the Factor D program and advance our other complement product candidates towards clinical trials.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate objectives for our product portfolio included goals to advance the BCX17725 program for Netherton syndrome and the avoralstat program for diabetic macular edema.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate organizational objectives included targets for talent and succession planning, culture surveys, individual development plans, internal audits of each major functional area in the Company, and enhancing operational discipline and excellence.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reviewing the Company&#8217;s performance against the pre-established </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> objectives in December </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Committee assessed the completion of the corporate objectives as described in the table below, as well as the achievements of the Company, and attributed the values set forth in the table below to the achievement of each of the Company objectives. In consideration of these results, the Committee awarded payouts under the AIP at 150% of target for each recipient, which were paid out in January 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:67.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Objective</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Committee<br/>Determination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Rationale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Points<br/>Awarded</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exceeds</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company made exceptional progress in advancing the commercialization of ORLADEYO by significantly increasing sales and the number of total and reimbursed patients in the United States and outside the United States, far exceeding the target revenue and patient numbers set for the AIP.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company successfully advanced the ORLADEYO pediatric clinical program, completing the APeX-P clinical trial through its primary endpoint.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exceeds</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company completed its clinical evaluation of the BCX10013 program, in line with the target set for the AIP, prior to its discontinuation in the third quarter of 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company exceeded expectations in advancing the discovery programs for other complement inhibitor product candidates.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Met</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the BCX17725 program for Netherton syndrome in line with the target set for the AIP, including by advancing BCX17725 into a Phase 1 clinical trial. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the avoralstat program towards an expected clinical trial of patients with diabetic macular edema in 2025. </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exceeds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company facilitated talent reviews across the entire Company, in addition to succession planning and completion of individual development plans for employees, exceeding the participation target set for the AIP.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company increased engagement in its culture programs and improved metrics related to individual corporate objectives, exceeding the target set for the AIP.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company exhibited operational discipline and completed a company-wide internal audit to identify and address opportunities for significant performance improvement and areas of business vulnerability.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">150</span></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Equity Incentive Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Named Executive Officers are eligible to participate in the Company&#8217;s periodic awards of equity grants under the Company&#8217;s Stock Incentive Plan. These awards are designed to:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create a greater sense of employee ownership;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhance the link between creation of stockholder value and long-term employee compensation;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide an opportunity for increased equity ownership by the officers, which increases the alignment of their financial interests with those of our stockholders; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain competitive levels of total compensation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee has historically granted equity awards to the executive officers on an annual basis. The overall grant pool is established on an annual basis based, in part, on the Committee&#8217;s assessment of competitive equity grant levels by organization level and the number of employees at each level using competitive data provided by Aon based on its analysis of the Company&#8217;s current Peer Group. In determining the amount of each grant, the Committee also considers the Company performance, assessed on an annual basis.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards Granted in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting the levels of long-term equity incentive awards in December </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Committee assessed the Company&#8217;s performance against the corporat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e performance objectives for 2024, as described above under the caption &#8220;Annual Incentive Plan Compensation,&#8221; and in reviewing the analysis provided by Aon regarding the Company&#8217;s 2024 Peer Group equity compensation practices and the number of shares of Common Stock available for grant under the Company&#8217;s Stock Incentive Plan, the Committee determined to grant long-term equity incentive awards at a level representing approximately the 65th percentile among comparative companies based on the 2024 Peer Group data, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with certain additional long-term equity incentive awards to be granted to selected individuals in light of the particular individual contributions made by such individuals to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Company performance. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee further determined that, after evaluating current compensation trends, reviewing the intended purpose of this program, and considering the Company&#8217;s stage of development as a growing commercial-stage biotechnology </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">company and related financial results, the long-term equity incentive awards for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> performance should continue to consist of a mix of stock options and RSUs. Stock options are inherently performance based, as they only provide value to the participant when the stock price appreciates over time, and typically have a four-year vesting schedule, which provides a retention component. Time-based RSUs also serve a retention function and further align executive interests with stockholders. The Committee continues to evaluate the appropriate mix of equity awards in light of the Company&#8217;s stage of development, business strategy, financial results, competitive market conditions in the industry, and Peer Group practices. In consideration of the foregoing factors, in December </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Committee awarded options and RSUs to the Named Executive Officers as set forth in the table below.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RSUs (#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,250</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">362,100</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">250,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120,700</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">260,950</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125,950</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">250,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120,700</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">260,950</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125,950</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each stock option represents the right to purchase one share of Common Stock at the option exercise price (once the option is vested), and each RSU represents the right to receive one share of Common Stock upon vesting of the RSU. The stock options and RSUs granted to the Named Executive Officers in December </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vest 25% annually on each of the first four anniversaries of the date of the grant, until fully vested on the fourth anniversary. The stock options expire 10 years after the date of the grant. This provides a reasonable timeframe during which the Named Executive Officers can benefit from the appreciation of the Company&#8217;s shares. The exercise price of the stock options was equal to the fair market value of the underlying stock on the date of grant.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Elements of Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to attract and retain key talent and pay market levels of compensation, we offer broad-based retirement, health and welfare employee benefits to our eligible employees, including our Named Executive Officers, subject to the terms and conditions of each benefit program. Our Named Executive Officers are eligible to participate in these benefits on the same basis as other full-time employees.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Medical Insurance</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes available to eligible employees and their dependents group health, dental and vision insurance coverage.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Life and Disability Insurance</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes available disability and life insurance at coverage levels based upon the employee&#8217;s level of compensation. In addition, as part of Mr. Stonehouse&#8217;s employment agreement, he is entitled to have either a $1 million life insurance policy payable to his beneficiary upon death, or, if there is no policy in place, we are required to pay his beneficiary $1 million upon his death. An insurance policy was in place as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Defined Contribution Plan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a retirement plan designed to meet the requirements under Section 401(k) of the Code. The 401(k) plan permits eligible employees to defer up to 100% of their annual eligible compensation, subject to certain limitations imposed by the Code. Employee elective deferrals are immediately vested and non-forfeitable. The Company makes matching contributions equal to the first 5% of the employee elective deferrals, which vest over a period not to exceed six years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock Purchase Plan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a broad-based employee stock purchase plan (the &#8220;ESPP&#8221;), designed to meet the requirements under Section 423 of the Code. The ESPP permits employees to purchase Company stock at a discount through payroll deductions. ESPP participants are granted a purchase right to acquire shares of Common Stock at a price that is 85% of the stock price on either the first day of the stock purchase period or the last day of the stock purchase period, whichever is lower. The purchase dates occur on the last business days of January and July of each year. To pay for the shares, each participant may authorize periodic payroll deductions from 1% to 15% of the employee&#8217;s cash compensation, subject to certain limitations imposed by the Code. In addition, no employee may purchase more than 3,000 shares in each purchase period and/or $25,000 in each calendar year. All payroll deductions collected from the participant during the purchase period are automatically applied to the purchase of Common Stock on the dates indicated above provided the participant remains an eligible employee and has not withdrawn from the ESPP prior to the purchase date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Fringe Benefits</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the commuting expense reimbursements described below and the relocation expenses described below under the caption &#8220;Executive Relocation,&#8221; the Company makes certain other fringe benefits available to the Named Executive Officers on t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he same basis as are made available to its other employees, such as tuition reimbursement and payment of professional dues. The aggregate amount of these other fringe benefits was less than $10,000 for each Named Executive Officer during 2024. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Executive Relocation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted an Executive Relocation Policy (the &#8220;Relocation Policy&#8221;) for certain new employees of the Company, including executive officers. The Relocation Policy provides for a house hunting trip, temporary living and trips home for up to 90 days, home selling support or direct reimbursement for some selling expenses, moving costs and temporary storage of goods, customary closing expenses on the new home, a miscellaneous allowance of one month&#8217;s salary, not to exceed $5,000, and gross up of all taxable expenses. The Relocation Policy requires 100% repayment of benefits if the employee leaves or is terminated for cause within 12 months from the hire date. The Company did not pay any relocation expenses to Named Executive Officers in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Retirement Policy</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In July 2024, the Company adopted the BioCryst Pharmaceuticals, Inc. Equity Award Retirement Policy (the &#8220;Retirement Policy&#8221;), which provides for the continued vesting of qualifying unvested equity awards in connection with an eligible employee&#8217;s qualifying retirement, as discussed further in the &#8220;Potential Payments upon Termination or Change in Control&#8221; section below. The Committee believes the Retirement Policy is consistent with competitive market practice, and as an element of compensation will attract and retain top talent and encourage eligible employees, including executive officers, to remain focused on the Company&#8217;s performance for the long term.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practice with Respect to the Grant of Equity Compensation Awards</span></div><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiDiscTextBlock" id="f-6" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants all equity incentive awards based on the fair market value as of the date of grant. The exercise price for stock option grants and similar awards is determined by reference to the last quoted price per share on the Nasdaq Global Select Market at the close of business on the date of grant.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="f-8" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMethodTextBlock" id="f-7" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally grants annual equity awards to employees in <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgPredtrmndFlag" format="ixt:fixed-true" id="f-9">mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees.</ix:nonNumeric> Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiCnsdrdFlag" format="ixt:fixed-true" id="f-10">The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future</ix:nonNumeric>. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company <ix:nonNumeric contextRef="c-1" name="ecd:MnpiDiscTimedForCompValFlag" format="ixt:fixed-false" id="f-11">did not take</ix:nonNumeric> material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.</span></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clawback Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a &#8220;clawback&#8221; policy (the &#8220;Clawback Policy&#8221;) that complies with the final Nasdaq listing rule implementing Rule 10D-1 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The Clawback Policy provides that, in the event the Company is required to prepare an accounting restatement of the Company&#8217;s financial statements (including any such correction that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period) due to material non-compliance with any financial reporting requirement under the federal securities laws, the Company will recover the amount of any incentive-based compensation received by any covered executive, including the Named Executive Officers, during the three fiscal years prior to the date that the Company is required to prepare such accounting restatement or during any transition period of less than nine months that is within or immediately following such three fiscal years, that exceeds the amount that otherwise would have been received had it been determined based on the restated financial statements. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Assessment of Compensation Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company, together with the Company&#8217;s compensation consultant, outside counsel, and the Committee, has examined the Company&#8217;s compensation program and discussed whether any elements of the program created risks that were reasonably likely to have a material adverse effect on the Company. Following this analysis, which occurs on an annual basis, the Committee concluded that the elements of the Company&#8217;s compensation program did not create risks that are reasonably likely to have a material adverse effect on the Company. In its analysis, the Committee and management considered a number of factors, including primarily: (1) the total value of the payments made under the Company&#8217;s compensation program for the prior year and (2) that any corporate actions that would potentially lead to achievement of corporate performance objectives would require approval by the Company&#8217;s Board of Directors, which provides a check on the ability of any individual to take risks that could have a material adverse effect on the Company in an effort to achieve a certain performance objective. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION COMMITTEE REPORT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee reviewed the Compensation Discussion and Analysis and discussed its contents with Company management. Based on such review and discussions, the Committee recommended that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference into the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D., Chair of the Committee</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div id="i08dd44edc832493d888aecb8122c7631_46"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Summary Compensation Table</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total compensation awarded, paid to, or earned by our Named Executive Officers, as specified by Item 402(a)(3) of Regulation S-K.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Salary <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Equity </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incentive </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>($)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jon P. Stonehouse </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">President, Chief Executive Officer, Interim Chief Financial Officer, and Director</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">705,536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,675,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,002,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">899,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,317,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">665,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">819,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,724,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">537,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">640,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,355,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,482,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,982,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anthony J. Doyle </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Former Chief Financial Officer and Treasurer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">549,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">891,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,334,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">494,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,287,271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">528,297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">218,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">301,129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,790,349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">507,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">361,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,194,012&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">203,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,281,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief R&amp;D Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">599,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">930,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,392,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">629,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,568,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">576,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,089,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">383,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,393,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">554,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">861,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,792,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">277,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,497,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alane P. Barnes</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief Legal Officer and Corporate Secretary</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">525,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">891,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,334,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">472,898&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,241,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">495,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">411,520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">282,549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,932,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">457,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">361,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,194,012&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">182,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,210,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charles K. Gayer</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief Commercial Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">544,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">930,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,392,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">490,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,375,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">495,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">218,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">282,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,738,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">448,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">361,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,194,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">179,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,198,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For 2024, these amounts reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, of RSUs granted pursuant to the Stock Incentive Plan for the fiscal year ended December&#160;31, 2024, calculated based on the closing price of our Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">as reported by Nasdaq </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">on December&#160;19, 2024 (the date of grant) of $7.39.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For 2024, these amounts reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, of stock option awards granted pursuant to the Stock Incentive Plan for the fiscal year ended December&#160;31, 2024. Assumptions used in the calculation of these amounts are included in Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December&#160;31, 2024, which is included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February&#160;25, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents payments earned under the AIP. Values shown reflect the full calculated payout of the incentive awards under the AIP.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Except as otherwise noted, the amounts shown reflect the Company contribution for the executive to his or her 401(k) plan.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of Company contributions to the 401(k) plan and life insurance premiums described above in the Compensation Discussion and Analysis under the caption &#8220;Other Elements of Compensation&#8212;Life and Disability Insurance.&#8221; For 2024, such amounts were $17,250 and $16,889, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants of Plan-Based Awards in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about plan-based awards granted during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Named Executive Officers.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated Future Payments Under <br/>Non-Equity Incentive Plan Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation<br/>Committee<br/>Action Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Target</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or Base</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($/Sh)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">750,250</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,002,134&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">362,100</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,675,919&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">599,706&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250,100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,334,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120,700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">891,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">329,657&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">260,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,392,012&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">930,771&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">419,596&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250,100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,334,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120,700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">891,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">260,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,392,012&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/18/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">930,771&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">326,898&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents possible payouts under our AIP. The amount shown in the &#8220;Target&#8221; column represents the incentive payment that will be earned if performance is assessed at target. There is no specific &#8220;threshold&#8221; amount payable for minimal performance under the AIP or &#8220;maximum&#8221; amount payable for performance in excess of target under the AIP. Payout could be zero if corporate objectives are not met. In addition, the Committee has discretion to establish a payout that exceeds the applicable target percentage of annual base salary if warranted by Company performance.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents RSUs that vest 25% on each of the first four anniversaries of the grant date until fully vested after four years, subject to the executive&#8217;s continued service to the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock options vest 25% on each of the first four anniversaries of the grant date until fully vested after four years, and they have a term of 10 years, subject in each case to the executive&#8217;s continued service to the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The exercise price is the closing market price of our Common Stock on the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Notes (1) and (2) to the &#8220;2024 Summary Compensation Table&#8221; above for more information about the assumptions used to determine these amounts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the equity awards we have granted to our Named Executive Officers that were outstanding as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant Date</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Exercisable</span></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercised</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercisable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Expiration</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Units of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Market Value of Shares or Units of Stock that Have Not Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:6pt"><td colspan="3" rowspan="14" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/15</span></td><td colspan="3" rowspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">115,345</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.16&#160;</span></td><td rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/25</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">162,950</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/16</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">305,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/26</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">300,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/18</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">675,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/28</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/19</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">629,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/29</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">870,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">430,875</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">143,625</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30,750</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">231,240&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">297,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">297,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63,750</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">479,400&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">148,750</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">446,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95,625</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">719,100&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">750,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/34</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">362,100</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,722,992&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4/30/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4/30/30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">332,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,750</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">141,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,250</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,250</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,625</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,875</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">191,760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250,100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/34</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120,700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">907,664&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="7" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9/20/19</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.86&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9/20/29</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/12/20</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.41&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/12/30</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3/31/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">300,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.17&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3/31/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">188,000&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">153,750</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,250</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,720&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">304,560&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">178,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38,250</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">287,640&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">260,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/34</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">947,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant Date</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Exercisable</span></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercised</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercisable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Expiration</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Units of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Market Value of Shares or Units of Stock that Have Not Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:6pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1/1/15</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,200</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="2" rowspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.16&#160;</span></td><td rowspan="2" style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/25</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="2" rowspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td rowspan="2" style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="45" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43,997</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91,004</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">190,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">190,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/29</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">280,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,750</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">103,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,250</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,250</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,625</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,875</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">360,960&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250,100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/34</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120,700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">907,664&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="12" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8/25/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8/25/25</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,837</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/25</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/16</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,142</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.22&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/26</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.51&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.04&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/18</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.06&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/28</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/19</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">106,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.23&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/29</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">190,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150,400&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,250</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,250</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127,840&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,625</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,875</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">191,760&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/24</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">260,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.39&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/34</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125,950</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">947,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock options vest 25% on each of the first four anniversaries of the grant date until fully vested after four years.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The option exercise price is equal to the closing price of our Common Stock as reported by Nasdaq on the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock options expire 10 years after the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">RSUs vest 25% on each of the first four anniversaries of the grant date until fully vested after four years.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Calculated based on a price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$7.52</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> per share, which was the closing price of our Common Stock as reported by Nasdaq on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, multiplied by the number of shares of Common Stock subject to RSUs that had not yet vested.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Option Exercises and Stock Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on shares acquired during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by our Named Executive Officers upon the exercise of stock options and the vesting of RSUs.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Shares Acquired<br/>on Exercise<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Realized on</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Shares<br/>Acquired<br/>on Vesting</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Realized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">on Vesting</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94,500</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">707,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,750</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">268,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">455,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">286,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">277,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Value is calculated by multiplying (a) the number of shares acquired upon exercise by (b) the difference between the market price of our Common Stock at the time of exercise (or, for non-cash exercises, the closing price of our Common Stock as reported by Nasdaq on the date of exercise) and the applicable exercise price.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Value is calculated by multiplying (a) the number of shares acquired upon vesting of RSUs by (b) the closing price of our Common Stock as reported by Nasdaq on the applicable vesting date (or on the most recent business day if the vesting date was not a business day).</span></div><div id="i08dd44edc832493d888aecb8122c7631_58"></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments upon Termination or Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth potential payments payable to our Named Executive Officers upon termination of employment or a change in control. The amounts include compensation payable upon termination without cause or constructive termination, termination in the event of disability or death, retirement, and a termination following a change in control. None of the Named Executive Officers are entitled to any payments upon termination with cause. The effect of a Named Executive Officer&#8217;s termination of employment on annual incentive awards under the AIP is subject to determination by the Compensation Committee in its sole discretion. Absent a contrary determination by the Compensation Committee or provisions to the contrary in an employment agreement, all awards under the AIP are forfeited if the executive terminates employment with the Company before the annual incentive awards are paid. The Compensation Committee may, in its discretion, revise, amend, or add to the benefits if it deems it advisable. The amounts shown assume the stock options and RSUs are valued at their last intrinsic value in fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and that termination is effective </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and thus include amounts earned through such time and are estimates of the amounts which would be paid out to the executives upon their termination. The actual amounts to be paid out can only be determined at the time of such executive&#8217;s separation from the Company. The amounts shown in the table do not include accrued vacation, vested amounts payable under the Company&#8217;s 401(k) plan, any accrued but unpaid bonus or base salary, benefits under the Company&#8217;s disability benefit program or life insurance policies, or potential compensation recognized upon exercise of vested options as disclosed in the Outstanding Equity Awards table above. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Benefit</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Termination</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Without</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cause or Constructive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Termination</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Disability</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Death</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Retirement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Control and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Termination</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">(3)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="6" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,411,072&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,411,072&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,411,072&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,199,411&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,199,411&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,199,411&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">20,711&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">20,711&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">20,711&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">583,945&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">4,736,677&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity continued vesting</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,916,153&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,631,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,631,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">583,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1,916,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">7,367,871</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">549,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">549,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">329,657&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">329,657&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">32,167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">32,167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,530,351&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">911,253</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,441,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">599,423&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">599,423&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">419,596&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">419,596&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">32,167&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">32,167&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">2,038,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1,051,186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">3,089,739</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">525,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">525,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">315,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">315,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">32,167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">32,167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">162,087&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,661,951&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">872,874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">162,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,534,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">544,830&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">544,830&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">326,898&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">326,898&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">31,661&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">31,661&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">163,497&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,580,641&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">903,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">163,497</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,484,030</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pursuant to the terms of the Company&#8217;s Stock Incentive Plan, acceleration of unvested stock options occurs in the event of death only after five years of service.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the value of continued vesting of unvested stock options and RSUs upon qualified retirement pursuant to the Retirement Policy. Under the terms of the Retirement Policy, the amounts in this column exclude awards granted less than one year prior to December&#160;31, 2024. Amounts reported are based on the closing price of our Common Stock as reported by Nasdaq on December&#160;31, 2024 of $7.52. No value is reflected for stock options with an exercise price in excess of $7.52.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Benefits for Mr. Stonehouse are triggered if his employment is terminated without Cause or as a result of Disability or Constructive Termination at any time following a Change of Control. Benefits for the other Named Executive Officers are triggered if their employment is terminated without Cause or if they are Constructively Terminated within six months following a Change of Control. The employment agreement for Mr. Stonehouse provides that if any benefit would be subject to excise tax imposed by section 4999 of the Code or any interest or penalties with respect to such excise tax, the employee shall be entitled to the greater of the employee&#8217;s net after tax benefit of the entire payment assuming the payment is subject to section 4999 (which payment would be subject to the excise tax) and the employee&#8217;s net after tax benefit of the payments after the payments are reduced just to the point that there is no section 4999 excise tax. The Company will not pay the excise tax if the payments are subject to section 4999.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents AIP awards at the target percentage for each individual (except with respect to Mr. Stonehouse, who, as described below, receives twice the AIP award at the target percentage in the event of termination without Cause, Constructive Termination, or Disability).</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents 12 months of premiums under COBRA based on the Named Executive Officers&#8217; elections in effect as of December 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on the closing price of our Common Stock as reported by Nasdaq on December&#160;31, 2024 of $7.52. No value is reflected in these rows for stock options with an exercise price in excess of $7.52.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment Agreement Terms</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. Stonehouse</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of his employment letter agreement, in the event of termination by the Company without Cause, upon non-renewal of the term of the agreement by the Company, as a result of a Constructive Termination, or by the Company as a result of a Disability, Mr. Stonehouse is entitled to severance equal to the product of (x) two and (y) the sum of (i) his annual base salary in effect immediately prior to the effective date of the termination and (ii) his target bonus in effect for the fiscal year of termination, to be paid in equal installments over the regularly scheduled payroll periods of the Company for the two years following the effective date of termination. The Company will also pay the monthly premium for health insurance coverage under COBRA until the earlier of 12 months following the effective date of termination or the date upon which COBRA continuation coverage ceases. If there is a Change of Control and his employment is terminated without Cause or as a result of Disability or Constructive Termination at any time following the Change of Control, he shall receive the benefits described above. The receipt of such benefits is subject to his signing and not revoking a release of any and all claims against the Company, its officers, directors and employees, resigning from the Board, and returning to the Company all of its property and confidential information. To the extent required, the payments described in this paragraph may be delayed for the minimum period and in the minimum manner necessary to avoid the imposition of the tax required by Section 409A of the Code.</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of Mr. Stonehouse&#8217;s letter agreement:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Cause&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is defined as: determination by the Board that his employment be terminated for any of the following reasons: (i) a violation of a federal or state law or regulation that materially and adversely impacts the business of the Company; (ii) conviction or plea of no contest to a felony under the laws of the United States or any state; (iii) a breach of the terms of any confidentiality, invention assignment or proprietary information agreement with the Company or with a former employer that materially and adversely impacts the Company; (iv) fraud or misappropriation of property belonging to the Company or its affiliates; or (v) willful misconduct or gross negligence in connection with the performance of his duties; provided, however, that no act or failure to act shall be considered &#8220;willful&#8221; unless it is done, or omitted to be done, in bad faith or without reasonable belief that his action or omission was in the best interests of the Company.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Constructive Termination&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is defined as resignation of employment within 30 days of the occurrence of any of: (i) a reduction in his responsibilities or any change in his status or title with regard to his employment; (ii) a reduction in his base salary, unless such reduction occurs prior to a Change of Control (as defined below) and is made in connection with a fiscal downturn of the Company pursuant to which the base salaries of all executive officers of the Company are reduced by a comparable percentage; or (iii) a relocation of his principal office to a location more than 50 miles from the location of his then-current principal office.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Change of Control&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is defined as (i) a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the State of the Company&#8217;s incorporation; (ii) the sale, transfer or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company; (iii) any reverse merger in which the Company is the surviving entity but in which securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such merger; or (iv) any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Disability&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the inability to perform his duties under the agreement by reason of physical or mental incapacity for 90 days, whether consecutive or not, during any consecutive 12-month period.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Named Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of their employment letter agreements, in the event of termination by the Company without Cause, or Constructive Termination, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer are entitled to (i) continuation of base salary for one year beyond the effective termination date, payable in accordance with the Company&#8217;s regular payroll practices; (ii) payment of one times the executive&#8217;s annual target bonus under the AIP in effect for the fiscal year in which his or her termination date occurs, payable in equal installments over the regularly scheduled payroll periods of the Company for the one year following the effective date of termination; and (iii) if the executive elects to continue health insurance coverage under COBRA, the monthly premium for such coverage until the earlier of 12 months following the effective date of termination or the date upon which the executive commences employment with another entity. In the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">event the executive&#8217;s employment is terminated without Cause or the executive is Constructively Terminated within six months of a Change of Control, he or she is entitled to the benefits described in the table above. The receipt of such benefits is conditioned on the executive signing and not revoking a release of any and all claims, in a form prescribed by the Company and returning to the Company all of its property and confidential information. To the extent required, the payments described in this paragraph may be delayed for the minimum period and in the minimum manner necessary to avoid the imposition of the tax required by Section 409A of the Code.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the agreements of Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cause</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a determination by the Board that his or her employment be terminated for any of the following reasons: (i) failure or refusal to comply in any material respect with lawful policies, standards or regulations of the Company; (ii) a violation of a federal or state law or regulation applicable to the business of the Company; (iii) conviction or plea of no contest to a felony under the laws of the United States or any State; (iv) fraud or misappropriation of property belonging to the Company or its affiliates; (v) a breach in any material respect of the terms of any confidentiality, invention assignment or proprietary information agreement with the Company or with a former employer; (vi) failure to satisfactorily perform his or her duties after having received written notice of such failure and at least 30 days to cure such failure; or (vii) misconduct or gross negligence in connection with the performance of his or her duties.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Constructive Termination</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a resignation of employment within 30 days of the occurrence of any of the following events which occurs within six months following a Change of Control (as defined below): (i) a material reduction in his or her responsibilities; (ii) a material reduction in his or her base salary, unless such reduction is comparable in percentage to, and is part of, a reduction in the base salary of all executive officers of the Company; or (iii) a relocation of his or her principal office to a location more than 50 miles from the location of his or her principal office immediately preceding a Change of Control.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change of Control</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the sale, transfer, or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company; (ii) the consummation of a merger or consolidation of the Company with any other corporation or other entity, other than (I) a merger or consolidation (A) which results in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent 50% or more of the combined voting power of the surviving entity or the ultimate parent thereof outstanding immediately after such merger or consolidation and (B) immediately following which the individuals who comprise the Board immediately prior thereto constitute 50% or more of the board of directors of the surviving entity or, if the Company or the surviving entity is then a subsidiary, the ultimate parent thereof, or (II) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no person is or becomes the beneficial owner (within the meaning of Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such person any securities acquired directly from the Company or its affiliates) representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities; (iii) any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders; or (iv) a change in the composition of the Board over a period of 12 consecutive months such that a majority of the Board members (rounded up to the next whole number) ceases to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election as Board members during such period by at least two-thirds of the Board members described in clause (A) who were still in office at the time such election or nomination was approved by the Board.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Vesting Acceleration</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of termination of service other than on account of death or disability, each executive has three months to exercise any options exercisable prior to the termination in service. In the event of permanent disability, the executive will be able to exercise all outstanding options vested at the time of such disability in their entirety within the earlier of 12 months or the expiration of the option. In the event of death, the executor of the executive&#8217;s estate will be able to exercise all of the outstanding options in their entirety within the earlier of 12 months or the expiration of the option. If the executive has completed five years of service, all outstanding options vest in their entirety at death, but with less than five years of service, only the portion of the option that was exercisable at the time of death will be exercisable during the 12-month period. If the executive is no longer an employee of the Company, but on or prior to the last date of employment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continues service with the Company in another capacity, such as service as a consultant or service as a member of the Board of Directors, his or her outstanding options will continue to vest and be exercisable until three months after separation from such service or expiration of the option.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All unvested stock options are subject to &#8220;double-trigger&#8221; vesting if the options are assumed after a change in control, in which case accelerated vesting will apply only if the optionee&#8217;s service is terminated by us without &#8220;cause&#8221; or by the optionee due to a &#8220;constructive termination&#8221; within 90 days preceding or two years following the change in control. If the options are not assumed in connection with the change in control, they will fully vest upon the change in control.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSUs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of termination of service, outstanding RSUs will automatically terminate and no shares of Common Stock will be issued in satisfaction of those awards. However, the Compensation Committee has discretionary authority to issue shares of Common Stock in satisfaction of one or more outstanding RSUs as to which the designated service requirement is not attained. Such authority may be exercised at any time, whether before or after the executive&#8217;s termination of service. In addition, outstanding RSUs are subject to &#8220;double-trigger&#8221; vesting if the RSUs are assumed after a change in control, in which case accelerated vesting will apply only if the executive&#8217;s service is terminated by us without &#8220;cause&#8221; or by the executive due to a &#8220;constructive termination&#8221; within 90 days preceding or two years following the change in control. If the RSUs are not assumed in connection with the change in control, they will fully vest upon the change in control.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, the Company adopted the Retirement Policy, which provides for the continued vesting of qualifying equity awards in connection with an eligible employee&#8217;s qualifying retirement. For purposes of the Retirement Policy, a qualifying retirement means an eligible employee&#8217;s resignation on or after age 60 with at least seven years of continuous service with the Company and adequate notice. Upon a qualified retirement, the Retirement Policy provides that (i) any unvested restricted stock unit award granted more than one year prior to the eligible employee&#8217;s qualifying retirement shall become vested and settled in accordance with the original vesting schedule applicable to such award, and (ii) certain stock options granted more than one year prior to the eligible employee&#8217;s qualifying retirement shall become vested and exercisable in accordance with the original vesting schedule applicable to such award and remain exercisable for the entirety of their original term. As of December 31, 2024, Mr. Stonehouse was the only Named Executive Officer eligible for benefits under the Retirement Policy.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consulting Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Doyle resigned as Chief Financial Officer of the Company, effective April 9, 2025. The Compensation Committee approved a Consulting Agreement with Mr. Doyle, effective as of April 9, 2025, pursuant to which Mr. Doyle will provide transition services to the Company in exchange for a $450 hourly fee until May 31, 2025, or a later date mutually agreed by Mr. Doyle and the Company. For the duration of the Consulting Agreement, Mr. Doyle&#8217;s outstanding vested equity awards shall remain in full force and effect, and his outstanding unvested equity awards shall continue to vest in accordance with the original vesting schedule applicable to such awards.</span></div><div id="i08dd44edc832493d888aecb8122c7631_61"></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CEO Pay Ratio</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reasonable estimate, prepared under applicable SEC rules, of the ratio of the annual total compensation of our CEO to the median of the annual total compensation of our other employ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ees. We determined our median employee based on 2024 annual base salary and 2024 cash incentive awards for each of our 579 employees (excluding the CEO) as of December&#160;31, 2024. Of these 579 employees, 455 employees are located in the United States and 124 employees are located outside the United States. No foreign employees were excluded in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the process of identifying our median employee. For employees paid other than in U.S. dollars, we converted their compensation to U.S. dollars using the applicable yearly average exchange rates published by the Internal Revenue Service, and we did not make any cost-of-living adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual total co</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mpensation of our median employee (other than the CEO) for 2024, calculated in accordance with Item 402(c)(2)(x) under Regulation S-K, was $274,492. As disclosed in the Summary Compensation Table included in this Proxy Statement, our CEO&#8217;s annual total compensation for 2024 was $8,317,286. Based on the foregoing, the ratio of the 2024 annual total compensation of our CEO to the median of the annual total compensation of all other employees was 30 to 1. Given the different methodologies that various public companies use to determine an estimate of their pay ratio, the estimated ratio reported abo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ve should not be used as a basis for comparison between companies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance </span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-12" continuedAt="f-12-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#8220;compensation actually paid&#8221; and certain financial performance of the Company. For further information concerning the Company&#8217;s pay-for-performance philosophy and how the Company aligns executive compensation with the Company&#8217;s performance, refer to the &#8220;Compensation Discussion and Analysis&#8221; section above.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Initial Fixed $100 <br/>Investment Based On:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Peer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Group</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ORLADEYO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sales</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-13">8,317,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">10,979,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">3,368,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">4,160,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-17">217.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-18">172.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-19">88,881</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-20">434,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-21">4,777,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">3,691,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">1,963,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">1,232,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-25">173.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-26">159.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-27">226,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-28">323,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-29">6,982,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">4,009,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">2,568,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">1,452,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-33">332.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-34">153.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-35">247,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-36">249,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-37">7,061,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-38">17,053,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-39">4,523,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-40">7,254,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-41">401.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-42">137.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-43">184,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-44">121,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">6,034,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">10,853,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">2,353,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">3,630,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-49">215.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-50">110.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-51">182,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ecd:CoSelectedMeasureAmt" scale="3" id="f-52">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-53" continuedAt="f-53-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amounts reported for our CEO, <ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-54">Jon P. Stonehouse</ix:nonNumeric>, in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year.</span></ix:nonNumeric></div><div style="padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-56" continuedAt="f-56-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-55" continuedAt="f-55-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-56-1"><ix:continuation id="f-55-1"><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"><tr><td style="width:1.0%"/><td style="width:57.039%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.114%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2024<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2024<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-57">8,317,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-58">3,368,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-59">6,678,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">2,274,445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-61">6,818,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-62">2,322,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-63">1,507,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-64">520,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-65">1,013,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-66">224,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-67">10,979,333</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-68">4,160,611</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"><ix:continuation id="f-53-1">These amounts represent the average of the amounts reported for the Company&#8217;s named executive officers (referred to as &#8220;NEOs&#8221; in this section) as a group (excluding Mr. Stonehouse) in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2024 and 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#8217;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#8217;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#8217;s former Chief Business Officer; and (iv) for 2020 Thomas R. Staab II, the Company&#8217;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#8220;2023 Summary Compensation Table,&#8221; &#8220;2022 Summary Compensation Table,&#8221; &#8220;2021 Summary Compensation Table&#8221; and &#8220;2020 Summary Compensation Table&#8221; in our proxy statements for our 2024, 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2023, 2022, 2021 and 2020, respectively.</ix:continuation> </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-69" continuedAt="f-69-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on December&#160;31, 2019 and the closing share price of our Common Stock at the end of each fiscal year shown. </span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:PeerGroupIssuersFnTextBlock" id="f-70" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.</span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><ix:continuation id="f-69-1" continuedAt="f-69-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year.</span></ix:continuation></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><ix:continuation id="f-69-2" continuedAt="f-69-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#8220;Company-Selected Measure,&#8221; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#8220;Pay Versus Performance&#8221; table) used to link &#8220;compensation actually paid&#8221; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have </span></ix:continuation></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-12-1"><div style="margin-top:3pt;padding-left:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="f-69-3" continuedAt="f-69-4">selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month</ix:continuation>.</span></div></ix:continuation><ix:continuation id="f-69-4" continuedAt="f-69-5"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Certain Relationships between Information Presented in the Pay Versus Performance Table</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><ix:continuation id="f-69-5" continuedAt="f-69-6"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail in the &#8220;Compensation Discussion and Analysis&#8221; section above, the Company&#8217;s executive compensation program reflects a variable-pay-for-performance philosophy. It is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Company&#8217;s primary objectives for our executive compensation program are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_37">27</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Compensation Discussion and Analysis,&#8221; and the pre-established corporate objectives used to determine the variable component of executive compensation for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i.e., cash bonus under the AIP and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term equity grants) are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id9ea9e013d6740e696bf1d820d021d58_26709">31</a></span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-69-6">. While the Company uses several performance measures to align executive compensation with Company performance, not all of those Company measures are presented in the &#8220;Pay Versus Performance&#8221; table above. Further, not all of the Company&#8217;s performance measures are &#8220;financial performance measures&#8221; as defined above in note 7 to the &#8220;Pay Versus Performance&#8221; table. For example, as a growing commercial-stage biotechnology company with the goal of developing first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, some of our performance measures relate to developments in the Company&#8217;s product pipeline and to building a robust and adaptable organization. The Company generally seeks to incentivize long-term performance of the Company as a whole and, therefore, does not specifically align the Company&#8217;s performance measures with &#8220;compensation actually paid&#8221; (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year, which can be impacted in large part by changes in stock price. The Compensation Committee does not consider the information presented in this &#8220;Pay Versus Performance&#8221; section when making determinations regarding executive compensation.</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC rules, the Company is providing the following descriptions of the relationships between information presented in the &#8220;Pay Versus Performance&#8221; table.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-72" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-71" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid, Cumulative TSR, and Peer Group TSR </span></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20250424_g2.jpg" alt="6343" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-73" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and Net Loss</span></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20250424_g3.jpg" alt="6385" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-74" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and ORLADEYO Sales</span></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20250424_g4.jpg" alt="6433" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div></ix:nonNumeric><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-75" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Measures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed above under &#8220;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table,&#8221; the Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the &#8220;Pay Versus Performance&#8221; table. These performance measures include the pre-established corporate objectives for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as described in the &#8220;Compensation Discussion and Analysis&#8221; section, and reflect the Company&#8217;s variable pay-for-performance philosophy. As a growing company that engages heavily in research and development, the majority of our corporate objectives were not &#8220;financial performance measures,&#8221; as defined by SEC rules. However, they did include one financial performance measure for ORLADEYO sales. Accordingly, the most important financial performance measure used by the Company to link executive &#8220;compensation actually paid&#8221; to the Company&#8217;s NEOs, for the most recently completed fiscal year, to the Company&#8217;s performance is as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ORLADEYO sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span id="i830655254dc8407a904e56626902ed14_7756"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our financial performance measure, the Company views stock price as a key driver of value for all of our equity awards and, in particular, the stock options, which have no value unless the stock price appreciates from the date of grant.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> DIRECTOR COMPENSATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the compensation of our non-employee directors during fiscal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fees <br/>Earned <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">346,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">330,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">342,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">377,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">342,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">335,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">347,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">330,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Each non-employee director serving at the time of the Company&#8217;s 2024 annual meeting of stockholders received an automatic annual grant of RSUs under the Stock Incentive Plan, in accordance with the terms of the Company&#8217;s Director Compensation Policy, as amended, for 6,820 shares of Common Stock, which RSUs vest on the 12-month anniversary of the grant date, subject to the terms of the Stock Incentive Plan. As of December&#160;31, 2024, each non-employee director had RSUs covering 6,820 shares of Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of RSUs pursuant to the Stock Incentive Plan granted in 2024, calculated based on the closing price of our Common Stock as reported by Nasdaq on June 12, 2024 (the date of grant) of $6.30. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Options are granted to new directors automatically in accordance with our Stock Incentive Plan at the time they became a director. Prior to April 2022, new directors received an option to purchase 80,000 shares of Common Stock, prorated from the date of appointment until the next scheduled annual meeting, which options vest, subject to the terms of the Stock Incentive Plan, in 36 equal monthly installments over a three-year period measured from the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Each non-employee director serving at the time of the Company&#8217;s 2024 annual meeting of stockholders received an automatic annual grant of stock options under the Stock Incentive Plan, in accordance with the terms of the Company&#8217;s Director Compensation Policy, as amended, to purchase 49,933 shares of Common Stock, which options vest on the 12-month anniversary of the grant date, subject to the terms of the Stock Incentive Plan. As of December&#160;31, 2024, each non-employee director had options outstanding to purchase the following number of shares: Mr. Abercrombie: 274,027; Mr. Aselage: 254,027; Dr. Galson: 179,027; Ms. Heggie: 259,027; Dr. Hutson: 244,027; Mr. Levin: 214,027; Dr. McKee: 172,360; Mr. Milano: 185,694; and Ms. Sanders: 145,694.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of stock options pursuant to the Stock Incentive Plan granted in 2024. Assumptions used in the calculation of these amounts are included in Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December&#160;31, 2024, which are included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February&#160;25, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of our 2023 annual meeting of stockholders, Ms. Heggie and Mr. Milano elected to receive 50% of their respective cash retainers in the form of shares of our Common Stock in lieu of cash. As of our 2024 annual meeting of stockholders, Mr. Milano elected to receive 50% of his base retainer in the form of shares of our Common Stock in lieu of cash. Accordingly, in 2024, the Company issued the following number of shares of Common Stock in lieu of cash retainers: to Ms. Heggie, 1,536 shares in lieu of $9,375 of cash and to Mr. Milano, 3,151 shares in lieu of $22,500 of cash.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Narrative to Director Compensation Table</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors who are employees of the Company do not receive any additional compensation for their services as a director. Non-employee directors of the Company receive compensation for their services as a director in accordance with the terms of the Company&#8217;s Director Compensation Policy and the Stock Incentive Plan. The Director Compensation Policy was originally adopted by the Board on April 18, 2022 and amended and restated by the Board o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n April 21, 2025, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and may be further revised or amended by the Board in its discretion; provided, however, that, in accordance with the terms of the Stock Incentive Plan, the aggregate grant date fair value of all awards granted under the Stock Incentive Plan during any calendar year to any non-employee director (excluding any awards granted at the election of the director in lieu of all or any portion of cash retainers or fees otherwise payable to the director in cash), together with the amou</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nt of any cash fees or retainers paid to such director during such calendar year with respect to the director&#8217;s service as a non-employee director, cannot exceed $750,000 (or, for a non-employee director who first joins the Board, $1,000,000).</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Retainer Fees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual cash retainer fee consisting of four equal installment payments paid in arrears on a quarterly basis. Annual retainers are also paid in arrears to members of Board committees and committee Chairs on a quarterly basis. Directors are also reimbursed for expenses incurred in attending Boa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rd or committee meetings </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and while representing the Company in conducting certain business. The annual retainer fee in 2024 was $45,000 ($80,000 for the Chair). Fees are not paid for attending committee meetings. The 2024 annual retainers for committee members and Chairs remained the same as in 2023 and are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Member Retainer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Chair Retainer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit Committee</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Science Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Governance and Nominating Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are given the opportunity to elect to receive, in lieu of cash retainers, a number of shares of our Common Stock equivalent in value to the Board retainer earned by such director. Directors can elect to receive either 50% </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or 100% of their Board retainer (excluding any committee retainers) in the form of Common Stock. These shares are distributed four times a year, in line with the quarterly cash retainer payments. The number of shares to be distributed is determined using the closing price of our Common Stock on the last business day of the applicable three-month period. Elections to receive Company shares in lieu of cash for a year shall be made as of the date of each annual meeting of the Company&#8217;s stockholders, effective until the subsequent annual meeting.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New directors who join the Board are eligible to receive an initial equity grant equal to $500,000 upon their appointment to the Board, prorated based on the date of appointment relative to the Company&#8217;s annual meeting of stockholders and, prior to April 21, 2025, payable 70% in stock options and 30% in RSUs. In addition, on the date of each annual meeting of the Company&#8217;s stockholders, continuing directors are eligible to receive an equity grant equal to $325,000, which was payable 70% in stock options and 30% in RSUs prior to April 21, 2025. Initial equity grants in the form of options vest in 36 equal monthly installments, and initial equity grants in the form of RSUs vest in three equal annual installments, in each case over a three-year period measured from the grant date, subject to the terms of the Stock Incentive Plan. Annual equity grants vest on the 12-month anniversary of the grant date, subject to the terms of the Stock Incentive Plan. Following a grantee&#8217;s cessation of Board service for any reason, each stock option vested at the time of cessation of Board service will remain exercisable for the remainder of the ten-year term of that option. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Amendment to Director Compensation Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 7, 2022 and on June 13, 2023, the Company issued excess RSU grants to each member of the Board serving as a non-employee director on such date due to a miscalculation in applying the Director Compensation Policy. Upon discovery of the miscalculation, the Board approved an amendment to the Director Compensation Policy to reduce the number of RSUs granted to the non-employee directors in connection with the 2024 annual meeting of stockholders by the aggregate amount of the excess RSU grants.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended and Restated Director Compensation Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2025, the Board approved an Amended and Restated Director Compensation Policy. Under the terms of the Amended and Restated Director Compensation Policy, initial equity grants for new directors and annual equity grants for continuing directors are now payable 60% in stock options and 40% in RSUs. All other terms remained the same.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUDIT COMMITTEE REPORT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors has furnished the following report, in accordance with rules established by the SEC, for inclusion in this Proxy Statement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management the audited consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including a discussion of the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements. In addition, the Audit Committee reviewed and discussed with the Company&#8217;s management the internal audit plan for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Furthermore, the Audit Committee reviewed and discussed with the Company&#8217;s management and Ernst and Young LLP the evaluation of the Company&#8217;s design and functioning of its internal control over financial reporting, including the required Section 404 testing undertaken by Company management and Ernst and Young LLP with respect to the Company&#8217;s internal control over financial reporting. The Audit Committee reviewed with Ernst &amp; Young LLP, who are responsible for expressing an opinion on the conformity of those audited financial statements with generally accepted accounting principles, their judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed with the Audit Committee under generally accepted auditing standards. In addition, the Audit Committee has discussed with Ernst &amp; Young LLP the matters required to be discussed by applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC. The Audit Committee has received the written disclosures and the letter from Ernst &amp; Young LLP required by applicable requirements of the PCAOB regarding Ernst &amp; Young LLP&#8217;s communications with the Audit Committee concerning independence, and has discussed with Ernst &amp; Young LLP their independence. The Audit Committee also considered the compatibility of non-audit services with Ernst &amp; Young LLP&#8217;s independence.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee discussed with Ernst &amp; Young LLP the overall scope and plans for their audit. The Audit Committee regularly meets with Ernst &amp; Young LLP, with and without management present, to discuss the results of their examination, their evaluation of the Company&#8217;s internal controls, and the overall quality of the Company&#8217;s financial reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for filing with the SEC. The Audit Committee and the Board approved the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and has approved the retention of Ernst &amp; Young LLP as the principal accounting firm to be used by the Company throughout the fiscal year ending December 31, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee currently consists of Mr. Levin, as Chair, Mr. Abercrombie, Ms. Heggie, and Mr. Milano. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin, Chair of the Committee</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OWNERS AND MANAGEMENT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise indicated in the notes to the table, the following table sets forth information regarding beneficial ownership of the Company&#8217;s Common Stock as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;14, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by (i) each director, (ii) each of the Named Executive Officers, (iii) all directors and executive officers of the Company as a group, and (iv) each person known to the Company to be the beneficial owner of more than five percent of our Common Stock. Unless otherwise noted below, the address for each person listed in the table is the principal executive offices of the Company.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name and Address of Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount and Nature </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Beneficial </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Ownership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percent </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5% Stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vanguard Group </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Vanguard Blvd. </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malvern, PA 19355</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,730,939</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BlackRock, Inc. </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50 Hudson Yards</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY 10001</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,483,490</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avoro Capital Advisors LLC</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110 Greene Street, Suite 800 </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY 10012</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,050,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors and Named Executive Officers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">310,458</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">326,686</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237,398</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">311,879</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">330,665</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">265,798</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200,191</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">262,431</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,436</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,259,954</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(15)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,373,292</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">973,868</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,464,403</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,014,169</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(19)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All current executive officers and directors as a group (13 persons)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,131,336</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(20)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(*)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Less than one percent.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Gives effect to the shares of Common Stock each indicated stockholder has the right to acquire as of April&#160;14, 2025 or within 60 days from that date through the exercise of options and other rights beneficially held by such stockholder on that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Ownership percentage is reported based on 209,207,928 shares of Common Stock issued and outstanding on April&#160;14, 2025, plus, as to the holder thereof only and no other person, the number of shares (if any) that the person has the right to acquire as of April&#160;14, 2025 or within 60 days from that date through the exercise of options and other rights.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G/A filed with the SEC on November 7, 2024 indicating that 20,730,939 shares of Common Stock are held by The Vanguard Group as of October 31, 2024. The Vanguard Group may be deemed to have shared power to vote or to direct the vote of 380,460 shares of Common Stock, sole power to dispose or to direct the disposition of 20,140,642 shares of Common Stock, and shared power to dispose or to direct the disposition of 590,297 shares of Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G/A filed with the SEC on April 17, 2025 indicating that 17,483,490 shares are held by BlackRock, Inc. and certain subsidiaries as of March 31, 2025. No such subsidiary has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, more than five percent of our Common Stock. BlackRock, Inc. may be deemed to have sole power to vote or to direct the vote of 17,252,025 shares of Common Stock and sole power to dispose or to direct the disposition of 17,483,490 shares of Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G filed with the SEC on February 14, 2024 indicating that 13,050,000 shares of Common Stock are held by Avoro Capital Advisors LLC and Dr. Behzad Aghazadeh as of December 31, 2023. Dr. Aghazadeh serves as the portfolio manager and controlling person of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Avoro Capital Advisors LLC. Each of Avoro Capital Advisors LLC and Dr. Aghazadeh may be deemed to have sole power to vote or to direct the vote of 13,050,000 shares of Common Stock and sole power to dispose or to direct the disposition of 13,050,000 shares of Common Stock. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 274,027 shares issuable to Mr. Abercrombie upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Mr. Abercrombie upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 254,027 shares issuable to Mr. Aselage upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Mr. Aselage upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 179,027 shares issuable to Dr. Galson upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Dr. Galson upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 259,027 shares issuable to Ms. Heggie upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Ms. Heggie upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 244,027 shares issuable to Dr. Hutson upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Dr. Hutson upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 214,027 shares issuable to Mr. Levin upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Mr. Levin upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 172,360 shares issuable to Dr. McKee upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Dr. McKee upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 185,694 shares issuable to Mr. Milano upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Mr. Milano upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 145,694 shares issuable to Ms. Sanders upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 6,820 shares issuable to Ms. Sanders upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 4,320,070 shares issuable to Mr. Stonehouse upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 1,174,375 shares issuable to Mr. Doyle upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 812,250 shares issuable to Dr. Thackray upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 1,249,376 shares issuable to Ms. Barnes upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 776,354 shares issuable to Mr. Gayer upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 9,085,960 shares issuable to all of our current executive officers and directors upon exercise of stock options that are exercisable as of April&#160;14, 2025 or within 60 days from that date and (ii) 61,380 shares issuable to our directors upon vesting of RSUs within 60 days from April&#160;14, 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposals of stockholders intended to be presented at our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting of Stockholders (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting&#8221;) must be received by the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by December 25, 2025 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be considered for inclusion in our Proxy Statement relating to such meeting. Proposals for inclusion in the Proxy Statement must comply with the Exchange Act, including Rule 14a-8.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A stockholder must notify the Company of any proposal (including director nominations) that the stockholder intends to present, other than by inclusio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n in our proxy materials, at our 2026 Annual Meeting. To be timely, the notice must be delivered to the Company&#8217;s Corporate Secretary at the Company&#8217;s principal executive offices no earlier than February 12, 2026 and no later than March 14, 2026. In order for the proposal to be eligible for consideration at the 2026 Annual Meeting, the notice must include the infor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mation required by the Company&#8217;s By-Laws (which includes the information required by Exchange Act Rule 14a-19(b)), including, with respect to director nominations, specific information regarding both the stockholder making the nomination and the director nominee. These dates and notice requirements also apply to any stockholder nominations for directors to be included on a universal proxy card for election at our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual Meeting.  </span></div><div id="i08dd44edc832493d888aecb8122c7631_79"></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NO INCORPORATION BY REFERENCE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company&#8217;s filings with the SEC, information is sometimes &#8220;incorporated by reference.&#8221; This means that the Company is referring you to information that has previously been filed with the SEC and that the information should be considered part of a particular filing. As provided in regulations promulgated by the SEC, the &#8220;Audit Committee Report,&#8221; the &#8220;Compensation Committee Report,&#8221; and the &#8220;Pay Versus Performance&#8221; disclosures contained in this Proxy Statement specifically are not incorporated by reference into any other filings with the SEC. In addition, this Proxy Statement includes the Company&#8217;s website address. This website address is intended to provide inactive, textual references only. The information on the Company&#8217;s website is not part of this Proxy Statement.</span></div><div id="i08dd44edc832493d888aecb8122c7631_82"></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management does not intend to present to the Meeting any matters other than those previously mentioned herein and does not presently know of any matters that will be presented by other parties. If other matters should properly come before the Meeting, it is intended that the holders of the proxies will act in respect thereto and in accordance with their best judgment.</span></div><div id="i08dd44edc832493d888aecb8122c7631_85"></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; Proxy Statements and annual reports. This means that only one copy of the one-page notice regarding the Internet availability of proxy materials may have been sent to multiple stockholders in your household. You may have a separate copy of this document sent to you by contacting the Corporate Secretary, BioCryst Pharmaceuticals, Inc., 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703, (919) 859-1302. If you prefer to receive separate copies of the one-page notice regarding the Internet availability of proxy materials in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker or other nominee holder, or you may contact us at the above address.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders may obtain a copy of the Notice of Annual Meeting, Proxy Statement, Form of Proxy, and our Annual Report on Form 10-K, free of charge, by writing to the Corporate Secretary at the address stated above or by visiting www.proxyvote.com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BY ORDER OF THE BOARD OF DIRECTORS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes, Chief Legal Officer and <br/>Corporate Secretary</span></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Durham, North Carolina</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;24, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i08dd44edc832493d888aecb8122c7631_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNEX A</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BIOCRYST PHARMACEUTICALS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCK INCENTIVE PLAN</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(AS AMENDED AND RESTATED AS OF APRIL 21, 2025)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE ONE </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GENERAL PROVISIONS</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">PURPOSES OF THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">This Stock Incentive Plan (the &#8220;Plan&#8221;), formerly the &#8220;BioCryst Pharmaceuticals, Inc. 1991 Stock Option Plan,&#8221; is intended to promote the interests of BioCryst Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;), by providing a method whereby (i) employees (including officers and directors) of the Company (or its parent or subsidiary corporations), (ii) non-employee members of the board of directors of the Company (the &#8220;Board&#8221;) (or of any parent or subsidiary corporations) and (iii) consultants and other independent contractors who provide valuable services to the Company (or any parent or subsidiary corporations) may be offered the opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest, in the Company as an incentive for them to remain in the service of the Company (or any parent or subsidiary corporations).</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">For purposes of the Plan, the following provisions shall be applicable in determining the parent and subsidiary corporations of the Company:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Any corporation (other than the Company) in an unbroken chain of corporations ending with the Company shall be considered to be a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">parent </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corporation of the Company, provided each such corporation in the unbroken chain (other than the Company) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each corporation (other than the Company) in an unbroken chain of corporations beginning with the Company shall be considered to be a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">subsidiary</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company, provided each such corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The Plan, as amended and restated, was approved and adopted by the Board, effective on April 21, 2025, in order to increase by 11,000,000 the number of shares of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), available for issuance under the Plan, subject to approval by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders on June 12, 2025, and to make certain other changes.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">STRUCTURE OF THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan shall be divided into three separate equity programs: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">the Discretionary Option Grant Program specified in Article Two, pursuant to which eligible persons may, at the discretion of the Plan Administrator, be granted options to purchase shares of Common Stock, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Stock Issuance Program specified in Article Three, pursuant to which eligible persons may, at the discretion of the Plan Administrator, be issued shares of Common Stock directly or through the issuance of restricted stock units (&#8220;RSUs&#8221;) that provide for the issuance of shares of Common Stock if the applicable vesting criteria are satisfied, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">the Director Grant Program specified in Article Four, pursuant to which non-employee members of the Board may receive grants of awards.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Unless the context clearly indicates otherwise, the provisions of Articles One and Five of the Plan shall apply to all equity programs under the Plan and shall accordingly govern the interests of all individuals under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">ADMINISTRATION OF THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan shall be administered by the Committee who shall be the Compensation Committee of the Board or, in the absence of a Compensation Committee, a properly constituted committee or the Board itself (the administrator is referred to herein as the &#8220;Committee&#8221; or the &#8220;Plan Administrator&#8221;). Any power of the Committee may also be exercised by the Board, except to the extent that the grant or exercise of such authority would cause any award or transaction to become subject to (or lose an exemption under) the short-swing profit recovery provisions of Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;). To the extent that any permitted action taken </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by the Board conflicts with action taken by the Committee, the Board action shall control. The Committee may by resolution authorize one or more officers of the Company to perform any or all things that the Committee is authorized and empowered to do or perform under the Plan, and for all purposes under this Plan, such officer or officers shall be treated as the Committee; provided, however, that the resolution so authorizing such officer or officers shall specify the total number of awards (if any) such officer or officers may award pursuant to such delegated authority, and any such award shall be subject to the form of award agreement theretofore approved by the Compensation Committee. No such officer shall designate himself or herself as a recipient of any awards granted under authority delegated to such officer. In addition, the Compensation Committee may delegate any or all aspects of the day-to-day administration of the Plan to one or more officers or employees of the Company or any subsidiary or affiliate, and/or to one or more agents. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Subject to the express provisions of this Plan, the Committee shall be authorized and empowered to do all things that it determines to be necessary or appropriate in connection with the administration of this Plan, including, without limitation: (i) to prescribe, amend and rescind rules and regulations relating to this Plan and to define terms not otherwise defined herein; (ii) to determine which persons are grantees, to which of such grantees, if any, awards shall be granted hereunder and the timing of any such awards; (iii) to grant awards to grantees and determine the terms and conditions thereof, including the number of shares of Common Stock subject to awards and the exercise or purchase price of such shares and the circumstances under which awards become exercisable or vested or are forfeited or expire, which terms may but need not be conditioned upon the passage of time, continued employment, the satisfaction of performance criteria, the occurrence of certain events (including events which constitute a Change in Control to the extent permitted hereunder), or other factors; (iv) to establish and verify the extent of satisfaction of any performance goals or other conditions applicable to the grant, issuance, exercisability, vesting and/or ability to retain any award; (v) to prescribe and amend the terms of the agreements or other documents evidencing awards made under this Plan (which need not be identical) and the terms of or form of any document or notice required to be delivered to the Company by grantees under this Plan; (vi) to determine the extent to which adjustments are required pursuant to Article One; (vii) to interpret and construe this Plan, any rules and regulations under this Plan and the terms and conditions of any award granted hereunder, and to make exceptions to any such provisions for the benefit of the Company; (viii) to approve corrections in the documentation or administration of any award; and (ix) to make all other determinations deemed necessary or advisable for the administration of this Plan. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">All decisions, determinations and interpretations by the Committee regarding the Plan, any rules and regulations under the Plan and the terms and conditions of or operation of any award granted hereunder, shall be final and binding on all grantees, beneficiaries, heirs, assigns or other persons holding or claiming rights under the Plan or any award. The Committee shall consider such factors as it deems relevant, in its sole and absolute discretion, to making such decisions, determinations and interpretations including, without limitation, the recommendations or advice of any officer or other employee of the Company and such attorneys, consultants and accountants as it may select. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Committee may delegate all or a portion of their duties hereunder to one or more individuals or committees. Any reference to the Committee or the Plan Administrator shall refer to such individual(s) or committee(s) to the extent of such delegation.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">ELIGIBILITY</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The persons eligible to participate in the Discretionary Option Grant and Stock Issuance Programs shall be limited to the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">officers and other employees of the Company (or its parent or subsidiary corporations);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">individuals who are consultants or independent advisors and who provide valuable services to the Company (or its parent or subsidiary corporations); and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">non-employee members of the Board (or of the board of directors of parent or subsidiary corporations), subject to the limits set forth in Section II.A. of Article Four.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Only Board members who are not employees of the Company (or any parent or subsidiary) shall be eligible to receive grants pursuant to the Director Grant Program specified in Article Four.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The Plan Administrator shall, within the scope of its administrative jurisdiction under the Plan, have full power and authority to determine (i) whether to grant options in accordance with the Discretionary Option Grant Program or to effect stock issuances in accordance with the Stock Issuance Program, (ii) which eligible persons are to receive option grants under the Discretionary Option Grant Program, the time or times when such option grants are to be made, the number of shares to be covered by each such grant, the status of the granted option as either an incentive </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock option (&#8220;Incentive Option&#8221;) which satisfies the requirements of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or a non-statutory option not intended to meet such requirements, the time or times when each such option is to become exercisable, the vesting schedule (if any) applicable to the option shares and the maximum term for which such option is to remain outstanding, and (iii) which eligible persons are to receive stock issuances under the Stock Issuance Program, the time or times when such issuances are to be made, the number of shares to be issued to each grantee, the vesting schedule (if any) applicable to the shares and the consideration for such shares. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt">STOCK SUBJECT TO THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Shares of the Company&#8217;s Common Stock shall be available for issuance under the Plan and shall be drawn from either the Company&#8217;s authorized but unissued shares of Common Stock or from reacquired shares of Common Stock, including shares repurchased by the Company on the open market. The maximum number of shares of Common Stock which may be issued over the term of the Plan, as amended and restated, shall not exceed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,090,000</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares, subject to adjustment from time to time in accordance with the provisions of this Section V. The total number of shares available under th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e Plan, as amended and restated, as of April 21, 2025 is 60,095,997. This amount consists of 46,884,625 shares reserved for awards already issued, 2,211,372 shares of Common Stock available for future issuance under the Plan, and the increase of 11,000,000 shares of Common Stock authorized by the Board (subject to approval by the Company&#8217;s stockholders at the Annual Meeting </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Stockholders o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n June&#160;12, 2025).</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">In no event shall the number of shares of Common Stock for which a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny one individual participating in the Plan may receive options, separately exercisable stock appreciation rights and direct stock issuances and RSUs exceed 1,500,000 shares of Common Stock in the aggregate in any calendar year. For purposes of such limitation, however, no stock options granted prior to the date the Common Stock was first registered under Section 12 of the 1934 Act (the &#8220;Section 12(g) Registration Date&#8221;) shall be taken into account.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Should an outstanding option under this Plan expire or terminate for any reason prior to exercise in full, the shares subject to the portion of the option not so exercised shall be available for subsequent option grants or direct stock issuances or RSUs under the Plan. Unvested shares issued under the Plan and subsequently repurchased by the Company, at the original issue price paid per share, pursuant to the Company&#8217;s repurchase rights under the Plan, or shares underlying terminated RSUs, shall be added back to the number of shares of Common Stock reserved for issuance under the Plan and shall accordingly be available for reissuance through one or more subsequent option grants or direct stock issuances or RSUs under the Plan. However, shares subject to an award under the Plan may not again be made available for issuance under the Plan if such shares are: (i) shares that were subject to a stock-settled stock appreciation right and were not issued upon the net settlement or net exercise of such stock appreciation right, (ii) shares used to pay the exercise price of an option, (iii) shares delivered to or withheld by the Company to pay the withholding taxes related to an award, or (iv) shares repurchased on the open market with the proceeds of an option exercise. Shares of Common Stock subject to any option surrendered for an appreciation distribution under Section IV of Article Two or Section II.B.1.(iv) of Article Four shall not be available for subsequent issuance under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">In the event any change is made to the Common Stock issuable under the Plan by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without receipt of consideration, then appropriate adjustments shall be made to (i) the maximum number and/or class of securities issuable under the Plan, (ii) the maximum number and/or class of securities for which any one individual participating in the Plan may be granted stock options, separately exercisable stock appreciation rights, and direct stock issuances and RSUs under the Plan from and after the Section 12(g) Registration Date, (iii) the number and/or class of securities and price per share in effect under each outstanding option and stock appreciation right under the Plan, (iv) the number and/or class of securities in effect under each outstanding direct stock issuance and RSU under the Plan, and (v) the number and/or class of securities for which grants are subsequently to be made per non-employee Board member under the Director Grant Program. The purpose of such adjustments shall be to preclude the enlargement or dilution of rights and benefits under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.4pt">The fair market value per share of Common Stock on any relevant date under the Plan shall be determined in accordance with the following provisions:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If the Common Stock is not at the time listed or admitted to trading on any national securities exchange but is traded in the over-the-counter market, the fair market value shall be the mean between the highest bid and lowest asked prices (or, if such information is available, the closing selling price) per share of Common Stock on the date in question in the over-the-counter market, as such prices are reported on the Nasdaq National Market, the Nasdaq Global Select Market or any successor system. If there are no reported bid and asked prices (or closing selling price) for the Common Stock on the date in question, then the mean between the highest bid </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price and lowest asked price (or the closing selling price) on the last preceding date for which such quotations exist shall be determinative of fair market value.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If the Common Stock is at the time listed or admitted to trading on any national securities exchange, then the fair market value shall be the closing selling price per share of Common Stock on the date in question on the securities exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange. If there is no reported sale of Common Stock on the exchange on the date in question, then the fair market value shall be the closing selling price on the exchange on the last preceding date for which such quotation exists.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">If the Common Stock is at the time neither listed nor admitted to trading on any securities exchange nor traded in the over-the-counter market, then the fair market value shall be determined by the Plan Administrator after taking into account such factors as the Plan Administrator shall deem appropriate.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">MINIMUM VESTING</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan to the contrary, in no event shall any award granted pursuant to this Plan vest prior to the twelve (12)-month anniversary of the date of grant, other than in connection with the grantee&#8217;s death or permanent disability or, to the extent permitted hereunder, in connection with a Change in Control (provided that this limitation shall not apply with respect to up to five percent (5%) of the shares of Common Stock available for issuance under this Plan following approval of the Plan at the Company&#8217;s Annual Meeting of Stockholders on June 12, 2025). The minimum vesting period set forth in this Section VI may not be waived or superseded by any provision in an award or other agreement.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE TWO</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DISCRETIONARY OPTION GRANT PROGRAM</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">TERMS AND CONDITIONS OF OPTIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted pursuant to this Article Two shall be authorized by action of the Plan Administrator and may, at the Plan Administrator&#8217;s discretion, be either Incentive Options or non-statutory options. Individuals who are not Employees may only be granted non-statutory options under this Article Two. Each option granted shall be evidenced by one or more instruments in the form approved by the Plan Administrator. Each such instrument shall, however, comply with the terms and conditions specified below, and each instrument evidencing an Incentive Option shall, in addition, be subject to the applicable provisions of Section II of this Article Two.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Option Price</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The option price per share shall be fixed by the Plan Administrator. In no event, however, shall the option price per share be less than one hundred percent (100%) of the fair market value per share of Common Stock on the date of the option grant.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The option price shall become immediately due upon exercise of the option and shall, subject to the provisions of Section IV of this Article Two and the instrument evidencing the grant, be payable through one of the following methods (or a combination thereof):</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">full payment in cash or check drawn to the Company&#8217;s order;</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">full payment in shares of Common Stock held by the optionee for the requisite period necessary to avoid a charge to the Company&#8217;s earnings for financial reporting purposes and valued at fair market value on the Exercise Date (as such term is defined below);</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">full payment through a &#8220;net settlement&#8221; procedure pursuant to which the Company shall withhold shares of Common Stock issuable in connection with the exercise of the option with a fair market value equal to the exercise price and, if elected by the optionee, all applicable Federal and State income and employment taxes required to be withheld by the Company in connection with such exercise</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">full payment through a broker-dealer sale and remittance procedure pursuant to which the optionee (I) shall provide irrevocable written instructions to a designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate option price payable for the purchased shares plus all applicable Federal and State income and employment taxes required to be withheld by the Company in connection with such purchase and (II) shall provide written directives to the Company to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale transaction; or</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">such other method as permitted by the Plan Administrator, including any combination of the foregoing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this subparagraph 2, the Exercise Date shall be the date on which written notice of the option exercise is delivered to the Company. Except to the extent the sale and remittance procedure is utilized in connection with the exercise of the option, payment of the option price for the purchased shares must accompany such notice.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Term and Exercise of Options</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each option granted under this Article Two shall be exercisable at such time or times, during such period, and for such number of shares as shall be determined by the Plan Administrator and set forth in the instrument evidencing the option grant. No such option, however, shall have a maximum term in excess of ten (10) years from the grant date. During the lifetime of the optionee, the option, together with any stock appreciation rights pertaining to such option, shall be exercisable only by the optionee and shall not be assignable or transferable by the optionee except for a transfer of the option by will or by the laws of descent and distribution following the optionee&#8217;s death and, for the avoidance of doubt, may not be transferred to a third party for cash or other value. However, the Plan Administrator shall have the discretion to provide that a non-statutory option may, in connection with the optionee&#8217;s estate plan, be assigned in whole or in part during the optionee&#8217;s lifetime either (i) as a gift to one or more members of optionee&#8217;s immediate family, to a trust in which optionee and/or one or more such family members hold more than fifty percent (50%) of the beneficial interest or an entity in which more than fifty percent (50%) of the voting interests are owned by optionee and/or one or more such family members, or (ii) pursuant to a domestic relations order. The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Termination of Service</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Except to the extent otherwise provided pursuant to Section V of this Article Two or pursuant to an applicable award agreement, the following provisions shall govern the exercise period applicable to any options held by the optionee at the time of cessation of Service or death.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Should the optionee cease to remain in Service for any reason other than death or permanent disability, then the period for which each outstanding option held by such optionee is to remain exercisable shall be limited to the three (3)-month period following the date of such cessation of Service. However, should optionee die during the three (3)-month period following his or her cessation of Service, the personal representative of the optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to the optionee&#8217;s will or in accordance with the laws of descent and distribution shall have a twelve (12)-month period following the date of the optionee&#8217;s death during which to exercise such option.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event such Service terminates by reason of permanent disability (as defined in Section 22(e)(3) of the Code), then the period for which each outstanding option held by the optionee is to remain exercisable shall be limited to the twelve (12)-month period following the date of such cessation of Service.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">Should the optionee, after completing five (5) full years of Service, die while in Service, then the exercisability of each of his or her outstanding options shall automatically accelerate so that each such option shall become fully exercisable with respect to the total number of shares of Common Stock at the time subject to such option and may be exercised for all or any portion of such shares. The personal representative of the optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to the optionee&#8217;s will or in accordance with the laws of descent and distribution shall have a twelve (12)-month period following the date of the optionee&#8217;s death during which to exercise such option. </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">In the event such Service terminates by reason of death prior to the optionee obtaining five (5) full years of Service, then the period for which each outstanding vested option held by the optionee at the time of death shall be exercisable by the optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to the optionee&#8217;s will or in accordance with the laws of descent and distribution shall be limited to the twelve (12)-month period following the date of the optionee&#8217;s death.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Under no circumstances, however, shall any such option be exercisable after the specified expiration date of the option term.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Each such option shall, during such limited exercise period, be exercisable for any or all of the shares for which the option is exercisable on the date of the optionee&#8217;s cessation of Service. Upon the expiration of such limited exercise period or (if earlier) upon the expiration of the option term, the option shall terminate and cease to be exercisable. However, each outstanding option shall immediately terminate and cease to remain outstanding, at the time of the optionee&#8217;s cessation of Service, with respect to any shares for which the option is not otherwise at that time exercisable or in which the optionee is not otherwise vested.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.8pt">Should (i) the optionee&#8217;s Service be terminated for misconduct (including, but not limited to, any act of dishonesty, willful misconduct, fraud or embezzlement) or (ii) the optionee make any unauthorized use or disclosure of confidential information or trade secrets of the Company or its parent or subsidiary corporations, then in any such event all outstanding options held by the optionee under this Article Two shall terminate immediately and cease to be exercisable.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator shall have complete discretion, exercisable either at the time the option is granted or at any time while the option remains outstanding, to permit one or more options held by the optionee under this Article Two to be exercised, during the limited period of exercisability provided under subparagraph 1 above, not only with respect to the number of shares for which each such option is exercisable at the time of the optionee&#8217;s cessation of Service but also with respect to one or more subsequent installments of purchasable shares for which the option would otherwise have become exercisable had such cessation of Service not occurred.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">For purposes of the foregoing provisions of this Section I.C (and for all other purposes under the Plan):</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The optionee shall be deemed to remain in the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company for so long as such individual renders services on a periodic basis to the Company (or any parent or subsidiary corporation) in the capacity of an Employee, a non-employee member of the board of directors or an independent consultant or advisor, unless the agreement evidencing the applicable option grant specifically states otherwise.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The optionee shall be considered to be an </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for so long as such individual remains in the employ of the Company or one or more of its parent or subsidiary corporations, subject to the control and direction of the employer entity not only as to the work to be performed but also as to the manner and method of performance.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Stockholder Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An optionee shall have no stockholder rights with respect to any shares covered by the option until such individual shall have exercised the option and paid the option price for the purchased shares. Without limitation, an optionee shall not have any right to receive dividends with respect to an unexercised option.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt;text-decoration:underline">No Repricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&#8217;s capitalization as permitted under this Plan) without the approval of the stockholders of the Company. </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt;text-decoration:underline">Repurchase Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of Common Stock acquired upon the exercise of options granted under this Article Two may be subject to repurchase by the Company in accordance with the following provisions:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator shall have the discretion to grant options which are exercisable for unvested shares of Common Stock under this Article Two. Should the optionee cease Service while holding such unvested shares, the Company shall have the right to repurchase any or all those unvested shares at the option price paid per share. The terms and conditions upon which such repurchase right shall be exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established by the Plan Administrator and set forth in the instrument evidencing such repurchase right.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">All of the Company&#8217;s outstanding repurchase rights shall automatically terminate, and all shares subject to such terminated rights shall immediately vest in full, upon the occurrence of any Corporate Transaction </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under Section III of this Article Two, except to the extent: (i) any such repurchase right is expressly assigned to the successor corporation (or parent thereof) in connection with the Corporate Transaction or (ii) such termination is precluded by other limitations imposed by the Plan Administrator at the time the repurchase right is issued.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator shall have the discretionary authority, exercisable either before or after the optionee&#8217;s cessation of Service, to cancel the Company&#8217;s outstanding repurchase rights with respect to one or more shares purchased or purchasable by the optionee under this Discretionary Option Grant Program and thereby accelerate the vesting of such shares in whole or in part at any time.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">INCENTIVE OPTIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions specified below shall be applicable to all Incentive Options granted under this Article Two. Incentive Options may only be granted to individuals who are Employees of the Company. Options which are specifically designated as &#8220;non-statutory&#8221; options when issued under the Plan shall not be subject to such terms and conditions.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Dollar Limitation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The aggregate fair market value (determined as of the respective date or dates of grant) of the Common Stock for which one or more options granted to any Employee under this Plan (or any other option plan of the Company or its parent or subsidiary corporations) may for the first time become exercisable as incentive stock options under the Federal tax laws during any one calendar year shall not exceed the sum of One Hundred Thousand Dollars ($100,000). To the extent the Employee holds two or more such options which become exercisable for the first time in the same calendar year, the foregoing limitation on the exercisability of such options as incentive stock options under the Federal tax laws shall be applied on the basis of the order in which such options are granted. Should the number of shares of Common Stock for which any Incentive Option first becomes exercisable in any calendar year exceed the applicable One Hundred Thousand Dollar ($100,000) limitation, then that option may nevertheless be exercised in such calendar year for the excess number of shares as a non-statutory option under the Federal tax laws.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">10% Stockholder</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any individual to whom an Incentive Option is granted is the owner of stock (as determined under Section 424(d) of the Code) possessing 10% or more of the total combined voting power of all classes of stock of the Company or any one of its parent or subsidiary corporations, then the option price per share shall not be less than one hundred and ten percent (110%) of the fair market value per share of Common Stock on the grant date, and the option term shall not exceed five (5) years, measured from the grant date.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Termination of Employment</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any portion of an Incentive Option that remains outstanding (by reason of the optionee remaining in the Service of the Company, pursuant to the Plan Administrator&#8217;s exercise of discretion under Section V of this Article Two, or otherwise) more than 3 months following the date an optionee ceases to be an Employee of the Company shall thereafter be exercisable as a non-statutory option under federal tax laws.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as modified by the preceding provisions of this Section II, the provisions of Articles One, Two and Five of the Plan shall apply to all Incentive Options granted hereunder.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">CORPORATE TRANSACTIONS/CHANGES IN CONTROL</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">For purposes of this Section III (and for all other purposes under the Plan), a Corporate Transaction shall be deemed to occur in the event of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the State of the Company&#8217;s incorporation,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">the sale, transfer or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company, or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any reverse merger in which the Company is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such merger. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Immediately after the consummation of the Corporate Transaction, all outstanding options under this Article Two shall fully vest, terminate and cease to be outstanding, except to the extent continued or assumed (as applicable) by the Company or the successor corporation or its parent company. The Plan Administrator shall have complete discretion to provide, on such terms and conditions as it sees fit, for a cash payment to be made to any optionee on account of any option terminated in accordance with this paragraph, in an amount equal to the excess (if any) of (A) the fair market value of the shares subject to the option as of the date of the Corporate Transaction, over (B) the aggregate exercise price of the option.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Each outstanding option under this Article Two which is assumed in connection with the Corporate Transaction or is otherwise to continue in effect shall be appropriately adjusted, immediately after such Corporate Transaction, to apply and pertain to the number and class of securities which would have been issued to the option holder, in consummation of such Corporate Transaction, had such person exercised the option immediately prior to such Corporate Transaction. Appropriate adjustments shall also be made to the option price payable per share, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the aggregate option price payable for such securities shall remain the same. In addition, the class and number of securities available for issuance under the Plan following the consummation of the Corporate Transaction shall be appropriately adjusted. Any such options that are so continued or assumed in connection with a Corporate Transaction shall be treated as follows: if the grantee&#8217;s employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period following the Corporate Transaction, the exercisability of such option shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate; provided, however, that if the Company, the acquiror or successor refuses to continue (or, as applicable, assume) the option in connection with the Corporate Transaction, the exercisability of such option under this Article Two shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate upon the occurrence of such Corporate Transaction. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The grant of options under this Article Two shall in no way affect the right of the Company to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.4pt">In the event of a Change in Control: if the grantee&#8217;s employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period following the Change in Control, the exercisability of the grantee&#8217;s options shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate; provided, however, that if the acquiror or successor refuses to assume the option in connection with the Change in Control, the exercisability of such option under this Article Two shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate upon the occurrence of such Change in Control. In the event that the acquiror or successor refuses to assume the option in connection with the Change in Control, the Plan Administrator shall have complete discretion to provide, on such terms and conditions as it sees fit, for a cash payment to be made to any optionee on account of any option terminated in accordance with this paragraph, in an amount equal to the excess (if any) of (A) the fair market value of the shares subject to the option as of the date of the Change in Control, over (B) the aggregate exercise price of the option.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.94pt">For purposes of this Section III (and for all other purposes under the Plan), a Change in Control shall be deemed to occur in the event:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">there is a change in the composition of the Board over a period of twenty-four (24) consecutive months or less such that a majority of the Board members (rounded up to the next whole number) ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election as Board members during such period by at least two-thirds of the Board members described in clause (A) who were still in office at the time such election or nomination was approved by the Board.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Unless terminated in accordance with Section III.B of this Article Two above, all options accelerated in connection with the Corporate Transaction or Change in Control (either at the time of the Corporate Transaction or Change in Control or as otherwise provided in this Section III) shall remain fully exercisable until the expiration or sooner termination of the option term.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">H.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The portion of any Incentive Option accelerated under this Section III in connection with a Corporate Transaction or Change in Control shall remain exercisable as an incentive stock option under the Federal tax laws only to the extent the dollar limitation of Section II of this Article Two is not exceeded. To the extent such dollar limitation is exceeded, the accelerated portion of such option shall be exercisable as a non-statutory option under the Federal tax laws.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.17pt">For purposes of this Article Two and for purposes of Article Three:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;Cause&#8221; means, unless otherwise provided in the applicable award agreement, the Company&#8217;s termination of the grantee&#8217;s employment for any of the following reasons: (i) failure or refusal to comply in any material respect with lawful policies, standards or regulations of the Company; (ii) a violation of a federal or state law or regulation applicable to the business of the Company; (iii) conviction or plea of no contest to a felony under the laws of the United States or any State; (iv) fraud or misappropriation of property belonging to the Company or its affiliates; (v) a breach in any material respect of the terms of any confidentiality, invention assignment or proprietary information agreement with the Company or with a former employer; (vi) failure to satisfactorily perform the grantee&#8217;s duties after having received written notice of such failure and at least thirty (30) days to cure such failure; or (vii) misconduct or gross negligence in connection with the performance of the grantee&#8217;s duties.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;Constructive Termination&#8221; means, unless otherwise provided in the applicable award agreement, the grantee&#8217;s resignation of employment with the Company within ninety (90) days of the occurrence of any of the following: (i) a material reduction in the grantee&#8217;s responsibilities; (ii) a material reduction in the grantee&#8217;s base salary; or (iii) a relocation of the grantee&#8217;s principal office to a location more than 50 miles from the location of the grantee&#8217;s existing principal office.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">STOCK APPRECIATION RIGHTS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Provided and only if the Plan Administrator determines in its discretion to implement the stock appreciation right provisions of this Section IV, one or more optionees may be granted the right, exercisable upon such terms and conditions as the Plan Administrator may establish, to surrender all or part of an unexercised option granted under this Article Two in exchange for a distribution from the Company in an amount equal to the excess of (i) the fair market value (on the option surrender date) of the number of shares in which the optionee is at the time vested under the surrendered option (or surrendered portion thereof) over (ii) the aggregate option price payable for such vested shares. The distribution may be made in shares of Common Stock valued at fair market value on the option surrender date, in cash, or partly in shares and partly in cash, as the Plan Administrator shall determine in its sole discretion.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The shares of Common Stock subject to any option surrendered for an appreciation distribution pursuant to this Section IV shall not be available for subsequent option grant under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Stockholder Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A stock appreciation right holder shall have no stockholder rights with respect to any shares covered by the stock appreciation right until such individual shall have exercised the stock appreciation right and received the acquired shares. Without limitation, a stock appreciation right holder shall not have any right to receive dividends with respect to a stock appreciation right.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt">EXTENSION OF EXERCISE PERIOD</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator shall have full power and authority, exercisable either at the time the option is granted or at any time while the option remains outstanding, to extend the period of time for which any option granted under this Article Two is to remain exercisable following the optionee&#8217;s cessation of Service or death from the limited period in effect under Section I.C.1 of Article Two to such greater period of time as the Plan Administrator shall deem appropriate; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, however, that in no event shall such option be exercisable after the specified expiration date of the option term.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE THREE</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STOCK ISSUANCE PROGRAM</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">STOCK ISSUANCE TERMS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Common Stock may be issued under the Stock Issuance Program through direct and immediate issuances without any intervening option grants. Each such stock issuance shall be evidenced by a Stock Issuance Agreement which complies with the terms specified below. Shares of Common Stock may also be issued under the Stock Issuance Program pursuant to RSUs, which are awards granted to eligible individuals that entitle them to shares of Common Stock (or cash in lieu thereof) in the future following the satisfaction of vesting conditions imposed by the Plan Administrator.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Vesting Provisions</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator may issue shares of Common Stock under the Stock Issuance Program which are to vest in one or more installments over the grantee&#8217;s period of Service or upon attainment of specified performance objectives. Alternatively, the Plan Administrator may issue RSUs under the Stock Issuance Program which shall entitle the recipient to receive a specified number of shares of Common Stock upon the attainment of one or more Service and/or performance goals established by the Plan Administrator. Upon the attainment of such </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and/or performance goals, fully-vested shares of Common Stock shall be issued in satisfaction of those RSUs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any new, substituted or additional securities or other property (including money paid other than as a regular cash dividend) issued by reason of any stock dividend, stock split, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Company&#8217;s receipt of consideration, shall be issued or set aside with respect to the shares of unvested Common Stock granted to a grantee or subject to a grantee&#8217;s RSUs, subject to (i) the same vesting requirements applicable to the grantee&#8217;s unvested shares of Common Stock or RSUs, and (ii) such escrow arrangements as the Plan Administrator shall deem appropriate. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The grantee shall have full stockholder rights with respect to any shares of Common Stock issued to the grantee under the Stock Issuance Program, whether or not the grantee&#8217;s interest in those shares is vested, except that the grantee shall not have dividend rights with respect to such shares prior to the vesting of such shares. However, the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on such shares of Common Stock, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock granted hereunder, and (ii) payable upon vesting of the shares to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The grantee shall not have any stockholder rights with respect to any shares of Common Stock subject to an RSU. However, the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on the shares of Common Stock underlying the RSU, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock underlying the RSU, and (ii) payable upon issuance of the shares to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Should the grantee cease to remain in Service while holding one or more unvested shares of Common Stock issued under the Stock Issuance Program or should the performance objectives not be attained with respect to one or more such unvested shares of Common Stock, then those shares shall be immediately surrendered to the Company for cancellation, and the grantee shall have no further stockholder rights with respect to those shares. To the extent the surrendered shares were previously issued to the grantee for consideration paid in cash, the Company shall repay to the grantee the cash consideration paid for the surrendered shares. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Except as prohibited by the last sentence of Section VI of Article One, the Plan Administrator may in its discretion waive the surrender and cancellation of one or more unvested shares of Common Stock which would otherwise occur upon the cessation of the grantee&#8217;s Service or the non-attainment of the performance objectives applicable to those shares. Such waiver shall result in the immediate vesting of the grantee&#8217;s interest in the shares of Common Stock as to which the waiver applies. Such waiver may be effected at any time, whether before or after the grantee&#8217;s cessation of Service or the attainment or non-attainment of the applicable performance objectives. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Outstanding RSUs under the Stock Issuance Program shall automatically terminate, and no shares of Common Stock shall actually be issued in satisfaction of those awards, if the Service and/or performance goals established for such awards are not attained. The Plan Administrator, however, shall, except as prohibited by the last sentence of Section VI of Article One above, have the discretionary authority to issue shares of Common Stock in satisfaction of one or more outstanding RSUs as to which the designated Service and/or performance goals are not attained. Such authority may be exercised at any time, whether before or after the grantee&#8217;s cessation of Service or the attainment or non-attainment of the applicable performance objectives.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">CORPORATE TRANSACTION/CHANGE IN CONTROL</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">All of the Company&#8217;s outstanding repurchase rights under the Stock Issuance Program shall terminate automatically, and all the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Corporate Transaction, except to the extent (i) those repurchase rights are to be assigned to the successor corporation (or parent thereof) in connection with such Corporate Transaction, or (ii) such accelerated vesting is precluded by other limitations imposed in the Stock Issuance Agreement, unless the Plan Administrator determines to waive such limitations.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Each award which is assigned in connection with (or is otherwise to continue in effect after) a Corporate Transaction shall be appropriately adjusted such that it shall apply and pertain to the number and class of securities issued to the grantee in consummation of the Corporate Transaction with respect to the shares granted to grantee under this Article Three.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">In the event of a Change in Control, shares of restricted stock and RSUs shall be treated as follows: if the grantee&#8217;s employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period following the Change in Control, the vesting of such restricted stock and RSUs shall automatically accelerate (and all of the shares of Common Stock subject to such RSUs shall be issued to grantees), and the Company&#8217;s outstanding repurchase rights under this Article Three shall immediately terminate; provided, however, that if the acquiror or successor refuses to assume the shares of restricted stock or RSUs or substitute an award of equivalent value (as determined by the Committee in its discretion) in connection with the Change in Control, the vesting of such restricted stock or RSUs under this Article Three shall automatically accelerate (and all of the shares of Common Stock subject to such RSUs shall be issued to grantees). To the extent any shares of restricted stock or RSUs vest in whole or in part based on the achievement of performance criteria, the amount that shall vest in accordance with the proviso to the immediately-preceding sentence shall vest based on the higher of actual performance goal attainment through the date of the Change in Control or a prorated amount using target performance and based on the time elapsed in the performance period as of the date of the Change in Control.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">STOCKHOLDER RIGHTS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Individuals who are granted shares of Common Stock pursuant to this Article Three shall be the owners of such shares for all purposes while holding such Common Stock, and may exercise full voting rights with respect to those shares at all times while held by the individuals. Individuals who have been granted RSUs shall have no voting rights with respect to Common Stock underlying RSUs unless and until such Common Stock is reflected as issued and outstanding shares on the Company&#8217;s stock ledger. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Individuals who are granted shares of Common Stock pursuant to this Article Three shall not have dividend rights with respect to such shares prior to the vesting of such shares. However, the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on such shares of Common Stock, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock granted hereunder, and (ii) payable upon vesting of the shares to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">SHARE ESCROW / LEGENDS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested shares may, in the Plan Administrator&#8217;s discretion, be held in escrow by the Company until the grantee&#8217;s interest in such shares vests or may be issued directly to the grantee with restrictive legends on the certificates evidencing those unvested shares.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE FOUR</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DIRECTOR GRANT PROGRAM</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">ELIGIBILITY</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The individuals eligible to receive grants pursuant to the provisions of this Article Four shall be (i) those individuals who, after the effective date of this amendment and restatement, first become non-employee Board members, whether through appointment by the Board, election by the Company&#8217;s stockholders, or by continuing to serve as a Board member after ceasing to be employed by the Company, and (ii) those individuals already serving as non-employee Board members on the effective date of this amendment and restatement. As used herein, a &#8220;non-employee&#8221; Board member is any Board member who is not employed by the Company on the date in question.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">TERMS AND CONDITIONS OF DIRECTOR GRANTS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Grants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Grants under this Article Four shall be made pursuant to a Director Compensation Policy adopted by the Board (the &#8220;Director Compensation Policy&#8221;) and may be in the form of non-statutory options, RSUs, shares of Common Stock, other awards issuable under the Plan or a combination thereof, as determined by the Committee. In no event shall the aggregate grant date fair value (calculated in accordance with FASB ASC Topic 718 ) of all awards granted under the Plan during any calendar year to any non-employee Board member (excluding any awards granted at the election of a non-employee Board member in lieu of all or any portion of cash retainers or fees otherwise payable to non-employee Board members in cash), together with the amount of any cash fees or retainers paid to such non-employee Board members during such calendar year with respect to such individual&#8217;s service as a non-employee Board member, exceed $750,000 (or, for a non-employee Board member who first joins the Board, $1,000,000).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Terms and Conditions of Grants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Options</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Term</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each option granted under this Article Four shall be exercisable at such time or times, during such period, and for such number of shares as shall be set forth in the Director Compensation Policy or as otherwise determined by the Plan Administrator and set forth in the instrument evidencing the option grant. No such option, however, shall have a maximum term in excess of ten (10) years from the grant date.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Option Price</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The option price per share shall be fixed by the Plan Administrator. In no event, however, shall the option price per share be less than one hundred percent (100%) of the fair market value per share of Common Stock on the date of the option grant. The option price shall become immediately due upon exercise of the option and shall, subject to Section II.B.1.(iv) of this Article Four and the instrument evidencing the grant, be payable in any manner set forth in Section I.A.2 of Article Two. </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt;text-decoration:underline">Non-Transferability</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the lifetime of the optionee, each option grant, together with any limited stock appreciation right pertaining to such option, shall be exercisable only by the optionee and shall not be assignable or transferable by the optionee, except to the extent such option or the limited stock appreciation right is assigned or transferred (i) by will or by the laws of descent and distribution following the optionee&#8217;s death, or (ii) during optionee&#8217;s lifetime either (A) as a gift in connection with the optionee&#8217;s estate plan to one or more members of optionee&#8217;s immediate family, to a trust in which optionee and/or one or more such family members hold more than fifty percent (50%) of the beneficial interest or to an entity in which more than fifty percent (50%) of the voting interests are owned by optionee and/or one or more such family members, or (B) pursuant to a domestic relations order. The portion of any option assigned or transferred during optionee&#8217;s lifetime shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt;text-decoration:underline">Stock Appreciation Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to each option granted under this Article Four, solely to the extent provided by the Plan Administrator in its sole discretion, each optionee shall have the right to surrender all or part of the option (to the extent not then exercised) in exchange for a distribution from the Company in an amount equal to the excess of (i) the fair market value (on the option surrender date) of the number of shares in which the grantee is at the time vested under the surrendered option (or surrendered portion thereof) over (ii) the aggregate option price payable for such vested shares. The distribution shall be made in shares of Common Stock valued at fair market value on the option surrender date.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">No Repricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&#8217;s capitalization as permitted under this Plan) without the approval of the stockholders of the Company.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants Generally</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Stockholder Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The holder of an option grant under this Article Four shall have none of the rights of a stockholder with respect to any shares subject to such option until such individual shall have exercised the option and paid the exercise price for the purchased shares, and the holder of RSUs granted under this Article Four shall have none of the rights of a stockholder with respect to any shares subject to such RSUs until shares have been delivered in settlement thereof. Without limitation, a grantee shall not have any right to receive dividends with respect to an unexercised option or unsettled RSUs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Corporate Transactions/Changes in Control</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with a Corporate Transaction or a Change in Control, grants under this Article Four shall be treated in the manner specified in Article Two (with respect to options) or Article Three (with respect to shares of Common Stock and RSUs), as applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">Subject to the terms of the Plan, the terms and conditions of the grants under this Article Four shall be determined by the Plan Administrator consistent with the Director Compensation Policy. </span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE FIVE</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PERFORMANCE GOALS</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">GENERAL</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator may establish performance criteria and level of achievement versus such criteria that shall determine the number of shares of Common Stock or RSUs to be granted, retained, vested, issued or issuable under or in settlement of or the amount payable pursuant to an award hereunder. In addition, the Plan Administrator may specify that an award or a portion of an award shall be subject to measures based on one or more performance criteria selected by the Committee and specified at the time the award is granted. The Committee shall certify the extent to which any performance criteria have been satisfied, and the amount payable as a result thereof, prior to payment, settlement or vesting of any award subject thereto. Notwithstanding satisfaction of any performance goals, the number of shares of Common Stock issued under or the amount paid under an award may, to the extent specified in the applicable award agreement, be reduced by the Committee on the basis of such further considerations as the Committee in its sole discretion shall determine. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">PERFORMANCE CRITERIA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Plan, performance criteria may include any one or more performance criteria, either individually, alternatively or in any combination, applied to either the Company as a whole or to a business unit or subsidiary, either individually, alternatively or in any combination, and measured either quarterly, annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to previous years&#8217; results or to a designated comparison group, in each case as specified by the Committee. The Committee (A) shall appropriately adjust any evaluation of performance under applicable performance criteria to eliminate the effects of charges for restructurings, discontinued operations, extraordinary items and all items of gain, loss or expense determined to be extraordinary or unusual in nature or related to the acquisition or disposal of a segment of a business or related to a change in accounting principle all as determined in accordance with standards established by opinion No. 30 of the Accounting Principles Board (APB Opinion No. 30) or other applicable or successor accounting provisions, as well as the cumulative effect of accounting changes, in each case as determined in accordance with generally accepted accounting principles or identified in the Company&#8217;s financial statements or notes to the financial statements, and (B) may appropriately adjust any evaluation of performance under applicable performance criteria to exclude any of the following events that occurs during a performance period: (i) asset write-downs; (ii) litigation, claims, judgments or settlements; (iii) the effect of changes in tax law or other such laws or provisions affecting reported results; (iv) the adverse effect of work stoppages or slowdowns; (v) accruals for reorganization and restructuring programs; and (vi) accruals of any amounts for payment under this Plan or any other compensation arrangement maintained by the Company.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE SIX</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MISCELLANEOUS</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">AMENDMENT OF THE PLAN</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall have complete and exclusive power and authority to amend or modify the Plan in any or all respects whatsoever. However, no such amendment or modification shall, without the consent of the holders, adversely affect rights and obligations with respect to options at the time outstanding under the Plan. In addition, certain amendments may require stockholder approval pursuant to applicable laws or regulations.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">TAX WITHHOLDING</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Company&#8217;s obligation to deliver shares or cash upon the exercise of stock options or stock appreciation rights or upon the grant or vesting of direct stock issuances or RSUs under the Plan shall be subject to the satisfaction of all applicable Federal, State and local income and employment tax withholding requirements.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The Plan Administrator may, in its discretion and upon such terms and conditions as it may deem appropriate, provide any or all holders of outstanding options or stock issuances under the Plan (other than the grants under Article Four) with the election to have the Company withhold, from the shares of Common Stock otherwise issuable upon the exercise or vesting of such awards, a whole number of such shares with an aggregate fair market value equal to the minimum amount necessary (or, if determined by the Plan Administrator in its discretion and to the extent adverse accounting treatment does not result, at the maximum applicable individual statutory tax rates) to satisfy the Federal, State and local income and employment tax withholdings (the &#8220;Taxes&#8221;) incurred in connection with the acquisition or vesting of such shares. In lieu of such direct withholding, one or more grantees may also be granted the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">right to deliver whole shares of Common Stock to the Company in satisfaction of such Taxes. Any withheld or delivered shares shall be valued at their fair market value on the applicable determination date for such Taxes. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">EFFECTIVE DATE AND TERM OF PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan, as amended and restated, shall be effective on the date specified in the Board of Directors resolution adopting the Plan. Except as provided below, each option issued and outstanding under the Plan immediately prior to such effective date shall continue to be governed solely by the terms and conditions of the agreement evidencing such grant, and nothing in this restatement of the Plan shall be deemed to affect or otherwise modify the rights or obligations of the holders of such options with respect to their acquisition of shares of Common Stock thereunder. The Plan Administrator shall, however, have full power and authority, under such circumstances as the Plan Administrator may deem appropriate (but in accordance with Section I of this Article Five), to extend one or more features of this amendment and restatement to any options outstanding on the effective date.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Unless sooner terminated in accordance with the other provisions of this Plan, the Plan shall terminate upon the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">earlier</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of (i) ten (10) years following the date this amendment and restatement of the Plan is approved by the Board or (ii) the date on which all shares available for issuance under the Plan shall have been issued or cancelled pursuant to the exercise, surrender or cash-out of the options granted hereunder. If the date of termination is determined under clause (i) above, then any options or stock issuances outstanding on such date shall continue to have force and effect in accordance with the provisions of the agreements evidencing those awards.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Options may be granted with respect to a number of shares of Common Stock in excess of the number of shares at the time available for issuance under the Plan, provided each granted option is not to become exercisable, in whole or in part, at any time prior to stockholder approval of an amendment authorizing a sufficient increase in the number of shares issuable under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">USE OF PROCEEDS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any cash proceeds received by the Company from the sale of shares pursuant to options or stock issuances granted under the Plan shall be used for general corporate purposes.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt">REGULATORY APPROVALS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The implementation of the Plan, the granting of any option hereunder, and the issuance of stock (i) upon the exercise or surrender of any option or (ii) under the Stock Issuance Program shall be subject to the procurement by the Company of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the options granted under it and the stock issued pursuant to it.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">No shares of Common Stock or other assets shall be issued or delivered under the Plan unless and until there shall have been compliance with all applicable requirements of Federal and state securities laws, including (to the extent required) the filing and effectiveness of the Form S-8 registration statement for the shares of Common Stock issuable under the Plan, and all applicable listing requirements of any stock exchange (or the Nasdaq National Market, the Nasdaq Global Select Market or any successor system, if applicable) on which the Common Stock is then trading.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">NO EMPLOYMENT/SERVICE RIGHTS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the action of the Company in establishing or restating the Plan, nor any action taken by the Plan Administrator hereunder, nor any provision of the Plan shall be construed so as to grant any individual the right to remain in the employ or service of the Company (or any parent or subsidiary corporation) for any period of specific duration, and the Company (or any parent or subsidiary corporation retaining the services of such individual) may terminate such individual&#8217;s employment or service at any time and for any reason, with or without cause.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:0.5pt"> MISCELLANEOUS PROVISIONS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Except to the extent otherwise expressly provided in the Plan, the right to acquire Common Stock or other awards under the Plan may not be assigned, encumbered or otherwise transferred by any grantee.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Awards issued under the Plan shall be subject to any clawback policy of the Company as in effect from time-to-time. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No recovery of compensation under any such policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or be deemed a &#8220;constructive termination&#8221; (or any similar term) as such terms are used in any agreement between any grantee and the Company.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The provisions of the Plan relating to the exercise of options and the issuance and/or vesting of shares shall be governed by the laws of the State of Delaware without resort to that state&#8217;s conflict-of-laws provisions, as such laws are applied to contracts entered into and performed in such State.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08dd44edc832493d888aecb8122c7631_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan is intended to be an unfunded plan. Grantees are and shall at all times be general creditors of the Company with respect to their awards. If the Committee or the Company chooses to set aside funds in a trust or otherwise for the payment of awards under the Plan, such funds shall at all times be subject to the claims of the creditors of the Company in the event of its bankruptcy or insolvency.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt;text-decoration:underline">Awards to Non-U.S. Employees</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall have the power and authority to determine which subsidiary corporations shall be covered by this Plan and which employees outside the United States shall be eligible to participate in the Plan. The Committee may adopt, amend, or rescind rules, procedures, or sub-plans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws, procedures, and practices. Without limiting the generality of the foregoing, the Committee is specifically authorized to adopt rules, procedures, and sub-plans with provisions that limit or modify rights on death, disability, or retirement or on termination of employment; available methods of exercise or settlement of an award; payment of income, social insurance contributions and payroll taxes; the withholding procedures and handling of any stock certificates or other indicia of ownership which vary with local requirements. The Committee may also adopt rules, procedures or sub-plans applicable to particular subsidiary corporations or locations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-15</span></div></div></div><div id="i9343e569b8b94b0790aa63a163a60050"></div><div><img src="bcrx-20250424_g5.jpg" alt="null001.jpg" style="height:1820px;margin-bottom:5pt;vertical-align:text-bottom;width:1406px"/></div><div><span style="color:#FFFFFF;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLYTHIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. V71541-P29568 ! ! ! For  All  Withhold  All For All   Except For Against Abstain ! !! ! !! ! !! To withhold authority to vote for any individual  nominee(s), mark &amp;quot;For All Except&amp;quot; and write the  number(s) of the nominee(s) on the line below. BIOCRYST PHARMACEUTICALS, INC. C/O EQUINITI TRUST COMPANY, LLC 48 WALL STREET, 23RD FLOOR NEW YORK, NY 10005 Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint  owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. The Board of Directors recommends you vote FOR proposals 2, 3 and 4. 2. To ratify the selection of Ernst &amp;amp; Young LLP as the Company's independent registered public accountants for 2025. 3. To hold a non-binding, advisory vote regarding executive compensation. 4. To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. 5. To transact such other business as may properly come before the meeting or any adjournment thereof. NOTE: UNLESS OTHERWISE SPECIFIED, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE PERSONS NOMINATED FOR ELECTION AS  DIRECTORS AND FOR PROPOSALS 2, 3 AND 4. IN THEIR DISCRETION, THE PROXY HOLDERS ARE AUTHORIZED TO VOTE UPON SUCH OTHER BUSINESS  AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF, SUBJECT TO COMPLIANCE WITH RULE 14A-4(C)  OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. BIOCRYST PHARMACEUTICALS, INC. 1. Election of Directors (each to serve until the 2028  Annual Meeting of Stockholders)  Nominees: The Board of Directors recommends you vote FOR  the following: 01) Steven Galson, MD, MPH 02) Alan Levin SCAN TO  VIEW MATERIALS &amp;amp; VOTEw VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of  information up until 11:59 P.M. Eastern Daylight Time on June 11, 2025. Have your  proxy card in hand when you access the website and follow the instructions to obtain  your records and to create an electronic voting instruction form. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by BIOCRYST PHARMACEUTICALS, INC.  in mailing proxy materials, you can consent to receiving all future proxy statements,  proxy cards and annual reports electronically via e-mail or the Internet. To sign up for  electronic delivery, please follow the instructions above to vote using the Internet and,  when prompted, indicate that you agree to receive or access proxy materials electronically  in future years. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M.  Eastern Daylight Time on June 11, 2025. Have your proxy card in hand when you call  and then follow the instructions.  VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we  have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,  Edgewood, NY 11717. </span></div><div id="i9f2683780b7842c0b3cbaf3c3fe87fe7"></div><hr style="page-break-after:always"/><div><img src="bcrx-20250424_g6.jpg" alt="null002.jpg" style="height:1820px;margin-bottom:5pt;vertical-align:text-bottom;width:1406px"/></div><div><span style="color:#FFFFFF;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%">V71542-P29568 BIOCRYST PHARMACEUTICALS, INC. PROXY FOR ANNUAL MEETING OF STOCKHOLDERS - JUNE 12, 2025 (This Proxy is Solicited by the Board of Directors)  The undersigned stockholder(s) of BioCryst Pharmaceuticals, Inc., hereby appoint(s) Jon P. Stonehouse and Alane P. Barnes, and  each of them, with full power of substitution, as proxies to represent and to vote, as designated on the reverse side of this proxy,  all the shares of common stock which the undersigned would be entitled to vote if personally present at the Annual Meeting  of Stockholders of BioCryst Pharmaceuticals, Inc., to be held at the Company's corporate headquarters at 4505 Emperor Blvd.,  Suite 200, Durham, North Carolina 27703, on Thursday, June 12, 2025 at 10:00 a.m. Eastern Daylight Time, or any adjournment  or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this  proxy will be voted in accordance with the Board of Directors' recommendations. Continued and to be signed on reverse side Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:  The Notice and Proxy Statement and Annual Report on Form 10-K are available at www.proxyvote.com. </span></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>bcrx-20250424.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:79f1b597-5081-40c7-8541-415568e3d0b8,g:ecdcf9bc-7ed2-4584-936b-1fac065a649a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bcrx="http://biocryst.com/20250424" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://biocryst.com/20250424">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcrx-20250424_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcrx-20250424_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcrx-20250424_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" abstract="true" name="StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>bcrx-20250424_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:79f1b597-5081-40c7-8541-415568e3d0b8,g:ecdcf9bc-7ed2-4584-936b-1fac065a649a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_ec226740-8bef-4b9a-88e5-b55ef5ec84d4" xlink:href="bcrx-20250424.xsd#bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_ec226740-8bef-4b9a-88e5-b55ef5ec84d4" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bcrx-20250424_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:79f1b597-5081-40c7-8541-415568e3d0b8,g:ecdcf9bc-7ed2-4584-936b-1fac065a649a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_label_en-US" xlink:label="lab_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:href="bcrx-20250424.xsd#bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:to="lab_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bcrx-20250424_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:79f1b597-5081-40c7-8541-415568e3d0b8,g:ecdcf9bc-7ed2-4584-936b-1fac065a649a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:href="bcrx-20250424.xsd#bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bcrx-20250424_g1.jpg
<TEXT>
begin 644 bcrx-20250424_g1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M:Y923_G=XV4H^SFJDJ,E*I5I2Q%=PJXV5.<%C9IS=ZRE)3?22CR.RDSJM?\
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MZ?!,CI86]JRM7$_'M&D^/7QHC0 O)\7?B,B@E5!9O&>L*H+,0J@DC)8A1U)
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MLX_''XEVT-]X,^&GB34]-N4$MKJUW!;Z#HUY&02)+/6?$-SI6EW:<$;K:[E
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M]MOX=7GP_P#VA?&<S02KI/CBX'CK1;J0HXNEUYGEUM=T8"QM:>)(]8MU@?\
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M%P]<\7^%X?!'[,OBGP9;SM=0>$O@7KOAF&Z=0CW4>A> ;K3%N71>%>X%J)G
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MQLDW_5[7^1/_ ,%6_P#E)E^WO_V=M\>?_5C:_7^A[_P1P_X*WZ9_P59\&?M
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MKX;/*.7X#,:V9Y?47[SVBG*%*/)*4G!R;4?96BW.GRTYM\CC<_>W_@Y-!/\
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JO-/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>bcrx-20250424_g2.jpg
<TEXT>
begin 644 bcrx-20250424_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\D\9_M<>'+/XN77[/_ ,(O!&K>/?&>
MFVT=QKVG:))#%:Z'$_,;7MW.ZQPLXR5B7?*0,[,<UZ1XTUV;POX.U;Q-;6OG
MR:=ID]U'!_ST:.-G"_CC%?'7_!"2"3Q!^R;XA^,OB"\-]XD\;?$+4M0\0:I-
MS+<2@1J Q] 2[@=C*WK0![CXI_:YU/X8>(?#'A'XQ? ?Q%H=YXO\2V6B:+J%
MG<V]]IDEQ<2!=KW$3[HF5=S;9(TW[<(6^;;[/67XM\&^'?'&G0:5XFTY;F"U
MU2SU&!6.-ES:W$=S X/JLL2'WQCH37BGA_XW>/\ ]I3]HOXB?!CX5>.SX4\/
M_#$V=CJNN6.G075]J6JW"/(T<?VE)(HH(578^8V=W)VL@7Y@#W^BOE_X"_M1
M?'CQ=XX^+7[(_CV_\/0_$_X:QQ7.C^)7T:1M/UK3IT62"YDM8YT9) K1B14E
M"AI1M^Z17F7PN_:)_;W^.G_!-J/]L?0?C%X5T#5='T76]8GLAX26Z_MI;*[N
M\PNS.JVJ>5 (E"([DKO:3YBJ@'W;17Q'\8/VH/VV(_V(M)_X*#>#?'7A+0]/
MM?#^F:O=_#P>'6NTU*&9H4F\R]DD#Q$F1F5(T&Q0%+N3N'7_ +5G[5/[2/@/
MXH? JP^"W_"-R:-\5-2,$FE:I8NMPK_9DE19+KS&5829/GV0^8!'\I8MB@#Z
MMHKXX_X:%_;,_99_;-\"?!S]J/QQX:\:^"OBQ-/9:#K.A>'?[-ET?4D"E8-F
M]RT9:2- 7=F8/N# HRMO7W[4/CSXYZEX]B^%GQ'\2>$;;PKXCO?#_AZ?0_A1
M?:]'J%Y:82:XNIDM)HO),^Y%AA*2!8][.?,"* ?5-%?"'Q;_ &Z_VV]!_P""
M<^G?M*WWP]@^'WC6R\00:/XHT3Q/X/N8II_,G2-+JT6YD3RD8.I_>1RC)=01
MLR>^^-WQJ_:__9O_ &A/A1K/CWX@^&-7\'_$OQQ#X7U#P;IGATQ'1I;D'R)8
MKUY#)<LI!WLR1JVTXC7<-@!]8T5\R^-_VJUU#]LOQ%^RMX@^/4?PQN=,T/3;
MGP:;C3[1AXFGN5D:5S)>(R.D;".(01&.1V$A$AQA.B\9>)/VU]'^#?P\\/:-
MH.GW7C'6O$MMIWQ"\36]O#Y&AV&Z0W&H0P.X5OD1=@;<!O&Y6/! />*JVFM:
M1?:E=Z/9:E#+=6.S[;;QR M!O7<@8?PDCD9[<U\Q_ 3]J'QQXB_;?\8_LEVO
MQFTSQWH5O\/5\1^'_%:VMJUQ97"W26DMK,UF(X+@*[AOE5",;2<YQQO_  3=
MT?XYZI\:OC[J.N?'V?5&TGXNWVGZBNIZ#"YU)XK5889"RLIA1 L8$4>%"QA0
M0#0!]0?"+XE?$?Q]K_C'2O'GP2O_  C:^'O$DNGZ!J%YJ4=PNOVB@%;V-4 ,
M2MG[AW8R/FR&5>XKY:_96_:]^).I:1^T'XI_:8\0Z5<67PB\9ZC9)/H.D&TB
M%C9VYD9DC>21RS!2VUY'(+;=QHTOXA_MC_%+]D2+]L'P!\0M,TS6[[07\1Z'
M\/'T*&XTR6PVM-%9S3$"Y>XD@"YF22-!(V!&%&: /J6BOB7XY?\ !0SXP>(O
MV,OA9^UM^SA-HNG6OC/Q;IVCZWHFJZ<T]S#-)/+#/'%<&01HJR0/'EH6+*X<
M%2,'K?'WQH_:W_9Z_:Z^%7ASXH_$?PUXB\(_%75KS2;CP]I7AHVAT&X2%9(6
MAN6E>2Y&6 9I H(5B$3< @!]6U1\3>)-$\'>&]0\7>)M1CL]-TJQEO-0NY3A
M(((D+R.WL%4D_2KU>&?ME>(M \57_@[]E[5=>L[*W\<ZJ;KQ2]W=)$JZ!8%)
MKM"6(XN)&MK3'=;F0C[IH [?]F7]H3P3^U/\#M ^._P^$J:;KULSK;7!'FVT
MJ.T<L+XXW*Z,/? /0UWE?#7_  3M\1:#^S3^V;\6?V#=/UVSN/#6IW9\9_#5
MK6Z22);:?:+FU0J3_J_D4+_T[RMWS7T!\=_CSXHTSX[^!OV5?A;=VUEXA\8V
MM[J>IZY=VPG&D:5:J-\D<1($D\LC+''NRBX9V5PH1@#V6JNFZWI&L2W<.E:E
M#<-8W1MKP0R!O)F"JYC;'1@KJ2.V17BG@.T_;:TSXT>,_A3XQU^#4/ TWAV.
MZ\$_$ZYL;$7UK?L422TFM(3&DQ7,DBOY2* @#%]V!X-_P3-M_CWJ7[(GC3XC
M']H:]:Y3Q1XEFQ=:%;3R37\<Q8W,LL@)<.RG=& .&PI7 - 'W=17R#X2_:J^
M/OCG_@DFG[8T?C"TL/&UGX7U+6)I8=(B>UN6MKBX01-"X.U2D:\J001G)&0>
MXN?BU^U%X[^!'P1U[X9Z1;)<>/-.TN\^(?B]882N@6<E@ES//%#*P3<[DJI8
M.J=T8D4 ?0DSM%$TB0M(54D1H1ECZ#) R?<@5XO^SG^V!=?M ^./BEX''P:U
M70[OX9:O%I\MG=ZG;2W.HRO'(^ J-Y,1^0!?WS*=X)9<&N,_98_:E\6^-/VQ
M?B%^S'??%33?'OA[0O#MEK7AOQ9:PVRW 61Q%-:S/:*L$Q5SPZ(F-I!R>F3^
MP!_R>)^U7_V4+3?_ $EDH ]3_8\_:Q'[66B^-=6;X:7GA:3P9X^O?"]Q87^H
MQW$TDMM'"TDC>4-B'?*R;5:0?)D.<X'L%?%G_!/32/B!KGP]_:9T[X5^+X-"
M\1/^T=XJ.D:E=V*W,,<X%N4$L;?>C)P&QAL$X.:Z[]C_ /:Y\5>/OV*O%OQ=
M_:"\:R6?C#P1=:S9>.K:UTVWA;1;NS+XABBVD.3&(V&_?N=RHZ8 !]2UXA^U
M'^VWH_[*_C/PAX+\2?!CQ7KTWCO6X]'\,3:!+8%+F^=HU2!OM%S$8RS2 !FP
MO!)8 5W7[.]O\8(?@SX?N?CYKL-]XON]-BN=>^S6*6\5K<2(&:W1$_AC)*;B
M26()X! 'R[_P5QOVTKXN?LNZFMA<71MOCGITHM;1 TLVV>W.Q 2 6., $CDC
MF@#V72_V\? &G?&_1_V=_C5\-?%GPX\3^)%/_",)XKALWL]8<$#RH+JRN9XC
M)D@;&93EE7[S*#[E7Q1^U_\ !_XP_MX?M*?!_2_!_P (->\->$?AUXD_MWQ%
MXS\3VZ6;2$20.+6TA+&9V(@(+[0H9E.<+D^G_$GQW^T1)\1_B)_PEWQ+M/A)
MX(\.6EA;?#[Q!-#I\X\27\T#R3/-]J$AV1R>7$L$:QR.2<.3P #VWXE>)/$?
M@[X>ZWXL\'^"I_$FJZ;I4]SIWA^UN5ADU&9$+);K(P(0N0%R0<9Z'I2?#+Q-
MXD\9_#O0_%WC'P/<>&=6U+2X+G4?#UU<K-)ITSH&>!I% #E"2N<#..@Z#YF^
M'G[97QY^+G_!*.3]LSPTWAS2O&-AX6U?4K^.\TF6YM)CI\EU&_EQK/&8VD%N
M'!+.JEB"K"M35/VU/&_@_P#8K^#7CYX+#5OB1\7;?P_I.@QWD7EVCZKJ$,;/
M<S)%M(@CR\C*F,_*@*[MP .[_:>_:YF_9L\>_#?P5/\ "34M8M_B)XWL/#D.
MN)J4$%K8S7,H3++EY7=4W/M\M48+CS 3Q[-7PK_P4'\&?&7PG\6/V:)/%WQD
M?Q5H]Q\?= ^U1:AHEM:S6U^)3M:!K9$'D,AES'()'4JG[PY;/W3(K.C(KE20
M0&7&1[\\4 +17S#^S]\;?CU8?MX^/_V4_P!H'XBP7]OIWARUUWX>&VT2"T_M
M73I'9)Y)649:2*0I'A-H8K(V,  2^/OVB/C1\,?@'\9?VG=/U@^)-'\.ZA=V
MW@/2I-(B&V&VDCMKF\F:$(TT:7(NBH!4-!;ABQ+[P ?3-%>"_ 3XA^+?BKXB
M\+_$/X0?M0V7Q*^'FH65TOB-GT^QCNK&\\I6@Q]GCB:%,[PT,B&53LRQ!->]
M4 <5\=OC-'\#_"5GXCC^'VO>*;O4=9MM,T[0_#44+W=Q/,2!CSI(T"J%9F9F
M 55)/ ->4>)?^"@E_P"#_C5X6_9X\2_LC_$.U\7^,[.YNO#^E'4M!<7$=O$\
MLI,J:D8T*I&YPS#.,#.17T-<Z?87LUO<7EE#+):3&6UDEB#-#(49"Z$_=;8[
MKD<X=AT)KXV_:;_Y3._LU_\ 8K>)/_3?>T >Z>#OVM-+OK[QM8_%SX3^)_AQ
M_P ('H5OK.KW'BTV3P2V,HN3Y\,ME<3I($^RR;@#D$J,9.*PK3]LSQQ=?#M/
MCDG[(WCB7P--8_;[?4;6[L)-3>Q*[UNCI_GB3RRF'V!FEVG)CSD#T']H3X&>
M&_V@_@[XL^$VLRBQ/BGP[/I4FK00*TT"N&V-V+!'._83@\CC-?$WPU_;>_:B
M_P"":2:3^S__ ,%#/A/=ZMX)T]8]-\-?%CPO$9XC;( D2SK@;R$ &#LFVH3L
ME/S$ ^K_ !=^V%X?\)_LE:?^V(GPXUW4_#EWX6MM?NK+3I+;[7:6DT4<H)66
M6-7*J^2%8GY3C-<=>?\ !1[2M ^"FE_M)^,OV6_B7IO@#5+&WO4\31)I-XEM
M:SA3'<306U^\\<9# D^62N0& -1_M;7'PRN?^"5/C23X,:I;7OA-?A9,GAVY
MLY=\3V:VX6+:?90!@X((((!!%?/'_#46L:S^P1\*OV"_!OPHU.S\8?%OX66V
M@^'M=\72066B/"]DL4\R7 D=I)-C?NX@@<L\? +*K 'Z#> O'G@_XH>"]+^(
MG@#7X-4T76;*.[TS4+8DI/"XRK#."/<$ @@@@$$5KUYI^QU^SV/V5?V9O"'P
M .O?VI+X=TUH[J_"%5FGDE>:4H#R$\R1PH/.T#->ET %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ3^''_!'S5_V=/&'P>\5VGC:#PKXCTJ+0/[#E>2XN+^6_>V\MU!C*$3+N;<
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M3J=OK.FPZI:17$<<Z;D2[M)() /]J.15=3[$ U\C>!Q^T9X._;D^*.J?$O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M5JQB^SDD_P 6>KT5Y1_PV_\ LO?]%._\HM[_ /&:/^&W_P!E[_HIW_E%O?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
M 8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_
M  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_
M -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;
M_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%
M%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !
MC_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 >4?%;]E^X\=>)+[Q=X/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=_L+^/;OX1>(Y=TB^&]0,FI>'[A^NU0S&XL\D\LKRHHP%A K\?/B_P#L1?\
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M_;<\%VGQA\-0[8FUV(IIWB&VC'&3(B^1=[1VDC21S]Z;G-?N3^P'_P %K/\
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MX+!?MJV]GHVG,UYJ\YMM!TKS&:T\/Z6C9+.P'"HI+R28R[MP,LB5UW_!3O\
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M /(C^)_^PM#_ .BC79EW^]+Y_D>_PI_R.X>DOR9],4445]&?K(4444 %%%%
M!1110!\7?\%!O^" _P#P33_X*,"]\2?%+X)Q>%_&EV&8^/\ P'LTW4GD/\<X
M5##>$G&3/'(V!@,M?AK^WY_P:5?\%$/V1[NY^(W[)NIP_&CPQ8R?:+<^'(C9
M>(;,*=P8V+.?.8' !MI))&(SY:5_4W10!_)Q^Q!_P<T_\%5O^"=OB%?A!\>[
MR[^)WA_19_LNH^#_ (I+/%K&G[.&BCOF7[3"X "A;@3*@&!&*_;_ /X)\?\
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M]KKVJ37^JZ=I&BQ6>G[Y(8X#'%:IE$C\J&-2.=Y#.V2YH \*_:7^'6I_'O\
MX*$> ?"WABXQ'X-^%GB:ZUV\0Y2U_M:#[!:HY'1G9975>I6%B.!7EPGU./\
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M@#@ #@ 4 24444 %5-5T>UUB-(KJ250C9'E2E3^E6Z* ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
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MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK
M8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VK8HH HZ5H%EH\CR6LL[%UP?-F+#]:O444 %%%% 'G
M_C_]J/X$_#'Q4G@SQE\0+6VOE)^W+&CRIIH\EI@UTZ K; QJ6!D*_+\WW>:O
M_$?]H/X)?"3P!:_%+XB?$_1],\/7RQMI^JR7@>*\$B&1#!LW&;<@+C8&RH+=
M 37R/\2]?^(?_!/;]IJZ^(/Q4T67Q#\&O&/C_4/$K>(M(M6N-0\/7MU8-!/%
M=0#YGM$5582(#L2,CDE4KZN\.P?#_0/A)H/C/X-^#5\566C>%8K?P;%H=Q;&
M6XL&BB"1V\L\D<05TBB))=00@] * -[X:_$_X>_&/P79?$3X6>,;#7M#U!2U
MGJ>FW DBDP2K#(Z,&!!4X((((!%<IIW[8/[,&K_%AO@5I/QQ\/77C!;^6R;P
M[;WP>Z%Q&&,D109^90K;AVVG.,&O'O\ @G'J^B^(O@'\1O#_ ,,]$O?!'C@^
M/M=N/$WA[7]-4IX=UF[;S8HXX48"2UC0PA2"HD$;'";L#'_9ZU+XX?LC?&KP
M9^S=^TUX)\&Z[IGBB*>R\#?%/PMI1M[E[Z&!Y7MM123<PFEC61A*K'>V<ER7
M* 'TGXV^//P@^'.M_P#".^-?'MC87B6\=Q=1REF%E [E$FN64%;:)F#*LDI1
M&*D D@UUP(8!E.0>A%?(_P"Q%!#\9/!?[3/B7XB1+=3^(OB_XDT/4!<#)73;
M6TAM(+9L_P *1%AC_:/K7<?\$L?'?B7XC_\ !/SX8>*?%MW+<7W]@O9O/.Q+
MR1VUS-;1,Q/))CA3D\GK0!] 4444 >4?MN+\&G_9F\0+^T+=WD'@O[3IO_"0
MS6!E$J0?VC;<@P_O0-VW)C^<+DK\V*^&_BK?_P#!&S5?!\EG\!;#Q3XO\:&Z
M@;PQX6L]8\8/)JMVLJLEN#-*%3=@@R9!3[PR0 ?T#_:,U+XB:/\ "6]U;X3_
M  ]M_%7B*VU+39=,T"[G$4=TZW]N3ND8$1;5#/YA!V;-^#MKP/XK^*/^"D?Q
MG\ ZA\.;O]EGP5X!2^$;?\)M>?%!+P:$8Y%D%ZD4=LK-)$4$B?, &4$\9H ^
MM!P,?SHH&<<FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "OC/_@MK_P5W^&O_!)/]E>?Q].;
M/5OB/XG2:R^&WA.>3/VN["C?=SJ"&%K!N5W(QN)2,%3(&7W+]N']M+X&_P#!
M/S]FCQ)^U+^T'XA^Q:#X?MLQ6L14W.IW;9$%E;(2-\TK?*HZ ;G8JB,P_D^U
M/4/VY?\ @Y2_X*F*D$1.L^)[C9;PY>32_ _AR%^I/&V&%7R3PT\\O \R8 @&
M=^PM^Q-^T?\ \%?OVD_%O[1_QNUW5]2\-V>N1ZG\4_'5XQ\R\NKF0E+*%L8\
MZ4!L*H"PQ(3@ 1HW[?\ A'PEX9\ ^%M/\$^#-#MM,TG2;..TTW3[2,)%;PHH
M5$4#H  !7T]??L._ S_@G;_P38T;]EG]G_1/L^CZ'?VKWNH3(OVK5[YS^_OK
MEA]^:1AD]E4(B@(BJ/G*O!S2<G64>EC\SXRKU99C&DW[JBFEYMN[_ ****\T
M^/"BBB@ K[$_X)G_ /(C^)_^PM#_ .BC7QW7V)_P3/\ ^1'\3_\ 86A_]%&N
MW+O]Z7S_ "/H^%/^1W#TE^3/IBBBBOHS]9"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!EU:VU[;265[;I-#,A26*5 RNI&"I!X((XQ7YQ?\ !0?_ (-=
MO^"9W[;_ -M\8> _!3_!SQM<[G'B#X?VT<5C/*?XKC33B"09)),/D2,3EI#7
MZ044 ?R3_MG_ /!NA_P5N_X)B>+/^%U?!K3-4\;Z)H4YN=-^(/P?NKD:CIH7
M.)9;6,K=VS!<EGC$D:#.9:]2_P""?G_!WM^W;^S1)9_#_P#;*\,VOQF\,6S"
M&34;QUT_Q#:H/E_X^40QW)49)$T9D<CF9>M?U#5\??\ !0+_ ((3_P#!-K_@
MH_'>:Y\;/@7;Z-XPNE)'Q \%%--U?S#_ !RNJF.[/_7Q'+@=,4 2_P#!/[_@
MN9_P3>_X*00VFC? OX[6VE^+KE1N^'_C(+INL!R,E(XG8QW9'<VTDH'<BOI?
MXQ?$S2/@[\,]8^)&M*'BTNT,D<)8CSYB0L460#C<[*N<<9R> :_F8_X* _\
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MW*_\$'/VO?VL?VY/^";WA+]H;]LGPA'IWBO4[Z[AM-2BTS[$NO:?&X$&I"
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M20F2*-S@+)(A)4#</D?4=5_X)*/H\M]-^WU\1==WP[SI+_%#5)Y+\D?ZDPN
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MXA^ O@;X.T/7[]G-]KFD>&;2VO+DM]XR31QAWSWR3F@#Y>^)_P 2OV%?VDO
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MIG)P$#*PW[<@]* /J\9QSU[XHKGOA:/BHG@JS@^,ZZ"WB&) E]<>&Y9C:7!
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M-?AI^U/I/[,7Q1\3)KT'B_PI<:OX5U][&.VG^U6DBB\LI$B 1E\N2.6-@ P
M=7+D*QU?VO?VA+_]GKX<:7>^%]/M;SQ-XN\6:=X6\(6M\&-NVI7LOEQO*%(8
MQQJ))64$%A'MRN[</.OBQH5Y\1?^"H?PFN]"/F6WPV\!Z]J_B*X0_);KJ*K9
MVT;MT#.8Y753R5B8]!6+^W9XJ\$?%[X;_"/]I/X5>--+\2>%/A_\<M$U?Q%J
MNBWR7-O;V,<SV]Q,6C)'[EI49O[J[F. ,T >BZ?\<O%7PA_::T_]G3XP>+HM
M8L?$_@^ZUSPWXDFLH[65+BS<?;;25(@$9!$Z31N &55D5RY"L?.H_P!LSXMS
M_LGO_P %"HY;?_A#UU@W">!AIR^8WAU;_P"R&X,^=_VW8#<CGRMN(MF?WM2?
MM+_#K4_CW_P4(\ ^%O#%QB/P;\+/$UUKMXAREK_:T'V"U1R.C.RRNJ]2L+$<
M"O+A/J<?_!#L_!E='D'B\6I\"GPYQ]J_MO\ M7[(;79UW_\ +3']SY_N\T ?
M2&H_'CQ/\7/VGKK]F[X/>+(M(L?#W@RWU_Q+XE@LH[F9I;M\65I"LH,:J8U>
M:1V5B5**NTDL-W]D;X_ZC\?OA_K$GBJQM;7Q/X-\7:CX5\6P6*L+<ZA92[&E
MA#$L(Y$:.55))7S-N6V[CY%^S1\.-1^ ?_!0?QWX8\43Y3QA\*O#-SH-Z_"7
M(TF'[!=HA/5E9H9&7J%E4G@UM?\ !-#PYJ+:!\6OC!+&PTOXA?&O7M:\-28^
M6YTWS$@AN%_V9#"[ ]"NTC((- 'TO1110 4454U71[76(TBNI)5"-D>5*5/Z
M4 6Z*Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "
MVH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BB
ML?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$
M'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^
M$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/
M^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2
M/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VKX4_X+P?\%7/A
MA_P26_9C:]\.:B-4^+?C*":V^'?AR>\+K"P&V34[E,Y^SPDC"_\ +60K&,#>
MZ 'S;_P=%_\ !=7_ (9,\!WO_!/;]E#QCY?Q.\4Z;M\<^(-.G_>>%M+F3B!&
M4_N[VX1N#]Z*%MXPTD3K\I?\&K__  0J_P"%Z^*=,_X*7?M:^#MW@K0;[S?A
M;X;U&#Y==U")\?VE*K#YK:"12(QTDF0L?EBQ)\Q_\$.O^"2GQ=_X+9?MB:O\
M<?VC]8UF[^&VBZZ=4^*'BZ\G?[1X@U"5O._LV*8\M-,3NE=?]5$<Y5GB#?U;
M>%/@[X"\">%].\$^"]*.E:/I%C%9:5IFGOY4%I;Q($CBC1<!$55"A0,  "@#
MJ**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ /*_\ @H#_ ,FZW/\ V%K7
M_P!"-?!]?;_[=_AG3]*_9_N;NWGN68:I;#$MP6'+'L:^(*^?S/\ WGY'Y;QC
M_P C9?X5^;"BBBO//E0HHHH *^Q/^"9__(C^)_\ L+0_^BC7QW7UM_P3ET"R
MUCP7XDENI9U*:I$!Y4Q4?ZOVKMR[_>E\_P CZ/A3_D=P])?DSZFHK'_X0?2/
M^?F]_P# MJ/^$'TC_GYO?_ MJ^C/UDV**Q_^$'TC_GYO?_ MJ/\ A!](_P"?
MF]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^
M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
MP+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_
M  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH
MV**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8KY
MG_X*I?\ !+KX ?\ !5K]F>\^!/QDLUL-8L_,NO!/C*VMP]WX?U K@2IDCS(7
MPJRPDA9% Y5UC=/H#_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH _C_ /A'\5O^
M"@7_  ;7?\%)+W2-=T1[35=)E2W\3^')9W_LCQKH;.2DD<F/GC< O#.%WPR
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\
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MTS\0]?-O_P (Y_97_"*_:D_LO?Y_G?;?*V;OM./W>_=C9QM[UTE%% !1110
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MT!R3Y,S?ZMFVL0CL5_$K_@B7_P %E/CM_P $3?VF=5_9V_:2\/Z[_P *PO\
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M#_Z*-=N7?[TOG^1]'PI_R.X>DOR9],4445]&?K(4444 %%%% !1110 4444
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MFBHK&^LM3LH=2TV\BN+>XB66WN() Z2HPRK*PX8$$$$<$&I: "BBB@ HHHH
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M\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E7X2_\
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M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
M-*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH
M TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q
M\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_
M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
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M #+NS%41%!9W954%F /875U;65M)>WMPD,,*%Y997"JB@9+$G@ #G-?RQ?\
M!R)_P6WUW_@I?\=8OV-_V4=7N[SX0^$];$%LVE!G;QKK(;RQ<A4YDMT8E+=
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MJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\
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MJ=V!].4UHHO,%PT2ET4JK[?F ."0#[X'Y"@#X=_X3[]@_P#Z0Q>/O_$7(/\
MXW7TS^R#J?@K6?V?M&U'X=?"J]\#Z+)>ZD+#PGJ.G?8Y]-4:A<J8I+<<0-N#
M$Q#A-VT< 5X7X4^,G_!1GXF7?A_5- ^(7P,T:Q\:Z1+J?ANUGT?4;UH0JQR_
M899DND5[I895<A5PWES%1M0U[7^Q-XJ\3>-/V7_"OB'QIX\LO$NL21746J:Q
MI]OY<4EQ%=S121CYFWF)D,1DW-YAC+Y.[- 'JE%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?F%\5?^2H>)/^P_>?\
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M]"-?!]?/YG_O/R/RWC'_ )&R_P *_-A1117GGRH4444 %?8G_!,__D1_$_\
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M\+?VB/A5KWP1^-?@FQ\1^%?$VG/8ZWHNHQ;HKF%NH/0JP(#*ZD,C*K*0R@@
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MNO\ TKFK\]:_0K]BK_DV/PO_ -<KK_TKFKTLK_WA^GZH^OX+_P"1I/\ P/\
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M*10!]2OH^ER:Q'K[V,9O8K9[>.YV_.(G969,^A9%/X?6K-%% !1110 4444
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M'J-%%% !1110 44RVNK:\B$]I<1RQEB \;AAD$@C(]""/J*?0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!^87Q5_Y*AXD_[#]Y_Z/>L"
MM_XJ_P#)4/$G_8?O/_1[U@5\C/XV?A&(_CS]7^84445)D%%%% '<_LT?\G >
M#_\ L/V__H8K](Z_-S]FC_DX#P?_ -A^W_\ 0Q7W1^TU^TG\'/V0/@1XE_:0
M^/OB^'0_"?A336O-5OI>6(& D4:]9)9'*QQQCEW=5')KW,J_A2]3](X*_P!Q
MJ_XOT1X]_P %9?\ @I]\&O\ @E-^R?J?[0/Q)>'4==N]]CX$\(B?9-KNIE"4
MC'=(4X>:7&$0<9=D1OYD/V#_ -CG]KS_ (.*O^"D^L^+_BKXNOYK?4=276OB
MSX\\G]UH^GEMJ6UNK95)&1/(MH!D*J9QLB<BO^U=^T?^V?\ \''O_!3C3- \
M >&+F2?6[YM*^'/@[SR;/PQHZL7>:=P"%P@,]S/C+$84;5BC']17_!+[_@FY
M\$O^"6_[*.C?LU_!^W6[ND O/%WB>6W"7&OZHZ@2W4F,[5X"1QY(CC55RQW,
MWJ'VAZU\ O@-\)_V8/@SX<_9_P#@;X.M= \)^%-,CL-%TJT7Y8HEZLQ/+R,Q
M9WD8EG=V9B2Q-=?110 4444 %%%% !1110 4444 %%%% 'B?_!0'_DW6Y_["
MUK_Z$:^#Z^\/^"@/_)NMS_V%K7_T(U\'U\_F?^\_(_+>,?\ D;+_  K\V%%%
M%>>?*A1110 5]B?\$S_^1'\3_P#86A_]%&OCNOL3_@F?_P B/XG_ .PM#_Z*
M-=N7?[TOG^1]'PI_R.X>DOR9],4445]&?K(4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ HHHH **** "BBB@ HHHH **** /DW_@IS_Q^>"_^N6H?SMZ^5:^JO\
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MB_X*(^/=4U:'Q[^TC\-;#3O$^AIHOB:?P]X(N?M4]B&ESY?G7!190D\ZJY!
M\SD':N/8OVR+'X):C^S=XDA_:.\1R:5X)06DVOWD4DJ/Y4=W#(L:F'][NDD5
M(QY?SY<;?FQ7Q/?Z+_P2N-I*?#GP+^.^I71B/V&%5\70I<R$?(OF/* @8X&X
M\#.: /T?34=..H-HR7L1NHX%F:V\P;Q&25#XZX)4C/J#4]>0_ /]AG]G']F;
MQM>?$/X1>&M7L]6U#3#I]W<:AXJU"^$EOYBR;=ES/(H(9 0P&1E@#ACGUZ@
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M?#\LS""ZU+5D^TK<S*I D:.W"I&&R$9G<88@CRB;]J[XJ0_!63]F6'QKJ?\
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M?V=I_P#SXP_]^A7T9^LE/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
M?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C
M#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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M;_0O%7ADV^I:3,EMXN\*W,S'2?&6BLY*2Q2;<,C@,\%P%WQ/N#+D2Q'^K/\
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
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M-MK0DT_[->7UXX66W6,B8RM*<*IF1DPSH0#[IHH&<#=U[XHH **** "BBB@
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MS_\ !/2/X3Q?LZ1>!],T#XB^/[;P_>Z]?6\M_J\.?+D<Q0RH+:$%3(F7\\\
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M?M)U34(<'^U?%(.IS%AT<"X+1QM[QHM?0EM;6UE;I:6=ND442!(HHD"JBC@
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M,H$GF(TC(WF .&0AP&R* /0J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M1Q@*H]@*TZ /R$_95_X,U/\ @G/\(_LVK_M,?$GQK\6]1CQY]F]T-#TJ4_\
M7&T8W(_\"B,=J_2+]FK]A']C+]CK35TW]E_]F'P3X((C\N2]T'P_#%>3KC'[
MVYVF:8XXR[L:]9HH ^3?^"G/_'YX+_ZY:A_.WKY5KZJ_X*<_\?G@O_KEJ'\[
M>OE6OF\?_O<OE^2/R'B?_D>5O^W?_28A1117&>"%%%% !7Z%?L5?\FQ^%_\
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MOH ^FZ*** "BBJFJZA=:?&CVNE2W19L%8B,K[\T 6Z*Q_P#A)=7_ .A0O?\
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M!/J1SZ\6G^?QKU<E_P"1A'T?Y'N<._\ (TCZ/\CYVHHHK[<_1 HHHH ****
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MM]DEP)M@"SW"32.'G !D5XV;+;F;]*_^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: /QV_X.5_\
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M5'_*/SX:_P#8+N?_ $MN*^A*\:I_$?J>S3_AKT"BBBH+"BBB@ HHHH ****
M"BBB@ KYP_;3_P"";7P__:_?Q9XKT[XN^-/ 7B_Q;\++SP%J6N>&M5WVE[I,
MPNS'#>:?-NM[E8Y+VX<,!',!,ZK,F01]'T4 >4? G]C?X1_LW>'/%>G_  CN
M-7L=<\=:[)K7C+QM=WJ7FL:SJ+@ W$TUPCH2$4(D:HL42\1HE<1^Q!_P2V_9
MC_X)Y^)O%OB?]F>[\66#^/-1&H>,+36/$3ZA%J=V#*5G;SU9HW!FD),;)NR-
MVX  =]^T-^V%\"?V6I+,?&GQ2=)COHC)!<2(HBQNVX+LP )/0=Z\O_X?%_\
M!/\ _P"BY:?_ .!,'_QR@#%^ W_!%7]D3]G"^\6Z3\-/%WQ/C\$>-[V>Z\1?
M"N^^(=W-X;N7F8M,IMC\[))N*R(TC+,GR2B1,K72_%'_ ();? KX@_M<VW[;
MWA3XG?$KP!X^C\/0:'J-UX!\7FSL]4T^'=Y5O<VLD<L3HN[A550"%;[PW54_
MX?%_\$__ /HN6G_^!,'_ ,<KO/@'^WI^S3^TSXI/A#X,^-QK%VL3R2-;*KQH
M%&2&96(!QV- ';_!/X&?"W]G?P(GPX^$7A9-*TP7US?7.9Y)Y[V\N)6FN+NY
MGE9I;BXEE=GDFD9G=F))-=;110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% $&JZE:Z-I=SJ]Z6$-K;O-,5&2%52QP._ K\F?\ @N/^WI)^T5^S
MOJ7P!_8_^(?A^WUNYA:"ZDU_Q%;:<]K+*&B>0B1MZM' 90F.2\ZG'[O-?JC\
M37N(_AOXADM81)*NAW9CC+8#-Y+X&>V3WK^);_@IU_R?W\4_^QHD_P#0$I,9
MT_\ PZ8_:3_Z'WX7_P#AQ+/_ !K]7O\ @AO/\$?V<]#TCP9_P4>\%?"+Q?>^
M$O.L_ 7B&YN=+UN[TVVE=942 R;GB99 Z?+@['C ^X0?P#KI_@C_ ,EG\(?]
MC1I__I3'0(_N]^'_ (P\/>/_  7IOC'PF'&FZA;"2R#P^61'T V_P].E;%?G
M!X8_X.&/^"3/[(?PVTSX'_'7]IQ['QGX9@-GK7AW3?!VKWDEM(K,0IEBM3"3
MM*G D_BQV-<'XW_X/'?^"1GA7>- T?XM>)2I(4Z+X,MXPWO_ *7>08'UY]J8
M'ZMT5^(GC?\ X/=_V3[#?_PK?]B3XAZM@GR_[;UVPT_</?ROM&/UKR#QO_P?
M%_$J\WI\-_\ @G;H>G<D1R:W\1YKW(]2L5C!CZ9_$]: /Z&J*_F%\;_\'IO_
M  4UUS?!X*^!7P7T*)C\DCZ'J=W.H]-SWZH?^_=>/^-O^#L/_@MAXM+KH?[0
M7ASPV'/"Z'\/=+?:/0?:X9S_ %]Z /ZVJ*_C_/\ P5?_ .#BS]HO/_"+?M ?
M';6//Y'_  A/AF6WSG^[_9ULF/PH/[.7_!S)^T9G_A(O!7[8&M1S\Y\5WWB"
M")@>F/MLB+M],<8H _KUUG7M#\.6+:GXAUFTL+9/O7%[<+$@^K,0*\M\;_\
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M=CCZ=_7VK]1](_X-E_\ @ASHF/L?[".GOMSC[9XWU^XZ_P#76_;/]*Z?2/\
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MGZ*?1E%%% !1110 4444 %%%% !1110 4444 ,ENK:&6.":XC229B(49P"Y
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M 2+D$=+\,OV>_ 7P?TC7+3P'+?VVI^)M3?4?$/B.>X6XU#4+ML S222JR\*
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M_P"S#^RWX)^!-[>17%WX?T58]1F@.8VNY&::<H3R5\V1\$X)&*].HH ****
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M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
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MJ,%I:P)OGN;F98XXU]69B ![F@#._P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
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M@\W6D36FR._V^<0=V3;],>G]:^8:^JO^"G/_ !^>"_\ KEJ'\[>OE6OF\?\
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M;SCIFX>,RM^+&O<Z* &PPQ6\2V]O$J1HH5$1<!0.  !T%.HHH **** /$_\
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MBB@ KP7]O#_D%>#_ /KXU/\ ]!LZ]ZKP7]O#_D%>#_\ KXU/_P!!LZ]7)?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7_"/Q]_X)V^)?C)X$LYK;2?$/PHU2[LK6XC"/;J;"8&)@O *,"IQD?+P2,4
M=WX.^.?@_P 0_L[Z3^TIXAE&AZ#J'@VW\27C7L@;[!:R6BW+;V4<[$8Y('..
M*Y7P=^UK8ZQJ_@J/QO\ #R_\,Z9\2HF;P-J.H7<;M<R>3Y\=O=1K_P >L\L
M:2--T@(1E9DD 0^"_M&VNOW?_!!RTB\-+(;@?!3PT\@BSG[.L-BT_3MY(DS[
M9KHOV_\ 9>_"_P#9PL_!6'N)_CMX/?1?)YPBQ3L7&/X!$&)/3;G- 'K/B_\
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M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
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M^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:
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M_P!BIJG_ *1S5\(U]9P]_N\_7]#[CA;_ '2?^+]$%%%%?0'U 4444 %?=/\
MP;__ /)W?BG_ +)O=?\ IPL*^%J^Z?\ @W__ .3N_%/_ &3>Z_\ 3A85E7_@
MLUH?Q8GZ[T445Y!ZX4444 %%%% !1110!XG_ ,% ?^3=;G_L+6O_ *$:^#Z^
M\/\ @H#_ ,FZW/\ V%K7_P!"-?!]?/YG_O/R/RWC'_D;+_"OS84445YY\J%%
M%% !7@O[>'_(*\'_ /7QJ?\ Z#9U[U7@O[>'_(*\'_\ 7QJ?_H-G7JY+_P C
M"/H_R/<X=_Y&D?1_D?.M%%%?;GZ(%%%% !1110!^[G_!*C_E'Y\-?^P7<_\
MI;<5]"5\]_\ !*C_ )1^?#7_ +!=S_Z6W%?0E>-4_B/U/9I_PUZ!1114%A11
M10 4444 %? _[>G_ "<GJO\ UY6G_HA:^^*^!_V]/^3D]5_Z\K3_ -$+7G9G
M_NZ]?\SY/C+_ )%,?\:_)GC=%%%> ?EX4444 %%%% 'ZG^&_^1=L/^O*+_T
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M "BBB@ HHHH \@_;VTGXSZ[^R)XVTC]G^ZOX/%-QIT26DND@F[%N;B+[7]G
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _,+XJ_\E0\2?\
M8?O/_1[U@5O_ !5_Y*AXD_[#]Y_Z/>L"OD9_&S\(Q'\>?J_S"BBBI,@HHHH
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MO#_D%>#_ /KXU/\ ]!LZ]7)?^1A'T?Y'N<._\C2/H_R/G6BBBOMS]$"BBB@
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MCBNAH'0?UHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3'_&OR9XW1117@'Y>%%%% !1110!\._&#_DK7BG_ +&.^_\ 1[USM=%\8/\
MDK7BG_L8[[_T>]<[7Z7'X4?KZV"BBBF,**** /;_ /@FW_R?9\+_ /L:H?\
MT%J_?&OP._X)M_\ )]GPO_[&J'_T%J_?&O/QGQKT/0P?P/U"BBBN,[ HHHH
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M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 >;?'/X*^*_C=X"D\"7WC*TL8Y+J*8SKIYD(*'.,;E_G7BG
M_#L?4/\ HLL/_@A/_P ?KZTHKGJX6A6ES35W\SR\9DN69A6]KB*?-*UKWDM/
MDT?)?_#L?4/^BRP_^"$__'Z/^'8^H?\ 198?_!"?_C]?6E%9_4,)_+^+_P S
MD_U7R+_GS_Y-+_Y(^2_^'8^H?]%EA_\ !"?_ (_1_P .Q]0_Z++#_P""$_\
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M#,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&O$/C;^P[K?QI^(
M5UX_OOBA;V4ES#%&;==',@78@7.?-7KCTKZ'HK.K2IUH\LU=')C<#A<PI>RQ
M$>:-[[M:_)H^2_\ AV/J'_198?\ P0G_ ./T?\.Q]0_Z++#_ ."$_P#Q^OK2
MBN?ZAA/Y?Q?^9Y?^J^1?\^?_ ":7_P D?)?_  ['U#_HLL/_ ((3_P#'Z/\
MAV/J'_198?\ P0G_ ./U]:44?4,)_+^+_P P_P!5\B_Y\_\ DTO_ )(^2_\
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MO,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** /%_VC/V6?$?[0TND2ZE\0;;3O[)6<($TLR^9YOEY_Y:+C'ECUZU
MYG_P['U#_HLL/_@A/_Q^OK2BN:I@\/5FY2C=OS9Y&*R'*<;7=:M3O)[N\ELK
M=&EL?)?_  ['U#_HLL/_ ((3_P#'Z/\ AV/J'_198?\ P0G_ ./U]:45'U#"
M?R_B_P#,Y_\ 5?(O^?/_ )-+_P"2/DO_ (=CZA_T66'_ ,$)_P#C]'_#L?4/
M^BRP_P#@A/\ \?KZTHH^H83^7\7_ )A_JOD7_/G_ ,FE_P#)'R7_ ,.Q]0_Z
M++#_ ."$_P#Q^O)?C!_P0DU'XL>.9_&9_:@AL/.@AB%M_P (:9=NQ F=WVM<
MYQGI7Z'45OAZ-+"SYZ2L]OZN=.%R/*\%4<Z-.S:MO)Z?-OL?F3_Q#MZA_P!'
M<0_^$*?_ )-H_P"(=O4/^CN(?_"%/_R;7Z;45V?6:W?\CO\ JU'M^9^9/_$.
MWJ'_ $=Q#_X0I_\ DVC_ (AV]0_Z.XA_\(4__)M?IM11]9K=_P @^K4>WYGY
MD_\ $.WJ'_1W$/\ X0I_^3:/^(=O4/\ H[B'_P (4_\ R;7Z;44?6:W?\@^K
M4>WYF%8Z3XVLK*&S&O6;"*)4#?92,X&,]:E^Q>-_^@W9?^ Q_P :V**P-S'^
MQ>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@"CI4&OPR.=8OX)E*_((HMI!
MJ]110 4444 ,>""61)I(49XR3&S*"4)&"0>W!(I]%% !1110 4444 %%%% '
M#?M'6'Q!U7X1WNE_"KXAV_A3Q#<ZCIL6F:_=P"6.T=K^W!W1L0)0RED\LD!]
M^W(W5\Y?M">$?^"@OP<^$^I?$[QQ_P %"?#<6BZ++;76KS6_PJAMY([=9XR[
M(PN\L0/^68P7&5!R17N7[:R?!V3]F7Q*OQ]\/ZKJ_A(_8O[6T?1+>26[U#_3
M8/*MHTC969I9?+CX9>'/S+U'Q5JOAO\ 85^%.CWWQ,\,?\$7OC'%J&@6,VH6
M,_B'PF?L$<L,;2(]P9-1E"Q J"S&-]J@G:2,4 ?I2#D Y_*BN>^%WQ"@^*/@
MJS\8Q>$M?T)[E!Y^D>)='ELKRUDP"T;QR 9QG&Y"R'!PQKH: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KF/C9_P D9\7?]BQ?_P#I/)73US'QL_Y(SXN_[%B__P#2>2HJ
M? _0PQ7^[3]'^1^95%%%?)'X4%%%% !1110!YM^UG_R0_4O^OBV_]'+7R)7U
MW^UG_P D/U+_ *^+;_T<M?(E?:9%_N'S9^A<.?\ (L7JPHHHKV#W@HHHH *_
M6+_@WT_Y-\\<_P#8Y)_Z215^3M?K%_P;Z?\ )OGCG_L<D_\ 22*N?%?P6=&%
M_C'W]1117EGJ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E7QS\8?$?X;
M17^IW/P2U#XF>#-0B U#1M B@EU33_E"LJVL[(E[ V-VT.)48L LBD>7YA=?
M\%-?@_XOBN/ D?[*/QMURXO('MKSPX_PKF9I8V!1XY4F98]I!(;>=N,YXKZD
MHH X7X0ZW\8O'#R^.OB;X/'A"SF@\O2/"4EY%<W<:DAC<7DD>8UE. JPQ,RH
M-Q9W9PL7=444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQI.K:5K^E6VNZ%J=O>V-[;I/9WEI,LD4\3J&21'4D,K*00P)!!!% %BBBB@
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MV1Y4I4_I0!;HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
MMJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8H
MK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'
MTC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?
M2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO
M?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]
M_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:
M@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ
M/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_
M (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC
M_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/
M^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_
M  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?
M_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -B
MBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^
M$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X
M0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_G
MYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
MMJ/^$'TC_GYO?_ MJ -BN8^-G_)&?%W_ &+%_P#^D\E7_P#A!](_Y^;W_P "
MVKFOC+X.TNV^$'BNXCN+LM'X;OF4-=,1D6[GD5%3X'Z&&*_W:?H_R/S@HHHK
MY(_"@HHHH **** /?O\ @G'_ ,EWO_\ L6+C_P!'V]?;U?#'_!/?2[?5_C=?
M6MR\JJ/#<[ Q2%3GSX.X^M?9_P#P@^D?\_-[_P"!;5]!EO\ NWS9^J<(_P#(
MG7^)FQ16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M7H'U!L45C_ /"#Z1_S
M\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^
M!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\W
MO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0
M!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M
M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8
M_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"
M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\
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MC_Y+O?\ _8L7'_H^WK[>KZ#+?]V^;/U3A'_D3K_$PHHHKT#Z@**** "BBB@
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M=Q1B-=7TFYWB"["=%D62.6&55^7?&&7:LBHH!Z31110 4444 %%%% !1110
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
M,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$
M'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH HZ5
MH%EH\CR6LL[%UP?-F+#]:O444 %%%% 'QY^UY\(?A5\=?%NB?M#_  2^)*>
M?B%X<UG7-,G^(.FR)&]O+IEO=>9;7Z9VS0;[?D2#/E,,?*VTX/@;XD?$?XQ?
MM5?LC_&3XM^'?[+O/$OPR\1S?8UB9(X]0:TADD=%;)3S(0KJIY"G&3@U]3>)
M_P!F+]GKQEXPM_'WB;X+^&+S6(+HW+7\^@V[2W$NQD#2L4S*1N)&XG# $<BI
M?C3\&[+XJV>B:K87Z:=XB\)ZU'J_A;5S#O%K<JC1LCJ""\,L4DD,B @E)"05
M958 #?B;#^SC\1[VZ^#/Q=?P=K%W)I)O+KPUKLEM+.+)F9//\F0[UCW*P$@
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MYC6O^Q)_R9A\(O\ LF&@?^FZ"@#T^BBB@ HHHH **** "BBB@ HHHH ****
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MOX#\6P^)KW4;"V6/^R-"MHID^RY0#8EU.88DBX#B&5@"(6QW/Q_\)_"+P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M &9Y/E>6'W?Z/]I\X_NN?*W5].V]O!:6Z6MK"L<42!(XT7"JH&  !T %/HH
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M34O$C2_9[-#G?*%CC<O(!]U6&W)RVX+L;L:* /!_@3X!_;<\':YHOAGQY?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK\HZ*\?^UO[GX_\
M ^!_UX_ZA_\ R?\ ^U/U<HK\HZ*/[6_N?C_P _UX_P"H?_R?_P"U/U<HK\HZ
M*/[6_N?C_P  /]>/^H?_ ,G_ /M3]7**_*.OU<KLPF+^M<WNVM;J>_D>>?VS
M[3]WR<ENM[WOY+L%%>#/^V;XPN?CYXP_9W\-?LV:SK6M>"],M=0U*33=?LEC
MN+>X7=%Y!N'BW.<$;6V8(/.,$T-:_P""C?PN;]DC5?VQ? 7A+5=:T'PY=M:>
M)]$G9+/5-+N4ECB>"2)\IYB&5"PWXVL"I;-=A[Y]$45Y5=?'GXKZ=H&G^+K[
M]F_4'TN\FM//GLO$5I+):P3R(IG:/*EE0/O8+D[5. :O_$7]HS1/"GQ0T_X#
M^"O#ESXH\<:CIKZE_8EE.D4>GV*ML^V7D[\01%R$7 >1V.%1@&( /1J*\NTC
M]I>#2?BYI7P+^-'@N3PEXA\16TTWA:8:@EYIVM>2 TT,%P%1A.BD,T4D:$J<
MIO ./4: "BBB@ HHHH **** "BOF?_@L-_RCF^(G_<(_].]E7X;UTT</[6-[
MV.:MB/92M:Y_3!17\S]%:_4O[WX?\$R^N_W?Q_X!_3!17\S]%'U+^]^'_!#Z
M[_=_'_@'],%%?S/U],?\$>?^4C/P[_[B_P#Z:+VIEA.6+?-MY%1Q?-)+EW\S
M]R***\W^.O[4GPP_9[\8^ /!/CZ^:.[^(?B<:+I 1@/+<QDB5\_P>:T$1/9K
MA#TS7&=AZ11110 4444 %%%% !1110 45RWQL^+_ (.^ /PFU_XR^/YIDTCP
M[ILEY>"VC#2R!>%C120"[L5102!N89('-97P]^)'QCUKXE:GX#^)7P(_L&QM
M]*AOM+\3:;XA74+*\+-M>V?=##)#<(>2NUT*\A^@(!WU%%% !17B?QM_;9\(
M?LX?&_PA\*/C5X5N-'TGQS<S6N@^,Q?Q/8K<)L_=7"DK) 2TD:[BI0%Q\V Q
M7MOCA\5]9^#^AZ9K^G>!'UV+4-?T_2'CAU%('@FO;N*U@<[UPT?F3+N(.Y1R
M%;G !VU%,MFN7MHVO(DCF* RI%(756QR Q +#/? SZ"GT %%%4/%.I:QH_A^
M[U70=%74;NWA,D5BUT(?.QR5#E2 2,XR,9P"0.0 7Z*^7/"__!3_ ,,:A^SW
MHO[6?C#X!^+-'^&VL7?D/XGBN+.[_LX?:FM?.N;>.7SDB\Y2NY%<\CCD9[KX
ME_M>S^!/CMX)^!6A?"Z7Q!=?$/3;V^\+:K8:W"EM-#:P+-+YA< H=C KC<&!
M'/4  ]IHKA?!WQ3\>ZM\15^'_C;X,7V@K/HT]_9ZM_:UO=VTWE2P1O"?+.Y'
M_?HPW* P#8)VG'/>%OVG=2^,-WK$_P"SG\-O^$JT;0]1ET^Y\2WVM)I]C>W4
M1Q+%9MY<KW&QOE,A1(BP(61L' !ZW17!? W]H;P9\=8];TS2;&^TCQ#X5U+^
MS_%GA;6$1+W2;DKN4.$9D>.1?GCEC9DD7D'(('._M<?M;:;^QWX8L/B5X_\
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MNX/*GMI48I)#*F3L=6!!&2#P02I!/;T %%%% !1110 4444 %%%% !17R/\
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M&^/O[%GC/X2_"7P[_:WB#5O[._L_3_M<,'F^5J-K-)^\F=$7$<;MRPSC R2
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M7-M9&RTFX\>^)?MYTNU)4M#;JL<:(&V("Q5G(15W;1B@#SO_ (+!^'=/U?\
M8 \>:K=W%^DNG6MH]NMKJMQ!&Y:^ME(ECC=4G&#PL@8*>0 >:N_$/Q'<:/\
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M$LKS,S%I CA1(L@EB?  WPN>]?1G_#@C_@C;_P!(]OA__P" <W_QRF(^?/\
M@@7_ ,%]/B[_ ,%A/B]X_P#AO\2/@#X;\'0>#O#=MJ5M<Z'J=Q.]P\MP8BC"
M48  &<BOKW_@JY_RCP^*G_8O+_Z415M?LL?\$Y/V'?V)-?U7Q3^RA^S5X;\"
MZAKEFEKJUWH<#H]U"C[U1MS'@-S78_M&? +PS^TW\*=3^#/CCQ'K%AHFLQK'
MJD>BS0QRW$8=7"%Y(I"HW(/NX)Y&<&@#Y0_;O\&?M)WG[ UEJWC'QOX9U_X?
M:7I&E7_CKPOX?T*?1M3U+383#(8HKV:ZO$7!5&8")"P0@,,[3Z!\0_BMJ/B'
MXS_LI>,_A5XSU_2?"/CLW4LGAI+GR+>YLVT.2ZMQ/$O+LFY/E9F4%00,C->@
M>+_V)/"?Q,\#6GPJ^+7QD\>>)_"5JL"/X9O=1L[6VNXX2ICCG>QM8)ID!13M
M:0@D G)YKH/B%^R_X(^(/CKP'X[;Q#K&C2_#>:27POIVB&UBM86>$P,&1X'+
M+Y),84$!5Z 'F@#R;X+W_B3]M*/XTZEK'Q-\4>';[PW\2]5\(>%(_#WB&ZL%
MT:.PCA6.X:&%U6XDDF=IF\\2*5*QXV@@_/O@/X[_ !"_:%^-?[$/QO\ CM D
M5KJD7BFUNY1&$MY]:BCFM(9BH^57E:*%T  &7;:,5]FWG[(WA"U^(OB?XD_#
M[XA^*_!]QXUC3_A+K#PW=6JVNIS*AC%R5N+>5H)RAVF6!HF;AB2P#"]XZ_9'
M^ 7Q ^"&F?L]:OX&2W\-:$EM_P ([#IMQ);SZ1+;C$%Q;3J?,BF3J) <G+;M
MP9@0#T'5[;2KS2KJTUV&"2REMW2\CNE!B:(J0X<-P5*YSGC&:^3_ !1X(\?_
M !H_;W^('P1N/VF?B+H/AEOAGI&KVD'A7Q$+.2SN9+V=,V[JA6-=L0S\I9^
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M 7[,OA/Q5I]IX;T[4UU;5]7N89F>Y1F9"L8VX&W@U\E_\1O/[4W_ $8]\/\
M_P **^_PK]N_VC?^"4O_  3K_:Z^)<OQC_:5_9)\)^,?%$]G#:2ZUK%O(TS0
MQ B-"5<#"@G'%<'_ ,."/^"-O_2/;X?_ /@'-_\ '* /PD_X*8_\%A?B3_P6
M$_X)S>)?B1\2/@[H?@Z?P=XTTG3;:VT._FG2X24M*78R\@@C&!7Y.U_03_P<
M_P#[$?[)_P"Q)^Q)%X6_90^!>A^!=/US7+"ZU:TT.)D2ZF29D5VW,>0O%?S[
M4@"OV:_9J_X+Z?%W_@CW^Q'\&/AM\-_@#X;\8P>,?!?]IW-SKFIW$#V[Q3/$
M$41#!!'.37XRU_3C_P $'/\ @G)^P[^VW_P3E\!>*?VK_P!FKPWXZU'0]#@M
M-)N]<@=WM87+NR+M8<%N:8SY,_XC>?VIO^C'OA__ .%%??X5^Q?_  17_P""
MBWC3_@J1^P[8?M8>/?ASI?A;4+SQ)J.FMI.CW<DT*I;.JJX:3YLG/(JG_P .
M"/\ @C;_ -(]OA__ . <W_QROH/]G+]F+X _LB_#2+X.?LU_"S2_!WA>"\FN
MHM%T>-EA6:4@R. Q)RQ SS0(\+_X*!_VW_PU9^S#_P (Y]E^W?\ ">:I]G^V
M[O*+?8.C;>0,9Y'3WZ4?%'X4>/?V;]5^,/\ P4H\<^)M-UKQO:_#.XT[PQHF
ME:<\5AI5G HF57+NSW#-,B.[D)@!P  1CV#XS_LK>%?C?\2_!WQ3\1>/O$UA
MJ'@34)+[PW#I,]HD$,\BJDC.LENYDW*NTAF( )P!FO0M?\-Z+XK\-7OA#Q3I
M\6HZ=J5C)9ZC:W:!DN89$*2(X  (9201C'- 'SCX.^&G[3!\<_#;XU^$?BI8
MVWAZ2./_ (35-7^)NI:M;^);2ZC01206LUHEO:S^8X>/R/*4EPF-N%K@?!=S
M^U?^UO\ LX6'[2/P?^(UAX:\47.OW&HV6KZC\2=2CTVSM[>_DC?3[K28[4VK
M1K!&8FW%G+ 2%\DU[/\  +]@3X8_L\:U9W/AGXG_ !#UC1M'E>3PUX0\2^*V
MNM)T1V# &W@"*255F">:TFS<2N&^:J6F_P#!.+X*Z!\2]7\<>%?'?CW2-$\0
MZJVI>(/AWI?BAH?#VHW3G,CRVH3<5D/WXQ((W'R,I3Y: .#7P)\1/C?^W%\6
M_@_J_P"TW\1M#\/V'A?PWJFG6WA;Q(+5K*XF>Y9A XC(2(^7AEVYD!&\G:*[
M+_@K/#XVG_X)V?%&/P )S??V)"9Q;YW?8A=P&\Z?P_9A-N_V<UZ-X6_9N\-^
M$_V@O$/[1UCXU\03:SXGT^WL=5L+B6V-DUO!N\A%18 Z^7O?!W[CN.XM7H%Y
M9VFH6DMA?VL<\$\;1S0S(&21&&"K \$$$@@]: .&_9SU30/$/[,_@?4_AG=V
ML>FW'@K3CHLGE>9%%']EC$8**RDA1@%=RG@C(KY ^)_[3_[0OQ8_X)R?'+XS
M7/C"S\(Z]X.\97NCZ?>_#^WGT^:<VEQ;6[32RR3ROEU?&$*E0JC<<<?3O@3]
MC_1O@Y8W/AOX#?&7QGX+\/7%Q)/#X7TR2PN[&P>1BSFU6_M)WMU+$MY:MY0)
M.$&:SKW]@'X)7/[-^O?LO6NK^([3P_XJU:;4_$]Y#J,;7NIW4LJ2RR/))$RI
MO=$)$2(!MP  3D X'XV#QA^S_P".O 'PYL?CKXXU$_&OXCVMIXAU+6=:WIIE
MO!:/)-;:<%538_:7"*0C90%_+V-AAISWWC+X5_MWZ=^SI8>,O$NJ>!OB+\/K
M[4C8ZCXCO+FZT34+.5%::WNY)6N(XI4D13'OP'P5VY*GUGXM?LU^!/CA\,=.
M^&OQ(U75[V31[ZVU#1_$D5S'!J=AJ%N<PWL4L4:HDRG/(3:02"I!(-OP)\"M
M$\(>.)OBCKWBS6?%/BB;2$TI=?\ $'V43062R>:8(TM8((8U:3YW(CW.53<Q
M"(% /CW1OC'\7]5_X)5?!OXUWGQ6\2'Q5=^,=&@O];36YTFO(I];^SRQSD,!
M,K1?+AP< <8KT2^\&?$+XS?MX?%/X)ZO^TC\0M'\,6W@C1-1M;'PWK_V&6UF
MFDNE(@EC3,*C8"=HWN54,Y4%6Z4_\$Q/@N?AP/@]_P +0^(?_"*VGB&/5] T
M >(8EM]$D2[-UY=KM@#;#(>#*9'120C(6)/*>$?#,WB'_@II\0GT#XE>*/#Z
M+\.]%TRQU738898]0F@>X,\)DO;>:*:6,&-B1\ZG=S@N" =M_P $VO'WQ6\5
M_!WQ3X&^,?BRX\0ZM\._B7K7A"/Q)>_Z_5K>RD01W$A_B?#E"W4^7\Q+9)N_
M\%/_ /E'[\5_^Q1G_P#0EKU3X3_"GP;\%O!-OX#\#V<L=I%/-<3SW,QEGO+F
M:1I9[F:0\R2R2.[LQ[MP   ,[]H+X&>'?VC_ (5:K\'/&7B+5[#1M;@\C5!H
MTL,<L\.03'OEBDV@X&2N#UYH J_#,>&S^RWX?'C-8FT<^ +3^U5G4E#;?84\
MW<!R1LW9QVKY)\7^ /VJ/^"87@?4/$/PPUB#XO\ [/-I!))JW@C7Y!_:OA_3
M9,^9]EGY6>!58DJV0%S^[ W2U]E:'\)=,T;X.CX*S>)-4O\ 3DT(Z0E[?-#]
MJ%MY/DCYHXD0L$_B*Y)Y.:X*Z_8KT'4?AS%\$M6^.7Q O? :VB6<_A&[U&S>
M.YLU 'V22[^R_;6A(&UA]HW%?EW;<J0#R7]L;Q-<^/?VG?V2?&?PUO[53K.L
M:S?:1<:G:N\?E2Z2DBET5E;E&Z!A@FG_ +"UI)\4_P!JWXD?&G]HNZ%K\;_#
M%NOA;4?"MM%Y6GZ1HIE\^VGLMQ:2XBN,"3SW.=Q90J*1N]J^*'[(_@CXI_$C
MP1\3;WQGXBTF[^'4TDOA*QT1[.*ULS)$D4@V/;.7#1H%VL2%&=H7-6/B)^RM
MX%\??&30?V@K+Q+K_ASQCH&G2:<FM^';J&)[^R=@QMKI)89(YX@P+*K+\K,2
M,'! !Z;12(I1 K.6(&"S8R??BEH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.^.WPD3XX
M_#JY^'%UXFN-*M;V>)[N:UA5WD1&#A/FZ LJG/\ LX[UV-% 'YSZK_P;%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>bcrx-20250424_g3.jpg
<TEXT>
begin 644 bcrx-20250424_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\01>(_$%IHMI-HL]H/)N[EV6,2">:,A,KRXR!FOC7XI_LB_$/Q/J7C3]M/\
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M9I7C]?V)? GB7Q1\1Y-5L-1T-WLM,ETV-&M'-U,78S@EYBQR26]:Z'_@J?\
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO"7QC/PI\1OX7T[X73^']3\06NDRR6D&H2W4DH0':'>, J/-";/F!) #$/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG4"A'^]YQQ]:^LKCX.^+9/VN[?XVZ1X[\6PZ2GAA]/U?1+K6D;19VR##]GM
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M^"?@MX%LOAU\/M+-IIMEYC*))FDEFED=I)9I9&):2221W=G)R68F@#HJ***
M"JFJZ/:ZQ&D5U)*H1LCRI2I_2K=% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;
M%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U
M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
M8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (
M/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% %'2M
MLM'D>2UEG8NN#YLQ8?K5ZBB@ HHHH \L\/?M2?\ "0?%@_"C_AG3XIV.-1GM
M/^$EU#PCY6D_NM_[[[1YI_=/L^1MOS;EX&:]3HHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **\T\0_M@?LZ^%->O/#.O\
MQ#\B^T^Z>WO(/[(NW\N1&*LNY8B#@@\@D53_ .&W_P!E[_HIW_E%O?\ XS6+
MQ%!.SFOO1PRS3+(MIUX)K^]'_,]7HKRC_AM_]E[_ **=_P"46]_^,T?\-O\
M[+W_ $4[_P HM[_\9H^L8?\ G7WHG^ULK_Y_P_\  H_YGJ]%>4?\-O\ [+W_
M $4[_P HM[_\9H_X;?\ V7O^BG?^46]_^,T?6,/_ #K[T']K97_S_A_X%'_,
M]7HKSKPC^UE^S_X[\26GA'PKX_\ M6H7TGEVMO\ V5=IO;!.-SQ!1P#U(KT6
MM(3A45XN_H=5#$X?$Q<J,U)>33_(****HV"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#\U/VA?\ DN_C+_L9[[_T>]<=78_M"_\ )=_&7_8SWW_H]ZXZODJO\67J
MS\+QG^]U/\3_ #"BBBH.<**** /1OV2/^3CO"?\ V$3_ .BWK]%J_.G]DC_D
MX[PG_P!A$_\ HMZ_1:O=RO\ @2]?T1^E<%?\B^I_C_1!1117IGV04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA#$DC*N"_EAE+>3?\$V;^_TG]CW7=4TJR-S=6WCGQ=+;6X!/FR+JET53 ]2
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M];_$+P<+B&)KF>SO].OD5+G3KV"5HKBUG520LD<B,IP2#@%25()^;?V--/\
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q
M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45\P_'[]IOQI/
M^TY/^R_X8^($'@R;3[7PQJ%G.;2.2]UX7VM16LX@\[*"&&/AU",SF0\JJ-N]
MO^'#_&5_ UY8?$6YT=_$5KJ%W;VFHVFGR0VMU LA%O<-"968$QE"Z!\;PP4J
M,8 .OHKQC]@SXV?$GX__  $?Q]\69--;6T\5:SIT_P#9%HT%L$M;Z:! B,S,
M!MC'WF8^I-<W^U)^U?X\^'WQG^&WPU^%5E:R:;JGQ1TKP[XWU>XCWB$W<$\Z
MV,(Z>;Y47F2-UC62# )E)4 ^BZ*BOKVTTRRFU&_N%A@MXFDGE<X5$49+'V !
M-?*$?[9GQ;G_ &3W_P""A4<MO_PAZZP;A/ PTY?,;PZM_P#9#<&?._[;L!N1
MSY6W$6S/[V@#ZTHKP[4?CQXG^+G[3UU^S=\'O%D6D6/A[P9;Z_XE\2P64=S,
MTMV^+*TA64&-5,:O-([*Q*E%7:26'#R?\% _$$'[/$FH/H&F-\38_BW_ ,*M
M&G[9!I[^(OM7DBX"[M_V<PG[3LW;L?N]_P#'0!]4T5XKH/QE\:_#3]J?2?V8
MOBCXF37H/%_A2XU?PKK[V,=M/]JM)%%Y92)$ C+Y<D<L; !@ ZN7(5CJ_M>_
MM"7_ .SU\.-+O?"^GVMYXF\7>+-.\+>$+6^#&W;4KV7RXWE"D,8XU$DK*""P
MCVY7=N !ZK17B&G_ !R\5?"']IK3_P!G3XP>+HM8L?$_@^ZUSPWXDFLH[65+
MBS<?;;25(@$9!$Z31N &55D5RY"L?.H_VS/BW/\ LGO_ ,%"HY;?_A#UU@W"
M>!AIR^8WAU;_ .R&X,^=_P!MV W(Y\K;B+9G][0!]:45X=J/QX\3_%S]IZZ_
M9N^#WBR+2+'P]X,M]?\ $OB6"RCN9FENWQ96D*R@QJIC5YI'96)4HJ[22PW?
MV1OC_J/Q^^'^L2>*K&UM?$_@WQ=J/A7Q;!8JPMSJ%E+L:6$,2PCD1HY54DE?
M,VY;;N(!ZI1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'YJ?M"_\EW\9?\ 8SWW_H]ZXZNQ_:%_
MY+OXR_[&>^_]'O7'5\E5_BR]6?A>,_WNI_B?YA1114'.%%%% 'HW[)'_ "<=
MX3_[")_]%O7Z+5^=/[)'_)QWA/\ [")_]%O7Z+5[N5_P)>OZ(_2N"O\ D7U/
M\?Z(****],^R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+A5\QV.XE=FXOPQ^&R^,S\1E^'NACQ"PPVO#28?MI&S9CS]N_P"Z O7IQTH
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M]SY_N\U]T^#?A[X!^'.GR:3\/? ^CZ#:RR>9+;:-ID5K&[[0NXK$J@G  SZ
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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MBBO3/L@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFRRQ01---(J(BEG=
MC@*!U)/84 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBJ.E:!9:/(\EK+.Q=<'S9BP_6KU
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MR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%OL:E%?E'17D?VM_<_'_ (!\'_KQ_P!0_P#Y/_\ :GZN45^4=%']K?W/Q_X
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M_P#!*?3;>YN+R#_@H)^T^DUV5-U*GQ7 :8JNT;R+7+8' ST'%>Z?LW?!R;X
M?!W3?A+-XMU#7O[+NKYDUC5[HSW=VDU[/.CSR;5\R8K*-[8 +;B* .YHHHH
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MGZ-X1DU6PF,=Q8V=S*S74T3CE)/)C9 P^93)N4A@" #W^BOEOQIX^TS]C_\
M;/\ "O@+PU%);>"O'GP_UN[N]!BE9H;;4=(C%T;N(,3L>6W9TDQCS"B,V6!)
M\QA\7>/YO^"9C_\ !0V37+@?%$NWBY-3-W(8UMAJ) TH)G'V(V8\DPXVECYO
M^L^>@#[RHKY9\&?$.Q_;!_;4\1> /$<$MSX(\"?#K1KZ'P_+,P@NM2U9/M*W
M,RJ0)&CMPJ1ALA&9W&&((ZC_ ()]_%7Q1XV\'>/?AAXRUJYU.\^&'Q0UCPG:
MZI?3&6XO;&WD5[229SDO((I5C9CEF,6YB222 >_4444 %%%5]0U73M*19-1N
MTA5SA2YZF@"Q16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E67XY_Y$G6/
M^P5<?^BVIW_"8^&/^@U!_P!]5E^-O%WAJ3P9J\::S"6;3+@  ]3Y;5,OA9G5
M_A2]&?F31117R)^#A1110 4444 ?1?\ P37_ .2N:Y_V+C?^E$-?:-?$_P#P
M3GU33]*^*^M3ZC=I"C>'F56<]3Y\7%?8W_"8^&/^@U!_WU7T.7?[JO5GZOPE
M_P B:/K+\S2HK-_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^J[SZ4TJ*S?\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH
M TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q
M\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_
M $&H/^^J/^$Q\,?]!J#_ +ZH _.;]H7_ )+OXR_[&>^_]'O7'5UWQ^GAN?CC
MXON+>0.DGB2]9&'0@S/@UR-?)5?XLO5GX7C/][J?XG^84445!SA1110!Z-^R
M1_R<=X3_ .PB?_1;U^BU?G+^RE=6]E^T/X5NKJ4)&FH$N[= /+>OT(_X3'PQ
M_P!!J#_OJO=RO^!+U_1'Z5P5_P B^I_C_1&E16;_ ,)CX8_Z#4'_ 'U1_P )
MCX8_Z#4'_?5>F?9&E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8
M^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?
M]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'
M_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )
MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
M?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_
MPF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8
M^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?
M]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'
M_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )
MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
M?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_
MPF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8
M^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?
M]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'
M_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )
MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
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M*P\M%&-D:N5&(\5^]^DZ5IFA:7;:'HNGPVEG9VZ06EK;QA(X8D4*J*HX50
M .@%>EB91PM!4(;O?^OZT/K\XJT\FRV.64'[\M9OUZ?/\EYEBOM'_@FO_P D
MCUS_ +&-O_2>&OBZOL;_ ()SZ[H^E?"C6H-1U".%V\0LRJYZCR(N:QR[_>EZ
M,X>$O^1S'TE^1]+45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5]$?JYI45F_\
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M5$,R1P7*)*(XK53ND*!2\JJI;:^WS,?!;XRM_P $\6_X)R#P9K'_  F"W/\
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
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M65SHGPQC\106]H;D@HP;=Y;K(,YVC FZG=@?3E-:*+S!<-$I=%*J^WY@#@D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEC+$!XW##()!&1Z$$?44^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "LOQS_R).L?]@JX_P#1;5J5E^.?^1)UC_L%7'_HMJF7PLSJ_P *7HS\
MMZ***^1/P<**** "BBB@#Z+_ .":_P#R5S7/^Q<;_P!*(:^T:^+O^":__)7-
M<_[%QO\ THAK[1KZ'+O]U7JS]7X2_P"1-'UE^84445WGTH4444 %%%% !111
M0 4444 %%%% !1110!^:G[0O_)=_&7_8SWW_ */>N.KL?VA?^2[^,O\ L9[[
M_P!'O7'5\E5_BR]6?A>,_P![J?XG^84445!SA1110!Z-^R1_R<=X3_[")_\
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MX1H:\='G&DG2?[0\W^U/M>WR=GV+GR=_G>;^[V9YH [GP9\0[']L']M3Q%X
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MU$@:4$SC[$;,>28<;2Q\W_6?/7K_ (A^$US^U/\ MA^'_B]J'AC6;#P7X(\
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M_NWK]$?[.T__ )\8?^_0KW<K_@2]?T1^E<%?\B^I_C_1%/\ X3'PQ_T&H/\
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M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
MX3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z%
M %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]
M^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,
M/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?
M_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^
MA1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/
M_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/
MC#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^
M^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J
M#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\
M0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZK^<?\
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MMK/\)=;:>VC<CQ$P!= ?^6$-=V7?[TO1GTO"7_(YCZ2_(]]_X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z%?1'ZN4_^$Q\,
M?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_]^A1_9VG_P#/C#_WZ% %/_A,
M?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A
M0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?V=I__/C#
M_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\
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M2,3W8DX '0 #2HH **** "BBB@ HHHH **** "BBB@ K+\<_\B3K'_8*N/\
MT6U:E9?CG_D2=8_[!5Q_Z+:IE\+,ZO\ "EZ,_+>BBBOD3\'"BBB@ HHHH ^B
M_P#@FO\ \E<US_L7&_\ 2B&OM&OB[_@FO_R5S7/^Q<;_ -*(:^T:^AR[_=5Z
ML_5^$O\ D31]9?F%%%%=Y]*%%%% !1110 4444 %%%% !1110 4444 ?FI^T
M+_R7?QE_V,]]_P"CWKCJ[']H7_DN_C+_ +&>^_\ 1[UQU?)5?XLO5GX7C/\
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M\/\ A[2Y]2UO5KZ39#9VL,;22S.>RJBL3]*UZ_ G_@[^_P""NGV.UA_X)5?
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M<M=?%'3IOB>OPE\-67]HZI:V,=_KS+,$BTJUD9UA:1L$F64QR>7$!\PB=F*
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MS\MZ***^1/P<**** "BBB@#Z+_X)K_\ )7-<_P"Q<;_THAK[1KXN_P"":_\
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MKOX,?Q[JOB7PVMOOTNY\27GVC4=/<$#[.]P0&NHF!W*\F94*,&>0,NSN* ,
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M:@_=%;O_  31UN^\CXV_#E78Z3X1^/?B*Q\/PC[EI:O)'<&W0=E22:4@=M]
M'TW1110 4454U74+K3XT>UTJ6Z+-@K$1E??F@"W16/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+0!L5E^.?^1)UC_L%7'_HMJC_X275_^A0O?^^EK,\:^(]5
M?P;JR-X2O%!TR<%BR\?NVYJ9?"S.K_"EZ,_,ZBBBOD3\'"BBB@ HHHH ^B_^
M":__ "5S7/\ L7&_]*(:^T:^)/\ @G9?W.G_ !5UJ6UTR6Z9O#S I$1D#SXN
M>:^P_P#A)=7_ .A0O?\ OI:^AR[_ '5>K/U?A+_D31]9?F;%%8__  DNK_\
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M ,2B;_T&OB6OKN'_ /=)?XOT1]WPO_N$_P#$_P D%%%%>\?2A1110 5^I/\
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M[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:
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M?CLWB7Q+8^!EMKG3=+UV2735L?MFXS?9P?+^T"0HIDQN"2*N<&O<Z "BBB@
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M_P#9QDTGX[:QX1L_&_A+X@0:OX)\6>#HKB329KNP:*>WN8UGQ(\8D>>TD/\
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MP67AOXR/T7HHHKRCU0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>%VFCO[>\2*:S9%4L1,B?*">G-*7PLBK_#EZ,^!:*\C^ 7[>'[(_[4/BJ_\
M _P)^-VF:_J^G1-+<Z>D$]O*T:D*TD8GC3SD!(RT>Y1D<\BO4/$'B#0O">A7
MGBCQ1K-KIVFZ?;/<7]_>SK%#;PHI9Y'=B J@ DDG  KY*4)1=FK,_"ZE"M1J
M<E2+4NS33^XN45YKX(_:]_9X^(7B+0O"GAKX@,+WQ3927?A9-2T>\L4UJ",
MN]G)<PQI= *0W[IF^4AOND&NS\%>/?"'Q$TE];\&ZW'>P0W4EK= *R26UQ&<
M2031N \,JGAHW567N!0X2CN@G1K4OCBUZIK^MC7HHHZ=:DR/HC_@FS<0)\8M
M9MGF422>&W*(3RP%Q#G'YBOM2OPBT+_@K+X0_9F_X*F> /V?8!$[7]DW]KWO
MFX,-Q/M^RV)Z8,L(EX8$A[FW((P:_=+0-=TKQ/H=GXDT.\6XLK^UCN+2=.DD
M;J&5OQ!%?38.FZ6'47N?LF0X*I@,KITI_%N_)O6WR+=%%%=1[ 4444 %%%%
M!1110 4444 %%%% !1110!^:G[0O_)=_&7_8SWW_ */>N.KL?VA?^2[^,O\
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M:>=]WV6$X+)$.B!BH9B/F8@ DA5 U:**+6"]PK]2?^#>7_DG_P 3O^PSIO\
MZ*GK\MJ_4G_@WE_Y)_\ $[_L,Z;_ .BIZPQ/\%F^&_C(_1>BBBO*/5"BBB@
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MUN]T_P"&\D,T5HDZ&1P6O&W  DL@P67<JY)"D ^O!G'-% .0#G\J* "BBB@
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M<?#+]G[X8Z!'X=^(5EK'B:./P9:0?VKI<4-PDMD1%!^\#O)$WEO\A\O)Y H
M]Z^(/B>?PU\-M<\::*$N9=/T.YO;0*=RRLD+2+C'4$@?G7PQ!8NO_!!)_&,V
MIRG67\/-XI.L[_\ 2#JQU8WHNO,Z^;YV#NZ\8KZF_M[XQZ/^U%8_"33-+\%3
M?"^;P<P_LNPAF74]+ECPJM,H'D);."L4<8PS88@8B>O/!^PQXX/[.C?L.'7]
M('PO.N[UU<7LYU?^Q?MWVW^S/)\KRP^[_1_M/G']USY6Z@#'_9/\<Z_\8?\
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MMKN..2-\$$95L@\@'GN*L_\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\
M?2UF>-?$>JOX-U9&\)7B@Z9."Q9>/W;<UU=9?CG_ )$G6/\ L%7'_HMJF7PL
MSJ_PI>C/RWHHHKY$_!PJ*PL+'2[*+3=,LHK:W@C$<%O!&$2- ,!54<  =A4M
M% ",H92K#@C!J+^SK'_GU3\JFHJHSG#X78WI8G$T$U2FXW[-K\CV']B/X<>
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M-.),)'R_NI^N:_,-65E#*001D$=Z_4K_ (-Y?^2?_$[_ +#.F_\ HJ>JQ/\
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MI_\ P7W'_P :KX,HH_M3$=E^/^8?ZZ9I_)#[I?\ R1]Y_P##>W[/?_0Q3_\
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M;#_L88?_ $1/7RY7U'^VU_R2FP_[&&'_ -$3U\N5]MDG_(OCZO\ ,_1.'?\
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MKC0_$UM&<F&>,X2X3#?[,L6_*F-B#7%556E!P>J.VDZ52:FM'V/[7:*_/O\
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M[\</^"C'Q7\6>$)#MN_#*7?V(WT/_/&XG21FEC8<,-H)!X(/-?5WA'PEX:\
M^%M.\$>#-$M]-TG2;*.TTVPM4VQV\$:A411Z  "@#1HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LOQS_R).L?]@JX_]%M6
MI67XY_Y$G6/^P5<?^BVJ9?"S.K_"EZ,_+>BBBOD3\'"BBB@ HHHH \>_;:_Y
M)38?]C##_P"B)Z^7*^H_VVO^24V'_8PP_P#HB>OEROMLD_Y%\?5_F?HG#O\
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M_P#@F%^Q?XI_:E\>^1=7]G#]A\'Z!++M;6M9F5OLUJ,'.W*M)(1RL44C#)4
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M)$TUWJE\U[K&IW;!KC4+EE5#+*P !(1$154!41$1%5551N44 %%%% !1110
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M%%<YY04444 %?JY7Y1U^HGV+QO\ ]!NR_P# 8_XU[&4_;^7ZGWW _P#S$?\
M;G_MQL45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^->P??&Q16/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q
M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^->-_ML?MJ^!?V%?V8?'?[47Q
M:\=::^E^!;0BYTZV4?:+R_=$-M81@G_73-+$JYX ?<V%5B #\^_^#L;_ (*Z
M?\,F?LY+^P7\#_$_D_$/XJZ6_P#PD]U9S8ET7PXQ:.09'W9+LAX5](EG/RDQ
MFOG/_@T!_P""1?\ :FHS?\%5/CQX8S;VCW&F_!^QO8>))OFBN]7 /4)\]M$>
M?F^T-@%(VK\]/V1O@%^T]_P<3?\ !62\U+XD:W<-/XLU9]?^(_B&!3Y.@:'"
MR)Y,.<[0L?DVENAS\S1[L@.P_KA^%WPDA^"WPWT'X1?"VSTG1?#?AG2;?3-#
MTFSLRL5I:PQB..-><X"J!DY)ZDDF@#MJ*Q_L7C?_ *#=E_X#'_&C[%XW_P"@
MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_
M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@
MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_
M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH \]_;E_Y-B\1?\ 72R_]+(:_/VON_\
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M47\9>)/B%K>O>*(].U#3](UV\^S*='MKNY>XD%K%' D2R,QC9Y'1V8QJN?+
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M78>)]"N<O:M.NRZTVXP0MS:3KA[>9<_>0C(RK!E+*?YE?^"M_P#P;P?MB_\
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MW7!56%/V_,_Y?_;C],**_,__ (B)_P#JS[_S(/\ ][Z/^(B?_JS[_P R#_\
M>^O<^K5NWY'W?UFCW_,_3"BOS/\ ^(B?_JS[_P R#_\ >^C_ (B)_P#JS[_S
M(/\ ][Z/JU;M^0?6:/?\S],**_,__B(G_P"K/O\ S(/_ -[Z]H_81_X*U_\
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M\U?MP_\ (Y:+_P!@Q_\ T8:^E:^:OVX?^1RT7_L&/_Z,->OD?^_KT9[W#?\
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M]BKP3Y^G?LS_ ++_ (]\>W4>5CO/$%W;:%92'LR,/M,Q7V:)#V]Z^#?VBO\
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MX1_X*EWTNC^#OBK\=O'=K=2&.YTWX9Z3<V6G =-LR:5%%!L'K+P.I.>:])^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBO)OVC/VH[3X+W4_@GPGX6?Q!XM_X0[5/$L>F-=+!;
MVVGV2J)+B>0Y(4R21QJJ*SLS'@*&8 'K-%<G\+/B9J/Q ?6]*\0> =1\.ZIX
M>U1;'4+2]FBFCF+013I-;RQ,1+$R2KAB$8,&5E4K764 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^9_^"CW[,&G?&3X=ZG\8?!'Q$N_"WCWP'X0U.6RU"Q<.MYIT
MMO(9["[BS\\$PB=0W5&!9<X*GZ8KR_X]?LU_\+@75]8\._$_Q!X9U?5?"%SH
M%PVFR026EY;R"4HMQ#/#(&"/*Y#Q[) '8!P&- '!? _]L_QQJ'@KQMI7QM^
M6M+\1_AMJMEI_C'P[X#L?[1_M#[2@:VO;,%E9X9(\OM8[HU4YS7KGP6^,'_"
MY_#MUXA_X5;XQ\)_9KTVWV'QKHGV"YEPBMYB)O;='\V-V>JL.U.^%'P5\*_"
M2;6]7TR^O]4UKQ-J*WWB3Q#K$J/>:C,L:Q1ES&B1HB1HJ)'&B(@'"@DD]?0
M4444 %5-5AUB:-!H]Y%"P;YS+'N!%6Z* ,?[%XW_ .@W9?\ @,?\:/L7C?\
MZ#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QJKK.@>-=8T>[TA]?LT6ZMI(2X
MM"=H92N<9]ZZ*BAJZ$TI*S/DO_AV/J'_ $66'_P0G_X_1_P['U#_ *++#_X(
M3_\ 'Z^M**X_J&$_E_%_YG@_ZKY%_P ^?_)I?_)'R7_P['U#_HLL/_@A/_Q^
MC_AV/J'_ $66'_P0G_X_7UI11]0PG\OXO_,/]5\B_P"?/_DTO_DCY+_X=CZA
M_P!%EA_\$)_^/T?\.Q]0_P"BRP_^"$__ !^OK2BCZAA/Y?Q?^8?ZKY%_SY_\
MFE_\D?#7QM_X(WZC\8_"MOX8_P"&A8=.$&H)=>=_PBQFW;8Y$VX^TKC[^<Y[
M=*\N_P"(=O4/^CN(?_"%/_R;7Z;45VT)/#4^2GHOZ[GHX?+<%A*2ITH6BO-O
M\V?F3_Q#MZA_T=Q#_P"$*?\ Y-H_XAV]0_Z.XA_\(4__ ";7Z;45M]9K=_R-
M_JU'M^9^9/\ Q#MZA_T=Q#_X0I_^3:/^(=O4/^CN(?\ PA3_ /)M?IM11]9K
M=_R#ZM1[?F?F3_Q#MZA_T=Q#_P"$*?\ Y-K[3_9$_9G\6_LH?L_:'\!K+XB6
MFM1Z*]TRZDVDFW,OG7,L_P#J_,?;CS=OWCG&>,XKV.BIG6J5%:3+A1ITW>*,
M?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBBLC0Q_L7C?_H-V7_@,?\:/L7C?
M_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^
M@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH ^8?'?_  3QU7QSXUU;QG<?%N"!]5U&
M:[>$:(6$9D<L5SYPSC/7 K)_X=CZA_T66'_P0G_X_7UI17(\#A9.[C^+_P S
MPI\-9)4FY2I:O7XI?YGR7_P['U#_ *++#_X(3_\ 'Z/^'8^H?]%EA_\ !"?_
M (_7UI12^H83^7\7_F3_ *KY%_SY_P#)I?\ R1\E_P##L?4/^BRP_P#@A/\
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M/X?-IY'E*ZXQYTF[._VQCO7TY14RKU9QLV5&A2A*Z1C_ &+QO_T&[+_P&/\
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MWE?RX9";@I8PB10Y%?I)\>?VO/VGM,_X)-> /BW_ ,$YOV?=7^*'COQ[\/\
M1QX531)+=8='CN+")WOYVG8)F)20D9#EIMH9"BR8 /DG_@W@_9X^.'[*W[>O
M[7/[,GPA^+NM:Y^S]\.?$MOHV@2>(9VN((]<#&26& \()H8B\5P8PNXB NH.
MT#G?^"O7[4W[0GQB_P""@G["%OX=\8QVOP;\4?M+6#>%+:WB9/\ A)[C3=4T
ME/[:D.?GM"U[+':C&'2-K@%DN(=OM?\ P3@\._M]_'7X6>+O^"?OQW_X)W:I
M^S#\(K_X5Z]97GC.#QC'JVOZWK>I%('NS=$ F[87%Y=R3NC,\JIR%^4_-O\
MP41_X-]_VQK;]I?]E>Q^"7[8'[1_Q6\-Z7X^">)?%WB+QG!-<?#*Q6ZTL)?Z
M:2$^S2"-99 45L&RBX^4 @'T7_P4\_X-^/!/[<7[0GC?]N;]J?\ ;>\6>%-$
MTSP]"+32_"<,<,&E:3860>:25Y0^]C*+F8[54!6 Y()K#_X(B?\ !)'6M _X
M)U>"?B%J7Q,OM/NOB(LOBQ;+6; W-U#9WC V*R2>8H+&R2U9@%4!W? KZ_\
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MK]G7]E+X ^)?&GBFR^*5CXBU2WTNT"V]I91:9J5NQ:XF9(G<R748"(S-@$D
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M:9L@C;%&DDIR,'R]O<5*P6%@^91L_5_YF-/AS)J513A3LULU*?\ \D?RV_\
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M_MP,>]?3]-,&C\7_  /_ ,&:_P"S7X)V2O\ 'M-9G3I<:YX2DGS]8Q?+&?\
MOBO6?#G_  ;6Z'X.LO[-\(_M(Z3I=O\ \\-.^'*P)_WREX!7ZCT5K&M4CM^2
M,I4:<M_S9^9/_$.WJ'_1W$/_ (0I_P#DVO8?V'_^"2.N_L7?&B3XPV'[0=OK
M\CZ+/I_V%_"QM@!(\;;]_P!IDZ>7TV]^M?:M%.5>K)6;%'#THNZ1C_8O&_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN1:?L_ZS<Z;HC1S+/X?BME6WD\PABP^8E3O56X[Y_O&OI.BB@ HHHH ****
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^?LL>![_\ 9_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E__@II_P BUX3_
M .OZZ_\ 0(Z^0Z^O/^"FG_(M>$_^OZZ_] CKY#KYS,/][E\OR/R3BK_D=U/2
M/_I*"BBBN(^>"BBB@ KS'XF?\$SOVW/C=XUN_BG\,/@I_:>@ZPD,FG7_ /PD
MFFP^<JPHA.R6Y5U^9&'S*.GI7IU?HO\ LD_\FX^$_P#L&G_T8]>ODU65+$2:
M[?JCZ[@^G&KCJD7_ "_JC\?/^'//_!1G_HW;_P N[2/_ )+H_P"'//\ P49_
MZ-V_\N[2/_DNOW(HKZ3ZY5[(_0_J=+NS\-_^'//_  49_P"C=O\ R[M(_P#D
MNC_ASS_P49_Z-V_\N[2/_DNOW(HH^N5>R#ZG2[L_#?\ X<\_\%&?^C=O_+NT
MC_Y+KT#]E#_@EA^WC\-/VG?A]\0_&WP)^Q:/H?C+3K[5+S_A)]+D\BWBN4>1
M]D=TSMA03A02<< U^Q%%)XNHU:R&L)33O=A1117*=04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<Y\8
MO'EQ\*_A'XI^)]KH,NJR^'/#E]JD>F0-A[QK>W>40J<'!8IM'!Y/2NCK(\?^
M-?#OPV\#:S\0_%]UY&E:%I<]_J<V ?+MX8VDD;!]%4F@#YT_9H^,?Q]^-FE6
M7QC\&_&/0O%&G:A<Z!+K.AP:,HM+>VNXXOM:6CI+YL$MN7<D3-+GR75E#'CU
MD?%V_P#'7[0NH_ SP'>I!#X.TZSU#QMJ8C5W22Z+M::?&&!4,\<3RRN02L9C
M50&E#Q_+'CCX=2_L@_M)M\:_V0->BTO2O$_C_P /Z1K_ ,,K/#Z7XBBU%%,E
MU:Q@X@N(U+3!X\((T8D!0P?U/]AJ"_L?VI/VG-/\0!O[3_X638SG?]XV<FG1
MM:_\!\OI0!1_:G^(W[?/P6\ Z]^UAX>\6^"T\-^&6:\G^%U[X?<SW&DI)AI)
M-1$V5NC%^\\M(A&A^7,FW+_3WAS64\1^'K#Q#%:2VZW]E%<+!.N'C#H&VL.S
M#.#[BO _C5\=OV;/C/XCN_@KXS^.O@O3/"6@:I$WCC^U?$]I;G4[B"195TQ5
MDD!\I9%1KA_NG;Y W%IO*]<T[X[_  :U35/#>@VGQ,T;^T/&&G-?^%M.FOEC
MN-5M0F\S01.0\B;/FR!RN3T% 'A\/[3GQF^*GP[^*W[0GP?U/3X-"^&VM:E8
M>'?#]Q8+(OB0:9&'O))YC\\8E8210>5MV%%=_,#;!L7'[7TGQF\=_"KX5? C
M5%T]_B-X-D\8:GK4]LDT^DZ,L:!%CC?*&XDGD6+<X94$<A*,=HKRC]G>YA_9
M[_8*^/WPT\;O]FU7P/XA\5V]S;R\27(NHVGL9$4\L+A;B(1_WRVT<@BL_P#9
M:^!_C#]F?]I_]GZ\^(]G);#6/V<Y?!K>;]VUUF"Y74WM6/0/Y32A1_%Y#XSM
M- 'IFN_M]3?!7X8_&U_BW80ZEXG^"FH6ULZ62>0FMQ:A'&^DR%>?*>4RK'(%
MR T;NH (1>EOOC+\7?@)\6/AEX,^./BBQUNR^)TL^EW5Q:::MJNBZXL'GQ10
M;23):RA9H@)"\BNJ,9&#$+\K_M/_  :\;?&6P_;!^-W@329]0T__ (2/PG%H
M\5NI;^T6\/Q1-J03'W]A,BC&<O$R]0<>_?M=?9?CW\<_V9_#OPYODU"-O&X\
M;R75JVY8])L[0O\ :&(^ZDCW$,:D\,T@ H ]A_:Q_:#T;]E?]GCQ1\>-:TUK
MY=!L UIIZOM-W=22+#;PYYP'EDC4D X!)P<5Q%]\9?B[\!/BQ\,O!GQQ\46.
MMV7Q.EGTNZN+335M5T77%@\^**#:29+64+-$!(7D5U1C(P8A>1_X*37OA[]H
M_P#8@^(FE_ _Q1IWBG4_!.L6ESK.F:)>I<R0RV%Y#/<VTBH25D6))#L/)*XQ
MFI/VNOLOQ[^.?[,_AWX<WR:A&WC<>-Y+JU;<L>DV=H7^T,1]U)'N(8U)X9I
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MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /E_P#X*:?\BUX3_P"OZZ_] CKY#KZ\_P""
MFG_(M>$_^OZZ_P#0(Z^0Z^<S#_>Y?+\C\DXJ_P"1W4](_P#I*"BBBN(^>"BB
MB@ K]%_V2?\ DW'PG_V#3_Z,>OSHK]%_V2?^3<?"?_8-/_HQZ]/*_P"/+T_5
M'V/!7_(PJ?X/U1Z+1117NGZ6%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M36W0]_A[(,9E.*E5K2BTXVT;[I]4NQHT445Z1]>%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 45YMX<^+M_\4/COXA^&O@B^6#1_ )M8O$^HK&KO>:E/'YRV,98
M%52*$H\K8W%IXU4J5?/FGQM\;_ML?"'X@^"OB!:>*_#.L^'_ !/X]L=!OOAQ
M:>'66XM+2Y=@9XK_ ,XM--%&C2R$QI'M5S@*F2 ?2E%>,?$#XV^*_$W[5FF_
MLC?#/6TT>XA\&R^*/%GB 6B3S6UK]H6VMK:W60-&)9)"[LTBL%CBP%RX9?/]
M3_X*!:UX%^ 7C_4_%.A6%_\ $+P'X]_X0F'3X0T-KJ^HSRQI8707+-%%+',D
MKIN)7RI54\*2 ?4]%>'I\8OB'\%_VDO _P !?BWXM@\16?Q)T?4&T76(],2T
MDM-6L8TFGMRL9VFWDA<M%NS(C1,K/)O!7H?VO_VAC^S)\#K_ .)&GZ/%J6L3
MWMKI7AO3)Y"L=WJ-U,L,".1R$#-O;'.Q&QSB@#T^BO#7^+WQ%^#G[1O@GX _
M%CQG%KUK\2]%U$Z'KD&F1VLMCJUC&DT\&Q<H8)(7+Q;MSHT+*S2[P5ZGX3?&
M+4-4^*/BG]GKQ]-"?$_A6"UO[:[BC$:ZOI-SO$%V$Z+(LD<L,JK\N^,,NU9%
M10#TFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(\?\ C7P[\-O VL_$
M/Q?=>1I6A:7/?ZG-@'R[>&-I)&P?15)K7J*]LK+4K.73M1M(KBWN(VCG@GC#
MI(C#!5E/!!!((/6@#X4\<?#J7]D']I-OC7^R!KT6EZ5XG\?^'](U_P"&5GA]
M+\11:BBF2ZM8P<07$:EI@\>$$:,2 H8/ZE^P[#J5C^U#^T]8:VN=5_X6/93C
MS>";233HVM,G^[Y?3VKVCP+^S?\  ;X9>*[GQM\/OA#X<T;4[I0IN]-T6"!H
MEV[2L91 8PPY8+@,>3FH;SX0RZ'\<6^.G@.2"&[UK3+?2O&&GSDI'J-O [M;
M7"LH.+B#S9E&1B2.4H2NU&4 ^,/VV?"7[<'@7]CWQ!%\5/"/PIG35_&>BZAX
MBU[1_%FIS7MY>MJUF(<12Z?&BQ*4@A5=^8X(P!O9?F^V/#_Q6T_1;SPW\./C
M/XL\)Z3X_P!?LI9H?#>F:V9!=&($R&U$R1RS(JC))C!X;C@UTWB'PUX<\7:6
MVA^*_#]EJ=D\B2/9ZA:)-$SHX=&*.""5958''! (Y%<IX^^!?A'XC?$WPM\2
M/$.B:0]UX2N&N=/O6TF-[_S"K*(UN3\T4 +!VC3EW1,L%5E< ^6_V=[F']GO
M]@KX_?#3QN_V;5? _B'Q7;W-O+Q)<BZC:>QD13RPN%N(A'_?+;1R"*S_ -EK
MX'^,/V9_VG_V?KSXCV<EL-8_9SE\&MYOW;768+E=3>U8] _E-*%'\7D/C.TU
M]H:O\,?AKX@\46OCC7OA[H=]K5B$%EK%YI,,MU;A22NR5E+I@LQ&",$GUJUX
MJ\'>$?'>CMX>\;^%=-UG3WD5WL=5L8[B%F4Y5BD@*D@\@XX- 'YW?M/_  :\
M;?&6P_;!^-W@329]0T__ (2/PG%H\5NI;^T6\/Q1-J03'W]A,BC&<O$R]0<>
M_?M=?9?CW\<_V9_#OPYODU"-O&X\;R75JVY8])L[0O\ :&(^ZDCW$,:D\,T@
M KZ:T/0=#\,:1;^'_#>C6FGV%I$([6QL;=8H84'141 %4>P%9WA'X8_#;X?S
MW5UX"^'NAZ)+?,#>R:1I,-LUP0207,:C?RS'G/+'UH ^<O\ @I->^'OVC_V(
M/B)I?P/\4:=XIU/P3K%I<ZSIFB7J7,D,MA>0SW-M(J$E9%B20[#R2N,9J3]K
MK[+\>_CG^S/X=^'-\FH1MXW'C>2ZM6W+'I-G:%_M#$?=21[B&-2>&:0 5[;\
M*_@7X1^%OBWQ5XYT/0](LM0\77T<^I+HFDQV<3",RLC.J?ZZ8M/,\D[?,Y?L
M%4#<\(_#'X;?#^>ZNO 7P]T/1);Y@;V32-)AMFN""2"YC4;^68\YY8^M 'Q_
M^SO<P_L]_L%?'[X:>-W^S:KX'\0^*[>YMY>)+D74;3V,B*>6%PMQ$(_[Y;:.
M016?^RU\#_&'[,_[3_[/UY\1[.2V&L?LYR^#6\W[MKK,%RNIO:L>@?RFE"C^
M+R'QG::^T-7^&/PU\0>*+7QQKWP]T.^UJQ""RUB\TF&6ZMPI)79*RETP68C!
M&"3ZU:\5>#O"/CO1V\/>-_"NFZSI[R*[V.JV,=Q"S*<JQ20%20>0<<&@#YY_
M9"\/7^O_ +:W[2?QYM%+:#K&O:%H&D7(^Y<3Z7I_E7A4_P 02:3R\CC<CKU4
MXC_X)DPZ@MA\=+K##2[C]H_Q5)HI/W6A\R%7*=MGFK)C'<-7OVJZ!J?AWP0/
M"WPATK1]*DBA%OIB/;>7::>IR/,$,0&\)U$0*!R NY 2PK?!OX3>%?@=\-=+
M^&'@U9C9:9$VZXN6#37<\CM)-<2L  TLLKO(Y  +.< # H Z>BBB@ JIJNCV
MNL1I%=22J$;(\J4J?TJW10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10
M!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P
M@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_
M ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1
M_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'
M_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[
M_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/
MS>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X
M%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@
M6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L4
M4 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?
M\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C
M_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^
MD?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z
M1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S
M>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_
MS\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_
M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;
M%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U
M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M^U3@\\&NS\1^/O!/A'PA)X_\3>*]/LM$B@29]5GNE$!1R A#YPVXLH4#)8L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M LN9-BIL&7)8MN.0" .FHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#Y\^)W@']O36OC;-X^\"S?"*;0],4Q^$=.\33:I))8EE99+MQ BH;B1
M6*[N?+C)1"-\K27_ !Q^SI\8_BKX!\#>+_B)XM\.M\4_ GBP>(--O=*MI8=)
M9MSQR:>-P:9;>2V?RFD.]PX$F& \L^Z44 >+Z!\"?B=:?%SQC^U/J\7AQ_'V
MJ^$X/#OA32?[0N)--TJQAD>?9+<>2DLIEN9#*Y6)<!$1>A<\A\-?AC_P4?\
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M-^7^7T_P]JEQKF@6.M7>C7.G2WEG%/+I]Z%$UJSH&,4FTE=ZD[3@D9!P3UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML76OP)^%EC\%?A1^T;\1-(\-:9%-'86$;:/*\"RR/*^V:73FE&7D<@[\C/&
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MW_A"O!<<YADU"ZU"^N[MU:>\O+F9Y[BXD*JJ[WD=FPJJJC"JJJ   =31110
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M)=Z+\0?%6FZ]<^-1XJO_ !787-HE]=Z@+1K,>8IMC;F+[.WE^4(0I R026+
M&1^PS\6_AS\7/!_BG6/A]XN\87'E>*V&H^&/'LMRVJ^%I_LMNCZ?+]IDDD"[
MXY)5^=ES,P!^4@>X5Q_PM^"GA?X5ZOXC\4V&HW^IZYXMU**]\1:YJAA\^\DB
M@2WA!6"..-%CBC1%5$7N3EF9CV% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7R-^V'_ ,$<_P!G#]NOQE/X
MM_:/O)O$"M?&YL["[LU:&T/EK$H4!ADB-0N3SU]37US10!^<'_$+M_P3%_Z)
M=I__ (*U_P#BZUO G_!MC_P3V^&/B_3_ !]\/_",.DZSI=P)M/U&RT\++!(
M1D'?Z$@CH02#7Z$T4 8OPZ\)7/@/P/I?@RZU^?5&TRT6V2_N4"R2HO";@.X7
M SWQGO6U110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>bcrx-20250424_g4.jpg
<TEXT>
begin 644 bcrx-20250424_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP]$EMYEU/#%(PC+/(K*C$.B=T8D4 >[U5L-:TC5+R]T_3M2AGGTVY6WOXHI
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M#'X6?%_XE^'?%/A3XN1ZO!#IVE>%_L#>'[JSMUG412&:1[A&WHA:0Y/S':O
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MUV+S8="TQYXK4/M:ZG.%AMU)_BEE:.-?=Q0!A_#S]J?X7?$S]H3QU^S9X;U
MOK_@&VL9M5!8%)?M"%B(\=?*_=J_HT@'7-=GX[\3:CX.\*7OB;3/"EYK<EE
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MD/"_QHL[KX1/\9OBEX2U#X?Z;!8&^O;?Q=<6T<UG;!-^^?R99%B..J%MP/!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH AU"PLM5L)]+U*U2>VN8
M6BN(95RLB,"&4CN""17Q?^S'X*^.'_!,77/$/P,OO@[XG\??"'4]=FU3P7XD
M\&V?]H7^B^;C?9W=HI$K*-H(EC5@6R<?.5C^UJ* /.?#GQ3\<?%K4[*+P-\/
M/$'AW18KE)M5USQ;I!L99HE(8VUO:3?OB[X"M)(B*B,Q0N^ O@WP;\"_$O\
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M#/7_  U?ZI\3]8U[3X=8TYHUGLKDPF-Q(,INR&!0MN&,XQS7,7/[+WB33/\
M@IKJ6A>$-8@3X<>,+/3_ (A>.=  SMUBPG>*UP.B+/=>7=$D?O&LY!P$%?4/
MQV\%?$+XB_"76O!?PI^*<W@KQ#?6ZKIGB>WT]+IK%Q(K$^4Y 8,JLAY! <D<
M@5A?LX? 37_@SI.H:Q\2/BM?>//&NO& ^(O%VH6$-H;E($*0016\(V00QAG(
M09)>65R27- 'I5?&W_!0KPW\3?'?[5W[/WBCX=?!SQ7KVE_#OQI-J/BS4=.T
M:0Q6T$CVF-A?;YY"QNQ\O</EQG)Q7V310!#IU_!JEA#J5M',L<\8=%N;9X9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?&?P=\ _AW=?$?QL;F2WAGAMK.QL8P]S?W<\BQ06L"$@-+)(ZJ 2 ,Y8JH)
M!UM%>>>!?CV-:^*MQ\#/B%X2;PYXL70DUNQL1J"W<%_IYE\IY(IE5<O%)M26
M,J-ID0J75@U<E_PW%X-/AAOC$OA.Z_X5DGB;^PF\=F\C\OSOM7V,W8@ZFQ%U
M^Y,^[=G+^7Y?[R@#W"BO//'GQ\30_BO:? CX?^%&\1^+I]"DUN[L3?K:V]AI
MZR")99IF5BK2292-%1BQ1R=BJ6K6^"/QG\(_'KX?6_Q"\'"XAB:YGL[_ $Z^
M14N=.O8)6BN+6=5)"R1R(RG!(. 5)4@D ZVBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;5KQH(HUC4G"J ,GFEHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /S^_;E_Y.=\1?]<[+_TCAKR2O6_VY?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\?\ C!^U3+X-^(%Q\)?AGX'_ .$C\0:8=$EUX7&H+:VNGPZEJ*6=NK2$,S3.
M?,955"JA-SL,J&[/X>?%27Q[X&NO%LG@#6]+O;"^NK*]T"]6%KI;BWD:-E0Q
MR-&ZL5W(^\*RLK';DX^?OV]/V8_$>M>*;']JO]FSQ_'HWQ&TC5M!TB_TJ\D+
MZ5X@3^U;1[2VOT4[HS'-+%*)%^;9QC!5E]9_8_\ VB9/VDOAA>^)M;\ 3>%O
M$F@^(;O0?&7A^619!9:M;;1.B2+Q*A#HROW# <XS0!H_LO\ [1.B?M1?"P?%
M;P]X5U+1;9M9O]/&GZOY?VE&M;AX&+B-F5260G 9L>II;K]H"QUSXG:A\'OA
M/X;D\2ZSH:QGQ+="Z%OIVC,Z[DAN+C:Y,[+\PAB21E7!?RPREO)O^";-_?Z3
M^Q[KNJ:59&YNK;QSXNEMK< GS9%U2Z*I@>I 'XUX'\"9_CS\%?\ @E7:_MH?
M"CX[7DGB 3WOC'Q/H6H:78RZ?KKR7[_;$N','VGS3&N!(LRX,2J .M 'Z+J6
M*@N &QR <@&O$/\ AN+P:?##?&)?"=U_PK)/$W]A-X[-Y'Y?G?:OL9NQ!U-B
M+K]R9]V[.7\OR_WE>B>(]6UWQE\#+_7?"UE/;:GJOA.6?3K8_P"MBGEM2T:?
M[P9@/J*^)(9M#@_X-YSL"&$_#YHBN/\ EY.H%"/][SCCZT ?8GCSX^)H?Q7M
M/@1\/_"C>(_%T^A2:W=V)OUM;>PT]9!$LLTS*Q5I),I&BHQ8HY.Q5+5D?\-G
M?!]?V>F_:(E&HK9QZ@=*DT#R$.I+K N?LG]E^5OV_:?M'[O&[9_'NV?/7C7[
M&FG^*M+_ ."@?Q8M?B()1JK_  N\$&S%QG<8ELW2Y(SV^TJ^?]K-?/LMKKLW
MB!M982#PN?\ @HTLC-_RS)#!/,/;R_M  S]W?[T ??W@7X]C6OBK<? SXA>$
MF\.>+%T)-;L;$:@MW!?Z>9?*>2*957+Q2;4EC*C:9$*EU8-6M\;OC/X.^ ?P
M[NOB/XV-S);PSPVUG8V,8>YO[N>18H+6!"0&EDD=5 ) &<L54$CPSX^)?W?_
M  5,_9_BT,,6M/"'BV;6_+[6C00)&6_V?/VXSWI/^"FD%\]Y^S]=2;O[*@_:
M.\--JA'W5R9A$S_['F%1SQDK0!Z]X%^/8UKXJW'P,^(7A)O#GBQ="36[&Q&H
M+=P7^GF7RGDBF55R\4FU)8RHVF1"I=6#5R7_  W%X-/AAOC$OA.Z_P"%9)XF
M_L)O'9O(_+\[[5]C-V(.IL1=?N3/NW9R_E^7^\KS+]LNU\6:K_P4"^$-C\.Q
M*=4@^&GCB2Z^SYW"-[*..W)QV^TF/'^UBO-89M#@_P"#><[ AA/P^:(KC_EY
M.H%"/][SCCZT ?8GCSX^)H?Q7M/@1\/_  HWB/Q=/H4FMW=B;];6WL-/601+
M+-,RL5:23*1HJ,6*.3L52U:WP1^,_A'X]?#ZW^(7@X7$,37,]G?Z=?(J7.G7
ML$K17%K.JDA9(Y$93@D' *DJ03\V_L::?XJTO_@H'\6+7XB"4:J_PN\$&S%Q
MG<8ELW2Y(SV^TJ^?]K-;_P#P302_?4_V@[]0PTRX_:-\1MII/W7(\A9G7U4R
M \CC(;WH ^H**** "BBJFJPZQ-&@T>\BA8-\YECW B@"W16/]B\;_P#0;LO_
M  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+
M_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;
M_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O
M&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &
MQ16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
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MBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\
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M9?\ @,?\: /Q#_X*K?\ !/7XX_L!?M:Z5_P5M_X(^?%:34]8\6_%36[OQ/\
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M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
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M2221W=G)R68FNBHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBTN!9$>0-(L14A%<]W0H\+?[<#'O7T_3 **** "BBB@ HHHH **** "BBB@
MHHHH Y'XN_$?6OAA::)KECX%U?7-/N==6UU[^P]-EO+FPM&MYV%TL$(,DJK,
ML"L$5F"R,0IQ7R9\ _V=(O'OQ\O_ (B?!?3/%7@GP_XF\(>)M+^)NNVEG/I1
MU*^N+^5+"6UCN8QNO($::0W C94(122Q=:^X:9!!!;1^3;0I&@)(5% &2<DX
M'J23^- 'Q/\ M.?L%_$K34^#F@_#S]HGXP>(-/TGXJZ2DT+2:4\?ARPCM;I/
MM\(@TY!$8?DC5G#1J)2"AR"/HO6/V@(/AMXZC^#6K_"?XGZS+;:-;R6?BJS\
M(27UCJDA!4QM=6P\N&?*Y?SA#'EL@@5ZA10!\?\ C;]BKQGX8_9>\'/X'\,J
MWB+P#\9!\2++PE8S(56%]3N+F72(6R$+);7+1K@[7DB&" P([E/ >L_'[]N3
MPA^T)#X;UC3O"OPV\':A;Z;=:[H]QI\U]JNHE8Y$2"Y1)?+BMT^:0J%+RJJE
MMK[?H>B@#YC_ &C-%\:_M9? _P (?&?P1\(/%.B^(?AK\5++Q-8>$_$^GK9W
M^I1:==213Q(A<@":!I'B)/SD(,@-FM5/ >L_'[]N3PA^T)#X;UC3O"OPV\':
MA;Z;=:[H]QI\U]JNHE8Y$2"Y1)?+BMT^:0J%+RJJEMK[?H>B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#\_OVY?^3G?$7_7.R_](X:\DKUO]N7_
M ).=\1?]<[+_ -(X:\DKY7$_[Q/U?YGXGF__ "-:_P#CE^;"BBBL3SPHHHH
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M_48;_P 5:IJ[R0RP: F9(( [*69[AV\UR#RDFUN:\@_XAY_^"G7_ $273_\
MP9-_\;I#/J7_ (-1/^"D#? +X^77[+7CW7#'HNMF2[TD32?*JMM^U1#/]W:E
MR .@BN.[U_3PK*ZAT8$$9!!X(K^07X1?\$./^"LWP3^)^@_%OP-\,K"#5O#V
MJ0WUDYU)MK,C E& 3E&&58=U8CO7]1_[ _Q2\8?$3X!:;I?Q&\.7NE^(-!@B
MM+^VO4;=LV QD.0 ^!F,L.IC)_B%'4.A[91113$%%%% !1110 4444 %%%%
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M[.5?#/Y'Z#P1_"K^L?U"BBBO7/NPHHHH **** "BBB@ HHHH **** "BBB@
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MLG]HZB>"T40&1:6VX B",\[5+M(R[Z^O*    8 HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /FK]M_X3? ;]J31IO"&J7#V/CCP3XO\.V^G
M>(M)G%OJ^@_;]0LU6YMY%.X*R2OC<"IDB)QN0,.C_P""?OQ)^+GQ$^#&K6/Q
ME\06^OZCX4\;:IX<LO%]I;B*/Q':V<HC2_"K\N6;?&Q4E2T3<GDUW_Q,_9X^
M!_QBN(K_ .)?PI\/ZS=P2V[QWU_I$$LX6&9)EC\QT+>660!DSM92RD$$UTMO
MX9\-VGA]/"=KX?L8M*CMA;QZ9':(MNL(&!&(P-H7'&W&,4 ?-'_!.E_%]Q^Q
M3XF'PSFTP^(3XR\8#06U9W%H+TZE=F#SS&&<1;RA;:"VW. 3BO'_ -ICPO\
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M,)##$@544# 4 <  < "@"2BBB@ JIJNCVNL1I%=22J$;(\J4J?TJW10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M*]<^[,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P#
MMJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@
M#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'
MTC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?
M2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO
M?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]
M_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:
MMBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ
M/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_
M (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC
M_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/
M^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_
M  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?
M_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV**
M ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^
M$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X
M0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_G
MYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV*\3_;Q_P""A?[*
MG_!-WX*W'QR_:J^),&C6'SQZ1I-N!+J.M7*C/V:SM\AII.1D\(@.YV1<L #T
M3Q79^ / GAF_\:>-_%JZ/H^E6DEUJ>JZIJPM[:T@12SRRR.0L:*H)+,0 !DU
M_/K_ ,%K?^#I9_%,VJ_LR?\ !+'Q'J6GZ4"]KKOQADEDCN;P<JT>E(V&@CZC
M[4X$ASF-8\+*WR1_P4X_X+2?MZ_\%SOC/8_LY?"+P;K>F>!]2U=8/!_P@\(^
M9<W.K3!LQS7S1@&\F&-^W AA"Y5<JTC?J1_P1*_X-4OAQ^S/_9'[3G_!1[2=
M+\8_$&/9=:-\/,I<Z-X>DX96NCRE_<KQQS!&<X\TA)% /@G_ ((N_P#!LM^T
M!_P41U"P_:A_;3NM;\"_">^F%] MSE-=\7ASOWPB4$V]N^=QNI 6<$&-6#>8
MO])OP#_9$_9^_9;^%>E_!+]GSX?V_A/PMHT6RPT?2':.-2?O2.<EI)&/+2.6
M=R26))S7I*JJ*$10 !@ #I2T 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L
M44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6
MU'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!
MC_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@
M^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P
M@^D?\_-[_P"!;5KQH(HUC4G"J ,GFEHH **** ,WQ;XP\*^ O#USXL\:^(;/
M2M,M%!N;Z_N%BBCW,%4%F.,EB% ZDD 9) KF_A7^T5\'OC+=RZ3X$\8PS:E!
M%)-+H]Y$]M>K DQA,_D2A9#%Y@V^8!MR0,YXKD_VWO@?\3/C?\)=-C^"_B"Q
ML?%WA'Q9IWB?PY%JP)L[Z[LI"Z6UQMY$;Y//9@IXQD>8_L/?M3_"'XA6=WI_
MQ9T9_!'Q-^'FEZV_B31M=81K;:=/?BXNKFWF^Y<6BR6\8,JGY3'R,,K, ?2?
MC7XF^ /AU=:+8^-_%=IIL_B+6(M*T.&YDP][>2 E(8P.2Q"D^@ Y(J+Q[\6/
MA[\,FLX?&OB2.TN-1,@T^RCADGN;D1KND:.&)6D=44@NP4A 06(!KXW_ &H_
M%/AKX@^//@5\?O$WBG3H[N\^/6BQZ#I,FH1[]$T3[+?/NE7=F.:=UCEFSC9M
M@B/,.YO2_@IK]WX]_P""I?QDO=4N1-#X.\ >'-*\/$-E4MKU7O9F3M\\@7)'
M78H_A% 'T.OQ#\!/X%'Q/7QII1\-G3OM_P#;_P!OC^Q_9=N_S_.SL\O;SNSC
M%5/ /Q9^'GQ.:[A\$^)8[N>P\LWMG)#)!<0+("T3O#*JR*C@$HY7:X!*D@&O
MSJN/&FORZ-+^S6D[_P#")R_MZCP^UKG]R-)-S_:#:>!TV?:,MM_#%?3OQJUR
M^\'?\%2?@E_8+LA\8^!_$NDZ^J=);:U2*\M]P_V9B^T]O,8#[QR ?1_B#Q!H
M/A/0[OQ-XHUJUT[3;"W>>^O[ZX6*&WB499W=B J@ DDG K(\ _%GX>?$YKN'
MP3XECNY[#RS>V<D,D%Q L@+1.\,JK(J. 2CE=K@$J2 :\%_X*;:QJ,NF_!?X
M9!R-)\9?'KPYIWB&,_<NK-)7N#;L.X=X8SC_ &*=\:M<OO!W_!4GX)?V"[(?
M&/@?Q+I.OJG26VM4BO+?</\ 9F+[3V\Q@/O'(!]-T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAJEP]CXX\$^+_#MOIWB+29Q;ZOH/V_4+-5N;>13N"LDKXW J9(B<;D##H_\
M@G[\2?BY\1/@QJUC\9?$%OK^H^%/&VJ>'++Q?:6XBC\1VMG*(TOPJ_+EFWQL
M5)4M$W)Y- $W[#/QU^)?QS_9XN/B3\5HK&YURW\3:W8S0Z%9F&%EM+V:!$B1
MW8\K& -S$DGDUYQ\:OBO^WI^S3)X=^/GQ \5^#->\*:MXIT[2_$GP[TKP])#
M<:-!>SI!&UM?F9FO)D>1 Q:.-7))"J#\O1?\$LKB _LNW\PF38OQ&\4%FW#
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
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M?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\
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M#LLMWJ&OS;OW3WQBYNI20&$*CRH\# =E\UOTO_X(J?\ !IYX'^"\&E?M+_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K@?VJ?C@O[,O[,GQ#_ &C7\*7.NCP%X)U3Q"=%LVVRWWV.TDN/)5L'
M:6\O;NP<9S@XQ7?5R/[0'Q6\*? CX#>-OCAX[T^6[T/P;X1U+7=9M8(@[S6E
MI:R7$R*IX8E(V !X)- 'YM_L"?\ !2']N#_@H%H>H_M!?LQ?M&>!?&=SHWP_
M\$ZWXP^$S^#Q%8Z=>W^J:]#J^D03+,MY!=V]K96SQ2SR3).51O+6.=2O??\
M!<7XF?\ !6O]G_X ^,_VP?V2OVG_  )\-O!_PTBM[@>%+[PA;ZIJ/BJ)I88Y
M'EN[I9(K4F279#;11;W"@M.KRB./\[_V_P#]F+PG^Q7^WMI/[=W_  0O^*VE
MZ%>:O;^ [G2/ASX,U+[3I_CB;Q#J7B"&>WM(HW96MMND6[/:!3&BRR2+Y/E(
M*_0O_@I]?_\ !*/_ (*X?L]_&;]EOQA^U)IMIXS^"8U07L;>(+O2Y_#NLVL;
M?OGM)C%'J,"RQ^6SA)8^66-U<A@ >N:GXX_X*J_M+_L!_"O5_@/HO@_X2_%[
MQSX0M-2\>:_XST]Y[?PI*;:-WA@T]@[O=2RR#;',&2!$F$I,@C5_!/\ @AC_
M ,%$?^"C7[0GB7]I;]DC]MW2M \:?$C]GS74TVT\5:-##IUKK=V[7L0M96@B
M2% 9+,,DJPJ1'*=\>5P:/[//[??BG_@C]_P0 ^$'Q%_X*&^)9T^*%UH4NG>%
MO#OBJ6=KZYDFNYWTZ&Y5%>=8K6Q>V:X(0R11Q% K2E$?._X)"_\ !3+_ ()1
M_"GX+_$Z[^$7QBU_Q2^A6%]\2_VD/C5K'@N]M!?ZQ>7<:O+]G\MIV$CR3"&"
M)&$4=M@EG=G8 D\2_M&_\%K_ -E;_@L;\$OV<?BK\>/!'Q@\ _&J*^N]9\&^
M$OA_%I@\&V%L46YNA+F2Z$,)FC*3W$[K.4>/8CE:_1[]I/XJZI\"?V=?'WQO
MT/PC/X@O?!O@K5=<L]!MF(DU*6TM);A+9" 2&D:,(, \MT-?DO\ \%%OV8_@
M?^TI^V_^RI_P4P_X)/?'Z77/B;XW^+>FVNN2>&?%\]_%=>'$62XO=1FA>1FL
MK:VCC:WN(-L<9%X(GC$C!7^U_C7_ ,%?/A+'X^_:+_9)_9D\.ZUXJ^.GP,^$
M^H>*QX8N- F^Q:C-%:121P12*=T["2YM5:-0K/YN(RY!*@'PA\#/^"Y_[4WQ
M1_8W^!W[7GPZ_:-TWQ_\4?&?[05OX+^(_P"SM:>&].BM[6RO);TQ1V*10_VC
M$R6MO#+'=2W$T;%Y-X.PHO[:U_,)XE_9_P!0_9?_ &?/V2/^"WW[$'QHM[7X
MW?%+X@S6?C[PKI!M;33]2N[F:]N+M8[.!8XK2T@CA>TN8@HB5'B<^6P9W^@?
M^"VO_!V5'!_:_P"R[_P2L\0!W^>TU_XS"/*KU5X](1ASW'VQQCJ85/R34 ?>
M/_!9?_@X6_9>_P""5FB7?PS\-/:>/_C+/:YT_P #6%Y^YTDLN4GU.9,^0F"&
M$ _?2 K@(C>:/Y[O OPT_P""K'_!R5^V?<:Y=W][XKU175=4\0:EOM?#G@S3
MW8E8EV@I;1#!*PQAIIBK-B1M[U[1_P $</\ @W&_:@_X*F>([?\ :B_:PUK7
M?!GPGU.\-_<^(M3+/KGC!G;>[68G#'8Y)+7LH926RBS'=M_IP_9=_93_ &?/
MV+_@WI?P"_9E^%VF^$_"VDI^XT_3HCNFD( :>:1B7GF; W2R,SM@9/ H ^;/
M^"1G_!#3]DG_ (),>!TOO ^FIXL^)FH68B\1_$O6+-1=2@@;X+2/+"RML_\
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ML/$7BI=EUH?PG+I<:;I+<,KZBRY2\F!Q^X4F!<'<9LX3[F_X)"_\$)_V2_\
M@DSX-CUGPK8)XP^*5_9^5XA^)6KV:K<$,/GM[*/+"RM\]54EWX\QWPH7[=H
M9;V]O:6Z6EI D442!(HHU"JB@8  '  ':GT44 %%%% !1110 4444 %%%% !
M7FWB7]KO]GCP?X@O/"WB+XA?9[^PN&@NX/[)NW\N13@C<L14\]P2*])K\V_V
ME?\ DO\ XP_[&"Y_]#-<6-Q,\-!.*6O<^>XAS;$Y3AX5**3;=M;]O)H^S?\
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MQ<FIF[D,:VPU$@:4$SC[$;,>28<;2Q\W_6?/0!]Y45\L^#/B'8_M@_MJ>(O
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M_P#R-:_^.7YL****Q//"BBB@#2\'?\C=I7_82@_]&+7ZE5^6GA%U3Q7I;N<
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MQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\
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MQ(50-.@#YK\/_"BX_96_;#UWXLZ=X7UF_P#!?CCP#I>F7-QHFC7&HSZ?J6E
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MHZJHAF2."Y1)1'%:J=TA0*7E55+;7V^9CX+?&5O^">+?\$Y!X,UC_A,%N?\
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M_GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\
MOT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM
M/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J
M:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
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M<CXH^)(MLO\ PAFA22VGA^UD'.V23Y+B^P0#SY,9Y5HW% 'Y":'X+_X+.?\
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ML#Z'_:Z\8>+O /P*OO%G@'P9;>(M<M=<T4:1H5W,L:7]R^K6B1P^8X(C+,P
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M7B76)(KJ+5-8T^W\N*2XBNYHI(Q\S;S$R&(R;F\PQE\G=F@#U2BBB@ HHHH
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M$@ D ]1HHHH **** "BF6UU;7D0GM+B.6,L0'C<,,@D$9'H01]13Z "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *I>)O\ D7-0_P"O&7_T U=J
MEXF_Y%S4/^O&7_T TGL14^!^A^6%%%%?('X,%%%% !1110![U_P3I_Y+W<_]
MBY<?^C8:^XJ^'?\ @G3_ ,E[N?\ L7+C_P!&PU]Q5]!EG^[?-GZGPA_R)_\
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M_'I#7DU?*XG_ 'B?J_S/Q/-_^1K7_P <OS84445B>>%%%% &CX1=4\5Z6[G
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M &9_AW9?"7]GWP'X:\&^&M/'^BZ-X=TZ.U@5L %RJ*-[M@%G;+,>6)/-=?\
M\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4
M?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!
M_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&
M/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF
M/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_
M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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MK]2J_*O2=2_L;5+;5_)\S[+<)-Y>[&[:P;&<'&<=:Z3_ (B)_P#JS[_S(/\
M][Z]W)Z52I&?*NQ]]P74A3I5N9]8_J?IA17YG_\ $1/_ -6??^9!_P#O?1_Q
M$3_]6??^9!_^]]>U]6K=OR/M_K-'O^9^F%%?F?\ \1$__5GW_F0?_O?1_P 1
M$_\ U9]_YD'_ .]]'U:MV_(/K-'O^9^F%%?F?_Q$3_\ 5GW_ )D'_P"]]>W?
ML$?\%8?^&X/C1>?"'_A0?_",?9/#L^J?VC_PE/VW?Y<T$?E^7]EBQGSL[MW&
MW&.<A2H58J[0XUZ4G9,^PJ***Q-@HHHH **** "BBB@ HHHH **** "BBB@
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M8C\-_$CX63^'I[C3=3U"TU:WU**ZTZ6"RO4M9D:3*R1RJ98FPT85E+%6.T@
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M  H\37VL>'@+FXTR_P!4ED>Y9)[J6<I,90)/,1I&1O, <,A#@-D4 >A4444
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M.>&?[7;^TM>AT'2H+:2]N)V=VFN3$H\V=9/-A=FR=T+=L"NO_P""L'_!/?\
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M'PCDU*;1M&ENYUO=:NUGO;RXNKJ6[N+BXE55$DLDT\CEMH^]T %>C4 %%%%
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MH J_M">#K/\ ::\3:-\!;:-9M"T'Q)8:WX[O0,I&+5UN;735/>::40R.!S'
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M^FZ-IFG>%WT^/1X(Y9)'$;-=S&0RLZF0MR3%'@A5"UZ30!@8SGW-% !1110
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MGC&0 =9\*_VBO@]\9;N72? GC&&;4H(I)I='O(GMKU8$F,)G\B4+(8O,&WS
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M_9/+[_TLLJ^)*^TO^"$E[<6'[9&KS6VG2W3'X?WH,<1&0/M=ESS_ )YK*O\
MPI&M#^+$_8ZBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6O(/7-BBL?_A)=
M7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z
M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
MZ%"]_P"^EH_X275_^A0O?^^EH V*\-_X*!?\%$/V8/\ @FE\!+SX_P#[3OC9
M;"S7=%HFB6FV34==NPN5M;2$D>8YXRQ(1 =SLJC->/?\%9O^"VO[.W_!)_X5
M#6OB9I,FL^/-9M'?P;\/K6_1+K4&&5$\Q&XVUJ&&&F93G!5%=@5'\V=K8?\
M!3S_ (.3/V[YKZ07'B36Y0#/,$D@T#P1I)<X4#YA;P+SA?FFG<$_O)"20#6_
M;9_;X_X*(_\ !Q1^V1HOPL\#^"=2O+2?47C^'?PF\/3%[+28NC75Q(VU7E"9
M,UY+M5%W8\N/Y1^^G_!#S_@WW^!O_!*CPE;_ !7^(O\ 9_C3XWZG9;=5\6&#
M=:Z&CKA[/35< HN"5>X($DHSPB-Y=>D_\$F_^"3W[.O_  25^#/_  A7PB^'
MMWK7C+5[=/\ A-/B'J5O&M]K$HY\M1D_9[56^Y;J2!@%B[Y<_6G_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%?FW^TK_
M ,E_\8?]C!<_^AFOT,_X275_^A0O?^^EK\[_ -HN:2X^.WBV>6W:)GUVX+1O
MU4[SP:\K-?X4?4^+XU_W*E_B_1G%T445XA^;A1110 5VG[.7_)>_!W_8QVG_
M *-6N+KL/V?)GM_CEX2GB@:5D\0VI6-.K'S5X%:4?XL?5'3@O]\I_P"*/YH_
M2RBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6OK#]S-BBL?_A)=7_Z%"]_[Z6C_
M (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:UXV+QJ[(5)4$J>H]J %HHHH ***
M* "BBB@ HHHH **** "BBB@#@_VF?"%WXX^"6M:#:?%.3P1M:UNYO%L5PL3:
M5#;W45Q+.'?Y5(CB?EOEY^;C-?)OPU\9_"7XM^*[?P5\/O\ @L7\3KZ^O+@V
M]BTNF6<%O=2A@GEQ7$VFK#*Q9E4!')8L ,DBOI?]N+X&ZM^TE^RQXM^"^A:W
M!87>L6UN8);NX:*&4PW4,_D2.H)1)1%Y3, 2!(3@XP?//VE?!OQL\3>&?!7@
M/]G/X'Z-I]CK_A+5_#&I'6-6M+>#PC;7!L2EPD,#N+IT6V<QQP$X*JQ( H [
MOX$?LN^,?@]\1;_XB>*_VI?'?CN2_P!'&GG3_%+VGV>$+*)$E18(8\./G'IB
M1L]L>OT $  G/N:* "BBB@ HHHH *J:]H>A^)M%N_#WB72;6_P!.OK=X+VRO
M8%DAGB8$,CHP(92"001@BK=!Z=* /@;PI<^'YK71_#7PG_X(A>']9T:XT!;S
MPMJ.MZMX;M[S4]+C\N-+ITN5:7>0\)82,9 95+\L"?K+]D7Q5XC\;?LW>$O$
MWBSP)I7AB_N=-(FT#19HWM[$)(Z)&/* 1&"*NZ, >6Y9, J17S)\2=8^!_@#
M]G_PR/!OB#X\6^J^-O%+-\(=,T?4HI=>MHFMT#P:<D[E8]+6$*3'.2H!1QTB
M8?2O['7A7P-X(_9Q\.>%/AVWB(Z?9"[2;_A+FW:H+TW<S7@NR.#/]J,^_;E-
MV=I*X) /3:*** "N1^+NF?%Z\M-$U3X-:AI"WVF:ZMSJ.FZY<RP6VJ69MYXG
MMFEB21HFW2QRJ^QP&A7*D&NNHH ^<O@O^S!X\UWXL:#\</C;HFBZ3)X6T?7M
M*TC1-+NY+N2[&HW[2RRW4SPQ#RUC4+'"%;_6LY8$[!0T?]BOXFZ+^S#JG[#$
M'B#1)/A]=7,]GIWB22^G_M:UT2:Y,[VAMC 8I)E5G@2?S@-I1S&2A1OIRB@#
MR"+6OC'H/[3NG_!_3+#P?=?"]_!A7^S[87#:MILL6$5Y\YA%NX*Q(F=[D.0,
M1O7GP_88\<']G1OV'#K^D#X7G7=ZZN+V<ZO_ &+]N^V_V9Y/E>6'W?Z/]I\X
M_NN?*W5]/K'&C,Z( 7.6('4XQS^ %+0!X]XA^ 7BSP=^T7)^TC\$+31);O5_
M"4>@>)?#VL7\ME;W*6\GF6=U'-#!,5DC#21%#&0R.N&4QX;D'_X)_P!F/V=6
M^'Z>,83XY/Q$/Q$'BPV9$/\ PE'VO[5YWE;L^3_R[[<[O*[[N:^D** /(/#W
MP)\9^)OVC+?]IWXP1Z+:ZGH7A231/"NA:-?RWEO9^?()+J[DGEAA9I'VQQ!1
M& B(QW,7^3A--^&OQR_:_P#V<9-)^.VL>$;/QOX2^($&K^"?%G@Z*XDTF:[L
M&BGM[F-9\2/&)'GM)#_$$D9"<J:^FB P*L 01R#2*JHH1% 4#  ' % 'D&@?
M 'Q3XR_:*@_:2^-UKHL5YH_A.70?#?A[1[Z6]M[9;B027=U)--#"7DD"I$$$
M8"HC9+&3">?C]ACQP?V=&_8<.OZ0/A>==WKJXO9SJ_\ 8OV[[;_9GD^5Y8?=
M_H_VGSC^ZY\K=7U!10!X]XA^ 7BSP=^T7)^TC\$+31);O5_"4>@>)?#VL7\M
ME;W*6\GF6=U'-#!,5DC#21%#&0R.N&4QX;9_9<_9_@_9V^'E[X?N]935-<\0
M^([_ ,1>*]6C@,27NJ7LQEF=$))5!\L:@DG9&N3G->D44 %%%% !1110 444
M4 %4O$W_ "+FH?\ 7C+_ .@&KM4O$W_(N:A_UXR_^@&D]B*GP/T/RPHHHKY
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M444 %%%% !1110 5^;'_  7/_P"#AOX+_P#!+?PW=_!+X--IWC3XY7]GFTT
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M_ KX _#S3?"WA/P]:"WTG1=*AV1Q+U+$G+22,Q+/(Y+NS,S$L23U] !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?FW^TK_P E_P#&'_8P
M7/\ Z&:_22OS;_:5_P"2_P#C#_L8+G_T,UY6:_PH^I\7QK_N5+_%^C.'HHHK
MQ#\W"BBB@ KM/V<O^2]^#O\ L8[3_P!&K7%UVG[.7_)>_!W_ &,=I_Z-6M*/
M\6/JCIP7^^4_\4?S1^E%%%%?6'[F%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Y_P#M1?#^Z^)WP4U/PE;>"H/$H-]IUY/X
M;N9XXTU:&UOK>YEM-TGR9E2%HP'(0E@&(4DCY?\ ^&:?CC\:-2\:?M*?%O\
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MD\C'E7B+_@IUI^D6$<]K^Q/^T*)9KVWMXA?_  INH(R9)43&_).<,<  EC@
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MXY\Q@L77_@@D_C&;4Y3K+^'F\4G6=_\ I!U8ZL;T77F=?-\[!W=>,5]1Z!\
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M&5]^:MT4 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\
M]"A>_P#?2U2\1^)-6;P]?J?"-X ;*4$EEX^0UTM4O$W_ "+FH?\ 7C+_ .@&
MD]B*GP/T/RPHHHKY _!@HHHH **** /<?^"?M[<6'QRN9[;3I+ICX>N!Y<1&
M<>;#SS7VG_PDNK_]"A>_]]+7QK_P3I_Y+W<_]BY<?^C8:^XJ^@RS_=OFS]3X
M0_Y$_P#V\_T,?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6MBBO0/J3'_ .$EU?\
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M7V/6-#T^>^TN[\E)/(N(HV>-]DBLK88 X8$''(-6ZY_XL_\ )*O$W_8O7O\
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M6X#6\AW$ R*05YWCD;<'V6N='PF^'J_%C_A>0\-I_P )7_PCO]A?VOY\F_\
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MX_-G<(O9 HH [*BBB@ HHHH **** $6.-&9T0 N<L0.IQCG\ *6BB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K\V_VE?\ DO\ XP_[&"Y_]#-?I)7YM_M*_P#)?_&'_8P7/_H9
MKRLU_A1]3XOC7_<J7^+]&</1117B'YN%%%% !7/_ !9_Y)5XF_[%Z]_]$/70
M5S_Q9_Y)5XF_[%Z]_P#1#UMAO]YAZK\SHP?^]T_\2_,^&Z***_1C]8"BBB@
MHHHH _1C_@WE_P"1_P#B=_V!]-_]&SU^I%?EO_P;R_\ (_\ Q._[ ^F_^C9Z
M_4BO+Q/\9GJ8;^"@HHHKG.@**** "BBB@ HHHH **** "BBB@ HHHH ****
M./\ COX5_P"$R^&T^BP:_8Z7>IJ>G7>C7NIP>;;IJ-O?03V8E0,I=&N8X5*J
MRL0Q"D'!'@OC^]_X*+?%&RO/A3\4/!?PR^'W@S4D_L_Q1XWL?$L^H32V<S>3
M(EE"\<?E2R!]BO,,)OW<D 5ZG^VZOPB?]F7Q!'\>M%O]1\'O=::NOV.F+*9Y
MH#J-L-JB']XWS;<B/YR,A>2*^%OB3X)_X)9:]X3ET_\ 9N_9.^(6M^.?M-O)
MX;TA=%\3Q)>7*S(PBDDGD5(HV (:3(**2RD,H- 'Z@ 8&!10!@ >W<T4 %%%
M% !1110 5Y)XJ\._#WQ7^V+X?_X3_P /Z=<ZEH7@FXOO \E[;(["9[I$OI8B
MP_UD2+9 $<J+E\8W&O6Z\\_:._9H^'O[3?A&V\.>,[S5M+O],N_M?A[Q-X<U
M%K/4]&NMI7SK:=>4)4D%2"K#J#@$ '?7]K8WUC-9:I;136TT3)<0W"!HWC((
M96!X*D9!!XQ7FW[('C6+X@? JT\1:?J+7FF+K^MV>@7K2%_M&F6VK7=O92!C
MDNIMHH<.22XPQ)W5X='_ ,$O/BOXKF/AWXX?\%&/BOXL\(2';=^&4N_L1OH?
M^>-Q.DC-+&PX8;02#P0>:^KO"/A+PUX!\+:=X(\&:);Z;I.DV4=IIMA:IMCM
MX(U"HBCT  % &C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4O$W_(N:A_UXR_^@&KM4O$W_(N:A_UXR_\ H!I/8BI\#]#\
ML****^0/P8**** "BBB@#RO]L7_DC;_]A.#_ -FKY/KZP_;%_P"2-O\ ]A.#
M_P!FKY/K[3(O]P^;/T+AO_D6+U84445[![P4444 %?LE_P $)/\ DR&?_L=[
M_P#]%6]?C;7[)?\ !"3_ ),AG_['>_\ _15O7-B_X1TX3^+\C[.HHHKS#TPH
MHHH **** "BBB@#\_OVY?^3G?$7_ %SLO_2.&O)*];_;E_Y.=\1?]<[+_P!(
MX:\DKY7$_P"\3]7^9^)YO_R-:_\ CE^;"BBBL3SPHHHH ;-_JF_W37Y^U^@4
MW^J;_=-?G[7U/#O\.IZK]3[3A7^#5]4%%%%?1GU@5C^//'WA#X9>%KKQIXYU
MV#3M-LTW37$[=^RJ!RS$\!1DD]!6/\;/CG\/O@%X-D\8^/M5$2'*V5E%@SWD
MH'^KC7/)Z9)P%')(K\]/BA\7/CC^W%\5+70-*TJ>97F(T7P[9.3#:)WD=C@$
MX^]*V!_NC K"K65/1:LWI474U>B-?]I[]KKXB?M5^)XO 7@C3KVV\/O=K'IN
MAVREI]0DSA'F"YWL3R(QE5]R-U?J9_P:Y_\ !,KX;Z#^VG#\4/VC_"&G>(/$
M^B>$+G5_#NFWL:S6^AWJ7%JD=P <K)<(LKX<Y6-B&3YE5Q\U_LE_L8^#_P!G
M+2TU[5O)U7Q9<0XN]4*92U!',4 /*KV+_>;V'RC]1_\ @@A_R>AK/_9/+[_T
MLLJPE1E[-SJ;F\:R]HH0V/V%HHHKA.X**** "BBB@ HHHH ^9O\ @IA_R)'A
MC_L*S?\ HH5\>5]A_P#!3#_D2/#'_85F_P#10KX\KYS,?]Z?R_(_)>*_^1W4
M](_D@HHHKB/G0HHHH *_07]B#_DU[PQ_V^_^EL]?GU7Z"_L0?\FO>&/^WW_T
MMGKTLK_WA^GZH^NX+_Y&D_\  _\ TJ)ZO1117O'Z<%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5^;?[2O_ "7_ ,8?]C!<_P#H9K])*_-O]I7_ )+_ .,/^Q@N
M?_0S7E9K_"CZGQ?&O^Y4O\7Z,X>BBBO$/S<**** "N?^+/\ R2KQ-_V+U[_Z
M(>N@KG_BS_R2KQ-_V+U[_P"B'K;#?[S#U7YG1@_][I_XE^9\-T445^C'ZP%%
M%% !1110!^C'_!O+_P C_P#$[_L#Z;_Z-GK]2*_+?_@WE_Y'_P")W_8'TW_T
M;/7ZD5Y>)_C,]3#?P4%%%%<YT!1110 4444 <;\;OC9X9^!GAK3];UZQNKZ[
MUO7K/0] TJRV";4-1NI-D,"M(RH@/S,S,P"JC'G !YWX(_M!^+?B)X@M_"'C
MWX2W6A7E[8:E>Z?J-GJ$=WI\\5G?):2Q;_ED28-+$=K1A64DJQVD"]^U'^SW
MX"_:=^%K?"KQSK=YI4LNH0WGA[6=+N_)O-.U*#=+#<V[?\]$VN<=UW].H\(_
M83^./QD\ >.M._9%_:6T2UU&]O+76;[P#\1-.3:NOV]M?,MY'<Q9)@N5<B0A
M?D*LHZ@,X![EIW[2^CZA^U;/^R@W@76K74H/!4OB5=:O!$MI<VRWD5H%B"NS
ML=[ODLJ8V<!@P-6/V@/CQ?\ P6L-,M?"OPHUWQSK^KS2?8O#7AMH1<FWB"F:
MZ8S.B+%&7A0DG.Z>, ?-7F=Q_P I=K/_ +-PN?\ T_P5TO[3_P"Q)X,_:4UZ
MS^(D/Q,\9^#O&6CZ:UIX?\3>%/$,ULUD"YD^: -Y<BE\;P0&=5"[A@8 -6\_
M:B@\%_L^CX[_ !H^%NN^$)I+M;6V\(WDD%QJ=Q<R7 M[:W18G,9EFD*[5WX
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M "+FH?\ 7C+_ .@&KM4O$W_(N:A_UXR_^@&D]B*GP/T/RPHHHKY _!@HHHH
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MV_\ @@A_R>AK/_9/+[_TLLJRK_PI&M#^+$_86BBBO(/7"BBB@ HHHH ****
M/F;_ (*8?\B1X8_["LW_ **%?'E?8?\ P4P_Y$CPQ_V%9O\ T4*^/*^<S'_>
MG\OR/R7BO_D=U/2/Y(****XCYT**** "OT%_8@_Y->\,?]OO_I;/7Y]5T.A_
M\%G?^&3M+B^ '_#-W]O_ -@;O^)M_P )C]E\_P ]C<_ZK[')MV^=M^^<[<\9
MP/5RB$JF):CV_5'UG!TXT\SFY?R/_P!*B?IW17YG_P#$1/\ ]6??^9!_^]]'
M_$1/_P!6??\ F0?_ +WU]%]6K=OR/TGZS1[_ )GZ845^9_\ Q$3_ /5GW_F0
M?_O?1_Q$3_\ 5GW_ )D'_P"]]'U:MV_(/K-'O^9^F%%?F?\ \1$__5GW_F0?
M_O?6EX,_X.!O^$N\8:5X4_X9)^S_ -IZE!:?:/\ A/=_E>9(J;MOV ;L;LXR
M,XZBCZM6[?D'UFCW_,_1ZBBBL#<**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\V_VE?^2_^,/^Q@N?
M_0S7Z25^;?[2O_)?_&'_ &,%S_Z&:\K-?X4?4^+XU_W*E_B_1G#T445XA^;A
M1110 5S_ ,6?^25>)O\ L7KW_P!$/705S_Q9_P"25>)O^Q>O?_1#UMAO]YAZ
MK\SHP?\ O=/_ !+\SX;HHHK]&/U@**** "BBB@#]&/\ @WE_Y'_XG?\ 8'TW
M_P!&SU^I%?EO_P &\O\ R/\ \3O^P/IO_HV>OU(KR\3_ !F>IAOX*"BBBN<Z
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JEXF_Y%S4/^O&7_ - -7:I>)O\ D7-0_P"O&7_T TGL14^!^A^6
M%%%%?('X,%%%% !1110!Y7^V+_R1M_\ L)P?^S5\GU]8?MB_\D;?_L)P?^S5
M\GU]ID7^X?-GZ%PW_P BQ>K"BBBO8/>"BBB@ K]DO^"$G_)D,_\ V.]__P"B
MK>OQMK]DO^"$G_)D,_\ V.]__P"BK>N;%_PCIPG\7Y'V=1117F'IA1110 5\
M#_M-?L1_\%%/B=<Z?\(T\6?#/QOX)N/BYXNUS3]>\30745WX=T?6]!\2V8LK
MVR+.FI16SZRL,9BEB9E2%&C2/?+']\44 ?$_BO\ X),ZAX+_ ."-_P#PZ*_9
MN\?:?;V%QX-N-"N_&GBJ.5G1[FZ:ZN[M;6$'>TLTMPPC\U1'O7F3;@]%^Q_^
MQA^UM^QS_P $O-,_8>^''Q>\%Q>//"GAR?2?"/Q"DTRXFM(VEN)9!=2V+8/F
M1)+\J>8Z.Z L N4/UM10!^ 5A_P3$_X*"?LO_M%Z;X)^,_\ P4-@\8>%O#NM
MP:KK>D:9X76Q?69W"W>^:9?WDLCSLLDLDC,TK;V<L7))^V=^Q#\5_P!J+]HC
MX3_&OP_XW\/Z+;?";Q -5L;"\@GG?4W^TVLY61E"B$'[*J\!R-Q.>U??G[<O
M_)SOB+_KG9?^D<->25\W7K3CBI-=&UL?D.9YAB:6<59QLG&4XK1;-M.^FK:Z
MO4\:^.WP;_:9^(_Q?^%_CKX8?M CP=H'AG5#<^.O#%O"TR:W$6B)A#[5W@JL
MD?S@;?,\P , *J_M$_LL^*OVNYK7P'\:O%UMI_PWM-1BN[_PCX?,C7'B%HG#
MQ+=W;A/*@#!6,$4>XL ?.^48]OKQK]M#]N;X&_L._#EO&OQ6UGSM1ND<:#X:
MLG4WNJ2CLBG[D8)&Z5OE4'NQ56QA*I*24%KT//PU7%U*M.%"/OK2-DKZN_W^
M;VZ-':?%?XM_!S]E_P"%,_CWXE^(M/\ #7AC0[5(D9E"(BJNV."&-1EV( 5(
MT!)Q@"OSCT;]O7X@?\%#?CAKGQ)N?#>J:9\"?@U9'Q#<>%;-"]UXEOXR3I\%
MUY>1(\DR"18!F-?*PVXX>OD7XL_&K]LS_@KY^T=9^&=+T:XU*9Y7_L#PIICE
M=/T2V) :5V;Y5P"OF7$G+' &!L0?KQ_P3?\ ^"?.B?L'?!N7P=>>+Y]>U_6;
M@7OB"Z5BEFD^Q5\N"/@[%"@;WR[<GY =@]"%.A@4I5=9]NW]?\,?6X?#9;PR
MHU\;[]9ZJ*UY?/\ X+^7<_#CXNZ%^TG\;/B?KWQ:\<_"_P 43ZMXAU2:^O7&
M@7.U6=B0B@IPBC"J.RJ!VK$TKX2_'G0]4MM:T?X8>++6[LYTGM;F#0[E7BD1
M@RNI"9!! (/J*_IIET^R$;$6RY"GM7Q;_P +O^+'_0]7W_?8_P *]? S6.C)
MPTMW/I,NS_#9E&4H1:MWM_F8/A[QQJWQ[^!?A+]HW5_#5UI6K:O9BQ\7:?=6
M3P-;ZK -DC;& PDH7S%_V2.<YJG6]KOQ/\?^)M-?2-?\4W-W;2$%X9B""0<@
M]/6L&O;I1G""C(UJRC.;E$****T,PK[;_P"""'_)Z&L_]D\OO_2RRKXDK[;_
M .""'_)Z&L_]D\OO_2RRK*O_  I&M#^+$_86BBBO(/7"BBB@ HHHH **** /
MF;_@IA_R)'AC_L*S?^BA7QY7V'_P4P_Y$CPQ_P!A6;_T4*^/*^<S'_>G\OR/
MR7BO_D=U/2/Y(****XCYT**** "OCS]J?_DO&N_]NO\ Z2PU]AU\>?M3_P#)
M>-=_[=?_ $EAKW.'_P#?)?X7^:/I.%_^1A+_  O\XGGU%%%?8'W@4444 %=)
M\&O^2P>%/^QEL?\ TH2N;KI/@U_R6#PI_P!C+8_^E"4/8:W/Z/****\,]L**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K\V_P!I7_DO_C#_ +&"Y_\ 0S7Z25^;?[2O_)?_ !A_V,%S
M_P"AFO*S7^%'U/B^-?\ <J7^+]&</1117B'YN%%%% !7/_%G_DE7B;_L7KW_
M -$/705S_P 6?^25>)O^Q>O?_1#UMAO]YAZK\SHP?^]T_P#$OS/ANBBBOT8_
M6 HHHH **** /T8_X-Y?^1_^)W_8'TW_ -&SU^I%?EO_ ,&\O_(__$[_ + ^
MF_\ HV>OU(KR\3_&9ZF&_@H****YSH"BBB@ HHHH ***9;75M>1">TN(Y8RQ
M >-PPR"01D>A!'U% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO)OVC/VH[3X+W4
M_@GPGX6?Q!XM_P"$.U3Q+'IC72P6]MI]DJB2XGD.2%,DD<:JBL[,QX"AF !Z
MS17)_"SXF:C\0'UO2O$'@'4?#NJ>'M46QU"TO9HIHYBT$4Z36\L3$2Q,DJX8
MA&#!E95*UUE !1110 4444 %%%% !5+Q-_R+FH?]>,O_ * :NU2\3?\ (N:A
M_P!>,O\ Z :3V(J? _0_+"BBBOD#\&"BBB@ HHHH \K_ &Q?^2-O_P!A.#_V
M:OD^OK#]L7_DC;_]A.#_ -FKY/K[3(O]P^;/T+AO_D6+U84445[![P4444 %
M?LE_P0D_Y,AG_P"QWO\ _P!%6]?C;7[)?\$)/^3(9_\ L=[_ /\ 15O7-B_X
M1TX3^+\C[.HHHKS#TPHHHH **** "BBB@#\_OVY?^3G?$7_7.R_](X:\DKUK
M]N4@?M.^(R3_ ,L[+_TCAK\@O^"GG_!;31_AC_:/P#_8[UNVU+Q(NZWUKQK#
MMEM=+/1H[7JLTX[R<HG0;VSL^;G1J5\7.,%U?YGY#7R_%9EGE>E05WSRN^B7
M,]6>U_\ !2+_ (*O_"O]B#1Y_ GA'[+XF^)%S;YM-!67,&F!AE9KQE.5&"&$
M0(=QC[BD/7Y9_ O]G7]L3_@KI^T-?^,=;U^ZOO,N%/B;QKJZ'[%I4.<K#&JX
M4D GR[>/'J=J[G':_P#!._\ X)5?&/\ ;V\4'XV?&K5=5TCP)<7SW%_X@O79
M[_Q!*7)D%N9,ELMD/<-E020-[!@O[5?"/X/_  U^ _P_T_X7?"/P?9Z'H6EQ
M;+2PLTP!ZNS'+2.QY9V)9B222:Z95*. CR4]9]7V_K_ASV:V+P'#-)T,+:==
M_%+MY?\  ^_L<1^QY^Q5\#OV)?AJGP_^$&@_Z1.J-K>OWBJU[JLP'WY7 X49
M.V-<(@)P,EB?7***\R4I3ES2=V?&5JU6O4=2H[R>[8V;_5-_NFOS]K] IO\
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M ,2_,^&Z***_1C]8"BBB@ HHHH _1C_@WE_Y'_XG?]@?3?\ T;/7ZD5^6_\
MP;R_\C_\3O\ L#Z;_P"C9Z_4BO+Q/\9GJ8;^"@HHHKG.@**** "BBB@#PO\
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M4+?3;K7='N-/FOM5U$K'(B07*)+Y<5NGS2%0I>554MM?: 6/^"A7Q9\6> _
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M*%@WSF6/<"*MT4 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\
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M]H;]J'XD6GASP[IPV1>8=]SJ%P02EK:PCYIYWP<(O0 LQ559A_+9_P %4/\
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MBBB@ HHHH **** "BBB@#C_VA?\ DA'C+_L6+[_T0]?FG7Z6?M"_\D(\9?\
M8L7W_HAZ_-.O$S7^)'T/SCC;_>Z7^%_F%%%%>4?%!1110 5XK^V__P B#I'_
M &&/_:3U[57BO[;_ /R(.D?]AC_VD]>CE'_(QI_/\F>OD/\ R-J?S_\ 26?,
MM%%%?=GZ2%%%% !1110!^YW_  2'_P"4=OPY_P"N.I_^G2[KZ2KYM_X)#_\
M*.WX<_\ 7'4__3I=U])5XU3^(_4]BE_"CZ(****@T"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
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M+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V
M**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$
M'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:C_A!](_Y^
M;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GY
MO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:M>-!%&L:DX50!D\
MT +1110!X[^V]\#_ (F?&_X2Z;'\%_$%C8^+O"/BS3O$_AR+5@39WUW92%TM
MKC;R(WR>>S!3QC(\[_8!_:+^'/QHU >"O&_A.Z\*_%WP;:ZO#JWAK5$PPM+O
M45EGEM)1\MU;>=#$GF*>&3D896;WCXNZ9\7KRTT35/@UJ&D+?:9KJW.HZ;KE
MS+!;:I9FWGB>V:6))&B;=+'*K[' :%<J0:\A^"G[-/Q+U'XMZ!\>_BQINBZ%
M?>$=(U[3?#^E:7=27<EPVH7[3//=3-%#^[5%41PJ#_K&<NI;8 #SOQ5<?M(_
ML5?$^7XL_'GP]X&^(GPW\4^.5?6?$VFZ"UMK?AB2[N$BMI7\QG$UM%F" 88N
MJHF,8PW9_!K6-1\:?\%4?C/)KLA=?!7@+PYI&@H_2*WO%DO)RH[;I57<>_EJ
M#]T5U]G\,OVGOC3X/@^'7[5UO\/;?2TU.VNM7E\$7=].=92WN$GBA\JZB3[&
MC/''YG[R<LH95*%@ZZ'BGX%>,_#/[2=Q^TW\&HM&N;_7/"J:'XIT+7-1ELX;
ML02F6TNTFB@F*RQ[I(F0QD.CJ0RE/F ."_X)HZW?>1\;?ARKL=)\(_'OQ%8^
M'X1]RTM7DCN#;H.RI)-*0.V^F_!K6-1\:?\ !5'XSR:[(77P5X"\.:1H*/TB
MM[Q9+R<J.VZ55W'OY:@_=%=7X!_9Z^,G[/GP'OO#GP*\1^%K[Q[XA\9S>(_%
M6L^*+6X2QO;J\NQ+?,J0$NN(OW<0)/$:;CDDC4\4_ KQGX9_:3N/VF_@U%HU
MS?ZYX530_%.A:YJ,MG#=B"4RVEVDT4$Q66/=)$R&,AT=2&4I\P!P7_!-'6[[
MR/C;\.5=CI/A'X]^(K'P_"/N6EJ\D=P;=!V5))I2!VWU]-UYO^RY^S_!^SM\
M/+WP_=ZRFJ:YXA\1W_B+Q7JT<!B2]U2]F,LSHA)*H/EC4$D[(UR<YKTB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *BO;*RU*SET[4;2*XM[B-HYX)
MXPZ2(PP593P002"#UJ6B@#B? O[-_P !OAEXKN?&WP^^$/AS1M3NE"F[TW18
M(&B7;M*QE$!C##E@N QY.:AO/A#+H?QQ;XZ> Y((;O6M,M]*\8:?.2D>HV\#
MNUM<*R@XN(/-F49&)(Y2A*[49>\HH X)_P!E;]F"1S))^SAX"9F.69O!]D23
MZ_ZJE\9_ #P-XW^(?A'QUJ?AO1$?P9(9=(GCT6+[9&VQD2&.X^]#;C(<Q(!O
M9$R0JLK]Y10!AZO\,?AKX@\46OCC7OA[H=]K5B$%EK%YI,,MU;A22NR5E+I@
MLQ&",$GUJUXJ\'>$?'>CMX>\;^%=-UG3WD5WL=5L8[B%F4Y5BD@*D@\@XX-:
M5% %30]!T/PQI%OX?\-Z-::?86D0CM;&QMUBAA0=%1$ 51[ 5G>$?AC\-OA_
M/=77@+X>Z'HDM\P-[)I&DPVS7!!)!<QJ-_+,><\L?6MRB@#A_A7\"_"/PM\6
M^*O'.AZ'I%EJ'BZ^CGU)=$TF.SB81F5D9U3_ %TQ:>9Y)V^9R_8*H&YX1^&/
MPV^'\]U=> OA[H>B2WS WLFD:3#;-<$$D%S&HW\LQYSRQ]:W** ,/5_AC\-?
M$'BBU\<:]\/=#OM:L0@LM8O-)AENK<*25V2LI=,%F(P1@D^M6O%7@[PCX[T=
MO#WC?PKINLZ>\BN]CJMC'<0LRG*L4D!4D'D''!K2HH P=5T#4_#O@@>%OA#I
M6CZ5)%"+?3$>V\NTT]3D>8(8@-X3J(@4#D!=R EA6^#?PF\*_ [X:Z7\,/!J
MS&RTR)MUQ<L&FNYY':2:XE8 !I997>1R  6<X &!73T4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%0:KJNEZ%I=SK>MZE;V=E9V[SW
MEY=3+'%!$BEGD=V("JJ@DDG  )-?SX_\%X/^#J2]\5?VS^R!_P $N_&4MKIG
M[RR\5?&*Q<I+=]5>#2&ZQQ]0;S[S<^3M 65P#ZO_ ."[/_!S%\+_ -@.#5OV
M7OV-[_3/&/QGVO;:IJ>5N-+\'/T)FQ\MS>+VMQ\L;#,Q^7RG_';_ ()B?\$@
M?VYO^"\O[0VJ_M!?%WQOK=IX+NM:,WC[XO\ B4-/-?SY&^UL@^!<W&W"X&(H
M%"[L?NXW]V_X(4_\&R/Q'_;@N=*_:W_;VT_5?#'PHG=;W1O#4KO!JWC%2=PD
M8\/:V3]?-XEF4_N]JLLU?TO?#;X:_#[X.> M)^%OPI\&:;X=\.:%9)9Z-HFC
MV:6]M9P(,+''&@ 4?S))/)H \_\ V*?V'/V:/^"?/P+T[]GK]EOX=6^@:%98
MDNYSB2\U2Y*@/=W<Y :>9L#+'A0 J!455'K=%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q_[0O\
MR0CQE_V+%]_Z(>OS3K]+/VA?^2$>,O\ L6+[_P!$/7YIUXF:_P 2/H?G'&W^
M]TO\+_,****\H^*"BBB@ KZ=_P""9O\ R-OBK_L'6W_HQZ^8J^G?^"9O_(V^
M*O\ L'6W_HQZZL#_ +U'^NA[G#?_ ".Z/J__ $EGU_1117TQ^P!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M D<9"B-&9#^DE "*JHH1%  &  . *6BB@ HHHH **** "BBB@ HHHH ****
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M!5'L!6=X1^&/PV^'\]U=> OA[H>B2WS WLFD:3#;-<$$D%S&HW\LQYSRQ]:
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M$L*WP;^$WA7X'?#72_AAX-68V6F1-NN+E@TUW/([237$K  -++*[R.0 "SG
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M8+DZ=<RB'.<[]A#;>NTYQBOV+_X0?P5_PF7_  L7_A#]+_X2#^S_ +!_;O\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
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M?["WV3_A"_[1^T_:=Z;=_P!I^3R]GF9Q\V[;VS7IE%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51\2^)?#O@WP_>>*_%
MNNVFF:9IUL]Q?ZA?W"Q0V\2C+.[L0%4#DDFKU97C#P3X8\?:;%HOB_28K^RB
MO8;LV=P-T4DL+B2(NIX<+(J. >-R*>U ')_ _P#:M_9R_:3:_B^!?QBT3Q++
MIA'V^WTZZS+ I. [1L VPG@/C:3T-:6O?'OX/>&?%Q\"Z[X_L;?4TGMX+F)B
MQ2UFN"!;Q3R@&."24D"-)&5I-PVALBO*O^%6:5XX_P""CMM\;/!FGQVL7@GP
M%<Z-XLU:UC"C4KZ[DBDM[%R,>8T$*&9LYV_:(!W^7Q7]F^-/BQ_P2(^+GQ%\
M<J)M3\:Q>-M<UJ:7[RW:O<K&_L8Q;0[?[HC4#  H ^M?CA^TO\!/V:])M-:^
M.OQ5TCPS!J$K1V']I7&)+EEQN\N-07<+D9(!"[AG&16_X2^(_@#QYX(MOB7X
M,\9Z9J?AZ[M6N;?6K*]1[9XESN?S =H"X8')^4J0<$&O+OV4]4\-^+?V8? W
M[3GQ76U_MO4OA/I?_"0Z_JI7 MDMC-,[,_"([222.>-WR[LA%Q\L?&#X=>(O
M@5_P33\2^'=*TVY\/:5\6OC0)[/0MC0OHN@:GJ<8CLRG'D[K:-=\7&S[0Z$
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M\% /B!^TGX)T^.RT2+P;:>%-2N+9 L>MZS'=//<S\<2&WC$%L9.?G\V/.8F
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M^ KG1O%FK6L84:E?7<D4EO8N1CS&@A0S-G.W[1 ._P H!ZKKWQ[^#WAGQ<?
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M $K]G?4] L/%%T!%::EXD:7[/9H<[Y0L<;EY /NJPVY.6W!=C=C10!X/\"?
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M#>99)WNB79SF-5";5 5L@DC'HU% !1110 4444 %%%% !1110 4444 %%%%
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ME)%O$B)Y2A%\PDN9!L]1HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "'R\GD"OI:B@"'3M.T_1]/@TG2;"&UM+6%8;6UMH@D<,:@*J*JX"J   !P
M*FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***\H_;?\ ^37O$_\ VY?^EL%14G[.FY=E
M<Y\77^JX6I6M?EBW;O97/5Z*_*.BO*_M;^Y^/_ /B?\ 7C_J'_\ )_\ [4_5
MRBORCHH_M;^Y^/\ P _UX_ZA_P#R?_[4_5RBORCHH_M;^Y^/_ #_ %X_ZA__
M "?_ .U/U<HK\^OV(/\ DZ'PQ_V^_P#I%/7W[JTVIVVFS3Z-8175TB$PV\UQ
MY2R'T+[6V_7!_K7?A<1]9IN5K:V/I\ES7^V,+*MR<MI-6O?HGV7<L45\N^&/
M^"FNG:O\#+K]IG7/V;O&%GX%TW5IK#6=8M+RQNIM/,,_D2S26ZS"1H5DX+1A
MV RVW S7:?%+]L^P\">./AKX3\)_#Z3Q3:_%E9&\&ZQIFKQ1P3!+9;G=+YJ@
MHK1N&4C=D=<'BND]<]NHK@O#GQ6^(ES\0['P/XU^"%]HMOJ-C<36VMIK-O=6
MXEB\L^0X0AU=E=F4[<$1MSFL72?VF;KXF>*_$'A?]GOX?_\ "5P^%=1;3M=U
M^\U=;#34OT ,EG#+LE>>:/*[]L8C4L%,F[*@ ]7HKS[X+_M%>$_C%KOB'P$^
MDWN@^+O"-S'!XG\*ZOY?VFS\Q=\,RM&S)-!*OS)*A((X(5@5'H- !1110 44
M44 %%%% !17YG_\ !Q/_ ,T>_P"Y@_\ <;7YGUUTL+[2"E<Y*N*]G-QL?TP4
M5_,_15_4O[WX?\$CZ[_=_'_@'],%%?S/T4?4O[WX?\$/KO\ =_'_ (!_3!17
M\S]?IA_P;L?\UA_[E_\ ]R515POLX.5RZ6*]I-1L?IA117F^A_M2?##Q!^U'
MKG[)5A?,?$^@^&+;6KH;AL9)9"K1#OO16MY".ZW*>AKD.L](HHHH **** "B
MBB@ HHHH **X?XM_&JR^&WB+PI\/M+TJ+4O$_CC4[BR\-Z;<7AMH7-O:RW4\
MLTPCD,<:11'E4=BSHH7YB19^"GCWQ_\ $+PC/JGQ.^$5UX+UBTU2XLKC29]2
MCO(I1&V%N()T5?-AD!RK,B-URH[@'7T44V8S+"[6Z*T@4[%=]H)[ D X'O@_
M2@!U%>*_";]M?P5X_P#VD/$_[)?C#PQ=>%?'/AN".YATZ_O89HM6MGC63SK6
M2,_/M1T9D8*X5L[?E?;V.K?%GQ%IOQWTOX*Q?#_S8]6T.[U:'7/[558DM[:6
MUBF5H]F_S=]W%M495ADEEP0 #N:*** "BBO+/VP?VG+?]D'X-W?QRUSP)=:[
MHVFW$$6I1:?>QQW$1GGC@B95D 5UWR*#\P(R#@\X /4Z*\9M?VQM+\/_ !J\
M/? #XU?"[6_!.O\ C"WFD\)76H7-M=:?JLD(!DMTN+>1BDR@J=DB*#N7:6+*
M#3\"_M>^,?B/\7?'OP6\*_ &ZFU;X<WME;:_+)XCMT@=KJ%IH6A9EW.I1<G*
MJ1D B@#W*BO.M._:'TK1/AQXK^)7QQ\.3> K+P9>R0ZTVKWD4Z")8(9UGC>$
ML)%=9T557+%\IMW<5BC]I#XH3?#X?&2S_9CUR7PPUE]N6U.K0+KK6>W?YPL"
M-F=GSB(SB;''EA_DH ]?HK!^%_Q.\"?&?X?Z3\4OAEXC@U;0=;M%N=-U"WSM
ME0Y!R" 58$%65@&5E*D @BO,?&'[;'A#X6_M1:!^S#\8/"MQX?N/%]M))X1\
M2/?Q2V&HRJX46Q/#PS-G #KM+$*K,6&0#VRBN'^+OQ9\0?#+6O"VDZ5X .LK
MXIUY-(@F35%@^RSM#--OE#(?W02!\LNYLX&P]:XS6/VM/$MC^U'=?LG:3\$K
MG4/$$'@X>*(KR+7X([673C=_90VYU#"3S."A7L2"1R0#VNBN&\#?%OQ%K&N^
M(M#^)'PSN?"(\/Z=:W[:A?:K;SVMS;S&X!=98VPGE_9GWAPI 93T.:YGP5^T
MYXO^,GA5OB9\"/@A=:_X4=Y!IFJZCK<6G3:U&C%3-902(VZ-BK!&G:WWXR/E
M(8@'K]%<;\"OCQ\/OVA_ Y\<_#V[N!';W\VGZMINH6_DWFEWT+;9K.YB))CF
MC;@KD@@@J64@GLJ "BBB@ HHHH **** "BBB@ HHHH **\S_ &NOVA]%_9B^
M!VK?%'5;ZS@E@0QV+ZA+L@63:S-)(QX5(XTDE8D@8CQD9%=5\)_B-HWQ;^'6
MD_$306'D:G:+(8PV3#)TDC/NKAE_"@#HJ*** "BBN"^-/[0G@_X,:AX?\)W6
MGWNM>*/%UZ]IX5\*Z0J-=ZC(B[Y7'F,J10Q)\\DSL%1?4E5(!WM%>2>(?VG[
M_P"$_B/0M'_:)^''_"*Z?XFU./3=)\2V.LI?Z='?2 ^5;7+^7%);O(00C%&B
M)&#(I(!I_%_]K/6_A9^T+X5_9TL/@M?:[JOC2PO;O0+NRUJWAA9+2,/.LOG;
M3&P!! &X'(P<Y  /9Z*\K^"/[6'@_P",?Q+\4_ _4/"FL^%O&_@T0R:UX;UU
M82[6\H!BNH)8))(YH6#+\P8,I8!E7(S0^%?[5>K?$_\ :.\<?LW)\);C3[_X
M>+8-XCU:;6(GMBM["9K?R J[Y"R DAE3&""0< @'L=%%>;ZI^U)\,-)_:FTO
M]D>ZOF'B?5O"L^N6_P P\ORXY0@A]3*RB:3'9(23U% 'I%%>=?M4?']?V7?@
MIK'QTU#P7<:YIF@0K-JEI97B17"Q,ZINC#C:^"P)!93@<9/%<GXG_;(\2?#?
MX<0_&/XI?LQ^,+#PJUG'=W^KZ-=V.IG3;9U#_:+B"*<3>6JG+-&DA4 DC )H
M ]QHKQ?]H?\ ;2\&? []G6S_ &IO#^A'QCX/O/L;)>:)J**[1W4L<4,B+( &
M4M(H;+!E_NG!QOZE\8_BUX>O=+/B/]G:^CT^_P!9M+"ZO['Q#:W'V+[1.D"S
M/&-K,@>1=VW) R2, D 'I-%>(VO[8UU%^V!#^QWXG^$%]H^J7NCRZMI.O7NK
M0_8=3M(V 8VQ4%Y)1\Q,152 C$X4!CU7C#XV^)=!^.NB? _PY\++C6I-6TB7
M4[O6(-5BC@TJVCD2,O<JPWKO=\1A QD*28 $;D 'HE%>8:K^TG;ZQ\5]6^!_
MP8\'2>+/$/AVWAE\43'4%M-.T8S M%#/<%78SNH+"*..0A1E]@(S-\-OVD-%
M\7?%'4?@+XW\,W7A;QSIFFIJ1T.^N$FCU"P9B@O+.=.)X0X*-D)(C##(N02
M>DT5R?QQ^,W@[]G[X7:K\6O'9N6T_2TC!M[*(//<S2RI##!$I(!DDED1%R0,
ML,D#)')R_M#?$;PQXN\+>%?B;^SOJ>EQ^+]66PL-5TS6[:_M;*4PR3;+PC8\
M3E8F V++&6&WS!D9 /6***\O\?\ [1]SX#_:=^'W[.=Q\/)YHO'UGJT]KXB.
MI1K';FPMUFD00A69R?,C&24'S$C=MP0#U"BBB@ HHHH **** "BBB@ HHHH
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MA:A!%HQ93#Y,Z?9R3]YHMAD'#EAQ6I\*-7O_ -JKXR_&GP5XH\=>*M'T_P
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MA1I7P.^&&B_"7P]XAU34=+\/Z?#8:5)J[PM-#:Q1K'%%NBCC#!54 $@L>Y-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>bcrx-20250424_g5.jpg
<TEXT>
begin 644 bcrx-20250424_g5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHIDLL<$+S32+'%&I9W<X"@=23V% #Z*\\T+XP
M:#KGBR31E62W@D.VPOIOECNV!PP7(XYZ>OL< ^AT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<7
M$%I TUS-'#$OWGD8*H^I-2UP'QJ_Y)+K?TA_]&I0!V]I?V=^C/9W<%PJG#&&
M0. ??%6*\2_9L_Y%G6O^OQ?_ $ 5[;0 5Q/B_P"*GASP5JUOINIM<O<RJ'80
M1[A$I. 6Y'H>!D\5VU>?^-_A'H?CG6H-5O;F[MKB.,12>05Q(H)(SD'!Y/-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **Y[5/'7AG1;]['4-
M8@@N4QOC(9BN1D9P#BJ?_"S_  9_T'H/^_;_ /Q- '6T5R7_  L_P9_T'H/^
M_;__ !-'_"S_  9_T'H/^_;_ /Q- '6T5RUO\2/!]S<1P1:[;F21@J@JR@D^
MY&*ZF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIK6EPW++PLO*R+[!EP<>V<5S-G\$/ =G<K/_ &3),5.0LUP[+^6>?QH \O\
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M*J!R<'C/'3O70^%/B7XA\5>!-;URWT&VCNM/'[E3(Q2X(&YU Z@A?<\D5!\
MO#^FVO@*+65MHVO[R6023LH+!58J%![#C/XUZPD4<88(BJ&.2 ,9/K0!Y?\
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MDB@#H9/C#\3=-07&H^$(EMNI9K*=!CZ[N*[S3OB7J&J_"J_\7PZ'Y-Q;DK%
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MEPI^42YYSZ$KC'T/O3=!T[X1^,8X+*UAN-&U1L!$DG8,S>@9BR-S]"?2N_\
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MZJQ4BD!K_#+QQ>^&]6/@;Q9NADB?R[2:4_</9">ZG^$^^.F,9W@C_DXK6_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC&.Y8],4 ;E%-C\PQ+YH428^8*<C/M3J "BBB@ HHHH **** "BBB@ HHHH
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M+<,) V05Y8+AM@Q\V,CM4AU/Q";2_71KK5[M!/:#39;VV*-),2?.23*J?*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,2YUBXAL]:F5(BUC.(X\@X(,<;<\^KG]*;+XJLH(9Y)(
MW017/V4;Y(UWR9.1RWR\*6^;&1@C.:GET:UN[NXD,MRD<DJ/<0 [8YG4+@G(
MR> H.TX.,'/-5Y-+L[G6IU:YO&OU2.99@%'D*&?8%(7!ZN,'<<9S0!I6&I0Z
MGIB7UJ&='#84%<[E)!7.<=01G./?%84'BJ<PVUY/I\ZP/IPO)4383&,\MG=R
M,= .?:NFAC,42HTCRE1@N^,M[G  _(5F1^'[-+-[4O,\36IM!N896(_PC [
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M?,=N,,"7.UAC@X..,  8I)/#2B1YK:>..XDE\V21H=V\B82KG!!X^[UZ8]*
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MRU-S%Y<A8J%* AL@?WU/'N/<@'.V&G7S.MO)8R-?P+8J;GS5(MV5$,@R3GD
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M2K[L#D#D%3^GTK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8YHM,66T,-O&9"!(NVW\ID #<_+@D8_W:N(=,MK2&\1[:.VAB\N*;< BH2.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8"XX(QCKSF@#;HKF_!GB:;Q5IC7[Q6,4;;2D=O=F:2,G.5E!5=C#CCGO724
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT@FF*<#[WRB/ .001QTJ9WNT%W(XU$W\=V'(193$;<3J0$ ^0GR@,@?,3N%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <?%ILEUX@OY(K!%D34TD^W;ERJ"% 4_O<\C XPQ.<\5!_PBTUOI
M<=K'IL,LC:9';1N&4?9;@;MTN3SR2IW+EB4'M5G5M>OY8=7BM[9Q;PI/"9%1
M@T96$MYF_./O8 4#/(.>U23>*+R WLZV)EM+4S(WR%2OEH3N9^F"1C&. P.>
MHH J7^F7.GG4M4F6(+S/:)O_ -5(CA@H_P"NS $@=^.<UM-I=U_PB;V*.OVV
M6)FD.XA7D8[G&1R 26&>P-0W=WJ]G?6HDNK1XS;SRR(ENP#; I R7/J>?TJ
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M?OGM["!+=YDB@MA.[(S,V]06??G "@YYSG!Z5-'XDU"<W @A62-(X;A9_LS
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M16V6SE$4B&7][G!C+0NBL/HS"HM$TY[6^FG33DTZW:".+R$*G>ZELM\O&,$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%U)9PV;W4*Q6D#PVSK&=S$XVE^>P49 ^\>>.E74TO4#9ZKNNXXKJ^D\Q&A!
MBQ&B8SU/W.HP>>.E "W5WX>N+;S+MK&2*27)\U%.748)((SD+W/0>U2G5M%,
M2I]JM&CB5)%4$$*#MV$#MG<N/7(Q6*=)N]&F:_CE,ES(\H$8AEN0%=(A@DG.
M081RQ .2..SK7PK/'H=O TP2ZC:WEPK,HW1PK&5+*0><-R.F1UZ$ U9)O#\T
M=M;R&PD21%2!"JD;,@* .PR  /48ZTQ[C0;?4IK:2*TBGL[:)V9HU4)$&)0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/[99^7-=&>X5V0R;T99-H4DQLBJ&7YAS@$'(/2MJBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH I-J^FI;W5PU_;+#:.4N)#* L+#&0Q['D=?6H9O$>B6^IIIDVK64
M=\^ MN\ZAR3T&W.<GMZUQVN>'-3G\:FUMK5GT/6);:ZU"7(VQM!DE2/]O;$/
MP-4-0T751HOB3PX-"GN+S5-0EN+>_&SR=KN&5W?.5*#C&,_*,=: .Z_X2WPX
M;XV/]NZ=]K#F,P?:4WA@<%<9SG/:K&F:_H^M&4:7J=G>F( R"WF5]N<XS@\=
M#^584NDW?_";7UWY#/ ^AI;K-@8:42.2/K@@_C5?X:6VH6'A^&QU"/58Y8+>
M)"E[#$D:$ @K&4&6'^]D]/>@#H(_%&@2S7,,>M:>\MLK-/&MPA:,+]XL,Y '
M?TJXFHV4DT$,=W \MQ$9H460$R1C'S*.XY'/N*\R\,>'M7B\7VTEWIMXUM#=
MZ@TANEC$$<<K,5:(@[F9N 0V1@G&*Z/P+X9;0[K6)9XYQLNFM; S-NV6:X9%
M3_9W.WY#TH Z)?$.BOJ4FG+JUD;Z+.^V\]?,7 R<KG/ YJ>/5-/F^R>5>V[_
M &Q2]MMD!\Y0,DI_>&.>*X2V\%W=[K6M7]])-'#%JLMW9VRQJ/-8P*@??]['
M)&W@9%9FG^#?$"67A6-[R]9H]-N8)$F6,)8N]OM4 JH;[QQR3TH ]&L_$>B:
MC>RV=EJUE<7,0)>**=688Z\ ]N]20:YI5U!;3V^I6DL-TS+ Z3*1*5!+!3GD
M@*<X]#7!6&F:E>1>$M.3P_<:;+HC!KJYD"!,+$R,D9!)?>Q!_G61X?\ ".NZ
M/-X4A6PD^P[6N;I21FUN/L[QL"/1\H?J&]: /4M,\0:/K32+I>J6=ZT8!<6\
MROM!Z9P>*T:X;X8VNHZ=H$5AJ,6JQRPP1IY=Y#$L49&<B,H-S#_>ST%=980Z
MBL,R:I<6MP6<[/(MVB 3T(+MD^_'TH EM+^SO_.^QW4-QY,ABE\IPVQQU4XZ
M$9'%5HO$&CSZA/81:I9O>0 F6!9U+H!UR,\8[^E<UX<T'5-'AUVVTF.TTR-]
M6,EN)[8R1M!Y2#Y55UQR.N>QXKCKGPIXCO-3U6"*PGC$HU/8LFT6\/G#Y&B?
M=DLY # \#<W"T >HIXGT&33)-236;%K&-]CW G4HK>A.>O(X]ZT(KJWGM%NX
M9XI+9T\Q9E<%"N,Y!Z8QWKRY=(U=]:C\0C1+R.S@O+-FL2J^:PBMY(V<+G!P
MSJ!W(7/I5V+PUXH_X5E<:3');0F:SN,631'S@SN[JGF;]H&U@N-OKS0!V0\6
M>'CISZ@-;T\V:2^2TXN%V!\9VYSUQSCTJ>37]'AGM()-4LUEO &MD,ZYF!Z%
M>>0>V.M>>#3=;>Q6\ECUG%A?J^EH]K#).%,&QPZ JH3)8*>W':LZ'P=KVGZ4
MVDO837$]]9:?%%<H59+1HIF>0,V>,!@00.<<4 >M:CJ=AI%H;K4;R"TMP0OF
M32!%R>@R>]0'Q#HPN[6T.JV8N+M%DMXO/7=*I^Z5&>0>WK7'^+M)\1SW.EWD
MD\ES':SSL/[)MPDL>Z,B,XD9@2#P2,<-TK*NO#>OWE[IOFK=C4+T:?+J;B&/
MR$:!MQ(DSD$ 'Y5')(P<9H ]$'B/1#)>1C5K+?9 M=+YZYA X);GC!XYJQIV
MJ:?K%K]JTV]@NX-Q7S() X!'49'>O-]#TC5].N+'S]+OHSI-K?13SPHC-<M-
M,&0Q GY^ 7Y'!]^*Z7P!87UG9:K+?P7"-=:@\\<MVJK/,I50&D53M4\$ #'
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M," 1UQP>]+<Z7I?F(9B8II)-RR"X>.1GV!.&# G*JH(SS@=Z *</B22:4O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[FVFQ$9$U"6YDD_B=&C=!SCKEEX]J77-*O-4N)!$L21K8SPH[N?FDDV8X X
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MZGN/+$D9;<89$"RJ/01@ K[(@Z\GNJ* ,K5;"29;!K:&*5;.<2&W<[5==C*
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MA6U110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 5S86;3O.UI 9G&'D,8W,
M,8Y/?CBG36MO<(Z3V\4J. '5T#!@.0#GKBG^;'M9O,3:APQSP/K2&>$2K$94
M$C#*H6&2/84  MX%MS;B&,0D$&,*-I!ZC'3G-(EM!$@2."-$4@A50 #  'Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF]=JAB2=VW&&3H?XA[TEGK7_ !2]AJERCO)<10G9&N&=Y-H  ) &2PZD8[T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,?7BI==US^Q8X&%N9RQ+R@-CRX%YDDZ<[<CCOD4 :]%9,VK3_P!OIID$5O\
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MX SP *IR>&+F1))=]B)GN8I_(6 K!\@(Y&>6.>6]@,<5U-% &$NFZG#J,5[
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MG17-:MI'BJ[U*2;3/%4-A:,!LMVTQ9BO S\Q<9R<GIWJE_PC_CG_ *'FV_\
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M -VBL37M.U^^DA.C:_%I:J")%>Q6XWGL<EAC'-9'_"/^.?\ H>;;_P $J?\
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ME8=SH7C22ZF>W\:6\,+.3'$=(1BBYX&=_.!QFHO^$?\ '/\ T/-M_P""5/\
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M$?\ '/\ T/-M_P""5/\ XN@:!XYR,^.;8C_L"I_\70!V5%%% !1110 4444
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M206UV=I;$<8<JXP.5VX&1UQ71:GJEIK_ (\T*_TR1Y[4:=?QF3RF4!MHX^8
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MC@TV8P7<D@*B*08RO(Y/(Z9SFO/-;U >'/'$\OA;4YI]2O[V);_1'M6=9,@
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MHZC!J2/:Z<Y2[<(^8B.N1C)_ 5#J/C[PSI-V+6^U/RIO*68CR)& 1ONL2%(
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MFE8$D9 !52"<>AK@/$>FZSXL\176GP:6FI6VDZ9]@,DUSY*BZE4%I5)4[B
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M=3).]NLDD@@CE?<?ERP&-J9'3>*MV5\VL+HUC?RS+'B>*Z#!HFFGBVA58'!
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MD\>] '-6%H]YXHUF26UAG@2Z6/SWN6#H#:Q':J!<$98]Q]X_C1^R06-KJ5Q
M&C:+6;:+?YC?+%YT!8<G@8SG\:ZI=%TI+M;M--LUN5QMF$"AQ@!1SC/  'T%
M6#:6S131-;Q&.<DRJ4&),C!W#OD<<T <GXHEF:_O88F+?N+$&/S"JDM=$8)'
M3(!&<=*H"*_D%G#;3/:W<>K3%+7SV=(2ENQ$98\LCX#=.DG &!7:V^D:;:P-
M#;V%M%$SK(R)$H!92"">.H(&#VP*E^QVOVC[1]GB\[=N\S8-V=NW.?7:<?3B
M@#%\-WR:N^MS?/Y;7BIY3GF,_9X=R'T(;<"/7-8T]G'8V?B":SC*SPZC!%#F
M5@ I%N=N>< DGMW-=K#:V]LTS001Q-,_F2E$"EWP!N;'4X &3Z"D:SMF616M
MXB)7$D@*#YV&,,?4C:O/L/2@#C]7N]3_ +3F%U'';$16FU8+EI <W2@GE5QQ
MQ]*T]-A.EZ^]O>1"6XO#-)!>B0L73=N\MU/W=H( QD87^'I6[+9VT[[Y;>*1
MR%&YD!. =P_(\CWJ*WTO3[2YDN;:RMX9Y<[Y$C 9LG)R1ZGGZT <U/9WE]XK
MOOLR%6AGMF^TFX*^6@"LZA1][<,C!XYJNB(/"=MKHFD_MEWC9I/-;)F,@5H,
M9QMR2FWM]1FNU6&))))$C17DP78#!; P,GOQ54:/IBW_ -N&GVHN\[O/$2[\
MXQG.,YQQF@#D=,CEEU]!/&8H+B^OD,XN&;[2 T@$+)P%P/F!YXC[9J2.SAL[
M2ZFMPR2#6X( P=N(_M$7R]>E=A]CM0% MXL+(9E&P<.226'N23S[FE-G;%2I
MMXBK2"4C8,%P00WUR <^PH XTHG_  B<FN^=)_;(D9A)YK9\\2;1!C.-N[]W
MM_KS52ZO+K3M,UEY+B4V][=W*1.7/[F99& 4'LK*.!T!7U:NV.CZ8;_[<=/M
M?M>=WG^4N_.,9SC.<<9J633[.:W>WEM('@=_,:-HP59MV[<1T)W<Y]>: ,S7
M0)]0TFRGD9+.XF<2!6*^:RH2L9(['!..^W'3(KGM3MY%U*32=-O)K>W2\MFB
M97)$$S)*2@Y^[\L3%.GS'L:[:ZM+:^MV@N[>*>%L$QRH&4XY'!J.#3+"UACA
M@L[>**-_,1$C "O_ 'A[\GGK0!R":K-?:Z&+/#(MQ9Q3P!SB.0&<.OTR!SW&
M#6G-;78\0#1UG(T^YW7S'>=ZA67?$/\ 99F5NO0NO3&-FXT?3+LS&XTZTF,S
M*TOF0JWF%1A2V1R0.F>E2P6-I:B,6]K#$(D*1^7&%V*2"0,= 2 <>U %BBBB
M@ HHHH **** "BBD9@BEF("@9)/0"@!:*\5NO&WC/X@Z[=:?X$$=GIEJVU[^
M0 ;_ '+$' .. HSCD^TW_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YV
MG_?Y_P#XW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T
M?\(7\7O^ASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<
M[3_O\_\ \;H ]DHKQO\ X0OXO?\ 0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&
MZ /9**\;_P"$+^+W_0YVG_?Y_P#XW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO
M_A"_B]_T.=I_W^?_ .-T?\(7\7O^ASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_
M '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\ 0YVG_?Y__C='
M_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#XW1_PA?Q>_P"A
MSM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^ASM/^_S_ /QN
M@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\
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M@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\
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M@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\
MX0OXO?\ 0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YV
MG_?Y_P#XW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T
M?\(7\7O^ASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<
M[3_O\_\ \;H ]DHKQO\ X0OXO?\ 0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&
MZ /9**\;_P"$+^+W_0YVG_?Y_P#XW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO
M_A"_B]_T.=I_W^?_ .-T?\(7\7O^ASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_
M '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\ 0YVG_?Y__C='
M_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#XW1_PA?Q>_P"A
MSM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^ASM/^_S_ /QN
M@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\
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M@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\
MX0OXO?\ 0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$,^+XY'C*
MT)]/.?\ ^-U-X;\?>)O#_BR#PKX\B0O<D+;7R@ ,2<+DK@,I/&< @]?8 ]>H
MHHH **** "BBB@ K%\8NT7@G7I$)5ETZX((['RVK:K#\:?\ (B^(/^P;<?\
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M?RT_=HHCP,8P?O'KGK70-X'L#J*7ZZAJ\=T(4A>6.^=6E5"2-Y'WNIZTR_\
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M<R&ZN6ML"WD!B<(7^<;<KP!P<<'/0$U:M-9L;ZY-O;S,T@5F7,;*KJIP2C$
M. 2.5)ZCU%9R:)>?:([]KB!KLW_VMU"D1[?(,.T=^%.<]SZ#HF@>&_[%>-6$
M,BV\1AAFR_F;,C@@D@<*,XZD9XZ4 6;_ %DVNOV6G ^6DD$MQ+*\#LH5"HQN
M&%7[Q)))Q@<?,*</$VD^1),UQ)&B*CGS8)$)5F"JRAE!8$D#(R.:75-%759R
M992L3V-Q9NJCG$ICY!]@A_.J,^@WU_-#/J%W;^9 L:1^3&0& FCD<G)ZGRE
M';GDYH WXYTDMEG42!&7> T;*V,9Y4C(/MC-9Q\1:8J;GEF1O-$/EO;2+(7*
ME@ A7<<@'''.*N:C;RWFF75M;W#6\LT3(DR]8R1@,,8Z?6L*P\,26VHI>-)
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MZ;?BZ:6'&Z9O*B0A1Y@B&!D]O+Z]\]J .AHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\:_:"54TW0+E1B>.
MZ<(XZ@8!_F!^5>RUXY^T)_R M$_Z^V_]!H ]B'*@TM(OW1]*6@ HHHH ****
M "L/QI_R(OB#_L&W'_HMJW*P_&G_ "(OB#_L&W'_ *+:@#D_@;_R36#_ *^9
M?YUZ17F_P-_Y)K!_U\R_SKTB@ JM?W]MI=E+>7DOE6\0!=\$XR<=!SU-6:*
M.97X@>&9;&YO(-2$T-MM,ICB<[=SA!V_O,!735Y9-H>J2?!W5--%C="\EU!W
M2%8SYA4W8;<!U^[SGTI=4T37K&W\66.BQWXLS/926ZF220R(0//$;%@S$XY
M8$\@$$T >I5B:KXOT#1+\66IZG#:W!02;9 >%)(!)Q@#(/6LWP!:7=KI5X)Y
M;@PO<EH(I[66#REVKD*LK,^W.3R>I..*Y'X@:3J=WXLU-K:TUF2*ZT>.WC%E
M &BGD$CGRY6(X7D9P0<'K0!ZTK!E#*05(R".]+7D_B+3]:>[OA<Z;JKW+:=
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MC6XE*2QVZFPN(P@&^^ 8\'L"510._FBK4=QJGFD7.HF4KJ,=FH$,8 &P$O\
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M\$4?EQPQI'P-JJ ./:D6V@6X:X6&,3,,-(%&XCT)ZT 2T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !115#6]/EU70[[3X;IK66Y@>))U!)C)&-P
MP1T^HH OT5XW_P *6U__ **#?_\ ?J3_ ..T?\*6U_\ Z*#?_P#?J3_X[0![
M)17C?_"EM?\ ^B@W_P#WZD_^.T?\*6U__HH-_P#]^I/_ ([0![)17C?_  I;
M7_\ HH-__P!^I/\ X[7*?$#P3KO@;08=3;QC?WHDN5@\OYX\95FSGS#_ '?U
MH ^CZ*I:.6;0]/+,68VT9))Y)VBKM !7CG[0G_("T3_K[;_T&O8Z\<_:$_Y
M6B?]?;?^@T >Q+]T?2EI%^Z/I2T %%%% !1110 5A^-/^1%\0?\ 8-N/_1;5
MN5A^-/\ D1?$'_8-N/\ T6U ')_ W_DFL'_7S+_.O2*\W^!O_)-8/^OF7^=>
MD4 %4=:U"32M%O+^*UDNGMXFD$,9 +8^I QW/L*O5%<V\=W:36TH)CF1HW .
M.",&@#SJ#X@ZI)?:'<R:5>&"]TB2[DLH$C9F8%"'4EN$VEL9()XXSQ6K=_$[
M0[6&WF6*ZGADM([V5T"#R(GZ%@S D\'Y5W'@U;TOP/;Z:]FSZE=W)L[&33X?
M,"#$+;< [5&2 H /YU3_ .%::=$EG]EOKB![>T2S=S##*98TSM)#HP#<GD8H
M L>/_$&H:-X>MYM(29IKNYA@6>%8W\L.X&0'(!)!P.HSUQUIK>/;*R9H;BTU
M*2"TDBMKW4#''Y<$S!?E?#=<L,[00":W-:T.WURQ@M)G>*.&XBN%\K YC8,!
MR.G%8U]X!LKZ^NW-_>QV%[<I=7>GH4\J:5<<DE=P!VKD \XH Q+3Q?JAU^W@
MN;Q1:'7=0M)<QJ,011%E&<=B,YZFM:/XCZ>\ G?2]4BAFM9;NS9XD'VR.,;F
M\L;LYV\@-MR*LIX$TU;Y+EYKB3%_<WQC8KM9IT*.IX^[@\=Z;I'@2TTR\LYI
M=0O;Z'3X7@L+>Y*;+='&&'RJ"WRC;EB>* &2?$;0H[JX@/V@K#IW]H^:$&QT
MV*^Q3GE]KJ<>_6JQ\>065UJ#7,>H3C[7:VL-HEM&'B>:(.JYW_-SUSC!.!D<
MU&GPIT1-)MM.^TWK1P7GVK>S@LZ[0GE,<?<VJHQ["M6Y\$V-UJLVH/<W DEU
M&VU J"N \*;57IT('/>@"LGQ!LI+>(1Z9J+ZA)>R6(T]5C\X2QKN?)W[,!2#
MG=W%7]%\60:\EK)::=J"Q3R3Q-))$H6%HC@A_FXR>G7H<XK$USP8;8?;])34
M)]1.J27ZO;7$43PF2,(X'F*5*D*!@\\_A5SP7X8U#1='L%OKV:.>.6XFGMDD
M#HYE;< [8RQ7U&.2>M '7T444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!4U'3++5[)[/4+:.YMG(+1R#(..15F.-(8DCC14C0!551@*!T %.
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH QM2T5[XZQMF5/M^GK9KE<["/-^8^H_>C\J@;1
M+XWH"SVXLUOOMO*GS#D<IZ=23G\,=ZZ"B@#GH_#<B:;#:_:$S'I)T_=M[X W
M?3CI40\.WI,UK)<6YL9KV*[8A2)%\O80H['+1CGL"1CN.FHH Y*Q\(/;6=O;
M2-$S6I@6*X,LCLR1RQR$;6)"9$:]._MQ5B]T.[GCO+6W6%=T[7%M=,[*\#..
M2I7G<&W'' (8#/6NEHH QH](>ZL]7BO&93J.Z(D8RL>P1@\<9."WMNQVJI/H
M.H:C\]]<6RRQVQMHO)4X;<Z,SG/3/EKA1G'/)SQTE% %#5;.:[2U:W:,2V]P
MLP$F0K8!!&1TX)K)O?"K7NC1:<UT$"M<EG53G]Z) ,<]MX^N*Z6B@#*T;3'L
M/.DFBB6XE"JSI/)+N"YQRYR.6;CMGO6=)X6E?3=*MA=(LFGV2VZOLR#(KP.K
M8S]W,/(]#7344 8$>B7<VM0ZM>2P+.DJ$Q1 E0B13(!D]3F=CG X 'N8;GPQ
M+/IHM1<HI$=VF[:?^6S$C\LUTM% &!<>&_M-@+22<!#>7%PY4<[91*,#W'F=
M?:L[_A$)FMX&=HOMEJZ-'*MS/^]"JRD$ELH"'. I.#Z]*["B@#F4\/O;>:D=
ME:RI=0!9HI)79 ZR,X.XY8D^8QW=05!JUI.EWEO>0R7LQF-K;O#'(6)+>8X=
MADDDA0D:@GDX)-;E% ',OX<O)(%L&N(!8Q7$MQ&X4^82^\A3V !?KW Q@9)K
M3L]+:UN[68R*1#9"V( ZD$'/Z5IT4 8::+<#55G:2+R8[\WB8SN.Z!HBI[#!
M8'/I6=)X0<W<TI>.XCN1*DT3RR1KL:>60?</S<3,"#UP.1SGK:* ,;6]%?5<
M;)ECQ:S0<C/+[,'\-OZU!<^&OM6G)923@)]KNIW91R5F$PP/<>:.?:N@HH Q
M="T>332[W"Q-.8UB\U)I'+@9[.3M&3G )QSR:RI?"5[>Z5%IEW>0+!;K,898
M48.7=65=PSP%#GH?FXZ5U]% '*3^$6OK1HYS';R2;UDDCEDF+*89(QRYSP9"
M<=*FO-"U+46DNY[FUAOHXT6U:)&9%=7#[FSR02H&WL,\G-=+10!SUIX<DT[4
M1<6DZ&&.!4BBE4G$FU$9R<_W(U ]RWK70T44 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>4?M _\B'9?]A*/_T7
M)7J]>4?M _\ (AV7_82C_P#1<E 'I.C?\@+3_P#KVC_]!%7JHZ-_R M/_P"O
M:/\ ]!%7J "O'/VA/^0%HG_7VW_H->QUXY^T)_R M$_Z^V_]!H ]B7[H^E+2
M+]T?2EH **** "BBB@ K#\:?\B+X@_[!MQ_Z+:MRL/QI_P B+X@_[!MQ_P"B
MVH Y/X&_\DU@_P"OF7^=>D5YO\#?^2:P?]?,O\Z](H *0D*I)S@#/ S2T4 4
MM*U.+5[,W,,4T2B5XBLR;6RK%3D=NG?GU J[67IMK<Z?:W"F)9'DO99  ^,(
M\I.?P4YQ[8K4H *IZGJ":78FY>&6;]Y'$L<6W<S.ZHH&X@=6'4U<K)\26,VH
MZ*UO!%YK^?!(8]^S<J3([ 'L<*: )H]39KJTMY;.:WDN$D?;*R$KL*]=I(YW
M>M31ZG836TES%?6TD$61)*LJE4QUR<X%8-YHEUJ%BD$$+6.;.[MQYDWF-&T@
M4*<Y.>034":'>O#]J:"9KJ.2W9H+B6+9*L18A5V* ,%B02.H7.* -Y->TJ2]
MM[.*_MI)[F-Y85253O52 <$'U/Z'T-2C5+-$M?M%U;P27*@QQO,N6)QPO/S=
M>U4GBNY]7T^_^QLB"WN()49UW1EVC*DX."/W9Z$]1[UBKH&I6^DS6(M(;A[O
M2X+(R-( (&1"IW9Y*9;<-N3G/ ZT =4VH627BVC7EN+EC@0F5=YXS]W.>G-3
MNZ1QM)(RHB@EF8X 'J37//H=QB_(5&DGU.TN5D)^9DB$ 8GW_=OQ[^]:6NV,
MNH:3);P!&D\R.0(YPLFR17*$^C!2IZ]: (=0\1Z=9:3_ &A'=VD\;2I!&PN%
M",[,% +<XQG)ZX )Q5^YNTM-.FO9AE(8C*XC.[( R<=,_I6%)I5]>S7=VULM
ML9[BR80,X)Q#*'9V(XW$<8!/"+]!LZM;27FC7UK%CS)K>2-,G R5('\Z *UI
MKB7$Z03V5U9RRQF6$7&S$H&,X9&8 C(X)![]C5M-1M"84>X@2:6/S%B,JEB,
M9)'/('J.*R$L=2OY+-[NWCM8K.)]B>;O>21D*9.!@* 6[G)(Z8YIMX9NY-*O
MH!Y27$^EV]HKYZM&'W*3@_*=V.AZGB@#HDU33Y+-KQ+ZV:U4X:<3*4'U;.*B
MBUS3+C4$L8;ZWDN'B\Y$20'<OJ,=:PUT:]!AU 07$EQ'>)/+!=2Q9E"Q,@QL
M 4$;P1GKL'3C%K4M.O=2EF*0M;B\TV6U+EUS;N<X)P>>O\.: -B'4]/N8Y)(
M+ZVECB.)&256"'T)!XI(]4T^:6&**_M7DF7?$BS*3(O/*C/(X/(]*YV\T6]U
M99"^GPVBBS6U\GS PE_>*QZ<;5"D+GGYSP.^E+9WD?B.*XLHGBA? NW9U,<J
M!2!A?O!P2.1@8SG/% &E>7BV<<9*EY)95BC0'EF)_D!DGV!I4OK22ZDMDNH&
MN(AF2)9 70>I'4=:JZM#(TNG72*SBUNA(ZJ,DJR/&2/IYF[Z U@VN@ZI;-<;
M6E:ZA-U+9S2/'Y!>0L5W +O_ (AD'(R._% '31:GI\]M)<PWUM)!%GS)4E4J
MG?D@X%5&\1:8MU'&UY;""2+S$N#.NQCNV[0<X)R#^582Z'JLD]Q=R1O(=UI(
ML-U,A:4Q,Y8'8-H^\"O;('3MJ3:=/J%[+>2VBQ&33Y+8)*REE+-G!QD8( [T
M ;KNJ(SNP55&2Q. !ZUG0:_I-QIJZ@FHVPM&8H)7E55W>F2>OM5JPBD@TZVA
ME.9$B57YSR  :YZTTW4;(Z;.;$3-9+<0-")%!8.RE94)..BD8.#AC]" =0K*
MZ*Z,&5AD$'((JL-3L&%P5OK8BV_UY$J_NO\ >Y^7H>OI4&AV,NG:/!:S;!(N
MYBL9RJ;F+!%]ESM'L*Y^?1=5EMI[>U66WLXIX9X+>26-FW+(6<(V& 7[I4-G
MYAV% '3G4[ 0Q3&^MO*F_P!6_FKM?D#@YYY(''K4AN[81K(;B((T9E#;Q@H,
M9;/IR.?<5A:=HCQ:A8W;QR_NS<R2?:'1G620IR-@VC(5NGJ?6J,WAC4)+*_A
M5T7RGC2P 8?ZE9A,5Y!"Y&V/D$8C!/7% '66UU;WD"SVL\4\3=)(G#*?Q%*9
MX5W9E0;&"-EA\K'& ?<Y'YBL_0[)[2&YDE6Y6:YF\V3[0\;,3M5<_(-HX4=/
MZUG7^G:DUU>Q6]LDD-W?6UUYQD "+&8@RD=2<19&..>V.0#<&HV+7)MA>VYN
M "3$)5W #@G&<\56M==L;^W6>QGBN(C))$621>&3.1UYZ=NQ!Z50@T6>(VS>
M7&'359[QR#R4?S0#]<.HJ.VTF]'V9'A5!;WMW(6W@ATD\PJ1C_? (/O0!N65
MXEYIEO?8\M)H5FPQ^Z",\G\:SE\4Z5(EM-%=P-:S/)&;@RJ$0IUR??\ J*O:
M3;26>C6-K-CS(;>.-\'(R% /\JQ[#2+E)].-Q;HHLKFY?<6!W!]VUE_!L<X/
M6@#;EU&Q@2%Y;RWC6? A9Y5 DSTV\\_A5AF*HS!2Q S@=37%2^&K]5C1A-);
MO:26DD-O)$"JF1F_C4_*58 XP1M'![=B_F06C>2AFD2,[%9L;R!P">V?6@#+
M'B*%%O1=V=U:2VD:2O#*$9G5RP3;L9@265EQG.1[BI8=9::*X"Z;>"Z@90]H
M3%YF&&0P._81UYW=B.M9$&E:G=:3>_:K41ZI-)%<&6252DCQN'6,;<E4&T#\
M2>23F6>'7/\ B8:A:VB17ET(;>.,RJQBC3<2_P#=+9=L#IPN>XH NKXCADM;
M:2&SNY)YYI(%M@$$@>,L'!)8+QM/\7/;-7].OHM2L(KN%75),_*XPRD$@@XX
MX((XR*YZ[T26?2]-M_[,9K2V=VELVN0)'8YQ)Y@/)R6)Y&=Q.>,':T&TN+#1
M;>UN=OF1[@JJVX(FX[$S@9VKM7/?&: -&BBB@#!\7:W<Z%HJ364,4M[<7,5I
M;B8D1AY'"@MCG SGBL34I/'VD:7=:G)J.@W,=I"T[P"TD0NJC) ;><' ..*L
M?$=UBT73)Y&"0PZQ922.QP$42C))["KWB[4[!?!FMDWUMS83@?O5Y)0@#KZT
M ;.FWJZEI5G?HA1;F!)@IZ@,H./UJU65X71H_"6C(ZE66Q@!!'(/EK6K0 44
M44 <SXHUG5;75-(T711:)>ZD9F\^[5F2)(U!;Y5())W #FLN^U/QAX:-I>ZM
M=:1?6$EU%;S1V]N\4BB1@H926(."1P:L>))HK;XB^#YIY$BBV7R;W;"[BB8&
M3W.#4?Q#O;2?0;*WBNH9)I=4LUCC20%F/G*> .O - ';4444 %%%% '(:GJW
MB&_\5W&AZ!)I]JMG;1SW$]Y$TA8R%@JJJD8&%))-,L]6\2:5XITS2=>ETV[A
MU-9O)ELXGB:-XUW$,&8@@C]:;8W,%I\5M>6YGCA:73K1HQ(P7> T@)&>N"12
M:Y=6]U\1_!T=O/%*\?VQW6-PQ5?)QDXZ#/% ':T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7E'[0/_ "(=E_V$H_\ T7)7J]>4?M _\B'9?]A*/_T7)0!Z
M3HW_ " M/_Z]H_\ T$5>JCHW_("T_P#Z]H__ $$5>H *\<_:$_Y 6B?]?;?^
M@U['7CG[0G_("T3_ *^V_P#0: /8E^Z/I2TB_='TI: "BBB@ HHHH *P_&G_
M "(OB#_L&W'_ *+:MRL/QI_R(OB#_L&W'_HMJ .3^!O_ "36#_KYE_G7I%>;
M_ W_ ))K!_U\R_SKTB@ HHHH **** "J.L:E'I&D75_)@B%"54G&YNBKGW)
M_&KU13VT-SY?G)O$<@D4$G 8=#[XZ_6@#DM,\0S6VF7=LEY#JUY;7-O&LQD
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M+B21I"TC*$WEF))(4;1SP#CTK2H **** "BBB@ HHHH **** "BBB@ HHHH
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M*/\ \',7_P 37944 <;_ ,)%XW_Z$*/_ ,',7_Q-'_"1>-_^A"C_ /!S%_\
M$UV5% '&_P#"1>-_^A"C_P#!S%_\31_PD7C?_H0H_P#P<Q?_ !-=E10!QO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^>U=GAAC+6[ALAE<9S[\4 4[NYNKK4KZ)+VXL[6Q1-WV6%9)9789Z%6^4#'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\@+1/
M^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$OW1]*6D7[H^E+0 4444 %%%%
M!6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#;C_T6U ')_ W_DFL'_7S+_.O
M2*\W^!O_ "36#_KYE_G7I% !1110 4444 %9/B*.1]/ADCB>4074$TD<:EF*
M+(I. .21C=@<G''-:U% '(2:G<V8U*ZM;2[!U*\ MY&LY6\M5A16E= NX#*D
M $#<0.@.1=L+:""_T6WL!+Y-K82*3*A5@A*!0P(!!8J3R/X3714@50Y<*-Q
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M?]@VX_\ 1;4 <G\#?^2:P?\ 7S+_ #KTBO-_@;_R36#_ *^9?YUZ10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUO+I,<8#;O[0G:,R,!E4C !W,<-^7>M*VU<MX<M]6N[.X@:2W29[98VDD0L
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M.!TH ["BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5H)+DG1[>2WM][@[E?;G=QR?E'3% '05XY^T)_R M$_Z^V_]!KV.O'/VA/\
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M8!:F:/:;=1D1*1E=^[@9^8YQQFM:73A_PA\=E<37,@54.X6Y9R P8*T?)*\
M%3DD9S0!T%06EW%>PM+#G:LLD1R,?,CE&_537#_V=J5W=PM=6PLE:");4P63
M2>0RNV2F'_<DC:QR#P<$G;BB\TC4'D*7$3K:NUYY9%JT[12/<R,' 5@58J5*
MOSC!Y&>0#OG=41G<A549)/0"HXKA)C^[W,I19%<#Y6#9Q@]^GZCUKF(],267
M4K;4M/:ZOYC((;N6#>C1E,* W(0=BO'.3SG-4H].N/L< CT^=;!+6R6>U$90
MN$>;S5V\9Y*DC^(<<YY .YHKCK31OM6I1^9I[KI'VF5X;:5,(J>4@YC/0%PY
M"D>^!5TV=_\ \(2MHJ3&X0*K1A\.T2R#<@.>IC! .>XYH V[^^CT^U\^1'DR
MZ1JD8!9F9@J@9('4CJ<5'?ZI:Z:L!N?.W3OLC2*!Y69L%B,(">@/Y5R\NB17
MSS?9])V:;]ILVBMY8 @#+(3,X0_=!0H#P,[3]3J^)8)I+C2)8A>!(;EVD>S3
M<Z@Q.HXP>,D#IWH W8I%FB210P5U# .I4X/J#R#[&GUR.H:3->0ZW<I!<//)
MI:Q6CR<2!BD@./[K'*YQCMZ4FI:)%!<7D<-L\5D4MY(XXK4SQ/,#,&WQC[P(
M\O/3G:<Y&: .K6:)IW@5U,J*K,@/(!S@GZX/Y54EUFQAU 6+RL)BRH<1,45F
M&54N!M!(Z GN/45DZ)9^3KLEY/I*6=Q<Z=;;C'&"J.-^]-X&.,H/? ]*R-7M
M=635;R_M;2YFU 2%88!&/(,83"2@_=\Q<D_,<GE0,;2 #M9[N"VFMXIGV/<.
M8XL@X9L$XST!P#U]*6"[@N9)TA?>T#^7)@' ; .,]#P1TJIK%J;[0;F)5=I?
M*WPD##B11N1AZ,& /UKG)M(6V58[O3+F\A.GHMN$7>R7)9VD8G^!V+(=YQR#
MR.X!VE%<<(M5@B>RN(+F>[FOK&<S1KF,H@MQ*Q;H.8Y..ISTYIIT.]BM(Y;&
M%H-2EGO5DN"?FVN)C'N/]T-Y6!VXH [.J;ZI9QVEY=/-B"SW_:&VGY-HRW&.
M<#TKGM A@A\2F.UTV:Q5=.7S4<!<OOZD \G@_-_%CJ<5'>I<MH_BC35L;MI[
ML7+0$1$H^Z+ PW3DC% '27^K6FFO"EP9B\V[8D,$DK$+C)PBD@#(JS!/%=6\
M5Q!(LD,J!T=3D,I&01^%<_>17&M:MILULVH6,<*SK)+Y*HPR$P,.IX//(';K
M5C5K3[%H%MI]E9I+:H8X662$SB.(#KLSESPH_'/.* -RHI+F&*01O(HD9&=4
MSR57&2/ID?G7%6%A=VPTR5[*6:ZCN)$6">URD<)N&(=6Z1,J$'&>0 N.F-O5
M[".3Q%IUZUD)BMO/")1%O*.Q0IDXR!P_/09]Z -FUN8[RS@NHL^7-&LB9&#@
MC(_G4U<')H%]9:):0Z;:M%(VFQK=A1S(RO$6#<C<Q3S1U!.<9%;^@6+0Z9=H
MLC(D\C&-%M6MEA^11A$8D@9!/U)H NVVLV=Y<^3;&>7DJ)5MY/*)'7$FW:>A
M[]>.M:%<_I,UQ!H]OI!LY[6^@MA '\HF$,J8#!QQM.,@=?4"L%M*N); 16.G
M7=K)_9[17I(*-+,2F/FS\[##G>">O7F@#OJ*Y&3P^+>[NYK2Q$;)?VC6Q08"
M1[HO-V#^$$;]V.O.<UFZ;%<?9+>[TS3)GU"%KMYY)/E6X3$@2,O_ ! OY>!_
M"%/3N >@45PEGH]S-=F)K-AI[W%O(R+:FVC;"RA_W9)./N YZ\=13[RPO;&.
M*"T1XEO+J?3E16QY<,C;Q(O^X%? '3=Z"@#LX;F&XDG2)]S02>7(,$;6VAL?
MDP_.G/($>-=KG>VT%5R!P3SZ#C\\5S_B:P3['"]M9^?-$S/';?9?-BF?;@!Q
MV.  ')&WZ<59UZWN[E+#R(W)620R!#T!MY5'_CQ4?E0!M5!#=Q3W-S F=]NR
MJ^1QDJ&&/P-<C/H=Q;6:1V=G((Y+2W^V)&<-,5E0R \_,Y3S!D\G.,U3ETNX
M-Q<26FFO!I3WZNT$MH9%9/("AO)!!VA_X?7YL4 >@T5YW/8$3WED]M=WUR-'
M@6SD\L@Q2E[C;P23&1\OS$\!>3ZWX-+U Z]-)=LPN1.[I,EHQ\V+80%\W=M"
M\XVD#YAG'>@#M:@BNXIKN>V7/F0!2^1Q\PR/Y5QIT*[M=+M([2TE5I-.C%\J
M-AYF62(LK'/+E/-&2>_6H+C2YVNIY;'39(-+:[B9X9+0NKQB%QD0@J2H<J=O
MK\V#0!Z!4:3122R1HZL\9 =0>5)&1G\*XMO#\TMC?[XI;ETTL+9,\90I+OF8
M!%))5E!C .<@8YZUMZ58QVOB+5939".6Y$<@G6+ <;0&&X#KN!XZ]Z -VBN(
MO=%N5B%P+4,)-3F>Z$D!GWPYD\O*!@60$J=HZ$YQ5'6=->TT'4'O+:YOD&E,
MME+Y>PV[@RL>"<QD!H^<YPF.HP0#T)) [2 *XV-MRRX!X!R/4<_SI(YHIC((
MW5C&VQ\'[K8!P?P(KC]2L;E9[FY^QR74ZW3/:VTMN989@881SV0[E(#G[OS=
M>E0WND2PSW:6VGJD+:H)[D?8S(DT)A(4[01Y@$AR5!)!YQZ@'=45P[:!?-9W
M;0>;+<)IFVRDD0Q[)&>8[54ME"%95!)R!W'-)%I;+'#*UM)+IOVI6N;&.P:%
M0!$XW>42Q?YBA..,J#S@F@#LK2[BO8GDASM662(Y&/F1BI_4&IZX\6\UE\-M
M;3R)K5O*U"2*.0_,BLTK)]."/I4;64JRS7&FZ;=6UJGV1I82A5I'2;=(0/XF
M"=6&=W&"V* .MENXH;N"V;/F3[MF!Q\HR?YTQ[^%+U[3;(TJ)&Y"KGAV*@_F
MISZ#FN2GMI+O5Q>WVE7<U@;Z5_+>(M^[-O&JL8^I!93QC(/) Q2VFEZFB(6M
MYE&;38K-EDC6\=]A.>JQ%0?I0!VU%<_X;MTMU*W-C)'JH#"ZNGA/[X[NHDZ$
M'@@9X&!@8Q6+>VFLW6JSS6=J+6\8W47FQV^SY?+<0LTI/SY(C;@87H<$<@'=
M45R#VEF5L6BT2X33T<_;;8VIW,^WY6=?^6H!R"1NY(/.,B*>PD:XN/*TZ<7K
MW,#Z?<"(A8( (_ES_P LPN'RG&<G@YH [2HYIHK>%YIG6.)!N9F. !7(R1:@
M\4%DMI=^9#=7LDDA4A-KK/Y>&_BSO7IT[X-17OATC2;JWAT[>LNE+YB;0WF3
MJ<@G/5^3SU/K0!V]-D=(HVDD8*B@LS$\ #O7&W$%U/KMK+;:;Y$<%S (72S*
MM]GVKN)D)&T<LOEXR,=.]);^'773+.+[#^]FTR:*[W@'?(0A0/GJ00<9Z<XQ
M0!V:.LB*Z$,K $$=Q5>2^1-2AL1'(\LB-(2H&U%&!ELGN3@8S7,Z?:+;ZGI,
MUIISY\E(I8Y[,H+90K99'(&PY."O.[(/'6K.N:/-<:E>7=E:J+MM->**=0%?
MS"> 'Z@XR >U '3U!=WD5E")95F92=H$,+RMG_=4$UR$ND_:Y9$T_39[737>
MT$L!C,0=EFRYV_[G#'^(=SBNAUFZN-,TM$TVS>21F6&/RXBRP#'WRHY( '0=
M3@<#D "OXATQ+6WN!/))'<*S1B*!W8JOWB552P ) .0,$X/-/EUS3X)8$>63
M;/L$<RPN8CO.%_> ;1DD 9/<>HK&MH?[(FL;NVL;ZXMA9R0$>7^^\PN&RRG'
MWSN)/3.,X!JO;PW<4&C:)>V=T+6Q@MVF>*(NLTR %5##HBL 2>Y '3.0#HX=
M9L[B_DLH?M#RQN8W86TGEA@,D>9MV_K5^N:%L\/B&,Z;#J$1>Y:2],C-]G9"
MIR0&.,EMN-O/KQFNAAE\Z%)-CQ[AG:XPP^HH DHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAK74O%WB2[U*?2+S2
MK"QM+V6SC2XMGED<QG:S$A@!DYP/2NYKB/ =_9VUMKUO/=013)K=X6CDD"L,
MR9'!]10!?\-:QJ\FN:IH6N&TENK*.*9+BU1D61)-W!4DX(*GOSFNHKC-#N(;
MOXG^));:5)HTLK.-GC8, V9#C([X-=G0 4444 0WERMG93W3@LL,;2$#J0!G
M^E<5I,_CO7M(M-7AU/1+.&]B6>.W-G)(8T894%MXR<$9XKK=:1I-"U!$4LS6
MT@  Y)VFL+P+JNG?\(#H ^WVV4L(48&5<A@@!!YZ@@B@"WX0UN\UK3+K^T(X
M4OK&\ELIS!GRW>,XW*#R 01P:Z"N.^'DB3VOB&XB8/#-KMV\<BG*NN0,@]QP
M>:[&@ HHHH Q/%NMR^'?#%YJD$*S31;$B1SA2[NJ+GVRP)K&N+?X@VUK+<_V
MQH,C1H7\K[#( V!G;NWY'UJ7XG\?#_4&/W4EMW8^BB>,D_@!FMG4M9TM=(NY
M3J-IY?D.V[SEQC:?>@"3P]JPU[P[IVK"+ROM=NDQCSG:2,D9[UI5S7P]1D^'
MGA]74J?L,1P1_LUTM !7CG[0G_("T3_K[;_T&O8Z\<_:$_Y 6B?]?;?^@T >
MQ+]T?2EI%^Z/I2T %%%% !1110 5A^-/^1%\0?\ 8-N/_1;5N5A^-/\ D1?$
M'_8-N/\ T6U ')_ W_DFL'_7S+_.O2*\W^!O_)-8/^OF7^=>D4 %%%% !111
M0 4444 %%%% !1110!%#;06WF>1#'%YKF238H&]CU8^I]ZEHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ I" RD$ @\$'O2T4 5K/3K+3U=;
M*T@MPY!811A<XZ9Q5FBB@ HHHH **** "BBB@ HHHH *9%%'!&(XHUC09PJC
M &>:?10 5$UM ]Q'</#&T\8(20J"R@]<'M4M% !1110 4444 ,$4:S-,(U$K
MJ%9P.2!D@$^@W'\S3Z** "BBB@ HHHH *JW&FV-W/'/<V=O-+'C8\D88K@Y&
M"??FK5% !1110 4444 ,EBCGA>&:-9(I%*NCC(8'@@CN*?110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C:CX2\.ZM=M=ZAHEA
M<W# !I9;=68XZ9..:V:* *>F:1IVC6QMM,L;>SA+;BD$80$^IQU-7*** "BB
MB@ KGY_ WA2ZG>>;P[ICRR,6=C;+EB>I/%=!10!#:VEM8VL=K:016]O&-J11
M(%51Z #@5-110 4444 ,EBCGA>*:-9(G4JZ.,A@>H(/45@+X!\(JX<>&M*W
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\\JVFGO9H(]H=P0F""> V8QC/&3S1H5GJ"ZG?ZA?^<#/%#"BS",-A"YSA"0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7E?:[=)C'G.TD9(S6G0 5XY^T)_R M$_Z^V_]!KV.O'/VA/^0%HG_7VW_H-
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MVK2?:KJ._6"]W1(DY9N&\O83\@Q\A4KSCWS7H-% '&ZSI;(+ZW'V^2RC^PW
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MIEC;V<);<8X(P@)]2!WJY0 4444 4=91I-"U!$4LS6T@  Y)VFL'P+JVF_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI \4,L#%410Z2%2PP!@<HN,>G>A/#]LEK-;B67;++#*3D9!B$87MT/EC/U-
M$</B.*>]MH%L;L0W5Q);PW)">6SHKEN-VX#]VV#CG'TJ34->CL9[B,6=S<"U
MB$UR\(7$2'..K DX4G !.![@'.@T:Y&NV9C%W%8V=U-<*DSQ&,ETD7"!?GZR
M$_-C X],:.H:$M]/<2)>7%LMU"(;E(MN)%&<<D$J<,1D=OH" ":PU9-1O+J&
M"WF\JV8(UPVW8[;5;"\Y/# YQBJ5YXIL["\N;:XBD5H();CY7C8NL8W'"AMP
M)'3('X5IV5A#8?:/)SMFE\PJ>BG:JX'MA16,WA"V=)HVO+CR9!< ( @V^=G>
M2=N2?F."?UH M)XBB^TBWN+*ZMI"T0_>!" )2P1CM8X!9"N.N2.,'-7(-2CN
M=.DO88Y&C4R!02H+[&(R"3C!QD$D<$=*H:[I#W5K?-:K(UW=V\=NC!E A9&9
MDEY_NL^>,G@8%6KC1+:?04TA2\=O&D:(5P2 A!7((((^49!X(R* *5OXKMKP
M*EK:SW%R9GB,,3QMC:JLS;M^W&'3OU8#UQ5TWQ/NLQ+="YEF<#9 L:@L7GD1
M%'(^;Y0#G  &<]:N1^&A%*US'J%RMXTS3&?:G\4:(5V[<;<1J?7('-4[;POL
MN9H#)<I!%%"(+IG0R-*LLDA8<8X+@<@9YXQS0!J6VO0SW:6DEO/!=&8PM%)M
M.PA/,R2"005Z$9].,&HD\2P37 BAL[I\1O*[@(%15=D).6]4. /7ZX3_ (1T
M;Q<"_N!?>?YYN=J9)V>7MVXQMV]O7G/7,ECX>M[&-U6>>0O T+-(02079R>!
MURYH KCQ7 +4W$NGWL0:&.>)&5"TJ.P48 8X(++D'!Y%/B\2*]TT$NFWD/EW
M"6TKOY96.1P"HX8YR&3D9QN&>^)9?#UM,ENC2S 00I"N".0KHX)XZY0?F:FD
MT:"1[AC))F>\BNVP1PR", #CI^['YF@#+3QMITD32K#<,AB\^'848S)O5<@!
MLCET.&P<'Z@2W7B2:)56/2KDSK=QV\L3-'E0X!# [\'(/KU!S3K;PO;VUB;%
M;F0VJA%B3RT#(JL& W!<G&T#GMUR>:M7>AQW+SRK<2Q32S13!U .UH\8P".A
MQS]: %U34Y["^TNWBLY)UO+@PNZLHV 1N^>6']WWX![X!R].\4A-,2?5(9XE
M$4TOVEE7:XC)W8 .>G3(&<'VSMWU@+U[203/%):S^<C* <G8R$$$="KM5*;P
MU97&GQ6,S2M!''+%C(!99 0V3CWXQ0!77Q=;.1$ME=/=&1(Q;HT3L=ZNRG(<
MJ!^[<=>"/3FD/C/34DE\Q94B3S<2Y1MYCSN 4,6S\K8R!G!QVS<M]#6(V[2W
M3S/;S"9&\N-,D(R8.U1GAR?KZ5 GA>U6.[MS,[6ER)<P[$!3S"2V' W<$G'/
M&?84 5M7\17,5A/%%I]Y;7P\G"$PE@DC[-ZG<5)!R,'H2.,<UT<(801ARY;:
M,[\;LX[XXS].*R?^$>68RR7E]<7,SB)1(P1=JQOO  4 <D<GO[8%:J(ZR2LT
MK.'8%5(&$& ,# ]03SGKZ8H DHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KQS]H3_ ) 6B?\ 7VW_ *#7L=>.
M?M"?\@+1/^OMO_0: /8E^Z/I2TB_='TI: "BBB@ HHHH *P_&G_(B^(/^P;<
M?^BVK<K#\:?\B+X@_P"P;<?^BVH Y/X&_P#)-8/^OF7^=>D5YO\  W_DFL'_
M %\R_P Z](H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_9GE[3N_X\\9QZ>?6W<>&K.TGU#0K^[:PM(_"]I#+=*NX(PF8DD=P6ZCT)H
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M"K"24)%RQQR<YP365X2DM8_&6OQ2W>FI<OJU\8[>2Q)N6&#RLV>%Z\8['UH
M]2M=2L;XL+2]MK@KR1#*KX_(U+<75O9PF:YGB@B!P7E<*H_$UXCX833[O3?
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MV0?FYH ]1NKVUL8Q)=W,-O&3M#2R! 3Z9-10:KIUR5%OJ%K*6;8OES*V6QG
MP>N.:I^*;.VO?#&I)<VT4X2VE=!(@;:P1L$9Z'WKSH:;+%H7PV&DQVUE>2E'
M:9K;<-_V8Y9U!4L>O>@#U.74K&!9&FO;:-8V".7E4!6(R <G@X[5+;W5O>0B
M:VGBGB/ >)PRG\17B&LPWD-IK?\ :5Q;/,OBBS:6X-J?)P(URQCW$E0.HSS@
M\UZSX2EMI?#L#6MQ97";G!ELK;R(F.X]$R<>_/)H THM1L9[B2WAO+>2>,D/
M&DJEEQUR <BHH]:TJ99&BU.R<1KO<K.IVKZGG@<UYCX;\*7.J>(=1U5C9V\%
MAXAO9A(D)^TRG)&POG'E\YQSFN=T9[=OA%JUNEUITEX-+;=;P6)CN$'F#.^3
M)W]NP[4 >ZQ:C93VSW,-Y;R0)]^5)5*K]2#@4D>IV$UDUY%?6SVJYW3K*I08
M]6SBO'X]#M!!XOT[7KJVTB:6*RD\^TMMEJ8@04;R^<_/\KY/Y5(=0;5-&T>[
MU+3;7^P;#6G6\DL;9EM[E!'B.<IC.P,<'J.* /7$U/3Y+(WJ7ULUH.LZRJ4'
M;[V<5+]I@\T1^?'YC)Y@7>,E?[V/3WKQ;Q#'9ZA9^,+O0(!_8$]O91N88RD4
MUP)UW%!@ X7 )'>K,=BZ>*M1\-ZQ-/!:6'AZZMDO@"2UJSH4;W*KE2.^SWH
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M Y9#O&TDDGOCCTJW8^&=8T/5;Q]&U6U73+V[-W+:W5JSM$S'+^6ZN.#Z$'%
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M48F;[2C.=D2 ?(^['(?C'_ NZD4R+0]1-O96-U?PRV%F\;J5B(EE\L@QASG
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M=ED4L1<XA6X)F;RF89*XX!V_J*EB\/WIC>SGOH3I[7DET8XX2)'W3&4(6+8
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M[XQ\JCD__7JXM[IEMXN;3A8I%>S6ZS?:A&H\PL7&PMU+8C8_0'TH Y2TLP/
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MK>&F6 LC9BQMA:MR8/*78?\ @.,4^*SM;>W2WAMH8X(SE(TC 53G.0!P.>:
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MI2T %%%% !1110 5A^-/^1%\0?\ 8-N/_1;5N5A^-/\ D1?$'_8-N/\ T6U
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ME%R=B3;"-V<*V,]>E07&@2ZK;6UG=106-E OF)#9R$[9P3L8':O"<,..6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7CG[0G_ " M$_Z^V_\ 0:]CKQS]
MH3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0 4444 %%%% !6'XT_P"1%\0?]@VX
M_P#1;5N5A^-/^1%\0?\ 8-N/_1;4 <G\#?\ DFL'_7S+_.O2*\W^!O\ R36#
M_KYE_G7I% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7CG[0G_("T3_K[;_T&O8Z\<_:$_Y
M6B?]?;?^@T >Q+]T?2EI%^Z/I2T %%%% !1110 5A^-/^1%\0?\ 8-N/_1;5
MN5A^-/\ D1?$'_8-N/\ T6U ')_ W_DFL'_7S+_.O2*\W^!O_)-8/^OF7^=>
MD4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %>.?M"?\ ("T3_K[;_P!!KV.O'/VA/^0%HG_7
MVW_H- 'L2_='TI:1?NCZ4M !1110 4444 %8?C3_ )$7Q!_V#;C_ -%M6Y6'
MXT_Y$7Q!_P!@VX_]%M0!R?P-_P"2:P?]?,O\Z](KS?X&_P#)-8/^OF7^=>D4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5XY^T)_P @+1/^OMO_ $&O8Z\<_:$_Y 6B?]?;?^@T >Q+
M]T?2EI%^Z/I2T %%%% !1110 5A^-/\ D1?$'_8-N/\ T6U;E8?C3_D1?$'_
M &#;C_T6U ')_ W_ ))K!_U\R_SKTBO-_@;_ ,DU@_Z^9?YUZ10 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5XY^T)_R M$_Z^V_]!KV.O'/VA/^0%HG_7VW_H- 'L2_='TI
M:1?NCZ4M !1110 4444 %8?C3_D1?$'_ &#;C_T6U;E8?C3_ )$7Q!_V#;C_
M -%M0!R?P-_Y)K!_U\R_SKTBO-_@;_R36#_KYE_G7I% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7CG[0G_ " M$_Z^V_\ 0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H
M^E+0 4444 %%%% !6'XT_P"1%\0?]@VX_P#1;5N5A^-/^1%\0?\ 8-N/_1;4
M <G\#?\ DFL'_7S+_.O2*\W^!O\ R36#_KYE_G7I% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7CG[0G_("T3_K[;_T&O8Z\<_:$_Y 6B?]?;?^@T >Q+]T?2EI%^Z/I2T
M%%%% !1110 5A^-/^1%\0?\ 8-N/_1;5N5A^-/\ D1?$'_8-N/\ T6U ')_
MW_DFL'_7S+_.O2*\W^!O_)-8/^OF7^=>D4 %9GB.ZFLO"^K7=NYCG@LII(W
M!*LJ$@\^XK3J"\M(;^QN+.X4M!<1M%(H.,JPP1D>QH Y-]3O;"Y@N;B>^.EI
M<%@UU&$E<+;3NXV@#*@JA&X9SGL!5VV\6F:WG:6"VAD1(W0M<,8V+DC86\O.
M\8Z '.1@^F[=V-M?&'[3&)!$S,H/3)1D.1W^5V'XU2'AZT%LD'GWA6)U>%FN
M&+1%00-I/L2.<Y!YS0!1LO%+WDED#:1P)<.\;232LJ[TD:,HA*<M\N0&VD@C
MWP_0O%*ZY<QHENJQ3VYN(720L0H*X#@J K$," ">C>G-M?#EBD4,(:X\B*7S
M_*,[%7D\PR;FR<D[SFK&GZ5;Z9E;9YQ"!M2%I2R1C/10>@]/0<# H R[C7W$
MM[!+ L7V>5%5!.5F=3(JA]NW&PYZ@GT.#G"IXCNFN+9AI\?V*YNIK:.7[1\X
M,:R'<4VXP3$0/F)Y'T%Z;0;.YNVN;@SS.1A0\I(C!=7(4=LLB_ECI60NCI+X
MJ12BPQVCO>A$N9'#^:LB9V$!4)+.3@GGZF@"_H^MW.H26JW5BEL+NT%W#LG\
MP[?ER&^48(WKTR.OIS7'BGS=7:R@M4D07#6P;S6W[U4\E=I 3<-N<Y[XK8M]
M-M;9[9HD(-M ;>+YB<)\O'O]Q>?:JEUIUE8K>Z@9KJ&(H\TZ13,%)V89@HZ'
M [=^>O- %&#Q6+K39+R*"&(+-]G5;B<J7E /F( JL25((X!S@GI@F73O$-QJ
MYA%E8QY\A)K@S3E!'N9AM7Y"6/R-U"]O4X+G1]'M(8+E4EME$D"1FW=EVL<0
MIP/4.%)] /08M0>';&U>!K4SP-$@CS',WSH&+!6R?F +-UYY//)H PEUW54B
M@O+J!&:*6^!@MY21(L3, /NCD!>..>O&>.DLM3COGNVC"_9[=P@FW</\@8D>
MPW8SZ@^E1+H\%JS3VL9DF5Y98DEF(0/(26YP< DD]#C-5]+T^ST?2;+P]( _
MF02;E .U^GF?09?CVH H+XOD=;G99PRF$0N)8IG:+RY"PWEO+S@;.H!'(Y R
M1M3:H(+.QNBD<D5Q)'&\D4FY$W\*RG'S L5&>.&S[5!#X=M;?>T5Q>K*Z)$9
M?M#%MB;MJY/8;C^?K4=_I*7/AR;0K&(10B,6NZ1F7RTVCYT."689!!SU'7(H
M K)XGN;F&::RTU)8H(/M+E[C86C+/L*?*<EE3=@X W 9ZD6U\0QR6TT\<!:-
M+R"U4[L;A+Y6&Z<8\WI[>]27/A[3[D %98D\A;=TAE9!)$,X1@#R!D^_)]:6
M7P_82W9N"LHS-'.8UE81F1-H5MH.,@*H]..E "Z3J5QJ.GO>2VJ01DMY2B7>
MS!21D\#&2..O'Y5GVGB::2UBGO+2VLUN+'[; 7NLKCY?E<[/E/SITW=3Z<[E
MM9PVEHMM"I6)<@#.>IR?YU2F\/Z=/;6\#1.$MH1#"5D(**&1@0<]0T:'/M0!
MG6WB>YO'2WM]/B:Y-P\#;YV2,;8UDW9,>[!#@?=Z^W-1#QA)%817EWIZPQW-
MK]HMPL^XGYXT"O\ *-N3*G(SQGTK9M=#LK.?ST$K3>:TIDDD9BSLBH2<_P"R
MH&.@Q37\/Z;):PVSP,8H;=K:,;V!5"4/!!SG,:D'J,4 9=MX@FU2]@M5A,;1
MO)))Y+EEF5%0@(Q"GEI%SP/NL.AI\&MSW=M9:@1'$1=+;SVT<K,5$F!M<,JE
M7#%3@CH#ZU:N[6VL_L DNKDS&X812.Q=C^[8LN>PV*WX@&BPTFSF%KJ$,LTJ
M2LMT6F8LTC%-J$D] %)XQUP>HY $UWQ"NBLOR0S87S)8_-82*F<;@H0\=>25
M'&,U''X@N6G5I+!$LC?/9>:)\ON#%0VW;C:2,=<C/2I=;TS2FBNM0U&26*'R
M EP4E90Z*25!"]<%CC')SCFLV.VTO2LWUY<22AGN=3C$;LT6W);?MZ9"./;/
M/7F@!5\8RPZ9;7]]IJPQ7EG]JMPEQO)/R81_E&TGS%Y&>_XS)XI9[25C#:K<
M),(E4SOLE!7=E"(]S$="-O&#3--\.:;8VMAH]Z9;BY.G&$ RN45%\L2;.?ER
MQ0COP,8Q6HVA6[K$7N+QI8F8I,;AMX#  KGT( X_'KS0!D/XJNKJQ::RLDC1
MK""Y$LLO*/-N"#;MYP1SDCBKGVVXFNKO1486\D,.()Y9F\V0A5(D"[<,H8X)
MW'D8(YJ6RTK29=/N;2UC<0>4-/<%CD+'N4 $^FX\U'%ID&L6,&H"\N'DGMP8
MY22 @=0&94SA6(^N,_7(!'>ZK<W&BZ)?V<9$EY- WE&3:"'4G#'!XYYX/3I4
M,_BYX#';M:0+>EI@Z/<$1CRV4<,$)).Y<?*.^>G.^]A;/';1F,!+9E>)5. I
M48'Z&JLN@V4DHF0S0SAW<2PRE6^?&X?0[5X]A0!E2>+W6":Y&GA+9&@C1II2
MC-)*L; %=IV@!_F/)&. :EM/$MUJ$B6UG81/=8D:3S)V2(*I4 JVPEL[QCY1
MT;/3G3FT:RGAN(G1\7$B3.PD8,'0*%8'.01L7\J9+H=O,L):>[\Z(,JSK.PD
MVL064D=C@<=L#&* ,O\ X2R:6"6Z@TX&VM[6.ZG:2?:ZABP954*02NQNX!XY
MKI)D:2&1$D,;,I <=5..M9L.CZ4]K<VL$:^2\*V<J(YX5 <+UX(#'WYJ^@6&
MX9 9F:8F3+;F5<;1@'HO; [\GUH Y2#7K^>?2)C*$A@2./4XPH^:65C$!GMM
MD0Y]C3;;6M5^T/>1QBZADLGO%CDF\M5B\QBF,*?F*;>OOS6^?#VFFSU&U\AA
M%J$C2W #L"6;J0<Y7IGC&#SUJQ_95GR!%@&W^RX!( C]/UH QE\71R:J+6&W
M#PB:*!FWGS-SJK A I!4;UR2P_B...;&D:]<ZC)8_:+%+>.^M6N82L^\@*4R
M&&T8^^",$]^E,V:787^^U>Z\XW"6SV\#MM>41!AN!.,B, D]P!U(Q6I;Z7:6
MOV/R8R/L<)@A^8G:AVY'O]Q?RH R=1U]X'U>"2!8UM+=Y4_?E)9E" ED&W&W
M)QD$X(Y%/;Q!=?:5:.PC:Q:^^Q>:;C#[@Q4MLVXQN!'WL]ZN7>@V=_-))=F>
M8/&\81I3M0.-K;1V)']<=:H3^'GN-;BN!''#;1W0NB5NI&WN!U\K 523U.3T
M/&3F@"LWBBX?1VNKC3_)BGTV:\A\JYR^$"D@_*-I.X$$9Z5>_MZY^W.AL4%F
MEZ+,R^?\Y8@88)MQC) ^]GK^-M]!T^2RBM&A8PQ6KVBKO/$;@!AGZ*.:F.EV
MA# QGYK@7)^8_P"L&,']!Q0!F:;X@NK^XT[?81Q6FHP-/;RK<;F"@*1N7:,$
MA@>"<<U)?>(5LM8AL@D,J/+'$Y25C)&S_=RH7:.HZL#@Y^L&G>'GMM:BO&CC
M@@MHY(X(DNI)1ARO0, $ "_=&>HY 4"K%SI6F-?SSNT[3"2.[D@BE8_.,*C[
M![1X]#M]: )M#U9]6M7EEAB@D0@/ )"TD1QG;("J[6]N?8XK%O?%MR;/4A8P
MVCRPVCW$$R3LT;*IP3DQ@$\@\9!]1WZ&RTN"QDFD5II99PHDDFD+L0N=HY[#
M)_,U3B\+Z9%;O!MG>-K4V8#SL=D)Q\B\\8P.>OO0!4FUW4K/4KZ.YM+=HHXK
M40I'.23--(T8!)0?+NQD]@,X.<!TOB&^BNTT\Z;"=0>=8@@N3Y6UHY'#[]F?
M^63 C;5^;0;.X=VG,\C20I"Y,I&[8Q9&XZ,"20PP?R%.@T.S@F2?$LLZS>?Y
MLLA9BVQHQD^@5B,=.<]: *"^(YEG#S621V1NYK7SA.2^8PYW;=O0[".N<]JJ
MV7C+[5Y3O9*L,HB;?'*6\M78+\^5 # LN0"1@DYXYW1I5F%1?*RJ7#W(!8_?
M;=N/_C[<>]9M]HD=KX=O;*UG9()+<PYNKABEO'@@E>OW1R/H.10!J:;??VC9
M_:5CV1M(ZQ\YWJ&(#?0@9'L16%;>+GO9I$M;%9@5E,(68[F*'H^5PFX XY/;
M.,UM:;IRZ>'6*=VM]L:01?PQ1J@4 ?4Y.?<>E0CP_9".XA#7'V:?<'M_.;RQ
MN.6P,\ G/'N0,9H R3XTCFM[2:TMXV2\666W:>8QAXD*@L<*Q!+-P,=.21TJ
M[9Z_/J*RSVMB!:P(AE:>4I(&:)9-H3:>BNN<D<Y]*L/X?L6E\V+SK>4.[J\$
MI0KO W@=L-M!(Z9&>O-1V]M83PQZU;-=>7<PI*RHS$3+M 4LG.6VX'J<#.<"
M@"GJWB*ZAT62>RMX_M#:8]\ADDP$P%X^Z<_>_'':IKCQ!=6XO9381-;Z>46\
M<7!W*2BNVP;/F"JZG)*YYXJ:/POIL<,L)$\B26K6>))V;;"?X!SQ]>OO3Y/#
MUC+(7D:X??L,RF9@LY7&TN!P3P ?4  Y Q0!+I.HW&I?:I'M4A@CN)((F\W<
MTGER,A)&!M&5XY/^-74_$*Z=J<%J$AE5Y(HY LK>9&9'"*2H0@#)!Y89YQTY
MF6W@LM6LX8IY8TD%S(+<9*R.[J[,3GL2V!_M'TIUQH-C<WC7,GG9>6.=T65@
MC21E2C%0>2-J^W ]* ,.Z\1WK?V?J M!'8O]HF3;<$M*B1.5#KM^7. 1RV,5
M9D\2:A ;@S:5"J6UM'=S$79)$3E@ !LY<;'R.G3GGBZ?"^F,^669D D"1F9M
MD8D!#A1GC.3].V*MS:19SK<K)&2+BW6VD^8\QKNP/;[[<^] &8FMW37HLK*R
M6:61[H[I[DJJB)T7J%)Y+C QQBJY\4GR4O(;1C'-;VTS--,1'"DBR-N;:K;0
M-H!.,<C. ,UM1Z?9VE]%.D4GG,9@&&X@>80[Y[#)0=?H.M1+H%G%;K#;M<6X
M6&* -%,RG9&&"KGZ,?\ (H S9?$&HVUU?LUI;3P1"U$"Q7!RS2N%Z[,8YSGV
M]^)[CQ%):ZE;V4D-J\DCI%*(;AV,4C#(!_=X SCJ0<'..U6'T+3;:/S%BF$4
M4,2^3&S$$0L&CPHY)!'U/3FGOH-C+?&[83;FF6X*"5@GFJ  VW/7"@>G'K0!
MFZ=KNJW,-O UE:R7TS7#@?:&6-8XY G)V9SE@,8Z G/:K6EZ_-JM^D$-B$A6
MV2:>22;YD9FD38% ^8AHCDY P:8^EZ='J,-E$;U;@^;.LD,I'DJ[9<9S]UF_
MAYY'; Q)<Z;9:=% MM))9^8]M;!HR265'+!,Y[[F!/4AC0!:U#49[>]MK&SM
MHY[F=)) )93&BHFT,20K'.748QW]JIZ9K\^J:@MM%8JB)%ON'>;F-M\D910%
M^;#1'G(XY]C::WL]=M+._C>9,IYD$T3F-PK@9'T(QD'T'<"IK'2K/3FW6L10
M^4L)RQ.54LPSGJ<NQ)ZG/- &??:_-:R:A)'9))9Z<RK=2M-M<?(KML7:0V%9
M3R1GD5G2:MK,EY$ODP;EU=K>-$N" Z>0[8<[.@.&Z'I["MNZT&QN[F2>42CS
M2IFC65E28KTW*#@] /<  Y Q4BZ/:+>M= 2%S/\ : I<[5DV%"0/=2<_G0!B
M7'C%H41!9Q?:@LQEC:<A1Y<AC(5@AW%B#C(''7%:NEZM-J=[>(MH(K6W94$K
MR'>[-&DGW,< !\=<Y'2E?0+)G62,SP2JTA\R&9E8^8V]P?4%N?;MBK<<5K93
MR$,$DO9MQ#-S(XC XS_LQ]!Z$T <W;:E<V^IW<]^K!&U(PIY=T[*B);L_P!P
MJ!CC/'4G)Z#*/XAU".^L[RYLA#;OILMPL*7&[=F2 #=\HPP#'U'S'!KH3I-F
M91(8LL+@W/+'&\H8R<?[I(Q5)/"VEHK*RSR+]F:T57G<A(F*G:O/'W1@]>.M
M !>:Z\&I'3X+42W+2)'%OEVJQ9'<EC@X 6-NQR<5%-K4EG+=K,D$=P@A&R2Y
M;RV9@W"80DG"GHO/MBK'_"-V!#LS7+3O(DOV@SMY@=00&!SQP2..""0>IITG
MA^SE=)6>X^T(RLLXE(<%590<_P"Z[#\: ,V+Q5=74!DM-*$ICM'N95,Y4Y5G
M0HHV9))0XSCWQTK9T_4X]2EN?LX#6\)15F#9$A*!S@>@#+SZY]*ABTVRT2UF
MN+9%0QPM\T\S!=H9G^9CG RS$GFH-"T$Z/;VD:7!$<,+JT"9V%W<,S<]<8PN
M>@SZT 1W7B"YM[F^Q8(UG8SQPS3&?#'>J,2J[><;QG)'3CTK+7Q8^GPS0F+[
M5-')=3.))2K%!<2JBIA3N;"$ ' X'/-;"^'(9=4O[NY>1EN+F.81)*P1@B(%
MW+T.&0GWXSGI4[:!9"02Q&>"0&0EX9F4L'<NP/J-Q)'IDXQF@"E<>*/)U5+2
M&W2Z60LB""1C('6)I-K KM4G:1C=GD<=<5W\7[8;4"*S-S<>8VS[2X2,)LW!
MCY>X/EU&TK[^U6H-,TNY@@U>'[68I";R%4D?"M*A!=4'0D.WTR<8J<>&[)6\
MU9+I;HNTAN1.PD)*JI!/IA$&,8^4'J,T .EUIO[(T^\M[5FFOS&L,$S>7M+C
M=\YP<8 .>#TQ69)XFGB>9KC3RLUIYXDCBN-RLL:QL2/E&?E?(&.WOQM:G8_:
MM-\A(A,Z%&C\R=HR"I&&WJ"P/OW[]:IZ-X?CL5::Y >Y>660XD9PN_:",MRW
M"+R>^>!TH JWOBQ;>\-K!!$Y+R+')+,41PBH7((5C]Z0+T[-Z<OUG4;JY\*V
MMY8Q-&UW):ADDE:%T221 1E02#\V..F21TJW'X;T^"SM+>V$UN+0,(9(IF#J
M&.6!.>03R<YY /4"K\]G#<VR6\P9XT>-QECG*,&4D]3RH^M &>NL^5"X-N<P
MWL=ECS2V=VP;LD9.-_?KBJ/A>\N;FX83SR2#^SK:3#L3\S23@GZD*OY"KD6E
MZ9J-W+>(9R4N][IYK!/.C(7=MSC^$#T.*O66EVFGL6MHRI,*0\L3\B%BHY]W
M;\Z ,:VU?49)U2YMX?,;49;: 1W!"G;%(PW_ "=/E]^N>V#GP^);RWLM-U+4
M%3=-IH<Q1R'8\CR1*A/R\<OSP< GK72IH]I'>?:0)-_GFY52YVK(49"0/<,>
M/QJJV@:3%!#:2[]K*;>!7F(8#(<*ASG*^6",<C;0!-I&L#4K6YEEC2$V\AC=
ME<M&PVAMRL0N1AL'@8(/IFLE?%\CI<;;.&0PB%S+',[0B.0N-Y;R\X&P\A2.
M0<@9QLV,5I>Z,R"2:YMKA65C<,2S _*1["HHO#UK"9'CN+U9I$2-IOM#%]J;
MMJY/8;V_//7F@!=1U9[+28+V.&*82%=SK*3%&I&=Y<*3M]]O<$X&2(CKX6VN
MY?)1_L\D"9CEW*_F!#D''0;_ ,<=LU:CT^W_ +.CTZV-S:P6NV)/+9D. HP
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M4\L+@R; >25D"CC)#=.M6HO#>G(FTB>4",11^;,S&- P;:N3P,JN>YVC/04
M00Z_=S7,:_V?$L$UW/9Q.;@[B\?F<D;>%/E'N2,C@U;\.WEWJ&@VEW?)$L\L
M88^4Q8'/?H,?2K":7:1^3MC(\FXDN4^8\2/OW'_R(W'O3["QATZU%M 7\I22
MBNQ;:/09["@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<'+#(;CDXJ.SL)9+RSCELKC[=]IF_M&>1&\N6$AQC<>'4DIM49VXZ#!KLJ*
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M_@6G^-'_  DN@_\ 0;TW_P "T_QH U*IQ?\ (:NO^O>'_P!"DJO_ ,)+H/\
MT&]-_P# M/\ &J2>)M!36+EFUO354V\0!-W& 2&DSW]Q^= '0T5D?\)5X=_Z
M#^E_^!D?^-'_  E7AW_H/Z7_ .!D?^- &O161_PE7AW_ *#^E_\ @9'_ (T?
M\)5X=_Z#^E_^!D?^- &O161_PE7AW_H/Z7_X&1_XT?\ "5>'?^@_I?\ X&1_
MXT :]4-%_P"05%]7_P#0C5?_ (2KP[_T']+_ / R/_&IM!D2;1;>6)U>-]S*
MRG(8%C@@]Z -&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK_\ "2Z#_P!!O3?_  +3_&J>J^(]#?1[U5UK3F8V\@ %TA).T^] '045D?\
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M[X_^O1_PK3P7_P!"Y8_]\?\ UZZJB@#E?^%:>"_^A<L?^^/_ *]'_"M/!?\
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MM#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\
MBZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?]
M BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX
M?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]D
MHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_
M[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] B
MP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \
M;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_
M^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z
M@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#
MXX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_
MM#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\
MBZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?]
M BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX
M?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]D
MHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_
M[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] B
MP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \
M;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_
M^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z
M@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#
MXX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_
MM#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\
MBZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?]
M BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX
M?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]D
MHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_
M[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] B
MP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \
M;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_
M^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z
M@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#
MXX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_
MM#XX?] BP_[Z@_\ BZ]DHH \;_M#XX?] BP_[Z@_^+H_M#XX?] BP_[Z@_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
H% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>bcrx-20250424_g6.jpg
<TEXT>
begin 644 bcrx-20250424_g6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#EVGB*6_O]0FC2YT^1HG^1L[V 50R[!\V<XXP>M=[H]O)::)86TP EAMHXW
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M!*H&2.%H V]7U^31TEN)=(O9+*"/S)[F-HMJ+C+':7W':.3@?3-5_P"WK_\
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M_3[T;(]1NKDJ5(/[N08!_+/% &>'U?1[?1M4N]6GNFO+B&&]MW5!$/.(4>6
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MH **** "BBB@ HHHH **** "BBB@"*VMH+.W2WMHEBA085%& *EHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J*6U@GF@EEB5Y(&+Q,1RC%2I(_!B/QJ6B@
M HHHH *JW>G6=^\#7=NDQ@<21[QD*PZ''J, _A5JB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY)(^5>!@$#CTH N45R=WX;\437D\L'CBZMX7D9DA&GP,(U)X7)&3@<9-0_\
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M69-*E5]S2QP)*67!^7#C ['/M6#_ ,(MXM_Z*!=_^"VW_P * .RHKF-,\/\
MB.TU&&>]\97-];H27MGL84$@QTW*,CUX]*UM;L=0U"Q$.FZM)I<X<,9XX4E)
M7!RN'&/3GVH T:*XW_A%O%O_ $4"[_\ !;;_ .%6+#P[XEMK^">Z\:W-W CA
MI+=K"!!(/3(&1^% '5450UBSO;_3V@T_4WTVX+ BX2)9" #R-K<<USG_  BW
MBW_HH%W_ ."VW_PH [*BN3M/#?B>"]@FN/'%U<0QR*TD#:? HD4')4D#(R.,
MBM_5;6[O=-EM['4'T^Y?&RY2)9"F""?E;@Y&1^- %VBN-_X1;Q;_ -% N_\
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MU2VNKS3IK>ROGL+EP-ERD:R&/D'[K<'C(Y]: +=%<;_PBWBW_HH%W_X+;?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYRV?O8./,ZC90!W=%%% !1110 4444 %%%% !1110 444C,$4LQ 4#))Z 4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>.?M"?\@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0
M![$OW1]*6D7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q
M!_V#;C_T6U ')_ W_DFL'_7S+_.O2*\W^!O_ "36#_KYE_G7I% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7CG[0G_("T3_ *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![$OW1
M]*6D7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_T6U;E8?C3_D1?$'_8-N/_
M $6U ')_ W_DFL'_ %\R_P Z](KS?X&_\DU@_P"OF7^=>D4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>.?M"?\@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$OW1]*
M6D7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#;C_T
M6U ')_ W_DFL'_7S+_.O2*\W^!O_ "36#_KYE_G7I% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7CG[0G_("T3_ *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^
ME+0 4444 %%%% !6'XT_Y$7Q!_V#;C_T6U;E8?C3_D1?$'_8-N/_ $6U ')_
M W_DFL'_ %\R_P Z](KS?X&_\DU@_P"OF7^=>D4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%>.?M"?\@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$OW1]*6D7[H^E+
M0 4444 %%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#;C_T6U ')_ W
M_DFL'_7S+_.O2*\W^!O_ "36#_KYE_G7I% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[
M0G_("T3_ *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0 4444
M %%%% !6'XT_Y$7Q!_V#;C_T6U;E8?C3_D1?$'_8-N/_ $6U ')_ W_DFL'_
M %\R_P Z](KS?X&_\DU@_P"OF7^=>D4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\
M@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$OW1]*6D7[H^E+0 4444 %
M%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#;C_T6U ')_ W_DFL'_7S
M+_.O2*\W^!O_ "36#_KYE_G7I% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[0G_("T3_
M *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0 4444 %%%% !6
M'XT_Y$7Q!_V#;C_T6U;E8?C3_D1?$'_8-N/_ $6U ')_ W_DFL'_ %\R_P Z
M](KS?X&_\DU@_P"OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)KHW5O8SN4@26+$DQY^ZH)]#R<=*\HN_"VI6OCE_AK;7OE^']1N5U';GYEA
M8E,_\!Q]54^M>D?$+P'/XBT+3(-#D@M;G29!):Q2#]V0  %[XZ#'&.,=Z +>
ME?$C3-6@OI5TO6;;[';&Z9;FTVM(@_N88Y//2LH_&KPVMPMN;'6A.PW",V?S
M$>N-V>QJ3P?X^U:]\32>%/%.DK8:S'$9$>%LQR@>G)QQSD$C@]*SM7_Y.0T'
M_L%-_*>@#T30]8@U[1X-3MHIXH9MVU+B/8XPQ7D=NE<EJ/Q=\-Z7JU[IUQ#J
M1DLI#'.\=MN1"#C.0>E=[7@VD:CK]E\1/'D.@>'UU>6YN-DF^=8TBY?!8-]X
M')XR.E 'INH_$;P[I_ABU\1"XDN=.N9A!&]NF6#D$X(."/NGK6MXD\1V/A71
M)=7U$2FVB95;REW-EB .,CN:\-\6^$KWP;\%;"POW1KR;6EN)$1LK&3$X"Y[
M\*,^Y-:WQ,N?B!)X%NUU^PT.'3M\6][1W,@.\8QDD=<4 >T1ZC;/I*:F7V6K
M0"X+/QM3;NR?PK"\(>/-%\;"[_LEIPUJ5\Q)T"G#9P1R<C@UQGQ(\0_V-\(-
M,L(I ESJEM#;@YZ1[%+GZ8PO_ JY?0]?\->&_BAH;^'M12XTZ\LH]/O2L;)B
M0 *'.X#J0AS_ +U 'J/B/XE:)X8UL:1>0:A-=F(2[;:#S!M.??VJYX>\>:#X
MGL;RZTVXD8V:EIX9(RDB#!/0]>AZ5YWXIN=9M/CS#+H-C#>WXTL;89I-BD?-
MGG(J3X:*FJVWC+Q+=2[-8N?-ANK-8]BP8!/'))SZG^Z?K0!V_A+XCZ#XTO;B
MTTLW*S01^:RSQA<KG&1@GN1^=1^)/B;X>\+:ZFCWYNFNV17_ ',895W$@ G(
MY[_B*\B\"8\.-X*\3 [+:\GGTN\;H/F<E"?Q.?\ @%4_$JG6]/U#QC(,B_\
M$<5M:L?^>,:.!CZ_*/\ @- 'T=J^JVNB:1=:G>N4MK6,R2$#)P.P]ST%9WA3
MQ?I7C+3)+_2FE\N*4Q.LJ[65L ],GC!K@_C=KMO'::1X:FNA;Q:A<K)>2X)\
MN!6') Y///\ P"LGP/XCT+3OC!J%AH5VDNBZU&K1!49!'.HSC# ?[?\ WT*
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MX'S#GZUH^*?&^A^$$B_M2Y;SYO\ 56T*;Y9/H/3W.*XWXP_\ACP1_P!A9?\
MT)*JZ,D-]^T5KK:D%:>TM%^Q))_#\L?*^^&8_P# C0!VWAGQU8^*+Z6S@T[5
M;*:.+S<7UMY6Y<@9')SU%,U7XB:!HWBRV\-W<LPOK@Q@%4!1"YPH8YX[=NXK
MIKFYAL[2:ZN'"0PHTDCGHJ@9)_(5\OW>KZ#X@T#Q1K&HZBL/B*\ODN+&$HY9
M$C^ZH8# RK$=?X10!](^(]?LO"^A7&L:@)3:P;=_E+N;YF"C R.Y%7+"]BU'
M3K6^@W>3<Q),FX8.U@",^^#7E?C#Q OBC]GJ;5=P,LL<"S =I%F16_4$_0BO
M0_"JA_!6B(<X;3H <?\ 7-: .8N?C!X<AO;BWM;75=0CMVVRW-G:[XD/^]D<
M>^*[]&#HK $!AG!KQ&U7Q7\%K:Z!L;;5O##7'FM-&VR6/=A03Z'@#H1GN,U[
M+INH0:KI=IJ-L28+J%)H]PP=K $9]^: #4K^'2]+N]0N-WD6L+SR;!D[54L<
M#UP*Y>\^)F@6/A"P\33+>?V??2F&(+$"^X;NHSQ]P]ZUO&G_ "(GB'_L&W'_
M *+:O$=419/@1X*1U#*VJD$'H1OFH ]KOO&.DV/@X>*6>673#&D@,2Y;#L%'
M&>N3SZ<U)J'BS1M)\.0Z[J%T+:RGC22,N/F;<,A0HR2<=A7BWB>1_"?A7Q;X
M$NF/V=3%>Z2S'[T+3IN0?0_R8UH^(%BO?%7PQL-3P=+:RA;8_P!QY"J\'UR0
M@_'WH [S1?BAI&N:I:V5OIFLQ"Z;;#<3VFV%S@GAMQ[#TKMZ    !@"B@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_:$_Y 6B?]?;?^@U['
M7CG[0G_("T3_ *^V_P#0: /8E^Z/I2TB_='TI: "BBB@ HHHH *P_&G_ "(O
MB#_L&W'_ *+:MRL/QI_R(OB#_L&W'_HMJ .3^!O_ "36#_KYE_G7I%>;_ W_
M ))K!_U\R_SKTB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHK)\0>)M'\+6D5UK-X+6"63RT8QL^6P3CY0>P- &M16#H7C7PWXFF:'
M1]6@N9E&XQ<H^/7:P!(K)_X6SX&$YA.O1JX;:0T$H /U*XH [2BJ@U2P.E_V
MF+VW^P>7YOVGS!Y>S^]NZ8KE8?BUX'GO1:KKT0<G:'>*14S_ +Q7'XYQ0!VM
M%9&N>)]'\.6<-YJUX+>VF<)'+Y;NI)&1RH../6G:UXDT?P]I\=_JE\EO;2N$
MC?!?>2,@ *"3P* -6BL:'Q7HLWB'^P5O=NJ>7YHMI(G0E< Y!8 '@] <]?0U
M)>>)-(L-;L]%N;P+J-X-T%NJ,S,.>> 0!P>3CH?2@#5HJKJ.HVNDZ=/J%]+Y
M-K;H7EDVD[5'? R:YO3OB?X.U;48+"QUI9KJX<)%'Y$HW,>V2H% '745SGB'
MQYX9\+3K;ZOJL<%P1GR55I' ]2%!(_&K>@>*M#\46[S:-J,5TJ8WJN59,],J
M0"/RH V**XZX^*G@JTO9K.?7$CGAD:*13!+\K X(SMQU%=187]IJEE%>V%S%
M<VTHRDL3;E8?6@"S14-U=06-G-=W,@C@@1I)';HJ@9)_*L_0/$VC>*+22ZT6
M]6ZAB?RW8(R[6P#C# 'H: -:BL.3QAH$/B9?#DFHHFK-C;;LCC.5W#YL;>GO
M5FY\0Z59Z]::)/=A-2O$+P0;&.]0"2<@8'W3U/:@#"\;^!#XPN])NX]6FTZX
MTQWDBDBB#G<2I!Y(Q@H*K^'OAQ%I7B-?$.J:U?:SJD<9CAEN3@1 @@X'/8GO
MCD\5N6'C#0-3U^YT.SU%)-2MBXE@V.I4J<-R0 <'T)JS%XATJ?Q#/H,=V&U2
M"(320;&^5#CG.,?Q#OWH P_#7P_L=!T?5]+N)SJ%KJD[RS))'MP&&"O!_6L&
M/X4ZE8VLFF:5XWU2ST9R?]$\L,RJ>H#Y&/P%=SH7B+2?$UG+=Z/=BZ@BE,+N
M$9<. "1A@#T8?G1I?B+2=:O=0L]/NQ/<:=+Y5T@1E\M\D8R0 >5;IGI0!4T;
MP9HNB>%V\.V]KYEA(K+.)3EIBPPQ8^I]NF!CI7*6WPLU/1?,M_#GC;4M-T]V
M+"U:)9@F>NTDC'Y5UVH^,- TG7;71;[4HX=1NMODPE&.[<=J\@8&2.Y%7]7U
M>QT+2YM2U*<06<&#)(5+;<D < $]2* .=A\"A/&6D^)9M5FGN;"P6R97C&9B
M%8&0MGJ=Q-2:9X(BTCQWJ7B6TOG1-13$]EY8VEN/F#9ZY!/3^(UTEE>0:A8V
M][:R>9;7$2RQ/@C<C#(.#ST(J+5M5LM#TR?4M1G$%I  9)"I;:"0!P 3U(H
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MHK/T76].\0Z8FHZ5<BXM')59 C+D@X/# 'K6A0 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\ ("T3_K[;_P!!
MKV.O'/VA/^0%HG_7VW_H- 'L2_='TI:1?NCZ4M !1110 4444 %8?C3_ )$7
MQ!_V#;C_ -%M6Y6'XT_Y$7Q!_P!@VX_]%M0!R?P-_P"2:P?]?,O\Z](KS?X&
M_P#)-8/^OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU_'>6]SI>W= Z+ON QPIB ;Y@<CKCKSBM&R\7V=WXF'A^2TO+2_-FMZJW"*
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M[S(.,*!D'<<C Q]<4 =A17"WOQ-T^.XELH=*UB>:&U2>\,%MN^Q!UW 2<Y!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZOK2.7:D99I&* L5103@9YP,"J,=W#HNI^)+?4+2XEDO[CS[<);M(+I#"B!
M0",@JPP<8!!Z'-<_I=M>:7%X<N[JZO\ 3+<Z#!:^;#:K+Y4JG+(X9&*9!7G
MR4QZ4 =]<>)-&M;.WNY=0A$%RI>!U);S ,?=QG)Y' YYI4\0:9+?BQCN2]QD
M A8W(4D9 9@,*<$'!(/-<YIVD0V^J^&WMFNKNW5[ZX\^XAV%6D.3QM7;DLV.
M!Q3Y;G^SO%"IHD]U*]W>@7]@]LYC4$8>97*C9@ 'J5;L,G- &VNN65GI:W=]
MJ,,B/<20I)'&1O8.P"*HR68;2#CKM)IT/B?19[6>YCU&'RK=D2=FROE,QPH8
M$94Y[&N5L8)]._L34[FTN6MK6\U)9@D+.\7FS/LDV %B, C('1\].:J79767
M\6-!8S>7/<Z=\DD+*TJATRQ0C(& >HZ#/2@#NM.U[3-5FDAL[H22QJ'*%&0E
M3T8!@,K[CBF67B/2-1N_LMI?1RRD,4 ! D"]2C$8?'?:361XDL+N]UZ)+-66
M271=0@68# 5V,&P$]N<D?0UEZ!;0W[:)#-JVJK=:> Z6,MBL0@<1,A5F$0P
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M*N/4QF0?6J\=I;0:!I^HZC>76FZM<RRWRW$,)D,;R\F-AM(("E$P>NSCD9H
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M]I"D\-JLH#IO+QON1BA^8$=,\]Q6GI.CQ66N>'!;_:;BU@T^^9)[B'8RM)+
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MC-5193WEKK(9;^\AGUK3766[@"O-&'@#-M"J-HVGG X&: .T;Q1HR6]O,UZ
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MY<\ T ='<7$5K;R7$[A(HU+.Q[ 5GP>(])N+:\G2["I9Q^;<"1&C:-,$[BK
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MLNUU&\'B#^RKHP.4L4N'EB0IN<NRG +' XZ9/UK$?4I=4U+P_-,B*T6O7EN
MF<%8XKE >>^%&: .OAGAN8O-@E26/)7<C!AD$@C(]""/PJ2N?\%_\BTG_7U=
M?^E$E8X\2^(!X;N/$CQ:>MC:O*9+41OYDD4<C*SA]V%.%) VG..HSP =Q17-
M_P!I:SJNHZC%H[V$%O82" O=0O(9Y=BN0-KKL4!U&?FYSQQS#I7C#[7(DMY"
MEM;2:>]T#G)1X7*3J3T(4E,' [T =517'V/BO49] 9[FT@AUG[9%:"WYV@R[
M&4GG/$;Y//56K/N/B"(_M5\FHZ.MM;W30_V>S9NI41]C.#OX/!8+M.1CGG@
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MGJ...8;7Q-J>MW6D1:5%:V\=]IWVZ22Y5I#%AE!0!67)^;';H3[$ Z^BN/\
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M]GS_ +M23M&0_(/X@'<7-M#>6LUK<()()D:.1#T92,$?E3T18T5$4*JC  '
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MM\P8!!D[1PW3/M3+77M:U:YTRULA8VYNM*COY9Y8FD",V 5"!USG/'/&#UH
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M+'[;+*<Y"N0(@/\ >Q(?^ T ;5%%% !7CG[0G_("T3_K[;_T&O8Z\<_:$_Y
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MYJWG@BVN-&TO38;N2)+%_P!Y(RAFN(V!$J-T^_G)/KVKI9)X8L>9*B9.T;F
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M++P]'97\2SZ/ +??-;EUF3RPC?*&!!^4$<G\:Z2F+-&TK1+(AD7EE##(^HH
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M4^ARR:]+?1W$(M+JT2TNK:2$L713(5VL&&W_ %C Y![5M4F]=I;<-HSDYZ4
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M[<!4 \R#:<#C) //7 'H*ZNUTVPL;=[>TLK:W@?.Z.*)45L]<@#%)::9I]@
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MME]NN6D2&Q3,WEM!(Q#N,!AG;GY?O8YXJUI44<__  CD,JAXY+_5%93T(+3
MBNV@TG3;61I+?3[2&1GWLT<*J2W/)('7D\^YJ;[-"BKY4,2LA9HSL&%8YR?Q
MR<^N: .'\.M+?:QI^ASEG_X1I9//+?Q/S';D_6+<_P!2*TOB!]E_LG31?-MM
M#JEN)B3@;-QSD_W<=?;-:^C:5+8/>W5W+%-?7TPEF>)"J@!0BJH))P%4=3U)
M/>GZQI7]JI9H9%5;>[CN&#+D.%S\OXYH XW7;>QM;_7XM(C@BMV\.7#7D=L
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M]1VKJ_#NGSZ7I36UQM\PW5S-\IR-LD[NOZ,*S;JTUNT\57VHZ=86EU#=V<$
M,]T8MC1M*3D!&R/W@_*@!FDZE,UKX:;5PYU"YMI':59 J#" DLJG:21CV!SB
MGQ^+W:S@U2329H]%G=0EV9%W!6("R-'U"$D<Y) .2!S4-CX4N+6'0[:66.2.
MTCNEN"F5&9N<(/[H)('L!5?^Q=>N/#=OX7N(+46L:QP2WZS??@0CI'C(=E4
M\X!).3TH N117'B;5M3\Z^N[;3K&X^RQ06DS0M*X52[NZX;JVT $#@DYSQ;O
M[Z/PIIEI&D5[?F>Y%O$KS&20L^X@%G/3(QDGC\*B:QU;1M6OKK2K>"]L[Z03
M2VTDWE/%+M"ED.""&"C(.,')R<XJ:\L]1U:'299K:*VFM[];B6(3;\(%<<'
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M0^BSB;4)VBM8?-7<RA-X9^R< Y')&.YXK$?PA=RP:_\ 9-)T[2TU#2&LH;>
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MX:3:6 RNY#M)'3-1:%X=ELO$ZZG'HVGZ5:_87MS#;E2[.71@S%5 /"GU_7@
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M[XS*6_#]XN/QK&O?#.H7VFZQI;V]MY<M^+^UFDDW)(PD601NN,@94J3SP<T
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M%J8Q*EYYF6VX'R[!Q^- %*/QI<26VFW)T*Y$&J!5L<2J6=RNX!A_ "H9LY/
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M_D1?$'_8-N/_ $6U ')_ W_DFL'_ %\R_P Z](KS?X&_\DU@_P"OF7^=>D4
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M$EO;3.+F-=[V\\+PRA>F=C@-CWQBM.N:\0E#XH\+K#C[:+N5CCJ+?R7$F?\
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MVMO<O"%DD\PL<J0>-H&,X]0<#&UX2N[B]\+V4UU*TTX#1O(W5]KE<GW.W)H
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M,=^: /1JR=1\1Z?I=\EE.+R2Y:+S1';64TY"9QD^6K8Y]:UJX_45U1OB(O\
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MN7: %))R.!7(M>ZI%I6LV,=Q>V4D&K6$,)EN?/EA25X-R[R3N'S,<$GAL=*
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M^=W8L<9Z#)P!Z 55N/">CW5Q-++!+MG?S)X%N)%AE;U>,-M8G SD<]\UMT4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XY^T)_R
MM$_Z^V_]!KV.O'/VA/\ D!:)_P!?;?\ H- 'L2_='TI:1?NCZ4M !1110 44
M44 %8?C3_D1?$'_8-N/_ $6U;E8?C3_D1?$'_8-N/_1;4 <G\#?^2:P?]?,O
M\Z](KS?X&_\ )-8/^OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\@+1/\
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M[AG&Q,_,OJ<5:MM>T>\OWL+;5;&>\3.ZWCN$:1<=<J#GBO++$^=XQ^'[3R.
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M(%G(* ]=H"*<>@-;,=SX=U7Q]X1D\"P11_90[:A);0&-8X-H^60X&3]X<]Z
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MO[&L+7X&^']6ALXDU)M21S=!!YN?-=?O=<8 X]J]T\1_\BOJ_P#UY3?^@&@
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MM] LWDCNA=0&>*WGV@ S(,;OFW'/OGOB@#V^UU*QO;+[;:7MO/:X)\^*563
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M=+Y7N(BQ(5I(P. <>O'\^N\9^(;CPKX:GUF"P%Z+=E,L7F;"$)P6!P>F1^M
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MRCTH [UVCC!=V5!W).*7:NTKM&#U&.M>$^._&&L^)_AR+Z;P\+31[RZC^S7
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MNG0:W/K$=N!J%Q$L,DQ8DE%Z* 3@#Z"KS$!26( QSFO+HO$R:YK_ (%U&[T
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MOC?4/#EAH(N!82PFXNC<A%CA907<@CJ,\*"<X/I0!W#(CIL959?0C(I0 H
M  Z 5Y?'\7F9(M5?3+9=!EN?($OVY?M*KNV^88<?=SVSFMJ3QKJ^H>*K_1O#
MFAQ7L6F,J7EU<7/E*'/\*C!R1@_E],@';8&2<#FC:, 8&!7F6D^)_%4WQ4U;
M3;RTA%A;0QEX?M0VVT9P?,!V_,3UP>F>M./Q0U2329?$EMX8,GAB*4H;DW0$
M[(&VF01XZ9[9H ]*V(6W;5W8QG'.*7 SG K@M5^(5\OB6+0] T/^U9[BPCO;
M=_M C4JQZMD8  ]^20*72O'U_KGB^]TBPTVR%M8W9MIS/>A+A@IPSK'CD#![
MT =YM7T'Y48&<XYKG_#6CZGI5[KLNH78N([V_>XM5$C-Y41'"\CCZ#BL?7?'
M.J67C%_#.D:!_:-Z;1;E&^T", $D-NR,  #UY) H [?RT,GF;%W@8W8Y_.G8
M .<<FO,;_P"+$L,NHW=GI=K/I&G7!MY7>^5+B7:0&:.,CD#/KS_+5O\ QW?7
M7B)=$\+:1'J=PMJEW/-/<>3'&C@%1T))((/X_7 !W/6FK&B !$50.@ QBN)O
MO&NL3>(+C0O#^@QW][8P)+?-+="*.)F&1&IQ\Q]^*HS_ !63_A&]+U6ST>6:
M>[U$:=-9M*%>&7!R <8)Z8Z=>U 'HNU<8P,?2D=%D4JZAE/4$9%>;?\ "Q?$
MOV_5](_X12$ZKID8N)5%\/*$6W=][;DMR,#Z],5//\3IFT[PK<Z?HANI?$'F
MJD)N AC=,#&<8(W$\\<#..U 'H850NT ;<8QCBFK%&B;%153^Z!@5Y@?B=X@
M^R:UM\*Q&ZT-B=0_TT"-4[;#MRQ(#'V ]\5J:E\2,-HUMI%E;RWFIV*W_P#I
MMT((X(F'&YB#DDY&!Z4 =WY49C\LQKL_NXX_*G;%V;-HVXQC'&*\WN/BN(O"
M5OK$>D&6Y_M4:7<VB7 .R3!)*,!A^@QTSGK5_3_'M[%K^HZ1XDT=--FM=/;4
ME:&X$P:%>H/ Y'/Y'\0#MR8H5!)2-1P,X ^E.(!ZBO"_&_BW6O$O@:QO;GP^
M+/2KR_B:UN!<AWX8XWK@8S@X/M[BO0?%_C#5O#EQ,;?3=-DM88?-+76I+#)-
MP251,$Y&/QH [/ SG'/K2".,2%PBASU(')KRKQ/XX\03S>#[K0;54L=5EB<*
MTX5IV/)A;Y3M _O#KFM*+7M/T[X@ZU=:AIGV6]M=$2YO+E+EI!M&TF,)@#@]
M#WQ[T >B@ =!BFB- Y<(H<]6 Y-><Q_$O5;>TT[6=6\-BT\/ZA*L<5TMT'DC
M#?<=TQT/7@\?EF:^^(&M'7O$&DZ1X<CO&T<+))-)=[%*%=W3;]X]A['F@#T'
M:N,8'Y48&<XYKS>]^*H&D>&[FPTZ'S]<5RGVRZ$,,!0X8,^.>>!T_7%=]I<]
MW<Z9;S7T$4%RZY>.&7S$'T; R,8- %H  8 Q1@9S@9I:*    8 P*3 SG'/K
M2T4 ( !T%(D:1C"(JC.<*,4ZB@!KHDB[7567T89%*44IL*@KC&,<8I:* $"J
MN,*!@8&!31%&'+A%W'@MCDT^B@!-HP!@<=*6BB@!JQHN=J*,G)P._K2[1SP.
M>M+10 A (P0"#VI$18U"HH51T &!3J* &I&D>=B*N3DX&,T+'&@PJ*HSG &.
M:=10 UHT9E9D4E>A(Z4[ SG'-%% !@ YQUI,#.<<TM% #5C1"2B*I;DD#&:4
M@'J,TM% "8&<XY]:1HT9-C(I4]B.*=10 F .@%(L:(,*BJ!S@#%.HH :8T9P
MY12PZ,1R*I6>BZ?I^HW^H6MN$N[]E:YEW,3(5&%ZGC [#%7Z* $90RE6 (/!
M![T*BJ %4  8&!TI:* $VKC&!^5)Y:&02%%WC@-CG\Z=10 4444 %>.?M"?\
M@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$OW1]*6D7[H^E+0 4444 %
M%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#;C_T6U ')_ W_DFL'_7S
M+_.O2*\W^!O_ "36#_KYE_G7I% !63XH_P"11UK_ *\)_P#T6U:U(RAE*L 5
M(P0>] 'BGAKP?XC\5?#[P_IMSJ=@OAS<MRX6-_M) 8GR_P"[C.<'@]/2O0M(
M\*36'C'Q/J]Q+#);:P(52)<[E"(5;=]<]JZA$2- D:JBCHJC %.H \K'PY\4
M0>'9O!]KK.G#PW+*2)GA<W21EMQ0#[IY[^Y^E:6M_#4^([V*UU"Z5=#L+#[+
MIUM$QWI)M"^:_0$@#@>P]\^A44 >2>.89=,^%4&F>(]7M6UZU99=/EB9B\[Q
ML I (R6VM@_7-=MX!T.30/!UE;7(/VV4&YNV;J9I#N;/N,X_"N@EM;>>2.26
M"*1XSE&= 2A]0>U2T <%\0O %UXOO-/NM/OH[.6*-[:Z9LYE@?&5&!]?SJ'4
MOAO+>?$&SUJ"ZABTA'MY[BSP=SRP*RQD<8P 5'YUZ'10!P=_X%OKO6?&=ZEU
M;A->L4M8%.[,;+'LRW'3/I2V'@6^M-8\&WK75N4T*P>UG4;LR,8]F5XZ9]:[
MNB@#D_B#X5O/%^AVMA8W<5I-#>QW/FR G 4,. ._(_*LJ#P/K6L^*&UCQ9?6
M$JQ6,EE!#IZ.H*R JSMNZ$ACP,]1Z<^@T4 >8:#\.=3T:>SM);/PI=6%M,&^
MVR6!^V.@;.#QMW=MV37HVHV,&J:;=6%RNZ"YB:*0?[+#!_G5FB@#SWP1\.)]
M!T[5H-<O8[Z:^MUL@\>1LME0J%&1QU_05FGX<^*+CP[#X0NM9TX^&XI03,D3
MBZ>,/N"$?='/?V'TKU2B@#BM7\)ZNOCG3O$FA7%@@ALQ83P7@?'E;RV5*_Q<
M]_2L ?#'4=-O+Z/3;7PO>6-S.TR2ZK8F2>WW=5! PP';)KU2B@#@;SP;KVG>
M,+K7/"M[IMNE_;1V]S!>1,5CV *K1A?0 <' Z_AI_#[PM=>#_#;Z9>745S*U
MS)-YD8(!#8ZY[\5U=% 'G^H> ;Z[O?&TZ7=LJZ_!#% #NS&43:2W'\LU9O?!
M-[<VW@J);J '0'A:<G/[S8BJ=O'^SWQ7;T4 <WX[\-3^+/"\VEVUTEO*TB2*
M9 2C[3G:X'.TUS5A\.M0E\03:CJS:1#;W.ERZ=+::7"T2(K=UR.>_)QV&.*]
M)HH \\T?P;XEM] E\*:K?Z7<^'S;26Z311R+=;2#MX/R\9]^E+I_@WQ++X9F
M\)Z[?Z7/H@M#;0SVZ2"YXQY98'Y<+CI[#FO0J* /-$\">)]4CT72_$.J:;)H
MVD31RQBUB<37)C&$#[N!QUQ_]>MS1O!LEGJ'BV2]FCDMM=ERJQYW(A5E(.1U
M^:NOHH \@NOAIXPNO",7A5]:TDZ7:3"2WD\J02R ,2%?L ,D\9Z#FM?6?A]J
MUYXJUG4;2?2);?5H4B:2_MVEFM J[3Y7;GKS[=<<^D44 >=Z5\/M0L;CP3))
M>6S#0([A)PN[]YY@P-O';WQ3KWX;2:I/XT%W>1K!KYMV@,8):%H@2"P. ><<
M ],UZ%10!YY<^#O$_B+PI<^'_$M_I1C6.,6ES9QN7\Q#PT@;@Y P0/4U<\*^
M%-2TO5DN]1TSPK;K%$RI)I5D4F9S@;BQ VC&>!ZUV]% '-^.?#,OBKP[]CM9
MTM[Z&>.YM9W!Q'(C=>/;(_&N.U?X4W]UX2T/3K#4H(-1LDGCN;A@V)EG!\T=
M,G)/&>U>JT4 <A>^#9'\4^%-1LY88K+0X983$V=S*T81=O&.,5G1^"]<LM;\
M3FTO-/;2=>61Y!*KB:*1HV48Q\NW<W/M7H%% 'GMS\/[^?P'X;T!;NV$^E7D
M-Q+(=VUPA;(7C.?F'6NZU"T6_P!-NK-V*K<0O$6'4!@1G]:L44 >6I\//$DW
M@BS\-7E]I1CT^]BFM98A(&:-2Y8/D?>^88Q[UTFJ>#Y-4\>Q:W+-%]@_LJ33
MY8>=YWELD<8QAJZZB@#R_0OAOJ6C36ED]GX4N]/MY@WVR:P)O'C#9P>-N['&
M[-=IXPT2;Q'X2U'2+>6.*:ZBV*\F=H.0><?2MRB@#S;3_ 7B.YU+P])X@U;3
MVLM!VFVAL86#.5  W,W^Z,XZ^E0GX?\ B?3M-U7P]HNK:;'H&I2R,S7$3FX@
M23AT7'RD8XY_2O3Z* /-;SX;7MIK&EW>C2:7<P6>G+IXAU>%I5CP<^:@'&X^
MG'?GGB&V^&.I6_AO2=+-_:.]CKHU-I-K /&,_*!CAN?I7J%% '$^(?"FMMXS
MMO%/AN\L8KP6IL[B&^5S'(F<@_+SG/\ (5-X#\)ZCX7&LMJ=]!>3ZA>M=&2)
M2N2>N0>G/89KL** .'U7PIKUIXQN?$OA>\T]+B^@6&[M]01S&Q7 5U*<YP ,
M?7UK.E^&5T?AOJV@+J,4NJZK="[N;J12J&3S%8X R<87\SVKTFB@".WC,-M%
M$2"40*2/85YI8^"/&VDRZU!I6N:7:6FIWLMT9?)=YH]Y_AS@9QC\>]>GT4 >
M=7/PP6W\'Z/H6EW:[K/4X]0GGN,YF(SN/&<$Y 'L.M;>D^%9['QGXFUFXEAD
MMM76!4B7.Y0B;3N^OM7544 >5Z7\,=0T=DT^*T\*WNFI-N6ZOK O=B,MDJ>-
MK'' )/\ A6LWA/Q-HGBK5=5\+WNE_9=6=9;FWU%)#Y<@SED*=<Y)Y]:[ZB@#
MBI_">KP_$.YU^PN+!]/U&".WOH+D/O"K@'RRO&2!W]:P!\.?%$'AV;P?;:SI
MP\-RRDB9X7-VD9?<4 ^Z>>_N?I7JE% '(:=X-?3?'L6MP31#3X='338X3DR#
M:P(/3&,"LC5O FM:]XQLM3O#HEI;V5]]I2YLX7%W*BME4<GCI@$__JKT:B@
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MG_7VW_H->QUXY^T)_P @+1/^OMO_ $&@#V)?NCZ4M(OW1]*6@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPUTYM7U""._TV4W3PW#*\H$>XY.>IQC/7FO39/!7AR75+S4FTJ'[7>Q/%<2
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MH+#P%X6TO55U.QT:W@NT8LCH6PA/!*KG:/P% '1T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %>.?M"?\@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_
M *#0![$OW1]*6D7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_
MY$7Q!_V#;C_T6U ')_ W_DFL'_7S+_.O2*\W^!O_ "36#_KYE_G7I% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7CG[0G_("T3_ *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![
M$OW1]*6D7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_T6U;E8?C3_D1?$'_8
M-N/_ $6U ')_ W_DFL'_ %\R_P Z](KS?X&_\DU@_P"OF7^=>D4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>.?M"?\@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$O
MW1]*6D7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#
M;C_T6U ')_ W_DFL'_7S+_.O2*\W^!O_ "36#_KYE_G7I% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7CG[0G_("T3_ *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D
M7[H^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_T6U;E8?C3_D1?$'_8-N/_ $6U
M ')_ W_DFL'_ %\R_P Z](KS?X&_\DU@_P"OF7^=>D4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>.?M"?\@+1/^OMO_0:]CKQS]H3_ ) 6B?\ 7VW_ *#0![$OW1]*6D7[
MH^E+0 4444 %%%% !6'XT_Y$7Q!_V#;C_P!%M6Y6'XT_Y$7Q!_V#;C_T6U '
M)_ W_DFL'_7S+_.O2*\W^!O_ "36#_KYE_G7I% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7CG[0G_("T3_ *^V_P#0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0
M4444 %%%% !6'XT_Y$7Q!_V#;C_T6U;E8WB^)Y_!>NQ1J6D?3YU51W)C; H
MY#X&_P#)-8/^OF7^=>D5YE\";B*7X=B)'!DANY%D7NI."/T->FT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>.?M"?\@+1/^OMO_0:]CKQG]H"19;/P_81G=<RW3,D8ZD8
M_F10![*OW1]*6D P *6@ HHHH **** "@C(P>E%% 'C>I?#CQ5X3U^YU?X?7
ML:V]R<R6$C* .^ &^5E'.,X(SBC^T/CA_P! FP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_
M $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]
MDHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_
M $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]
MDHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_
M $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]
MDHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_
M $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]
MDHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_
M $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]
MDHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_
M $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]
MDHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO^T/CA_T
M"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_[0^.'_0(L/\ OJ#_ .+H
M_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^H/\ XNC^T/CA_P! BP_[
MZ@_^+KV2B@#QO^T/CA_T"+#_ +Z@_P#BZ/[0^.'_ $"+#_OJ#_XNO9** /&_
M[0^.'_0(L/\ OJ#_ .+H_M#XX?\ 0(L/^^H/_BZ]DHH \;_M#XX?] BP_P"^
MH/\ XNC^T/CA_P! BP_[Z@_^+KV2B@#QO[?\<#Q_95B,]]T''_C]7?"GPVUN
M[\3Q^*O'-^MW?PD-;VR$,L9'0G "C!Y"KQGG->KT4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOCRYST PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#8220;compensation actually paid&#8221; and certain financial performance of the Company. For further information concerning the Company&#8217;s pay-for-performance philosophy and how the Company aligns executive compensation with the Company&#8217;s performance, refer to the &#8220;Compensation Discussion and Analysis&#8221; section above.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Initial Fixed $100 <br/>Investment Based On:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Peer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Group</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ORLADEYO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sales</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,317,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,979,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,368,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,160,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(88,881)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">434,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,691,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,963,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,232,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(226,539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">323,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,982,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,009,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,568,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,452,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">332.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(247,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,061,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,053,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,523,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,254,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">401.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(184,062)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,034,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,853,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,353,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,630,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(182,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year.</span></div><div style="padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span></div><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"><tr><td style="width:1.0%"></td><td style="width:57.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2024<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2024<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,317,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,368,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,678,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,274,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,818,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,322,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,507,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">520,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,013,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">10,979,333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">4,160,611</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the average of the amounts reported for the Company&#8217;s named executive officers (referred to as &#8220;NEOs&#8221; in this section) as a group (excluding Mr. Stonehouse) in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2024 and 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#8217;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#8217;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#8217;s former Chief Business Officer; and (iv) for 2020 Thomas R. Staab II, the Company&#8217;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#8220;2023 Summary Compensation Table,&#8221; &#8220;2022 Summary Compensation Table,&#8221; &#8220;2021 Summary Compensation Table&#8221; and &#8220;2020 Summary Compensation Table&#8221; in our proxy statements for our 2024, 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2023, 2022, 2021 and 2020, respectively. </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on December&#160;31, 2019 and the closing share price of our Common Stock at the end of each fiscal year shown. </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.</span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year.</span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#8220;Company-Selected Measure,&#8221; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#8220;Pay Versus Performance&#8221; table) used to link &#8220;compensation actually paid&#8221; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year.</span>These amounts represent the average of the amounts reported for the Company&#8217;s named executive officers (referred to as &#8220;NEOs&#8221; in this section) as a group (excluding Mr. Stonehouse) in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2024 and 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#8217;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#8217;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#8217;s former Chief Business Officer; and (iv) for 2020 Thomas R. Staab II, the Company&#8217;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#8220;2023 Summary Compensation Table,&#8221; &#8220;2022 Summary Compensation Table,&#8221; &#8220;2021 Summary Compensation Table&#8221; and &#8220;2020 Summary Compensation Table&#8221; in our proxy statements for our 2024, 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2023, 2022, 2021 and 2020, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 8,317,286<span></span>
</td>
<td class="nump">$ 4,777,778<span></span>
</td>
<td class="nump">$ 6,982,994<span></span>
</td>
<td class="nump">$ 7,061,225<span></span>
</td>
<td class="nump">$ 6,034,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 10,979,333<span></span>
</td>
<td class="num">(3,691,891)<span></span>
</td>
<td class="nump">4,009,070<span></span>
</td>
<td class="nump">17,053,230<span></span>
</td>
<td class="nump">10,853,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"><tr><td style="width:1.0%"></td><td style="width:57.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2024<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2024<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,317,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,368,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,678,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,274,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,818,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,322,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,507,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">520,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,013,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">10,979,333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">4,160,611</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 3,368,257<span></span>
</td>
<td class="nump">1,963,725<span></span>
</td>
<td class="nump">2,568,935<span></span>
</td>
<td class="nump">4,523,739<span></span>
</td>
<td class="nump">2,353,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 4,160,611<span></span>
</td>
<td class="num">(1,232,421)<span></span>
</td>
<td class="nump">1,452,633<span></span>
</td>
<td class="nump">7,254,142<span></span>
</td>
<td class="nump">3,630,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"><tr><td style="width:1.0%"></td><td style="width:57.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2024<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2024<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,317,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,368,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,678,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,274,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,818,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,322,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,507,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">520,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,013,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">10,979,333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">4,160,611</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid, Cumulative TSR, and Peer Group TSR </span></div><div style="margin-top:6pt;text-align:center"><img alt="6343" src="bcrx-20250424_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and Net Loss</span></div><div style="margin-top:6pt;text-align:center"><img alt="6385" src="bcrx-20250424_g3.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and ORLADEYO Sales</span></div><div style="margin-top:6pt;text-align:center"><img alt="6433" src="bcrx-20250424_g4.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid, Cumulative TSR, and Peer Group TSR </span></div><div style="margin-top:6pt;text-align:center"><img alt="6343" src="bcrx-20250424_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Measures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed above under &#8220;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table,&#8221; the Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the &#8220;Pay Versus Performance&#8221; table. These performance measures include the pre-established corporate objectives for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as described in the &#8220;Compensation Discussion and Analysis&#8221; section, and reflect the Company&#8217;s variable pay-for-performance philosophy. As a growing company that engages heavily in research and development, the majority of our corporate objectives were not &#8220;financial performance measures,&#8221; as defined by SEC rules. However, they did include one financial performance measure for ORLADEYO sales. Accordingly, the most important financial performance measure used by the Company to link executive &#8220;compensation actually paid&#8221; to the Company&#8217;s NEOs, for the most recently completed fiscal year, to the Company&#8217;s performance is as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ORLADEYO sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span id="i830655254dc8407a904e56626902ed14_7756"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our financial performance measure, the Company views stock price as a key driver of value for all of our equity awards and, in particular, the stock options, which have no value unless the stock price appreciates from the date of grant.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 217.97<span></span>
</td>
<td class="nump">173.62<span></span>
</td>
<td class="nump">332.75<span></span>
</td>
<td class="nump">401.45<span></span>
</td>
<td class="nump">215.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">172.62<span></span>
</td>
<td class="nump">159.01<span></span>
</td>
<td class="nump">153.08<span></span>
</td>
<td class="nump">137.47<span></span>
</td>
<td class="nump">110.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (88,881,000)<span></span>
</td>
<td class="num">$ (226,539,000)<span></span>
</td>
<td class="num">$ (247,116,000)<span></span>
</td>
<td class="num">$ (184,062,000)<span></span>
</td>
<td class="num">$ (182,814,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">434,090,000<span></span>
</td>
<td class="nump">323,812,000<span></span>
</td>
<td class="nump">249,689,000<span></span>
</td>
<td class="nump">121,865,000<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Jon P. Stonehouse<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on December&#160;31, 2019 and the closing share price of our Common Stock at the end of each fiscal year shown. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#8220;Company-Selected Measure,&#8221; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#8220;Pay Versus Performance&#8221; table) used to link &#8220;compensation actually paid&#8221; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have </span>selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month<div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Certain Relationships between Information Presented in the Pay Versus Performance Table</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail in the &#8220;Compensation Discussion and Analysis&#8221; section above, the Company&#8217;s executive compensation program reflects a variable-pay-for-performance philosophy. It is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Company&#8217;s primary objectives for our executive compensation program are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i08dd44edc832493d888aecb8122c7631_37" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">27</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Compensation Discussion and Analysis,&#8221; and the pre-established corporate objectives used to determine the variable component of executive compensation for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i.e., cash bonus under the AIP and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term equity grants) are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id9ea9e013d6740e696bf1d820d021d58_26709" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">31</a></span>. While the Company uses several performance measures to align executive compensation with Company performance, not all of those Company measures are presented in the &#8220;Pay Versus Performance&#8221; table above. Further, not all of the Company&#8217;s performance measures are &#8220;financial performance measures&#8221; as defined above in note 7 to the &#8220;Pay Versus Performance&#8221; table. For example, as a growing commercial-stage biotechnology company with the goal of developing first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, some of our performance measures relate to developments in the Company&#8217;s product pipeline and to building a robust and adaptable organization. The Company generally seeks to incentivize long-term performance of the Company as a whole and, therefore, does not specifically align the Company&#8217;s performance measures with &#8220;compensation actually paid&#8221; (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year, which can be impacted in large part by changes in stock price. The Compensation Committee does not consider the information presented in this &#8220;Pay Versus Performance&#8221; section when making determinations regarding executive compensation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 6,818,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,507,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,013,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(6,678,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">2,322,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">520,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">224,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (2,274,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants all equity incentive awards based on the fair market value as of the date of grant. The exercise price for stock option grants and similar awards is determined by reference to the last quoted price per share on the Nasdaq Global Select Market at the close of business on the date of grant.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally grants annual equity awards to employees in mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees. Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company did not take material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally grants annual equity awards to employees in mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees. Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company did not take material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally grants annual equity awards to employees in mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees. Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company did not take material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>13</ContextCount>
  <ElementCount>32</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>6</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="bcrx-20250424.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bcrx-20250424.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bcrx-20250424.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bcrx-20250424.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="bcrx-20250424.htm">bcrx-20250424.htm</File>
    <File>bcrx-20250424.xsd</File>
    <File>bcrx-20250424_def.xml</File>
    <File>bcrx-20250424_lab.xml</File>
    <File>bcrx-20250424_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bcrx-20250424_g1.jpg</File>
    <File>bcrx-20250424_g2.jpg</File>
    <File>bcrx-20250424_g3.jpg</File>
    <File>bcrx-20250424_g4.jpg</File>
    <File>bcrx-20250424_g5.jpg</File>
    <File>bcrx-20250424_g6.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="5">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="66">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bcrx-20250424.htm": {
   "nsprefix": "bcrx",
   "nsuri": "http://biocryst.com/20250424",
   "dts": {
    "inline": {
     "local": [
      "bcrx-20250424.htm"
     ]
    },
    "schema": {
     "local": [
      "bcrx-20250424.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bcrx-20250424_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bcrx-20250424_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bcrx-20250424_pre.xml"
     ]
    }
   },
   "keyStandard": 32,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 5,
   "memberCustom": 1,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 13,
   "entityCount": 1,
   "segmentCount": 6,
   "elementCount": 267,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 66,
    "http://fasb.org/us-gaap/2024": 5,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20250424.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://biocryst.com/20250424",
     "localname": "StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Awards and Option Awards Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001628280-25-019659-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-019659-xbrl.zip
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M\ W;XL_8N?U]Z]3W(CB7V]?3"2S%DG_]OA6)^^@=??G=A__YG__Y+7(B5WQ
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M4S8P?'1<8;/^E+9X)89.B*D=$=/;^='%?H5S@=PY_+%EWK]V\')V">KBE/D
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MZPTJWM[#[=1KQ[4:X]4Q;*/%0]BEQ\[XU,67,%Q+A7&/P(* XO8? !V/2 L
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MDZ<OOUE"P Q0]/=I09' _QJ),1L!FO (6*L441;N%2DM$+<.O-+W<GB"U2I
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M#S^0ZWO6Z;#!P!+KI#RP8)60$NP.3#2 T%&E43NH'#4.M08(&(:#5TJP)=P
M^$8$:BZ9+M5LEC@F&IIT2V2*V1B8,^HE20/2F43>,-"\GAA$+[\14[8H^B(%
MLNVQ2W)EKO)<Y*CI;N0S:^2CH,&D2W*I9GRI%BQ1DUBA(U8G\R!-HKZ =M68
M4E%'/HI-))'4$\,M2TPBG;=EECL@UT752KZDC_FZ495=I<X6O634V6A%\01>
MJ#Z=^'E(S\M^M,I.A"?@+P<MRCM/[ULG<3F!9@W1"$[_<$314'+Z5>3[,-^(
M]0/_.YJ2 2W/^UYA8S@,S.]CHJ?V*[-!X(_E0^H5^(#4.^4&#/T"MZS6CXYZ
M!1#'(Z55>A$3CY7.?X+%*MBLZY$N6^+#HB-],DTR;TMTJ),SFT\.AJ.:R@5%
M:U$0RWB%3O1-4I:?)V=];>FT;,D<#]#I!6"IC#2*R:\<$[[04:1SUJ40F'"0
M.$FF>D$6/;G[W-A6MR=9\94-I:]S'LP#E'X-0A.4#T^4D=PQ UXF6.I5LCCQ
M5D= LMN#0)A7M0>[K^I),+.>$B/U0RI9>K: L2PD_TJ=0BV, 9-BJ$S&U#IS
MPHP)AFC2\A8K@[2#$=6VD0-OR9""UE^Q! A-5"IN8%8\CF74P,A\R(>EDX1<
M>E;ICI:L,$@K!?LJB:2"CQA>+0Z?_L,/%":)"%(K,VL=IUN=,35SVG^F^ #N
MP5QN>"+&.]F?Y#B<<:+TBC\5"*4,*RI//;,R.I<$@*(X\)2#=9KX<J) <)5(
MH77JW%(QX).4^R(T51&%)GH-3@DKM7;4N[%*29X/W.'=2) ZG\HC!Y$:?)<?
M3VT8 A=^%$V&(<?C6,%_XRL1+717#*^7*,%ZJ! /N2S#R/FON:JG "+1'NQ<
M\<P<!.:@JKQBRIC!""EYMW7%ZE!V)' 7PO4I@ 0C+/=)63)9O&BJ>G<\;2AA
MY@4N7JX:Q#[:7V%J624I&CR4&,)#QU/L) DX2#]OG+=9UCCBM\0&8;?"2^\E
M2PZWTY^Q'GU=F!O.G(\*O!\^0,\E!J,V!6U?R$HF^F0:/,"S,_'O1%!1*]2O
M4/M7EN.((U!L-&OQ@ZHX*OO2E*#T@975=PK.GGQ,$Y"L9;7B@ J3I(=:Z.):
M5=RJ@$XFL^VG7\K 4 /+P;?!>\::TP$20XRKP+& []."*!5#KD?R."<P RE]
M.&U(&E3QA70510;[P=I*$9#)C>S!#[$X%8&&'U/E"W*1"4?V3/51/:'*6<G-
MKM:K1628,N!T@U7V2L,X,DM.G\RGE!*]+JF=]94FL10C"D#$Y7BWCB*K6:=7
M3G<C-T\B4Y[HWS(]291VR.P "V>3%",7M# O)'?1A(<A%A575'T4M]-#D%GF
MQCLVUSO&2'TS\$B04=%9V9(!U3:Y+/WM()664A4K]HEBC:-#4H 2L,6(NX.<
M,+Y[0OGO3ZZT7>-#?YU/_NW#P2 !,9Y$+F4IK](63-O9E#+J5-QBI\HNJ397
M=<[@2+@RB5R7#%LC87W?EG"VA(UD6P4TV Z79VWVX& Z-C)>Q8_@$%99!VP&
M4.\"#JH&CVW'1_)%.>PK1D#I>4#L$]G>)5,9#0?D5B:9)WPD= !$H",GC^@3
MTR?NA:D;.3;Z2B7[E>8 7U";KK F6 _(V"GU'%F*4K@[H'#3+6O, -(N8$EH
M7]6*2D/2C<&H,0Q?:8"@J:8:<<CZ>]*-,SG?2=GYV ^C7"*0^D15(D"3&:4'
M*:N/+#TT91);(I&<I.6F-TAE-4@%J3:3TGXM?##0Q;E@D%*RDMI-H8L@;W6O
M,?:1_0-T'&J^<JM],1(V"_T?2YC,A9Z5F3)US]9&@^]E+ UI?:J#.M#-&51J
MZQMMY>5RU:D'S$\JKUVE'"QQNDIBM/]PSGC>A%\Z=[EJ<G"Z/>^DD;Q N2N8
MD/R ]'S9C2HQ;S?YRBG-;?*55[Z4E\Y7+INFIDK%C-K--1;&JHO?6';QHY39
M3(,>*>6 HXP2AP+I5Q0#!J:G0T\5[%DTHNNZCE)I6.I%JH\0"6<4M/@<-FNK
MI,&S"AMPBPP"^*<KT.=986*;OJ4-ACLG!%OG5/D4E?1-M*B**F-5O4FDB2'
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M:L#"G-GPEY?A<WMAKT2$JW VZ,^GP1043N"EZ1&K'2PRL<VZ;@IFWFESP.-
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M&D]=P#,WZ/EYZ/EEU,YK?O^C'*!@ZZ^$Q'8/*H>-)XJB%U:JGLP 7B]VGL8
MG@D]OXXR@'7F5/_VRRH"!Y5&K;91 \J)G-6K >_(1?V$5-,5Q*P>6WQ)3B>*
M9:]QK"YUK:5Y$D51N;[CNBJV]D#XK3]=/DM3EXPG,;LD)(ZOX)X7PR>*PKZJ
MQRPU3E+U:=CV%JLG"R<WRZ[#^.+"MR7-.QV/OOQGS(.(!CG*=U![JH\8U:W7
MMO^WDG1BIIU3TSY,6?,PQ(FEL4F^I#,;^,>OQM1-%U_R<R:,+(G[M+'OP'%E
MG[; ")F'9N$V]?P/L96+[!2-@7D]8B*_18EN5<B6YL/HCR3Y#[W6:16A2H%0
M H?L'T0$E[2KMI=[*7:/H>2:>^KX"%CXZ\Y19:]6HQ?_M7%4 6#FPG?R=$L4
M2VSALF@U^**IF<SSZ!4-Y,9VL#]W3&2AO0J1G]PTYK9(YO/FP* G2/(Q'I60
MA2/_SF.\CYUX* >ICY/ED;)#^=) ##!K3#[DNKYE5+OYH3K(LNEB^IVE$Q$>
M8N&KX]1HIWV<4= >8-,EYLG:[ER:(^-<^J2-J^9+C^R8MEIX/%8V@V+>)<5\
MG?">-3=(I!@L(VT6O62:#*>N-CI/U)R.:4C?I*+;YJ#*\7#Y7-!7J]*E%2B7
M@=AN4F\S[JZQCM>.="N<B0^ 2II9Y,!!DX[2U#<E#?,P.QV1:E2A5#> G^H-
M5R&- +4\G6%'HQUE8K14LM17!\*FG@BAL.) MI=P^1WV6L"VI[$:UIIH5RBG
M<&Y4+IUN04G*TCGO6ONLJ%-'T\7"& Y#P0>Y/)#PW9'3I^Y-\"GL<$?=1W36
M7YH#_CC]E_IQIXO@84:'E(,O&#8(&%,/'DM,I-9A8DN-%L$\(WI8CN%8#/4J
M*ZK,&G/L@^5*80/[\SV!JB&-8%-]]VS5< &'ZU!:6ZCT=U U I41/0RX$EU)
M@GQ*,=05),7B2&5;VZK1.2T<$2K?_B9\*SL(^F.)H?1#3IBLU<X1)36<1&4/
M[PM'/)/?G=(.-OZ:@0&L1^!@#K7?$+N Q2YME_+!7V]Z]J89PKQF"$;W@^O/
MS6O6N^Z>_NMS]_RL!1<WW1">L70_7SN+",G5S[:N.KUKK=AT;SK4C8XU>V:_
M"E5ATWMDL>V*VRFLNL:I>&&;%@H)* YSKOY-<]277TH)FJ.62(S-K2M"T2UN
MI8M J5#YZL-,A:#MRXK%M)!45=WK)G9S2TF+7KTI+7V&BH(\$G0=(JAA:%(E
M7O4B:TS["%6/_!90 G,&N1)2ZO2)1:'8\K;H+6 \D$[OA-CN$!]!"T"^@''X
M'9N0+6G(1*2U1P B9LLF=OA%:@/@H"H-RCH65.'P'4FR4IW'+JTXPOG.CUTL
M^=9F3U_0%#/\9IC:D-K:TZ.[,V63&SFF:>OH65H![6U: :V]\'M5K8!V2M<*
MJ-/M;)^ #=+N?*JPYMF7=J][]4U:C-==-&RNNE]:K/7OUNG-=?N+-%]:G1Z9
M/VMA9L]O;''FV_8V-EG]SKZB Z87!4)@*;@LDL7.[3A6>"P";, :*9'5M$@9
M:=3J-?8&.;YJ-VN\#6Y)VJH+#]U>X4P)/7IX<*B%,<2"INRE@TBFZ-A"=U_?
MD8V!^CQTJ-\X"!SD\N0BD;((^XL++TS<)OBU#LW&G&D['Y(SU18#&L>)_>$=
M3_X$,M;U0^W7<W!<"48:>TG\4+7N#FR>]/0-8E>Z/,>Q*_U<2AV@".I7L]LZ
M;AP6;^RHDFZ50/&$S:"&"8^C$)=AR3O9_MLRM$X/:%'*<OH**3&^9<743!Y?
MOF+M;[^4VI_.<5!.143$<KK,>C"'1(\+ORMM<.K':%5@_Q*!?P1Z<G*2(O+H
M4ZCGJ>&-:=/YS&LF(P<.I3\932LR1J+'-NL.*:$\SKHE$9Q1Q9!.S=><P>&.
M*3-&]KOVN#L%;J+85!K0M]2D M*.)>>B9! 5[%,\(@YDN+Z(2Z#?WI$#>W03
M&E22/141 1D58.P/89O,G'3@49FZD2ZYPOHQ68,R]" HA0;9]*/8@][88V&:
M 6CQ-K_AA_4V$T9&^3>^9#*X]SZ.)Y7\6[&W#%Z,GG/!'&=WE7WV[Y#-518]
MGC&W,L_+M:@T([P%UJSBJ[&K\I4B[! #U\:R/X6V[N1'[D8"SV80Z][?@YCF
MR\VA6!X$:"]19$T&<?@ #3#9XT8R>FDK:5&(\10YL53-8"4C<41C+U0K?'AO
M#[E/FG@@43.!YY$, I0[,C.FH#F.VK%" ,:;_1!86VK.JA@0Q:95#&B=&=Q7
ME:8C0V78FWT! PK\8<#'='8CZK6.@R8CFKR+24MW0&\5Q20BKFSCS- 6TATB
M[DHS78$:7V>-'(%MC^#C:><GO_^'S()2E.GKN0&"N3YHMVBBFY*(FH0+TC7Z
MPJ47)I+?'!C"DY$!^%J+#H[V+"UF(30^S/DS3BW_3-_R=)B(TC_0.S+T !U*
M^U!Y5=S!K+T$ML*$&2^"F$"HXU9&,NAJQY:P*<3J$BQ5"W[C*%.6(9$X#Z-D
M<BBU&:E20Z, &1&.-%C 2;!;5)BE@33TB2<D2RQ^ B>:89IE'3K$FS2ZGP3.
MF(96)%@^7CH9*&/?[-:KM=TEC,'ZX0L8@_-SH!O[[TNHW>5,Q5UI*D:^:B"&
M+=]"=(YB+BHEJDI4JJ@SX3MQM&8(!=-=X;U(G?'$D'>F9U;E(W U85?K0'0_
M"EJ@,!3YF%%(8T)HUHCY#!U?+P+Q+&V@R$<>]/"W<&B6P4%H9#TH'T.?N^'[
M#1&6A@BE3$E93*ARQF1#.N*(*! BU!& ."4^<]@%+ !?59UM<K*B(DU7=*D%
M/JHS/JC&3/) TOD5.]W01'EH@@"ILI<,CWM&%!GYVWD^D*H7^MR+$ V,$)W]
MH2&-TMSFE)AFOFC:P60[;0BE/(2B=50YO]BYA5=FU-.L]B+5TG76]3_& 9K0
ME65T?)"^F&A+LYI@Y]]%)*-<J5T,$(:GT/HC/NQ0_J;1.11K"9SP^[9\C=*T
M)V")T4=EF8D#N^2!FHGH2$^"JLLA19IT>14-SJCT2^P ='VX"U1HZ50QU6E?
M6KFH/X<TD0@7NO9^K )_@ $C]&FAO0\VCIPQ:K@)LHT1ASR03HR'<8#*&2?O
M\AS?2;YZ9QE/%5 "8,-39CP&^58Z</"!CS\M-+<<YWN9,.&/KF7Y..'.P=:'
MQH$9&"S5(<HX:BFR$8_)A,U0[36IFFFNM':89@Z(X5#UT$M&1\A.Z+V"C!1L
M]9+0>+@A\N<C\MW]K0\[^_.(_&4V\C#;^JGT%(T":E._H:IEJ>IPI[:_M]?8
MVP6ZVJT=\*/:KMC;WV_L']4:PJ[O_N?@8 _H:O=P";KZR3SRKI2\F[IBZV&2
M-NK_+FDEJ6+SA)#S9M+D*U"(?ZBXXEOW9E-3\9PU%0CWC]WS\^Y7G!IYU>IU
MSV\PP>AXC6E-1>%ILU]:9Y4T*I5) \KD_LQ)CE&)/T6,JLC9M3CQYZ$LGZ<8
M9Y5E%&-9;3=7+:Z@O;] .ZZJ7(5-#FW2E;/V+$FTAYLDVDT2;9F2:'=+ET0K
MTV2;YS1+L\.:J"O@?-_.&0JSZ^8U_$$5F:S=.04,82+MY7FS4\&_KUK-'HH]
M%(*=FXN3UA6^IO>Y"8^RYI=F^YSPB]5_[5[OI@EO8#?P_BMZHNBU/['KTPMF
MH&!>A1HH5Y0<:Q9*H]:J!U=A="[)2-5*K..?!M,P8I>9(?,@4]J>55690VT5
M$!#LTH67OL&R^;',2S->J^I0E/0N>E*G]E99<]$;"C^J4UFD)\F+:<XG9E;*
M9"=^"Q8*"4R,>"9-C8AQS']I?\KJ=>HA!/^?R4GNX6OQ=OIHNO"B7)GLO92Z
M)]!3CA)=)S@6?AYPI1,AB[01"J^KWCY[/]';_F*M4"@,V)P$CBN[V]5W:5[.
MGD1[Y$?<G<4LYJP%MQA9"0PL+T:LC%/[<<2&SBT>$S$84&*S7X"P"F)L]ZA2
M.SJL@/1069BR09-N@$$KWST ,CFHU \/9M9&87:,O<.#+KS5GLI&"8J^&_#R
M6N5H9T\_F.9V9PE7Y0<N2;\R1_!97VFT)W*IT0QVKO 1D]P=:/L>V M&?6%S
MF**5CL&B='&94'YG.A!"YCIC:J^AEH;Y9#+A<^"*>T?]G61(_1GCGW$(JA1U
MS>!!DFO6#WQNJQB9ND\%3PI%W\K]*(0AF39)AH/B$:HB+BFEFT/[2]'[*MU7
MBHO5=Q("YZ5$ YW?50*J@.N5$E#ZY-Z9]2>Z+(2:XH0Q&L4.):HM9B7:;1V-
M5MH0$8&]OVJ'5/':%A>*L#=A3.DUI-09W&' R=UH^AMDI2UI"_0*3!>U4N_!
MA%MBGM,#(' 7C=X^LK5<65U*Q8#N>E+O8(VZ5CE0FD@7KM*7[4+=P$"!F0ZG
M<]UESCSH"RII7HKD8IW$4)MUJ=>L(L*CB&-;(KR[A"[)15Z"I@<* &N6\J1)
MU:^H&*6-98.VH_)A"]$R7\V<8PDQ?Y4<;Y;652M<4!)%0*E<SAC[J08.=]%9
MBCW(9--3S.T1JLO8&E@<[<$< RTY\JJQL<EV*RC\9.&5ZNJ*B=U79F/8M+!3
MMQ#N;1]F>N :B?MF28WJGO 8@ZYLWODL,->BL63Q1EO2O+B19@@00P>-G7)R
MMS46W4VP+V4B)NJAKDR/HQG$%=-:U-9W(+)%DX5)K3*A52:WZHHL,C-!L9UP
MU0%[KEZ+3RW(JK9U.+C"Q'CB^E.ADZ/1F1"[LG>.8A;8PKD@-UJJ$9A(C848
MCD]Q9E@U+D.&K]1^_3AR4XAH=I9\-RF[#57\C-+VX8GO\$!TA[VFX7?DB7J+
M84$:=QC+KK-Y_13O3#\%(/DNJJR;ZE4(W32--.,WF\5:ZC.C0H8QIR;D:09L
M+M558@%K*4/T5F"]#3UG!;&35"]*/&LF3 FY*FT9Q?ZF=5&Q 2@,@T^6)<6R
MU%#1P2"F4N*Q"+#EOO/?)*3:O3IOGK6^=<'./=A]S]Z N>+#\7-1*7I;D37,
MM[+9/'J1G(G [U=TM6(?TRS(6S)P*+()IR"M=91T2C[1['SX,=!#4@V(1"&/
M/+QQHK MOZ!(#J2_A<U2+4DQV@&K-XI$<RMPQ](NRE7_W9G^7Y$Z=-#N*O )
M+NMUF\0!WCC'0YEU*5--!QYV$PC4(U5FZU@ #Y_"R50$1L=6[ST]Y9B.GG*G
MQ)!,/:?DLE/UY%EVD'^9/L699F4%Y9%8C DJ.+!&!+Z;NDCEC@Q6HKIY2.N8
M8OC+6Z?EJ12IOX9*D4<I13.U(W4*\IE='Q#)LL8,6Y98(.YBV6#8O_- 9HR<
MB:030D9HX%P-TC#$"PHS;%)&#GQJ5J+O3L0'RB"#$(&0_O"=3/&D9 E$26Y2
MX8ZJO:[*1']U*3DQ1M]TI64LU02^P/]-C V;.6-OYSB8U[?![/KWF#.ZQ/%_
M^!3#/16,K*"O2W6GP*[+%:5.9507Y9\R]*O%*A.2"Q$>"?]"RJNRRPR?A069
M#2T6@&5Y*,QE]"LMNM#AQKV] X!P*<D]U5A7K9CMEA(^L['G'._$'!TLTU+\
M3\7]#-V=XF>Z<!/UBQ&\'HZXMH RK2522I=Z4*)O8T&'%*5Z9DZA%23/=SXU
M(=&7"MI0K!+K9R*<.)'4Z1143-LCV[9"UO>1+DA5_VFO#&00=TF_?^PA,81W
MQH%'[26H;"](6]1CXTV:MY78- %U!E'-,%)< Y]RZ&!0)-2.A7Y#BB1E&\+M
M'M=\+V=CD5F'70(20:QXY-.F@_R :E4ZO>:5:V&DA*F\(&J)4D#"DF@G+@:"
MT#+)DK3J,7.'3>TTW604"*";&'4.&A=!2H@[5<D!=- 5"3O:U:&M"&J-I>+[
MJ)B@/I=9E_H8"5C-(K2C)M,;1UER=W*2!2;BLN]B:AHQ,G)I46C=@:/FR'0"
MX_.R_)+:Y668H2IME\HB)D(MRY]6+A56[,:@\?0+L(90-NUP6?5LN&Q0CMVI
MC#;,<T@FC&29%]UGCD)3P6F)FWF13;/]E1Q*AW?M'%9K#&#ARA%OJ*3Y$]DA
M R@6N[?8VG^$MS=VJD=S;@=R"BPG7"(AB5K5+<A]DD 6]K86&NK50L5Q 6A_
M/:@>[<BY=_"O??0+2I=#?O[="8Z=DQ )\R]*Y;Z64F0JP&FB^3Q&Y!A> -^I
M[>)9*5AV28\#X'BE>C;B$ACR//I2/:E02ON8*07T"SJ3SGM<C@@.#U+45]E9
MJ@P@5O$2TAT^;62\;#+^Z_7-^(>5+V6UR?OS%=85T20!Y@[C\%DVH349[H9^
MVJ\K.>=Y*8>V!6;_9)S34M"FCNX".3M7%],&0Y1(6=711 I;,RJ0E_RE% JI
M.H(*XR/[UI3'G?PJ&@\]@R'3S>KL.IQCV@*)1LGN>#:<8P<RX=N,=O+8DS/?
M='Q*CI@(V2VN4Q^K- !DN$SP0O+4T/7[<#^8^P #K*LK);67(+)93@=:Q<"D
M\+#/IK!STZ57";>_[NX<:K6QE/!#UX(G(HJ/KC2]#8WQMF=83SK4D\]8#E.,
MZX4KH86]I57^PU_W=O82=9W,J[V]1']7#0_5R9^ 8LA"[LKFRG^MT[AF9 3/
M%*?.%P2E+&EAN'V9\#9Y_M+WZ=CV+R@%RR;L4H]#5OU2#66EJ84:'5"110F'
M1A!*QT/]E741>:2?5;N>DQRJ<3);N'!&0KDXX'6!^IW@(&OJ*_35:]LT)HO0
M1=M$BY^2_3$D,$#W"W693MMG:J5;>P$0)$Z:"(;.6^T8L',?U9FM4J"MM#!H
MRD+G7F^MG#UNB.@PXTB'K,S1!T86'U@X*P5EG+0//&T!L]?T,*9!$!G\4QFB
M._;#2(4 73=#@576=-$O3T4Y0O6%!S+,DEB8ANFT;<G>2)-4"I'<_+HY,7,:
M?C#F5*:<MD&7LV^DPS+)=IJ79>F$NHT%YE.I+%#I:55UNI=^I%S)9XX:[(,/
MGL2!QZ[@#.@Q'90>B3EH* <+&:CF3"#28QD/T./5<PQX8&:?&$F9D>^[J>E.
MV2VPV5)2?H[9FI'E3)*I)!)-77TCVI*6=E*$9SXG-_J/%H25C+R44(COH1&!
MWECH)1#8Q4I+*U$U,\FW2HGE%ER6_F%MM$N**JE03Q.6U1DP,AG-_,YDM(I.
M\<RD9:XV[ "G)DQ["W.S2%,O-C\.QIG;- '>AI,L,JY!'9]5)9U84IE&U!!$
MR"#2T3^\3YV9:*0'J0)##\<5<3+.8 FS^:@8+-3!Q#F=J$M)/JE7RHA$&XG^
M4J_#[E2)K#%4BYE4#ST[=19 V1QY1%@<SD^51[3D0_[YWMVR -_7N3KH',5R
M 6#K,1BOJ@\"1972:1*Z1D(F!7CS:O(+NQLKH3B3+H19@[HC?5I-8.I@N=2_
MK/!*9CRIH;/9-5+K>B \\@P*%D]2G28[6EGJ*V:.SD2@_!HZMU0E 7>OM@>H
M8+<XFR:9]E3*XZ!&D66ZDV>) 8"*[@= A&I47ACO]W,9OU6VSC5.7\UL&5U9
M[!<5+Q)/-4>DZ6A.$I*1BAG5A,^&=G(% />.M$6-G%V3 0._N<O4$J7HS&05
M*58A,V^ [VEWJIP&HMD1*'ITW%/W5,J%'&_D])THGZ^#A?'TFTIF3*=-5%E[
MD*GB7%#!B<G3!%E5Y@N?5K4:1M)&MN B+26:/PXA <S3--77403YD'VUQH<R
M7]5@"U">I&4H!Y0GTV^H5(;LYP1:MH86'DWET,F*K6YFXM@ 3Y/RED2Y#P><
M7#V)9V>E8@C/]5_KU<3WC:?;XN$H40W' GM1..$X5 (9-N!/N:L:_MBBC[OU
M0-/$U'\RHEU0!CR>LB7)JXR;9/B:V OYU?I"E#1&HC(O)?IE1<I,72<E40="
M.G!4+P^YQ3&W=0#! $H*"4D#V!\BU#S:03T[VW?48*"ZPQ!R9T02S:C,*#U*
M\AB\48%?4_!:]P7IR8DJ5-DGU3_IW-*@G.G().>P+G)<+:PCD4-",.&KJ I&
MNIN692%X=,8@K6+EBDOU6CAF?630*IT\'<*0-N[2U0$D]F2G+0<9&8!&Z^(8
M(S*5 UC:)':YI(FO^6&-"<6G;K*Y3A]I#X0Z#7>FIECI,GX<8LF60Q,T^]R5
MQJD*9%EP.M+R@T0G@5=2-S*5;VKJ*KDUJ+D\%=6Y+%,N7I1X/%L6G7J]9JR7
M^0&--3Q$S4UWK:53$+*R'4LDHY7VBHFDH=&H'54:M8/*4>-PWOA@(S=:=B=(
M.97D(@F_&@3^6&;"IKTU9W5O&86?K98N)>(>+N&NT ZD][^P410-8I(C9_^,
M5=;O*C$/Z]FK[OQ-FIFE!'I!JJ,1+9]#IC+1GC1/&\1?5;[#J+J:K/:\%1\9
M'H:^Y9!ED<@T"N.!D"6YK_S.1#E)C1WY4A)WBPIN&1G@1BQ8NMW&PG:XEP!(
MOT]'K;+A8Y"]>]7ZW[0?HACVEH2]"D,.M <#C$MR3&166$HB>VIG@;*9[W/Z
MWBF=\&FQM)_:N.N1.RGBN:^_05D7J_7D_$#B!:C)IR,KLH<Q;5%<U!IY7OO?
M93N0O$DJ]F3$GBQ%;EG4!7G60_;6:!2,'$7;'OX@M^KZT=_2R9A9DVH9;@Y*
MM^FK<Z<R%<(HTRHNN]]4OB25+XU-Y<O*E_+BE2^E*7)9O@X2S_K^8:)O+#[V
M9M[3@ZTWU*<#Q01ER<T;V33!FZFR\]2@6[T071V9U$52)E;&-"HLD7Q+,0I\
MP[Q"'^D&A*]A<TZ;JF.EDQ/4U5AUR4J].O,@AXKMT=^D338/1 \"1^8-9"&D
M4A@?*DO$5.BCZMY>6I:H0CHZE*S1E"]%#6!;N-!X@EOX:_V@VM@SRUJQM".G
MO,N2U/1#3\5-@IKYK4$K^9B18<TJVI3(2G)$2$LV!.%\8/NLT?@;.=$L[EKH
M5--NW^1Y*29#W:Y'-HB'E[[A;XMG7BB/GDK4>*C?F!N'[$W_;<$I0\\$D5$I
MU?7%4C^W2R) Z1Q]8[TUX#CCUC7/#<'FA\:*F&\H@NQC-O'$-+A789VH/++L
MAD/VB:IS0"=>8Y\I!<Q##&9CD4DV?D.]#W6+TR3/TN!$YAA.WD\2!X9#'#8>
M9:5 -J]"TEI?=0@P'/1I'ZL)X>"-4Q75!>-X:%XS/-[V4%*1$[P0F\NWE0<,
MR8TG*C>F@R%Z7#X)Q;'^QWO;"6&-TV/'([#20^_5NY2>CKHI,%)*,U"$000A
M+Z=J:[4F5=<H@/^W]9?5Y2I<>C?[^^%.]6#WL/!2K5HO_'W>J[!3P%YCX:O>
MT=+D\@ "",G?MW:V4K6=#OUQ8W+/ZMF3@'P@#P2Y_^?6!)?1C3'M%05P0@R1
M_80]24.J3+LR9AJQ?.B!]O@  F<9D64) 8RH%)A=EIG-$:HY8]X8I3!73UV"
M/N:"3'$,Y"< ,0;VN6,SO?L%\ QP*Z4"Z&ZC<K2W4]G;/?@Q6E)"[371TM<'
MK(U4]\][D!:1T6,@5&.O 4Y__:$MEIO\#ZI'1\7BXI&4SAZUV8?%[5IPZYD3
M)C/(2?O$M(9%YPKT0D^FJ;W]$4[]JICQ?O4')?HKY,(_)M&I[E VBY%VQY-H
MY6&PE8]6CBI'C?W*8:VQT0'G!'0R#A69^B^-4IT5H[M:HQGZR_"8G<KA4:VR
M4R_0]]Z1@;N63I"O(YRM)&>FJ$0(&O[@DB-6N.(V&7FOG< +ZDDJR70KG5-+
M#FS'&P CHN:\]+#*I$P<K53;5&4?G2",9G.O?ZP7.E _)HJGE0+9'LXO4U[U
ME)HJZ9Z2_9,*:J2-LETJJPI5SUE 1;*7!,#9NBKZJDY>"2NL'T>S?<NR9:6%
MS:SS+?YG)^CTA.5[=@:E/]ZTP4+Z2=HW<&K@(&^6M?,_H8W#BOL2I6T<2AD0
M4*FVR[5Q>-96"LF$)DT<Z:2FM*U'0@[J,&7*ZY%[C\0V2$>1_WQ:L9@) L83
MR5]LU:\\:4X ZA<.SY'K)O]N]MB_4"[R"_9YA=/#88NBDF'K:8UK0@8CX>;[
M?-5!UA[M5O8/]G)@GQMDK;)NT@YAGG%4R7VE43DXVJGL[];SM\'B&P=_J\CQ
M548/81DV-6A"MJ-&GI2VDU>M7;.?2LN',@,M@>AE>:WQE<HBLE,!:<66*JI_
M,X4>-0F:^85S0])JOK50D6P*P>$>TD7K >NX%9PU3D504BXD[Y_X(,C*.7'/
M*#ON"XO3?)8X*"(_$DY4YI&>2+-_)A[*7*.-@$=)?V:%#!4;&LO#+%Q7!XN,
M^*)4N9,)SF8F@1F:)HDXU77C,Y,<4N5F9J9#IE!#R+)HHYE,CH/Y9N-2_?&U
MKB;Z*#O45&;S97-=H%<ISV?R/(@?9=G)_L'?DL+\^=SN4?DA!X>O*C_D]8O(
MK^I  SRU/03'?>R02EQ*GFIH]%3C)8OF;*.ZG:RPM!Y[=LQC=@"5+DDMLIKN
MR/:D\91:G9\MGLMT)9'JV,Q4S+7.'_\5ZKRQ_P]0BA!2N==<+/:XC5L0&7K(
M668K[?JS7\4DLF8Y%:1-2> C2@)U17AYK/Y&I794JQSME!-H/YX!665G H2!
M= =0_54\UC8@2(!;#J9\'&K)64E:&1@C4BI%E=&JLZX:+2W;YJ,;RE$Z4S@B
MM;P@];0OC-13Y0:C+L8H 54_LD#U?ND+L\/7## >RO7U&0K!<#"=6Z*-]="I
M_%QIQ1RL$+N-X1S)4M(B*K#8I\:12;_+.5I^O2J4G4T5RLJ7\M)5**O3].8T
M,T+N]U'0@$35<>4RP#%XD624JF2[K?T>:ZST7L_-73?[N@Y\'#0N#6CX.4R'
M6*'H&O!;H#$]3::HD<=$0=<LB$^\2L<E:O#Z%=Z/WPA_=)9W8Z]1XJ[S1]4=
M.I9M !)J/Z@]$-:;-C!5AYI;S6O4^F*ZG>Z[-=L^1_9S"63$S'=11P:):_;6
M1.=VNC6ST:;:H.Q(_*RE%AN"_'&"[/BZH7<+S.\A&..>[MQ]J3G/:B<$SV68
MM@\?P6:,,KY(L1JU%Y'?RT#*'C8QQI!+;[ULHYMTZM4J?1R-_ !6:6?KCZ1O
M'Z[Z6 4BDQ,HV#)Q!5#Y".Z7P4AY;4/8*R/L<VP-J":V )M-LD/:1J/=E7/;
M0KJFIH9A<1>T!7F YL!6[IE>?AS;B^U,\ MV3$D4@N/ 7FRP97,9,,=7U"M[
MF3K+#?FNC'Q/^03I]DP)THQ<+C_=9H8#@_BGC"*:/.-A+,&<C$[=$3,N$-F?
M2J=\H?\_R9RB:%3:VHI&\N[1'[E9O!O"717A7@"ZQ_&8=>'F;\A7OJ@DG2MT
M=P54L;A: FZZ"0%J(ENB@8'):3&81YOT/16[R&8B)<6CB0,19Y^D @FXJ^HC
MC1V;J%^H#+52-HG*P]#'9T[A]),*I#?G8I6*]ID34E<?((NNGGL>*#PU)Q-@
M<HZDCRM\UXK5DZ[AE)>^=VXND3*Y0U(M5#]T?98HGR6?44 UU6S G2 STG9#
MCZNE1^11GDW]8$U\SR5)=@.\Q)4!E) U,8H"C =;9,-3QAO9)9\BHY=OIIPJ
MI8'+S/,;3XY?+ZDF ]R;NN*K.51R+\A[;1-BL=J$$B8;6EZ=LNSR.W3LKEBO
MD!3NR!/Q2)4"AZBJ7;")#Z"8SN3:4QJ1& SP$=GI%98/5+6-_YMO99%_63HA
M*#/%+>/N.Y,3W_2H@:;'W6GHA)2[WWBO@<PNZ8U5Y5K94/T*.?@Y8#3@BB&#
MAFU-+<Q/7>TY4-(A0]V21V;GIV04V$!@)J^C^J-J'1<[M0H7#DT@>RVB;D%9
MY48D'<]&Q._E-556X/>!IKA,Q(;'R$FHCN5$=4,,112Y0C/V9(5&<0C]GDF]
MW+#X51+[IP#GV-Q,RNJW2_S1ROB3E2R*.H>X^.UXLE$35DI#5P(-$MSR:HD(
MEJ)RK_U@KGE%UI6,+J 59:./*W&+J0PA"ZU^U^7Y=E;F[ZJS(F;92J(DGULR
M?DZJKY7DASOD?7R,H3Q;SF.B2@94A]6:55)WD$\X?Z.G:G!O9MRLS.F41@%-
M6Z'1>9XG.W')VSF+8'LAMS1DY/O4RM4TJWQ%H<4G1!5J/#NG1MPJ@7FQ$O8V
M&<)2-/XK$U//ZF*;,[RR,WSFQZ R;%_# <'YR1BDEM1!D1$O"GRWI.)!12FQ
M8M>6FXC4)I(4#SE!!?WGNNIU('L7ZL(/3-^ DQ;IPE4ZM/D?@>KQK+Y1*OY5
M[R94NOI;J?YP?:*HC3S![#T;Z:HJ+%Q3[GD<?(E.2LS13*=.TYC9 ($?Z%1\
M]$#.'F=2Y68^57E\*\8D]U(V[,[Y#C:'< 6"]!H9]0",#SGRJA26]U"WKS3=
MDI%::(#R$_L+3R(D9*(H==K L"4.CS:RGHMH8TX.%M&17(T]%ZO?S;&'\V=-
M+4N894O2Z\7C,4ZX7=! =\WS\D"+\; )A&MFW2T AZEPO5$TDJI00(#"5LUO
M02-)WY2;*RI=00A[RC<A5[EN!*%0XDC# L.DKHA4&5_(_HP!Q@,'IR)ZLM\%
MK"T0T503:/:[A7ZH*,*I=C;J32O.\GYL>F\3I,T]:Y8R-UV610**+@/_?@J@
MYU$V\OFJ2]:*^<=L&UHU;NY17*/D+*+P$-'P0E6N305M+!033G5KLUU^%5">
M(0GW:;K*LX*$%,O]0I5EQ>C*PJV^6]U#("$?1#<W,$GLZ RL5<:]V"=JB*4H
M]AF<VAO</ DWZGCI; :-#Q1XFY*>I*1G=U/2L_*EO/A@F0VO>78YH'(K,[R?
M?#!F90,[\3$P-!8T%F2=Q\EF3:"!+M?"3G:8+IRTNZ.HG XG)^;*W-'+/CJ5
M/#4@.\2&@*8[M:C8A'O2\0M?G&"/'5*P(B>*55-"_6+Y%L)/11OS$EM@# EW
M4*%.@O1AF<\O9W.G)2ET;:Z*]N#@4<IH=4._^#-C_GVV)CHT7J]Z%0H@$@?C
MH(Z1FKX(H!06P)1NDE?D]-;E"IB1B) 8^X'1"2F720#?!;#B) OI70QH&7(6
M=E+Q/._C3J8X B$ !\6_$ZH7C.WC^_3KEP'@0'U_$@<@BL7#4">WHMH;!0GT
M-F5:)?E\!/6O5%CY,3?-:SW)U"I%^8 G9.JGI69P)'5E#, H#J4'(3)<#A6<
M<$Z=U4)CK.BB$>M//+;9$[P$^59TRR' @: 1B53PH/U68Z)0B]SGZ(56G">T
M8$VZ+:@!"22K/^+ "6U'>JY_1@+MZ[#?=1()U4*M\>'83$U?OD4*L@TUW6B5
M *.3>U"CUBBU= Q<OAJ*^J+UA? *IIN3VG&KCK9NMS]?R.C(\! D,M9+R;0[
MQ7ER#420W_EA)MQL.%YQ,C3=P/\_>V_>W+:QK ]_%53.4G85Q5"K9?N>5-&R
MDB@GMO5:=G)_?]T"@2&)8Q!@L$CF^?1O;[, !"G*EL1%N%7GQI* P4Q/3T\O
M3W?'?*LO /2[/657KBBRI*OC@ZR@@]+5]L,5-[54E'3=8$<O8*->=/9/7\RM
MCRY\B3#&\/W0UG=&?< 4P'%W>2./A\MZB[H 2VF<5?,S"'3MHA!J&T5AJTK?
MP_M)#/$&ZSS>LTJ+QXW<Z[OE0V[AK?C)=GZMBU7BH16$D<"5PLR_21BA; ?$
M*A6.W8#%Q\M$,)G5LI!9_=7*GX'Q&7Y 0=BR4EW:"!HP)8*QV_H:=+]$$D]V
M>0_?IXO2?E.;;^2"OF[;48R7*Z#M.H7#R$E+WDC1(&RG71RF&236^$58OYME
MO<O<=\$$P/+$;)!IW)X _D3U6*'Y/#DW_)QKM>-(P,85E%]'D$XZ'T?_G(.A
M6E"QDD&4^+K:NR[/;#"03C[]/,8P2+-I2K$[,!#+@*YO5IXDN0V5*A1G=+:F
MA4";<IA()I,CG CH9%1MV\$]:AB32XY<@>H0%9'*K9Q]-L=+5-,'36O=IR(I
MGM_J**D/;[)'^$5RZKF[H9MZFXP_K3RPH^9F+)42*\Z QA+"MA#P+AO,Y^2X
M(_S3#A_K#VX]=5/BM[/$1ZZK3)MR0'@\RK@@3ZCT5D%;0$#$S*;R(VL*6%J:
ML@<183B HQ7Y6<05UA4=UR2] 9:+!"7)3ZF_2M; 58Z=>Z@:BY3ZUQY6]'R:
M3B\&47Q[0-@TDVB.3W:]]RXQ-!E<1Q?-@WS%MTZF*2JQR_=&ZX]9W1^S3BH-
MF_LLU)MO'+\XJ;==X/LC@1%1:FPD:>WI72>)JV*4>X(\N.S",MQZ;Q9)="Z2
M_.WB:S=*M3>K 7_X<4F*WP[+:/0.2"QIKHB#CB15&@376SVP%H^-Y; \(#+,
MBI#_4*D)AQ8'%*JUK<ETBPG=E&6N3?%:S5:.2]%*Q0GQWL]#_R_OES@=8,HN
M$ -4\7?LE/ ^-';#Z"Q9:%-/#;OX&S_GGAR[K(#?+OQV8O$+CJ1VT'^H==[>
M3>E3KY8*5\Q8^M 0)#XTO.!(EA5N1\0L* QVX W()2&; !FDOU,RI.M0$W@'
M'U,LPT#V#"V=FB]RDT?!@,@(8O]WFKWW3M8\V>?TKICRA5^4N7:)Z)")-MIS
M3T7LV4L<*(N;O4Z!);KD:22@H,XL<R@V5"%5%,"<9<R+Z53RT7),%2BIE1G-
MHF,RUEQZ&(UCXG^E,ED4;L,GF;X-TX]R)BYUQG)\$KML]YR;_;5TH%M/-YY;
MY%.!/?0HUX02;6G7ZG>RMCUE6.WMXJ=YD_!J0L-UR10\Z49&?F#N_KG?DYZ4
M9I/=UVP&UD!A5\1*DST8I\7P&@SO<946+8;W*6!XYZ74I@DE%X 5)2"&XU@*
M>7';7<SGYY0SVW15.^\FRL]+C,QQ=:*:I#%M&RL8+XE+2>C0>-RQS+B!(LZ,
M,1!-P!:(V,_@BA9=:4.@A$W"[S7?H1(CUS%$??&E3A-(_3%;WPL=XO9>MO%%
M'8(4Q&1=7OM1Z';-B]Q9@84=8 P_-]2CE.D2H1912M5X]:4;:3WBCD5YM_!*
M_(SIZ7C5V-@-4Z=3)9U[1U%=S0H_DB(6);K =VHWAGAD+N*1UQ"%=<X2-A#R
M>PNT43NG)IV49E$HN3--*VK=Y<%=G:ULT4 (7<"9UX;@&U2$485L6):<*MOM
M&O[^(S.7'P1@@%*8RV%=R>;VTLPM0<" 6]TB&^F:QG2$X=_H NIZ5_B$L]KY
M#W-$D':&&P#:%><->I_U] _4D 0%G.RA1FS/4<H'H0%*:Q/!=OZXK,XZ".5%
M&%89<S%#Y6/-%:*J[01L^AE73M^<5'6^U<1Y=!@<'J/FCHTJ(99TV.4]NDA0
M7>>@.!X+3:%G2PK_Y,]7K4R,#C+RN,8S/I#F)UTT:&&-FWK?F-UP%#5OPL*"
MICO,> NNJ6K^!MP$!,+R\ "KR6*.;*KO4O&!,*CA+JX7ODE9130N37_A%-RB
M'BM8OTW]AO%A]L@.K7JZR\+GTVV[>B=7F:YKAX]+3RG3O)RW",LR$A V9$>4
M< BKY]4)N 56K,&@"VP1:]A&]81!KKRAE?1*1,"X*3:IP]6];NBSZ/GZ@AI5
M:IUVCU_H5,J%_J>*ZKRL>PD99YIUC#.J0V;G[F[FYNSF<?=4;Z9%G<T9M#-C
M$SEE6G=9@/:722VXD(SM[Q@_POKS=V_'8/_P,I4:C%&RX'1TV%_O8AG1(%+I
M<#<TM05):(T@A1WF,*F6+!;SHN+A-7IXNOPGJ_L,N-.^,2??22YH;<N;XL?B
MH1!N]3&=&VA&.;/:6-2=3$@B% 78Y[I6,AR'/0=BIY-]Z8NCU(]SX5QQ%09U
MSPQ;G'J2<-57G"^^BW%M\I&A+:/G+YZ3A=-W<I'=Z=TH=M14%!?'K>=Z"OEX
M6X^>#GTY#LWFTVZ2PL.*9F53Q%V?R+Q'IE8"DE/-8^N4U$+#,;XMUTRUALWI
M0RB_II&%(-/BT?!V#4"M$M8+M\)X468PU-4J\X9XUVE1)5L2NM%2N$_*V)?"
MLZ:)0L/TPI14?)K@@OG4*.!4KERP#WBTQ!&MVU-@RO\UXO*E9EH1ZQ4)+;37
MJTYN6E/36LSEB YGYVYTFFQP6<&&&=1Z 1 9_<E\U)51X/(=84QZD(]5[FZ
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MX%9>+;V#;[/XMM.HV^UC\*)SVCOI'.Z?WNLI(#'](T5)G1CL>E;X?XW_MTJ
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M5UE_W2W.CG.W[V M02*U?<44UL/'J;2ER#YFFYS%AZY:QU[/7.MXIGD2U9S
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MQG"!#A,3ZUK.C;A>Q 0M0ZI>/LTB%'C.FG)]F,W:C51W^H)WJG4MM Y<+9U
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MK;- O"/H0*\H<HXB<MO(RS39UZZB;%:C567Q)-"/E$I'&[R'QO",RP7ZY#R
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MM+#5+"IW"U64PV-Z[0>HARF*TZJO4ZT5YM2%L>Z[PY_BZ M,:)RFDI11W:P
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M\GICW!OW8JIH0[PPRA2MAE]*E J]89IY?9A_X9#%S@)'P$=AMG')'\1O,(V
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MNH/'$GB1%S"_/%2G'-:#M4S\+SAQ<TV*@N7>9.ZA(ET*)P8+XEUR]01Y&=?
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M6":QRF%@6H(&\EJX96U1WX+D<?>"9ZDQ=/JNAP/'DV$Y28L@"E/H8<&225M
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ML2@P9][FU\,/%U@@/H7ELUB<'Q&D.18"CBF-Q@_^*B/I7S68>?W!X(](\8M
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M;//+]?>YCNZ%:1!Q"?IPI7O2JGVAMK&,_T6![;T6=+(;_$<%NE MU3&E0LU
MI4P5!*&C*ON"Z[(MP)B@MN.&[C54KVV)<#^$"E$5SMN*>%9Q8,$8&_KI-F/3
M3.V9TK94([,)-V>6@[6'Y^;HS[@(%]8=I>9MTS++2RE_C-_L7UQJM)?I=X"8
M*5\*Z>KN S@?4X2VWG;$]B; XJ51$$WI"]CWCRKIZ2]$!D 74^G[3.6X?(2
MZ4K"B); 5IV\$@>%U=@FH6V)U=BB^.)2=L_9F5M0@PV]&35*\LZP2T+).6!'
MIZARI5IW_T'+_*Y]'VK84UWB5\-K"??;3^NUE:4>>LI]:>?Z_,S5([=%GKG$
MKZY5C9T1DU  NT@W?=QMV]5YV0CR8@\^O>=NIH4E=]=ZWJKDG/BP0.Z9P'7V
ML72T*?\]AVAEF1;'BU&SNO4I(76QK#:WN$02ZW<%!(V?63@,;T(QAO=-$4)W
M[&,[-J.3-U*$T$2M&#$U%WDYV$9/@UV)OU[TJ"-TK2D.56%V"D8[,&)JVYE@
M]W _ 8E/-YZ#[5U,F5:XUX7[4BAX%<7NW2C<D5P:'2YI!_3D:BT?]MI:RVN?
MRF;46FZ1]]\*<C\X[IZ^:/Y3"W+?+3CW$=U#GU@[^)]!]N-/SZH&G*,+/&_A
MWIL)]WY JC\FTZY(]]/C?WP?(VYC$/RQT*'?1[<-Y):3WG=RRQ8&ZAX/O?9]
MA-M =GGQO>RRC<+ED1 VK6S9 =GR:"" G1,MC=SR<+4QUN[A>J-#8LOK1?@C
M'[/PET3);&2L(^&U@DI=^#-L\$EN!^,3#X  &?7&HTZD_U592H[SQ+3?KK>W
M%,_H[6$K=&7JI=A@FO[P-$UC"9TYBR/7<Y2;>%>ENZD)*(3XB(D@8@D1KLRA
M XBFD7D#V:BR@A2SH*\UT4WW*HWL]_-R0@N-8S?6!U\N'(I4ZV_@,GUR.-96
M )0$\X?;KU8:>NJB*?1!8)TZP>IU/2;^C!JXAAC+]7EQ1-B(^B*B_Q_^0YO*
ML4U:,84TX<=&,@%Q<53#61BAQ!%I?/4UH(Z=CG?<CHE_G'('V*:A=SGBU6?2
M%S!F&YY=R8-/'GE@]WKX=:!BA *$S&\BLH2SY\\9M\GTGNWW>M)+^#D%:8(Q
MG#N5C/ L43-; AB0?Y/;43MC8YM,/72F,#2/5V$(C$T=N7NO\P(.:#"FG_9?
M5SX_2OV8V^7B5Q.%U^<8C EL2VH^20%\<B=0N94RXTA9I*H!9B>\"8\U'*".
MGG*E(E!>$^BN9%QTP 6\4'VQVJ$5)5',I7<"/Q]WO3Y*<7X/GW0ZN(8<Z[IN
MD-4/<>:C\%\_1.%+Y;]4O?W#\.3%44^=O#P9#/?#TX->V#O8#X]/_^_@Y$7O
MY0\_;>1!0!F^RNU-\K45)4VBI)&SJ?>MTPV7908>>@J%=[U?TQL\HAWG+Z9Y
M>)0$<1DJ5]!(#UZ"#6#;8 S@BA)D^H#_A9BBJ/!-JWOX1:Q_=K:2JCYIZ4:W
M?ISF948W/'77YI;L?/YOTC(.I?P5G4"G$A28$Q,]"Z%"]SL0;5L3]^F^?+D\
MPO+X89\7+[O'=QSJ$28%A#IXH%#4YD5D/N@3]D0C4F])WI'6_40I<$EJ'T7B
M_(+^P\&YM<;>FLD$PZRK?.\NAMJ:7'U,XF:<S8-WE;XC4OW#Q]_[;\__WX=U
M:GA=T"$6*)YZ>EHS"LG:F6]KG)18[I$\%2DLG92@3$6309E1)510:0B)#7J-
M'K)C1S!?2<C\NE9)J;B5L1]>DUIGGHBCH0IF0:P<\%S-P-@E]F[,VEB?"#D\
M?N@XSZ8)S8,-#>QLN]Q#JR6FT[OW3H4(D V]MU%.M7HW5!:F949&F$Q[HJ<=
MRK1-3LR\K-1B#$7ESP11]]Z:QUTYA]]@$+7]$CY(%:L#>#(*X9LX)GMA E@!
M<H!79!%\ZWLDX</S[(8)L_WO%&;?&D];H_C>T+CCM@NS2SF@EVE6#.%J3Q]8
M@BV<W@*9MDZ!NER>:M$VU92[17B^.?O?_1<O,(]$A"<.]%ZAQ"Q M\QG29BE
M$^W@A_]>PZ?CO/"+RAL@N0<*N V4R*",_<Q3H9KX]Z!'/N AV3#IZ>0,/!%5
M\*A5!1_&!,Y&?A+]UW?]5VM7_9PY@7;E2"XCGRII2'ZL^R/D)1SE/$<//N:Z
M84)7QP,A4Z"?/R^S:S7+.V[0+\0 0SIE30_>H+]*@IA?AH@/T%G9$_\_\+%A
MF00R+Q_L9QWD,&U/<!8J&8/,Q,AG.I4>(OBI* \0T)"P@,18/49(Y\+R&\;@
M&R;Y#NXD^>[H;GW4Q[;.*]$L0/9[#3NRPQBQBT0B[QHEM*S&@@MYJL>;V[!R
MD\):$?;>6Q50*YN66$T3JR-W&((G:>GLPJ!@MD#8&@$.?KXT8E]IEE0K%%+/
M\16G<<%E&F0:UWY<*C<G?OX;.I9>JT'BEH[08 .WXLA%4FO3Q<_F2L+V<W4E
M"#M#_G#$\,R!;PIO_YB3R1UL'4TB4W!QHPM=%Q,AZ-34!WF=4J,R[S<_*3'U
M')/7%R-NGEYJ\WY-M6E3FQ]_*FUJ\U9#7/9[W8.3Y>V['G]2)R^ZQX>;B+MY
MJ#YGFX>Z>.JX&W.O$^+DK60K^$\8A_-1/ U/E2,<'%*?5;T6@71?"*2-1!BM
MAX[GG(&S_G#%@Z*VY/T]?/C5_NGMOIH]?&B-K90.3EZOSTGPNDJNH^XQTN*3
M8[E2!4PW/XLB8IBF@JV5*<BF'4I@N4]4%D1 Z_\:R]9@L 8S+X<]0.B[3\4L
M!<B%;^=^+/VZ[P(+$XO\<Q*AT7Y5$,8!'T8K.1) ?N6O'6^(83LZ"'K6)G^'
M &3TOGQ!)F*< -KD7FPHM\QWO\PG89%AB7E%$M%E'C%L-25 318%%M4B,=N.
M<27)3O<OU?_N7=;0+_ 7D%$C:2=/O==GGDI"R@G;@-CNUGG;%V1D@^'UU$*_
M6XD"W%;=9$,BYNT-<+\W@(AP]/$7#G!1H7O>]9X3QJ?7VS^TTA_4 PI:F]J]
M<M/7;O,.2OV4$FQU5GU*-6M]G5I/[XZCC#+TLH)5$PRNM(K 8[$!JVP*T0>8
M2^ES,>TY#90V#X[H3'.!8,;JV-@H&4>#" &U\RC9%M5P%]O\NZ_U%@_[*'C8
M]9#JG9-,MXGHR/9*7X,LK]AQJT)S5[[,&6E'U3MFSNU@O@-67>KYWN484\CV
M:\;@DG3XE@L>D L: -<Z5P5FSG<^5KJH6NY8C$C[@H@OF@':R#N$;_ V6A9M
MV,W>(K4W1>5;?$EM@J6^+;1J1?F#B?*A'T14N(;P[81IUPU[_"!+\]SI%F8Q
M=V2\A9&N6M6 @)=>/2X<<!D"GG%O\'0Z4^CJK[KY3>4]_F"C]M#:\X_%,K85
MCDI&NIM-Q 49==J#,>&I:N-$ZH1-%#K[<ZXMR:UT*K70FBI9-@9\VKU?FR^'
MG"]89VYQEHGU^_GT;WAQ[P9C>M4L%]I^)#KL@:1$AQ2<3*>8'%@F(%\D<= )
M/E:@[L)9$YV*@]DQA! >E#G,!L:Z+N,$)CI (3=KW4,/5OEADY->VA2:QESX
M;T^AV?QVL+^G(,4^J6SBG7-'0=L8EF!:^<(;8_N3A;!DYRW=+ZEHHH)510B0
M!CEL-2Q5RRYT4XRB- 0#7<J!8K8$TQ9N^J22VE!_]:I(@R^UWKQ4TSA7;G'1
M4*&<)[U@<:NVVOY4;JRC_6[O:&OO^#4S3O/ECZH>\(0/FXS_@*M8)3F5K]3:
MNI?>P V;CZ/IZW;3-F/3.!>8,53PQA=OH(H;I1*/=E/,L1P/Y3B-\=!2PA1I
M4#$*3H0UV_UU:Q2W6[PA6RQ]A='%:M7E&2G+CGW&\MD<4%VH.35-D*5/M;PA
MV7:X03HA#GX19=XP2M 73ZVP@3E4KKVVQ3AE:8"E/1R.RE\C-[7,LAG,HIL'
M5RH*2YEC@]1TC_DN%^VOME(8@[TXCH!S,ZF 3LJ,/3NBGDBVJ#*:5&I:SF);
M:J<11I176V#0>*8[@YN+/?\FEW G]QHJ9!TO-:I8K7%UM?&%NZVN3J;W&(Z]
M6]Y"RN?/0W:- PX34RD+E9\L">CK?J6IMWFM-0?8^3-<4S6;UJQ -^.PG< ;
M.][;#B(T'UK67(YMG*=.7W W=[=21]^D*C?LV8H,OTF6SP(?/^\_6SE 6.9F
MX*C-JE#EYK?OH)"YJ#9UL;+6T:_JK>Y%U+05"+ZG L&JA3&TLWF=%*XV>*K5
M2D/R=ZJ5$KAGB36S Y_R.G3#DC[+LZJ93031UWI'-S,AKWR]IHB1V'6YGJD1
M<.:BTB/4'==*<<W7E<XFT\R'I06->2+Y&&S_7/HW3>!A]A;XUWX44_XV4H.O
ML[MY&.I\XC27@NM<+LA;CR/<A+Y<@Z9-#,6WL/G)UV@"1G',6O7)<3'6_;&B
MF*XNN37]C!M#L#,<G=KFJL07ZQ3$R[73>/;7?O9(Z0>]A[1)'0($IKN=CD#R
M@3+:%08-5<S($+>I#4&%X'-::V"_%.%!*I&BA.M]$)*4LIP&,]U/PPX&'VD%
MZ(IM5+ZGF<C&W\95E5^W8G+EP=@'K9(*@1AX.IY=T5&K79K@5R&8SE7AB79Q
M0H5>2KA8<FGA%N46TLZ1,592%\G27#?6<P/D< >@^RV]$25<\O3V^.%!E!8J
M&"= RM%L\28^O3(P![5@7UL&YO&GLAEE8#9*%@4:0TF)L8R#L.ZU2A6IVR_5
MME/8HBO.U:SS,376DM0@BG>1(,Y)S?"]2?35.,2]=,I:!>[/QZO/>5=T2_/[
M#(4]W!^*$J'=[XCWAHN6S4"[BV=:EQ8/N[B1G$ZBWLU8L1;(GY]F$5HJH%RJ
M(**D:'0D48M)OD)LK[ZQCXP /%!F>]2,$TP'NK;R8*S",E;:O2MSP&LD@SLO
MH6L,^3!-L)>&AY3?8XT45\S^%" \#6_?T%5(:1KZ$J6SYOC%:OYAUR5<[V*J
M]X,4-;EU.69!NC50 G^6S:FZX^IJXBKW:,>"0O("84:C6:?IY+EN+I N7Q3>
M_PEKNB9O'90=$"^9E)]S='=CZ2RL%8>'5HU2W*@A-0:@\J^MS7\WFU_*ZM5/
MJSYABP/?R\L"WL$/N!W%Q?:[<.%N6,VL_8-N[_2N'W^423U4):_':T^_6M4B
M/!Y/M&#3!Y$8S_[V_(E2@.1D??F/7:CJ\4[$BC?,;W!!7Y*RERC0%_-5SL=N
M-!=;*]E?'/<Z!S4H8DOLA_*)G!QT&DNGWV]RV,:=[7Y2C%.PN7_K>F_3V4JU
M"C<& +Y6PL')G&.8EEY+2BH<]#HOOO> ?5OJ^UK7_:N*5>*]0PL?EI/YLPTM
ML[!Y''-PTNN\_+[[[TG1:__@>(Y>3^(*B_U$H8+ZQL\2M:DIO)O'+^T-UMY@
MJZS[;.QG6,?TWUWO%W^FLE8@MQ?8XUY@.]R^ZARANVYXS4*I&*Y+VT1Y:&46
M4'6?-%&,#)L'AC& 3P927Q$-D2L)G#U+==Z+_#W**2RFPN?2)@^G\O'J\\(9
M9"I0!/!>.(%R"O_4L3:)Z<"('-YJ#B*ZN*>EX8DV$'1;8!<)[QT<_T/@VS'&
M62MMFX91EA<4%<5'@+I9[F>1,D#TD"H,\+\%3EXB8,_C2L7,+1J:A\,48V>@
M6=,VJZ]3+(^QW_,P#IL+D*CQ8_BZA5AR2-;/TX2"21CE'6; &UY8$D:(X[=+
M.2: S1FH1 TC6'263DP E>+'3MAQ+D9*N$M>3NT4R1O51=[X.49AL8(3,_'0
MCS(=(>7PMKS'^(\9A:)YB*1"#";$%B+N%T04*!!^'MO^9"[F=H=A=1? 6QDA
M<E/JP.8'A<!:"![Z1<W<-JE3?Z:YQ<+A761=Q[NAO!H8<)"E?BB0!!@-#A='
M\,?*C^DXAM@?;DA9S#I-40X!A8#Q\)OT9J>LC"TPAT\L.E,=+R\)C*TY'3$X
MN0;P:22 3DG1AT^ ?EWOPY*A5TB\SIVER,')421PAA"6MR!^0VFUAP+#KF_+
ML[;NE$&R#/_V3H54:>XBR<L,D3GKNLGNF!/3W4S,=[6CQ!>\M PV'Y$[<^=,
M@_PCQ-A.%3$5JD"(C^$3W/'P=](>XCK*N5BS[)9'98#]4;U'\9/EY]^C(2=G
MOXURJ633\O;#\W9HJ4V9\;@+EDG]PO"I2;.D^XK, TH6E?-@-"[.(JG=>H03
MTYD4!![$*P&?>I>YX6@S"@_+R/!1ILS-2.FEH,@6,=L9! ]4$:/TO+_O>T"^
MF+(_JPN9IK"#,[R>]8E&!96O(% ALQFO*%0^GMLT@UN4U+R,OIBD>H"(BK]A
MGB5<XWC-98C9RW@R>/G7AW6F1%_ O]-7NEX_F9\@ZI_Z&QY7>5JGA:3-M'_^
M;?^D]_IPO^-MK,W4RE&6HV^!]3#;XRRUZ4.4*=;*T/N2H:2^"]!8M'8J\.C6
M]O$F2K$/1R0$VTV<W'>E&&-\U-M_]N6YM5U#Q9:J_)[&G&+Z#KS9H(' 5T*%
ME@2H'/!O3-6PU2PD\=N\5C5"'-U?)[K%T20R?0LFF-X3ZE(:/+-S;8103ALE
MR./7L2XR \8G$VIUI*R# :^4)$WVAFDV!"F-LM< I)WK:.(7P9@3?]R<MZHA
M3AZ/8[U":Q+-ST9#PLF+0LAR7PH[P61HS5QOT<NCK^S,:(4'"P_V_5UJ_V0K
M-NY3;.1P_^<I"0[7]#>,++D1FOAT^I\AJTOJ\_G5Y:7D-C_OW%W6'!S."QH<
MTDH85["8:9C9:[^TSTU,L&"%[DP&BD^6QECQ%EN5X-GMRM V!X1EA'81^_8#
MQBGM!S3YA;G2^&EVW6$F(^IEIU8<N(DEZ"MEE= *CM"?U1XU=&;)((568W^%
MAT7 *!0M,(TXO5$9$]0\&'):2Q"4F79PT- F/0.^06O4#>Y15/Y6QC/C<D'!
M!(.R6JGKP#)M.OR$FV$S@8?\LABG&7"G+6,WOS/L/]W_!]T8\^+4EB[Y_]E[
MT^:VC65A^*],*;FWI"J(PL(%E!-7R;:<.">Q]5I*[GL_I8; 4$0, @P6R;R_
M_NF>&2PD00J42!$DQ^<<'8G$TM-[]W3WT'BT :,QX_>#'YUS.P*<8VL<1IRJ
M ;$T$,B,!3R9])ZG%>#J A#RH]GA5V>7.9B'<VDD48<C BO6CUT+HB<[SR27
M$2F3TDF9F-EK 4C ,6B%1'8GT<G$]XH=CV)C9XYW2[GAF'=O.[PE3LPZR"<1
MS(,"@HRS'/@) _/6G_,+SO5!BX9=2&Y$'X-B24+\LG.CDGG65 9/&#R1UOZ(
M)&?DG<Q(*I/W$I/W/]D!*/F9K)F.P;;NE&\HXH$9.&$Q/S156*QB"@CO4\KG
M:$3PET/E5BB_<_':I1-#BOSTU_PQ^8R09,$7S32;3$ +SLASU3-)P95;5BCR
MNPS=%S+JJ+WX%(F9-? $/%]J:0>!#YG #L_4DQO9)3)E^QS97"Y07T,Q%Q^'
M9*?9;AN]O\>1*DEYNI5(_%=C%C,?/N.C^ %9/QHZ5^U\8C[J]B5XSM0U/^Q.
M#08HBN"M65RHP0 [ *4!@P$.REA7:7)EJU\:GKX+:21<2>J&$Y&U(56H)C<B
M1UV.21>^S0)4KKDS6QH M$5T.5NJ4=ZO7IP\*6S)(@QY:0F^AA*^>4!&J9A:
ME43>1",)O!&8"$(KWWO(#FO!KV*X?"PF;HG$65_GT9@F/H^9[_.JCI2/G,7
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M<Y<W/<UNHP\8CAN4'JWH? C8K*8HNI6&GB_##TJ R&-BZ.?_'\IB]L=_LEJ
M[$KL0X@"+Q[-WF?#E;P20:)8%#*M0._\R9RS'/+DWTWJ'EKI-+_WZ2,",1<S
M[V<N8?5>)P9G\M@AFD62CEQ^%AE.%N/G.0SE25/.3OQD6>SE>\QV4G& IY_Y
MD+XGXN<H]?G9L"("Q$^^XB>&_N'<*"GD6Q"R2!PR>_U=VHDKAX<M1M\2IR^
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MP(\,+.6/HE:,/^1'HZO9-KAZH.0FP-3 K/YT.5-*1+<[R)'@=R-<EQ%#N_S
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MRA&IQHTB2$8;&(M@*0K?(R.XTO7+EG>)NKM1Q.)1Z+L<4Z<_GM4I8WYRZ=O
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M?4\)?#_&9QGZ//]X$A '58QBIAEF:C>-F>X$<2+' V)-(D\8:*2#XX<Q7$X
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MEMGUA=Q3XI'L)9RA@&NS2\9AG, 3L$*2#%)X&8MCN&A*O.%,1R._#P<ZX'@
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MF4W;0C=@L>;J+=S<54/=PC<]HX7UR0AZ9IE;VMS-$;_&ONF;;/\:,"?+F(N
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M)KTND99G+Q2WO2:W95LFN"7Q3*9KG[PU=*W?ZVN692FN4USW!-=]#@-@O,_
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M1N@8N#N)2<0F$?P=)"09S7P:1B!8J(9)F$;D_?47C=1''D8;\$>.HO;)V]]
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MV_';"(C%2\'$'\[&]$Y;R"E1(/N"D#1X/'\G@=;=QTXD.#2*$-K9-(,MQNG
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MJ>]P2U94)0JG-!>.&\[@VGU9F'I#@45[E,,\2U7*]F*X+(G+,@[23*=P>\-
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MTIE.B<0"O(Q<>3=),$E_7ZKKT?JIMFN@V2J[&?GB^S#%]!C0"]#-(5V_'Y,
M%))S/BE5C\,5.SU," )>?74?^^B!06Y-3)FK2G7A+3?BHWQ'K1L-];MLEXW7
M&Z+[)<V 2N+$1S*ZP?=C@:7"08KQ5<!GTZHNYOZ&4M,ZD),TE*C6BN,42H;/
MIR!D#S^.AF1#\8IV;NR?Q^QGU#%,0VZM?L /4/]*P@$2(BO6Z,I.O2VIS2 6
MEG;>4_Z]\JNKHG1[L*JVY[P&RR6IT+8&24AYWY3<C=5X*6X@Z2$;2NKK0.OM
MUD[7L$Y9>[X$N_P0SY(R6I\73"*MG@(K*E^?^")]CR&TX3-4SAIK0.L4AO@:
MC3$Q'D\+@VRP@6".([K%@VJI*U(3U?)5.9H*26"R/Q-(ZIU%C,_W@;$R#&MC
MY<J@%< ?.54J9RNIMNI4[8:%23!O^.T-6(])5 S9XG,X66!=,ZPR<0=;0ZMF
M#<P:$)G$1GKOOYR<GH!QP[7^C6U3@YM=9=L$4L40+L:*+(_'N+I^5#D<2LKH
M'=Z.JHKT*0;7J9"J0E#Q6U^&SF51; 1GF\U0.QF8T1-K=%!6Q'C$'IC UH\,
MPH%LERN+>],<#  /JE) Y-A6PHFK=2E=J.5A/$Z[*-UM0FE&Z"O7&M2TZ,;Z
M/A!37;,,I$O5@*JXEV0@3L:!345W9C#+;N,$&2-7NPT"A.NGS(![WFT/9@K;
MRK LY%JGVF++M80I ..8?H8OF+ ]1"QQFU,'X!5 7BJX/ HSJOX$UOJ0X^R7
M$OZEO:^V 3Z98=$5D*X#K(--@H^ZNXX#T/:;X9?XH-GAJ^+>4.("NILSJM&2
M:PS03=UDNFL.]*;=]$)?^51^>M;Z$WJAKSQZ9?-$Y/8C,! S"6OBW.Z\*/*M
MW\D'63!1&E@\9K01ER43H K=80*L8D;Z'\%Q)!V1DOETN:PI=,XPY NCL"2D
M42)$](T+KB/?!\)'OX"C&<!F45JP,!K&.(0:,1\%P,='\A4Z_T<]A"@H,E9
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M@J>I$I>!$CKB+,AFFDFXA4KHY1$AG8P#1-3DWYG\NTZ3?[?RJ33Y=TN0*O-
M>;%5S9=!X&.6I.N_F-NI,JU4>INMEI-60O!NIZ/X![?^H*8-=R*:H=8Q%)P/
M?+A?F0^,#^DWDZ,2E6#B3""7'M2D32LH=DQ@4V+F9_;,*OFH87]RO#"U<J:M
MP#^/H&+%Z>!6#+%3J$YH*P:>Y8"YG(-)\#V<S"840J&@F]S4PA0DF%L\RS!!
M@5W^!@]O.<&3%W%&]%1)M7GBQHSS"%$C*Q11[ 8F+>7QNYE/W7#:W8[BQ$[P
M>$;<846^WS5P_1Y*?R/#(%]^???W_O&5=W76%/.L7(&7!S,7RL1-HM)9><O
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M^!^I/3*>MJ[%4%X5H4!9+-Z?.""_6)LM3"=Z6V%P+7 L:"=@;EV+0'KX-&-
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M;(K_.T+%U?0W_=NVVHJEDB,+D3RU_\;OIK,8;2#>E^GXN"WSH8&A86A$%63
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M\YKG8<RH 'R\F;+Z;BU$]2([G97,GLWC:]TY]Y^Y2$]!-E<;\SYU 3<I@U(
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M;Y]C8H/]Z.(^LXTX2A:CCS]#.6A0OW)M2?+SEZW.EZ)/I[E<GJQ"]84^:P*
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MLDKLM!"<GHSV<H$A!7Q3 ;3/Q(KY9S807@Z/4Y&[1,L,Q]RA;VA<2Y&E*'_
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M*]=([!+  ;V19;J^KS"_<+#RQ>6"%8R8H198N6+E';F3;\=XQ740_97,IME
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M3VM3@!.MT\><R__VM7=6 )1-!;]))3FI;'8BT3%ZL'DI",(6HQ(RL#_.,ZI
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MM!U?)OGL#?]YVB[FO_X;4$L#!!0    ( &6 F%J#I]Q<U@(  #,)   1
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M6GCWXJ945)CQ3\9GA6P;7<O:>VK6^PE02P,$%     @ 98"86N:]%'*D @
M5PD  !4   !B8W)X+3(P,C4P-#(T7V1E9BYX;6S%EEUOVC 4AN_Y%5EV.^,$
M8DA0H6*=)E5JU8JV6N\JQSZ!K(X=.>;KW\\.A!9!M:Y%V@VRG3?O><ZQ?<+9
M^:H0W@)TE2LY],-VX'L@F>*YG []A_N?*/;/1ZW6V1>$'K]/KKP?BLT+D,:[
MT$ -<&^9FYEG9N#]4OHY7U#O5E"3*5T@-*I?NU#E6N?3F?$Z08<TLN:I'O23
M+$Q)TD<DB$,4!:R/8A+944A(+X8N#]+XVW0 C+,L21GJ ^^@B,012KJ]%(49
M94&/T%Z4;$Q%+I\'[B>E%7@V/5G5TZ$_,Z8<8+Q<+MNK5(NVTE/<"8(N;M3^
M5KXZT"^[M3I,D@373W?2*C\FM+8A?KR^NF,S*"C*966H9"\!;'AN=B^^IB%X
M\]!*JWQ0U>]?*49-O4%_3<%[4^%FJ)$AMX3"#NJ&[57%_5'+\S:5HYII)6 "
MF;<=/DPN#TES:3#/"[S58"J$):X=S+J$H5_E12F@69MIR-ZD;U)V4,3A?'5N
M^--,,PNBV3P%9%=!NB-^0L9C[I]GWGDA#AF="W-"XD/OD_*J@N:G+/"!]0EH
M:R-40)&"/B7JGN\KS@;R*&$%K#U5"VQ;&Z[Q;A?EF/^>5\9UV.I&BO7[&*MC
MCK;;1FZ W*"F/&+_"M6>B5SFKLU<V>DVAL/Z)#2L#$@.FQ[3!!.*[8F$ZW!J
MMR6"IB#JU2<;YVDLA UQKRY445[O[=T_U^ -._PQN)3IU=.=4>QYO*2:5V/)
M;TI7PLUT J72]B-Y*>_F14'UVD6T9[INYO<T%; );Y/L='K]*$!Q"AF*4OLI
MBV,@*"4$,@(LCGBTG[*+[+(B0;3-[$0L^Z5X.11CW11E>YD^>-LRK8KW[*Q1
M_Z_$FVVW:?B>TASTT(^V-P4?N2KV/P?>^],Q:OT!4$L#!!0    ( &6 F%HC
M^0:GXU(  --6   4    8F-R>"TR,#(U,#0R-%]G,2YJ<&>TN@=<4T_7+KKI
MO7>0HO0NTFL$I N1#J&)U(" ]" E?U$ZB%*5%NG2%0A(EZX@(EU 2H* ]$0%
M(H1PX_O>[WS?_9USR[GGWD5F9V6Q9K*?F35KGI7?OOQZN0XPFQJ:& (D)"3
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MI$=X2,2_;>1_+Q0 +< $L ,\@  @#$@ LL -0!70!&X"!H I  9L $? %?
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MG$,$ODK!2A0C?OMPE>ZNQ-9)\W<NW1^GA1*#O!"LG0A'".$4$3IHQI? U\P
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M%$LJ2EJE;3)/6%T^GO%4=.'86QUH9$),O2-AG,&[2!XG<L?<&YF.Z,9+F,J
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MTLQ#%'I33[XH"N/I"X =WJ<D R#W4ND&FBR]@*&);R_L;E205MZ_&TDUV!8
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MZ>@2#QNX'9D=?8MPNJ1^_^BLS., KZ<V>,./.K'E[;54"&-4%S4&%]!&.E2
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M:QT7W,J[,"(9F/L8>_?-US43@^:*9?_2IJR2YUF%C_02TJ>K[G AWA.K*IB
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MVW<0,YTZ#NC"#[-S;B&Y:Y^BU C1MA?AU1!.4QA-F%[2RA9(ODR)!NL7MV7
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MX73.]GUK3%"ZU;^(;'HB6)9X?K9Z$S<'2\ +T^1(;SMDX5V8A'9(XUB=@]2
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M_TDKO?NO=A;L9W CC")5SP0^I2$A< 2ZPPR]/!N,WM ,9 (O94&Y:Y/Z6.$
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M3"G5K"[[X>SA,>,59/!DL=B"S^ASS/H.MQNEWGO7,WO#=.K",/(L$X0"+GF
MMG9,==>YQ/'$7/"4[42=*H;'NZYM6_B0>8=OU6UQF#;K!&RR#T$Z*='<">K2
M Q%I-0I_-$,0OGK@+J;C>C+\S)F+_@'SLJY:\;Y;2.(L"Q+X'J,].A J!VEX
M12=,[K^.[339AR&R2[)^AK*__GR(&'K0.OZ],9VCPH(!60&RA71P>[/)ZY"M
M;?ZR&V.%,B/6@$[3&=>SVX45E,G9GGJE0? G*MM^#82?#^&\NYRN,R??L+3"
M\%.Z3F^4[Y7F6T5V9XBL4O59,F"*\<PM]  R<89__"5VA_>N=;UQ)]>ZAHRI
M1X$&;^;+<VH-ONO(,1;I;G%0?;0I8,.T8^VEEQ50X2)H&#!7?(FS^^,UKR]-
MC8VUF8&-K^[6^V=-UU<,LC].]X(NM-VC\8P0Q#(?^3K,407DK-\O78A9F0Q2
M]#]3:\L\^C,@Q4(+)#;[:$L3*8X$XHV%7\=&XZUK$/'O#8QFQE-C3F5YD*+N
MF1N8]5V9_,IGGMZQ957X.1^:.6;FW_0(+,)^PE&YA%7=+-^BRD=K3-QG (G'
MR***%GQ:C]UYR1F+7Y2M^'(M,"#OXXV\A&2R6X'P;YX^D9,"R6^^KX#ETES(
M+I1WT(_L1G8EXUAP70T7M!Z4]1/-!446,<L["& T/^T;/-<.B";'0"Q?YL,-
MO4*43J:.F<8\CI1).2T5*Q #4GEF#/C1)M 7,&KZQ,]BJ(1$)5_%D[ 0M0MO
MHYB1[/=R^%.''04'$74VQ P;,H3'FWLQ\O3CZW!Y]%[:X+OX&RR-OI%SS&V3
MNXYX>#S.+JCP./U0/ 3;<<#\4$7#37KP[-;:YR.<7>C@\9=X<;NL_&\.JY)"
MH7+L0K%][;]TZM/CQ*/7_KU*T<#[,:F=\/"R$=O?(RE_WN)9JL"6V(.@[2!I
M/HU-;W?ZX[5HG_,'4N?M3JOY1SGGP9YX_5^X%^*_C60[(90+$ONQX<8C\.&1
MR",#^S_J)6J\TCWD]VE\%<%S+P0>CKF'[0Q_AL#T0/A8E@]D.V<'Z#-U@?IR
MXT(D.CG]<+<2> 9"#:N+S2#\!G.V;\Z&]*$"&>[  =SSI':<I"Y)IM4]VV>A
M,=]ERXSL2)^93S*SP.7;6O!:COF;ZU]WDW)(-"LDH.G'PM"](2^QO2%;^\FO
M97\U)ET;^+32O/0KY&T5F-28DG2D]';(%[6G9/RI!X=)[D]?>.H;?0TW-Y$2
MS8QZJ./>N<<J,I\PPMR 6& [)'DF6(B@E9N;!3-]6!$T#DDV6/9>JUJI3_?J
M1<95?1:Z&==B_@REXFS2L?X@CI,V;(6*J#SUVN80Y-X%^8WUS+VN\Z\1IP:*
M+:VDS]A(N(V1:*=\M@RXTQ I&LWY$7N>'1?,,W#BX"?;[/X&_F[Z%_P]3"MG
M95)^Z/?C++"=X%+LT. R9]M+""W^!V1U-9H+NAGB]0<LO\O#X'_YFPUKYX8-
MBS7#:X'7F6YIOBPN2 B:S07!3 F [.B?'G39R4+^/TER#E+OM@ACZF'&.%MS
M*>5+^K1H.WI#*C/]^@WVJ_M33?*&QW:MDW,A*R,F9U0R,&8\*H$E#PQM65B(
MGB4!FM]ZA0\HE31; 5BZ2.2K.K_Q@+;'BH7%\O*BAB?M8 >>Z:S%I8(X)N,N
M/%7YB.W@X^P1W[MN'DVK,4L;P?2&IY'$@ZL.YW7DO/G1D-5ZZTWL[V.("AP-
MG@68@\ERF1PB61_0)G4ZV'<<SEW*A*NB5.V6KY6'+A_)E6UJ0&Q\&=^:NW;:
M[2>L"YR$ +?I E F9;D;QG^1H_$^XN!)S_P4?%"MKZ>/UII_HJM_V*(EOA\'
M:,-8"JM,2<Q[4BA]?-&#.C44[ZMU[UI:<5Z,#7'-,*(W9^F;9ZCYA3V*!R#7
MI=(=!7\DM4/2<'7P)1>><E'+%RGT.CMZ8U+-%:G3M&_)LO,'T($#N7Y2TO&M
MH3*C- MC'K[[RP!@=R%48.0'.)HG$MAEVE4(-0I2C$QC:03Y4URH6***LU>U
MXOS.:;VN;+X7)H?8@U^"6G"W4YD%_\*$<"Q'6L$G-#_/.G<!>I#41;?+R%DN
MB,]2I:RXY'$.M2-UZIW=(4W96-#!C P0]BCD[XRTVQV>2=.<P9]R.2*B%!AP
M@@ORQT\J6= ],OGT.!DR'?$NSP7YV;O?G*WK,NKYZI!N.?GV$![Y2 S[)R=2
M\A?74WD^%=3[/[D?V)\\3X/V/P7_*?C?6[#DR4593_,LC:JZVHB.U0NZ,,_7
M5M(@)RMIOF\<&+N"LY5E0'=&&?4@)/1"\'=PC;H75\J*S//O&G]XI'-9[)*[
M@@B+8/KY*YYEPW[$$4:KT[;AN_63<5*_8HR(XP-*01M5!3>IK9*[LL643!4:
M=^XS$7@3]YG/> 76]1I+A;"DIAA%S4 \W<6JH LFT.HWRS[654W5V_VQQA@,
M]OWL?D"J.P*T_G!8QO56\O:N]$R[T_C*5C-!(IN?HAD_"XO'B"-D/"[.R*22
M.FHO1LKV>*4)I.[,GAHPS^Z2&=%.T1B5B'\O IH!@NDPRG(/;-L$^CC@,:LD
M'GUL5/KEP_*R:>'=N5LKQ3+3Y25.D^.$=N[P+GO /,MYJTCH3@1D2EEAM-_C
MZ;(<+TW:TFM:].,P>3]U*P%,@,A44DCYP0X\#X3'A<UOZ">W\;&L:5P0\8CD
M6H?J02AT/-3<@;*$=7!^J#(6.C68>I!BO<7>_7VG=%RQI9*RYJ(8=F+!&: P
MU="7:(&+GYD.**V.YI^%U.3R%S33;IAHD/7,W/+CFW/1(5;JTYU!?A[R)ZHB
M&ZYZ%VCS_<)EM)FS=@+AU3S_;3:+4/WTR5>C-5+.Z8U'PIWM<Y+!^8YG)C7/
MOGEQPDG^*2A'/*(]D>_.%]5;;GU<4*VT!,N?AE@RHB*2L_5&.;L! M4!["C'
MKW%MRLLV9&?#92Y(Y+B['[MDP:>7)=G;B]$ >#%[*PLX1\7)?AX(BV'',9#F
MB_;]*B_?C@T;2?5K'G3)[5^P@%ALJLP<I('*4L1.W.L291[]/&-))M3_(-!N
M#YX-D"R%3)I,QX.7+3XW:L+N[SO!^H1/Y.SED=(.)6.$8'\@39;8#=6G/VZ^
MV6I "3[BUP/6K+S^HE+CE=$)&=.S\9J6\%9#"\%?8$;Z:-ONBUR0,#(">8L+
M H>P7*DZ(?8.!2??[_NVP^;: C;TU _Y';(?Q3CG!"\, F;![1P=H(0C8D/'
MM1].(MXC3 1V^/+94Y2PG2%1=$M]@5M^V?YR3Z6OOQE4M]J:L@I2L#2_$ NM
M5Q;#'M96Z-7<W.;P7W/IS,( /3Q+AD3!LR3A##=<[X=[1[RHL)218/W$&:F'
M)]DUB]JDR,-Q\IX=33Y]/53G_:?[%&(&&!1V?9L KR=AL M9DIA10CTD&=/]
M",!,&7AVG9Z>CPS)WI;W0M)T4 ?][#!?TZ=G:OLY\)='CC'FN*#X.P3RT]3;
MQT_54:,S\FES7T988$H?XJEY2*(,.I<(-V\%&YX5$HA<U&-*889Y",UM>1+>
M3:C']BQ%NHVVF@;6V#QEN= _SD(,5^:_'G5^(]MC_L/B\M[8YUVWR'R*IDL\
MOX36H.! @!><!H\_8!9B9#=R>;;^PS6F;:<54D3[M!7_(Q ? H[ $ G\/ !"
MH#ED*#$\V+A?\+KO&RKLRIEYJ=WL2K>V<"9S(1^""9+W9[@*I6[97;'^IE5Y
MY&K$G1ONK*'TRH_Y?HH.S&=[GGR=:F%M2=7&'P!HF\L$?XV%_^;2^/3_6!K_
M#KAP;*[\*O@R5,8;D@VCW[?_C?4'OH(S#>,-(QZ^4Z7OWR9HI)X6JRD]^U0P
M3FA69KU[<QZ$U[\^!'(AJ8$+FD*?(\.VP3J&E+Q_AE'!28SA;C_S<J#FP(=D
M=07U7'"VFE3^[?$?VZ3Y6+F<"5Y'AR:Q9%HXPBG4(< '(5 _Z-*SH9EPJ.D#
M9B<+TMRDF%DD=S#?R_W-YZG]WOFHKNQ'[P+PSCQOA,%VS) :D8O#&C@B[UMU
MB"8$A5:#RYT*QDJ]/K NDPHH E@_;C"=IZ#NH)#=]S5@ 3%JC([AO>T6GK04
M3XM,".02^DPP3@FZ;>K[S/YF9YLN\#;I#Q'8_5R0<LTSOQ;8;[KR*Q4#"\E-
ME2.0FW TAV5@SU:3(M-V0N;8)"*MYG0H@)W=V1SZ7#G]3J:6G\J$RF!]SLWI
MU W$K%S7H!IYF7C$CVI=_Y@ZLB26W>F>!3U_M%O6XN#T8N7]L/L/^?!?_?Y(
M$1%(YO!0X0O6.%8"ZS<D,84.I'57*A2_^. GJ[JKWB)2;++E3I-.NX"PHHW:
M;ID?WM 2)A;;8<,%!>( C<#D-GG,.$Z)%1:.I6)W$)(X2H!-K]/^CP?<EZ@H
MY+*BURVY<T[^^VV4VC[=W^.J(+T%5DZ8,&7<Y"E)4-;-2=/N(Q"GNJ:<^6U>
M$[H:8%'[^OTYAL+;5!34G865O*\&CP33Y#CBO#Z(RX[:B%A;]*'+^;YMOMXU
MS%J/"K937M\:F#OW=HEO49;*-QR\-G_+1-KM*YPEZ\41A5"')O@9M]O8J:UZ
M=/U3 "(BDFFVP#%]S]DY7W3"9Z R>/C)](T+:8'?OLX(1.GY7\\Y7? 6N4_:
M-5(,4TNK)]"<'F@1"3O:E.<W<+&_/U\==WH!3\!*[*L/JEK2>MZ4M3:N^*#4
MI?%>V,4%[96E28U77;#YK>GT.&A",<$02[Y/JF]DR900(30W+B@52X-#IK1F
MM]^DXSJ@\K0CA&08Y>Q%J&C#<&+\D:$<1GZ.WHL$FSQ5Y*\H3X\3/2^J[LET
MS,'(>$0]@25GQ-A-+R<2)L/)O3W@+<&^2O2"K@6X:!"B+C&7?+=&7U]LX4 #
M'?IX9W3:TX=FD9(OFV[N"E0ZGORD3W!!7&95CB4=2<31G"$*:)/1<^P$PD4\
M/PO"Z:)]F:Q>3F,Y4;Z_C%JNN6W;V2^+GOK4_E3UQ[[2S*OHCR*I:E>G\2R)
M<,9K=A4V% YHKMTB7$1.:77N^#&C,[I<0ZD?+?X [6IFX)1N"I3N!.EB+OA@
M+':P" 8@-R<+B-_POT"<_^R+;W4MBR7(]$8L,";%/+7B6H^5;Z;GUM@_6? L
MPT<H--2VQOTXG_ASU+.Y;Y='_JX7CAI"SXY'Z7OBP&T2Z&CVW38%M#FPAPF=
M ,RZVI1I[U(88 D[*OO\JL/KAY;U58QE)/)JJJB"?,^/'M=CZ5*^4U:@*--$
MC@CK!!!-&4K&0&F:Y90&H&#VLU6$7:BQO<>471Q5QSTDI#JU9T#GZ.WVQZ7R
MD=>C3"K.*?93AA()<AQU(*NSS9A=6H7>XQ=&7F@R%M>WH>7]'OPB.0\/T<-/
MSD0GGSM;*;;Z[*C:P2!3!?EG-^?K'05O>F/>$F3:5.<1TK]PL1L]-T-*T&YM
M!:Y-]]R:'FC2.)7AH0UKD8[=RJ<:@W?:?MU1?YMJ=>Y5Y5R,&QG7"1-!;P-L
M**1X7Z&,\1.TL5SQA)(3EE%;M 5LU.)^3EQ7RW@;7%$<*Z)='&N.9?P>_PT3
MY?2WZ8U?(Z2& [H=*H5-=(T'O;EAP9>1.SW&A/<?=[$3SM&>)NOF[-*PF(;:
MC$8@ /62[RLD!V8,VFH\DMCZ0Y]^[/1#^Q6;C5S16.6F]1//03\[V@=CZIB.
MWD#S%#GQ.5J45C/>LU%:YW$,2;&?2DC4L_)O35#/>'+VS*ZYNL:[EL*-88(A
M49+H,#9AEL]O<V46B#F:=4>_I_H@[S?U"OX?;W1Z,7QH1_;SUDCZ]HT/LZ3%
MNG* G_BT1+"V^27]8T.M>F.QHPAD[\$W.M9=[!&^M(KI;=$R_R5E"F5R9PDJ
M*%,*-NXE,ID+VF'N$%#\_?#V!\:<NLIYH^1'=0TIHOVZF=-[GSU5WQ 9PW^]
MQ]F>PVOC/&02VS/.BTVG$!-&/0*()%^ET3CT4?KV>U"7KLG[^MWW+Q,P[V:L
M^F'7/0JNO.E*)T,.8CLN;):1@ZG R,W8!DX:+9@10?M:%TUV,//A] (VY#3;
MN_#*SR>H:A5#$ CA7L;CYSO31#M6?;B@1UP0L(O VK%,^;:)A[S3.L># IZQ
M'.G^CC-H6_I)X6QULF2^[**U5952H=OC[($^BYD=4$]>T#T'(R?X,;0!9##S
M.N:C*EB8CNS>"&2Y*&H^%EPV5WMRDM!5!8N,OI*TANN6/FZU4G>R_/=&K#G\
MKQ,3UY)8TH(<A[%OG,XQPL8.?/S"MU78&BY['2G/!?5-8!,PEWDX874H;U,]
M19A2'&$<%[0;EL(%+>J!.:G&],\QO/NM0UQ0-J2+"V+()G%!5HI+ X29@J$5
M:%8"[$LDV YS<N,\#[&4P#S^>,K_XCJ$3T=('<B*)XC]SDI1'$E*LZ\WM!$^
M;[Z>(BKM 9H-?U$3UG,5)4!(QP$Z0TM/*SE3A(:D%/,H=BNRWD?S9["X;(!:
M0(_&A8??^7J7R_:UQ\*NJT&(B(]#+!E1A@_[,>PR]M95M APC'K\_8&E8_!7
M7NQ0L[MCJ+(\,<N2,]_[I>P3WQEI'W%T^R+'L@R?!6_H*R9]"[*OV(!DDFK=
MEHRID E11@&-T!LB$,2JWLMV.=/8B#8>3,?ITK,8#9(##S.3/U<R#[.38)>7
M$PDOEXFB/O9$C$Y=\WC5M7MF#WS?[;'^$?)330^)5;PO&W>EQK5]ZK7&R5P%
M?-<R$/>M!_++UQC\;J2UD5$!/*#;<(3X9A%),#!KURQ.MH,>3+D\J)\4:G[L
M,1?45=X#E6Z]H_1@GQTY7&7P>81S^2[*1="60S*V_(\WZGB09Y8&9DFM,AH!
M';H?XR*[N%YO5YL.^@ @6,'SH"$5WKX:-260GR^-!0:)@D7&]TY:A@DHB P*
MJUT?0XCQ[.$ YM.-)):4#@76"[F)I3GI3\Y%9,411#$'@GC,!+,=[39:75,3
M@J^YD+I4_MSNL<=)Q_;;%E[A=ZL+Y^#[]]9 !]BWL4%(0.L;2P[/,,BBJO 8
M) 0,%/6L=/IH]?B*T36J7.95%5N*).NFHF*%=[_)&?;N<FQ>BM">/QISY"F/
M!-I7HV$0X9>XA!F5%EI%PCE5A>;AG;GP'4^GI187$X\\6A&8YC]I,P?NQ'V*
M[$#4];*4863"I-'F.1GG&5P0)2F]32$8J@ZLA9RC]D>DB:)FA&?KHO9Y>IQ,
MB[@VMDJ4:MEODMN*;?&I3.#U5_U[ AE'H+F1/IV"334RI-@EW^B0[N4M"\TQ
M.*(!!2F!.%;Q>5X2000SSO\P,K3?1EPVLEX0N_I5/3<L39W3@88!@302Q30I
ME^?U.9#O#Q5&G ;*"BEL326=B/,@7;4$5\N#RK//JW!"F"$(" I!=2Y3(;%M
M H#9L?'EB4%&4RGJPLCDRI?&&4,'Y7.D(RNG+O+/+?,L3))P#C%IWYZ/H-G"
M 6VMI6UGN2 9)%0^R USF#:+BENV+N)$UHOJTGQWI2KE&^J^N"MI!W5JHFJ+
M1R%92CI,&.L2^QXL )(*$3,_-UMMTP7;?HV4,;F$ZW#P<KK]8MX7TIA]UN?H
M^//ZIGS3_",X-8.<XV_Z%-I^ _%,*&LKT%C]";A';>R "*'N.7^0"[U7@4HB
MGFFLFQ3+32XM,KG88P?;HURTP#/SW>[G,IQV'"W6;G<\##(3 47\G\K--N8-
MJ,#'ZE^P3ZL]S4^6N_3<.AET3Z^8<K?W783+*QE?^)8H!CJ'^P_GAM;PB5R8
MOL)GO'*;_1@CX8'RA,?C0*TA3 OO!IRZ9SG1=N>(\<UKS3W]?IQW3?E?]1IE
MQ;XJH)L&=O^\*^LJ5+*$G QW!)*>L(3H*J1.W)8@7\UQ3E_VIXO-7_3U[C/G
MCF<_R80]=+6=^&)0_HYI@G_;V6I$Q>3QWB_R!1! 55HRI2(Z$E]E'6L.]G]O
MKO_L'B.W/Z3XD_EBV=4K$H;/28T[?ST"5_:$#?D"Q4W+"2748M3>=^#TA4>-
MR><M"L95E?+]@JY80%I="X]9Y>)N%_2N9:*^7_R;&65?(5FD>E*&%KM<BUW
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M,O-*?L@:> 1Y7GC(.2V;3]]I2\V0X]OA>C2!'P32YJ_XM[H0K/,W=Q83F)%
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M(YS]"@H"L(Q\]OW6&&@3!;O#<SW_@]Z$1W6 LEU(F*I=*FIJ[_<;.WHLMV[
M_Y2HX;A9<^3O)?. +CNY_]UDGG]*_E/R_U[)T]>JMPS89']YF7]]WROHY>ZD
M!;>*OTD4,X$U6J,C,$Q[P7-.;7FSU2Y$(]+T1%_1SQ180=2%72V)5VEM0AX&
M"B*V.R6%MX8A#-%8=B$:3//J2$( FXCR.#!<[B[L[.7%BTCR00MZK.'F9BLQ
M1("X6;[H+<=P4NH&D6J38(Q71BDYTW!)Z)AG*%_&QG0O$G]QN'W<).1VY,Z'
MAZ3NGYT+C[N>=WG_>CB15(N_R04%JL#<Z$,]X(FOB(S#745H A*X&5'1\+3*
M1_OH*:;7.GC"&NH8HI[=]*Y;FN_7)R#F!G0?MO,#3.+W*I+7,]\8;JS=A$OP
MQ=<<[ ,&2>?"<OWL6O2:7Z!2]+C=_[2^@>*">G$3&AQS]/'G])>]2W)T^\[\
M?,]#=;G':?J9^ZY5!A=N?3(6):L6!P0Z7Q'F,[1UU.;_M.<V?-OHGO 00SOE
M5,5#:F==;WZW5+%"Z]#P%/#B"DDP!.U&3^*(1-,O#+@WU ^EA>ASS+W=&W)O
M""XOS@C>-K?6$E<='WC0-.#O]AY".Y7&UG=F9YKO"G^$"':[<3;$ZD#&L2XC
ML\^DB;*2JPUKI[P%MES,TW"T>?-"NQ\DR;>T>7Q1&$X*%IC%ZRKYFMT$H(!6
M3MP8G):<:HT<WS@N^4Y6(2<@Z^TUO;E\"P6CEW=>W+8T'ID" HG7'T+@PI,
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MGC803V3U#_]":;@VC_V6.[.B&]*QH):G?E\B&:^&KN@AY,&2? 78K[!D'AX
M]CIT?WWYU.C2C$:3W&'&L]V1'] RE._>H-K',%TGG5N9YHE%00)?26JO-^M]
MGL:2BV&;"[I<$$=$^#'+&)"CB/LN$./=0\#D;T0 OBS2UW[D=_N[[H=GX^R\
M']SNEG>>.A^(_,[D"/7RL%<AX,'[S&/?J89*7T3X?T1'X)/Q;>JH-NWGDP\
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M1:4Q!^I2,%Y!<)#O[O1C!LQV(>^EE1G]C\^T^=>=N:!X#('<@H'R?)@KVKN
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M(1"..2K2DY:7ODW-1\I9MNZ2T3LN:'YIUMYC+F/.[[YV;FR5^[.G._G?82_
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M=_;-NN.%$V?[ANE.!OPW7_UV4Q+O6^EG@.3VX1@@*O<D [1P%VN\O!%(\6"
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M@X$BH9^QLDL]YBK2I]T?"J<%/W"3*=$<[?]SG?)_,6[Z_;D'+5];Z2*94]J
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M[6LX?=@U//BKJX&KU8X)5]NCJ+\22\C?/A;'&2 O\#'Z.(ID1S5!X7+I0O6
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MBLF6YN8VC6>#,C6"<DJ<A+9 CJ8[GK$[410LB"[N7(O&6R5?U5*:Y+G"7\(
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M8NO%NR,X8=X".[+6^)8OXF)@@#NZ9W'CTEV9398<$'*/.3K[1DDX-[X2C6.
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M&O=I]NZ ;\T+PWN/Y9\ UD61[9:MYBFG"J17UXLEFW^-11D^%_&$V@>;9FU
MY"&X0<CD8P)WI(8H=IQE-C*J<#%YK%M,1+:]Q$E108977?1>D53\RY\JA\$_
M,O?U*U!4*)\!;ZH1G&I"\L-251#7^W6T""J'X!-*7DM]K2-\?7GPL(X5K;34
MQ2J)R[%D!8Z*5Z[[S5+LVQ&5Q"RVE62JEOW5]#,SA^Z_G'L6;B0E'59XY.(!
MK8,-(G7<"-KFW@L([CE*.)52\SM<Y1VT/ ?S]+ZY& )2 T0)M?Q. /O(4WGV
MM=GCUD?#Z],S4*)AVC[8I_/Z^UN+X[2U7R25GYISIQ]BWLA:7T]F@)[I_"[=
M8J>D8%@)I!($AQ#^;)%ZXD5%;3T^!4+)7%W._KP&?A^$+Z1N&^<+B:7N]AFH
MZIUDKM8D<S.=1BJBFJP@KD72E*M (!G<<OO0@(_.==>B*>_7S!;FOOGB:R)\
M4Z958^.H6S#53O.OUG>HP\YT=CZF',:29VC\;!0-((@4[ "D9P'6!*%FC, "
M_02IO<K;5W,U->CC(JG^HI\D3-E<RC7X:YB==!67)"=X99>I<U58F?VKUSN3
M.>CLZ&Q4DS76DXER.3R1<J3TEB=XR&$XY,O@E*-]5.!]N:'B-;_C3WXE9]6_
MEGEZZ3V?F^/7,&3OWQK%F'\Z]SR:,+R'0:!P$/:%VP=&$=HXQT?;%R(WVF]+
M-7R?L4QH)G5(+)N:6KW6G>MT[>Z<DY**U]:[R3+J@4E#"B(G(;QZ$@A>H+<(
M.;QK]28(@S@Z]+-\2!-RI/V[W?+"2'^?5W]6VKIKDJF(VEQ^NF6[L:@Z#07T
MDFP;>> MLY%U3A\]T0*:;\PX; =7-H>?("#YTY/E(]X^7])3N!:^F\P+WNU)
M.7B!TX5E84)AWO2_.%>[!TLY$Q+M%]>W^#S@(S>L:3KF6^3[WM//ST_FL-CU
MC[(9+TGY()G4+_OKT_%5Q#VJ, T*A.H)TK3VLA":^<M]IV*GFT6;<Q<[2%]6
M]U][3% ;!R7;HRN@+9.)L=#]08D']?&O@CISJTNJ&[]+UMB@K<NK&L((A%9U
MM6+WR%/'6]0^;:CVY)N M8%)RE,F2\*: ^D]8!#*"28Z"<3NLKCG%E>0ICPF
M8!&_I ^C-%;W-RM]&[=H27-[=NGHE=<@JEHL&TOJ7RE(B8R3[T(-N4"(,J:Z
M$*()B,Y"PWV1<L#=21PL4H-HF_-8B>7V8-";!GWS6\E)34$RUCQYF?$Y#O*A
MA8>(MV>INEIMJ:3,-N:,3YAMQPY0+<QNSU_\03GCVI!A<4DX[2;/4XO"8&75
MJ7 HZP1<E&)02;9ZC^^+8H"X4%Y]T2*.N9@@B9Q9-,O,4HJGDNJKEL*K5?)^
M.O4^;C&B#WJ*5T:G&*#2JJ>-$G!IG'(XG@&*D#C1.**CP]K;_@J5;RH]56H>
MI/CSA-H3N9?/I*4?AIYU.?[%)Q:T*?^?*'K^OVJU_YTDC'[(O_63;^@I &YL
M08QQF&T1+&'OZ'4#@26PQ]_SB_Y?=NO&8:NB:&'U3)J@(FAZN/OMK=L<5#BJ
M4Z&) =HB?V(:4V>"EN:PZZJ)6;3$P"C4G"?8: =\OM] @#*_\.1?@PS85N=I
MO%GTZSND47I3,&37WA]ZR;H/1;J2N&,TWP*ELC(79M&W+>3P;4US L1R/(^F
MN<#L_:+3OP4I_.,?ME]Y-+%C3,DI3&*:LW)X'[0HDLVS\KQ1!Y3#L^W^XU\*
MG+?ERB_8>%;YW6/96G>#57<X'WU6 ^%#X>+!)#M( HID 'U&E]K+@'@P0"S>
MM9@6#N(UPF '],C:^_''[Y8\7V;^FC[U6?JY $\OAY/+];Z>:._='YBN/N#L
M#)UK=P"">R_!5;^'0;G\]O"VI?E]5U3_Y'E/OCU3LRSFGF3@%Z&2CZTWT(WO
M+LWO/Q//,@N;+* \(*FL/*,&+*!)%A! <JVM5]W@C6,%27PZCK365$74C'KV
MBWPDAW#(O;+RB4.B))?45)=KF<M=6X>')P3L=A_3CU!'F?CM"[1TKS&O8-*^
M$RLF7>OR.NB&9((,KVD8DK#J4'6QVKT(^3O18AU3D5E!65%-IR#>199?&* *
M\Q8/OF:D4HJXD"-9_%?*-0RN.UKV+9M%]R^EQIV?0D=!X*Q0.X@2 Y1_BP3^
M HNK?(#F90NKER5X:,:=]/,)FLV=F%8BUKWSR#:IK'H9P?[BCK&\X=EW1Q*M
M1S?-6"[4DJ^5Y3?YYH[;-@S_6"G=QV\A)>3)<9^=G]?\'8:)2L8@36BF9=V6
MR+2]V[DGV2B(FL_]C>KT0;K4J(XO;GF&M\Q(XI7[/8.T"-%.@6B;\N['GD>)
M=T2N$B63D#L2ATEW2&\;]TOP#AZ,T,U.*UO WDE<2;DH*67\6KR.7=6-,_M.
MY#FQX0R.2_TZ*A]L >\6.]WBC-S%D9*)Q=V09[4MK(4\'XT)"1K[K@M<L'@'
M H$XV4'T!Q ?%!>JR:91@#EEEMB[X"@T/_T(O>\U6US].?] 3U*J$<GM4T%O
M=J](EU!FT"D_%\_QKIWZMKO?>GKF2F08($/-C$^ ?K/=2(D[0<FY>3=H^GT>
M[WWJ\IN3<Z_',AOM/RNBGPAD_4L\C< O<#F,6$25HG<^.C?" 'G.3)@W(0]&
MM_W2YXZFZ;-6M#&7*5=5_6&91+UA(7P1^H:Y:M8T"6TFFP\"6I0,:<I]$NR9
MGO*2O\O%0&>GO6<YG4;._O /_GU!E7<>S>=>@-@O1<746^+1K![6>B?)Z=&%
M&AEJ7]5E?V5]FI8Y>B&\0"?ATL=M&>OU9>I-5!,>3;)<>Y8[:["'WC0_2),:
M//&U23DNA\OZ)CLJHEA%O_7:6<XT<O*0V*R$ !X]ID7G6&8")>2H;[TS(3$*
M*EP?XNDOF3;8BN*M\"PL_WB]MJ'^]?/DEL_[D?;W0O;/QX+HD4PC&0.<@](/
M[5!/[>5=&X)XB<(DE@7'P6-83L5OI0,\0QS9"FY'X"W7N.?\=PJHMU!-1"SO
M%JQ\ 5T"70G*7BA9KZ0?!Y+S&U9Z\H#&-H^[QF,/>M;CMP[<\T1^Q9)<L.W/
M4"L3,T0T];:'GNA3_/QW/;!G@)<U9Q[ -=P9>?9ML )_=^;3+<P =MR:SI7(
M!&NZ]&Z(VQ 6_P:+O[LL"#! ,1UMXA>6IIW T^43:4:9J"'WZ5 (VEP8U62"
MQ35"2%8S/ Z 4-,,OYXR_!M'U/JJCA(IR_#UU^:3DX!<XM5G EDL&:.<8V)I
MLYHKV-(^F@A3GK->!S9D1-8Z;.NE2:E7JYUDYELG.H<TI9Y]^UE9LL$7'%#:
MRR-.@F.63)LE.$C!+3-')N'Z7_3X!C5T3_2>L5U\I/OTP0A)Y8.1,'O6&/O@
M.^Y.<R;]G$-,^@-ITM0S&.I5A D9T]9@J/.0 KNOH2MOR0 Y^ I/)=+8I<4+
M-N,H7GM/4<XJ8\MFCEH4Z-Y+!!\N3'I]KN$[ L)IG5I\FCJ9D>N9<+:[3F3K
M]4F6N9F_3?R?C_W;D(]_/,/B?RZ7QM#'_S"6@SL1XMWW%,+>>!ZHNKSWGGX8
M86(.HETB_2HK]DRE71QT,9Z>=E2;7NZIQ%XEON:BT&(.(G*%=^P]-[E9D!.?
M%V=*TUO0L6!1V7X-L"BP<2G,#*(_7*$QB,O\F<4Y6'85Y>\CQ%LFWG9KF%\G
M/IJ>3$"-QU$>D=/CE6@A!%@87;A^1+)62PFE%^XW,&5:DJ11:*F67)U<_5;U
M0(""?3N:E7Z$9HR-N@7$D- M=GO#]7I7A<Z/1,""9/SG,F('LH[6R.#\4SQ8
M?B9.@+^ N1I5?D=\-JHBN/8RD:<\)?3(&<0G9+DX%<2Y8/'!F26S@'2SZ@O?
M2C3"AC]$[F][ZB_%U11H!ZY(RW*G&@-\%!=21XM]1'UZZPR?#H0 CZAS:<L>
MF^@*#+KGOWV)+>9<1Y\4Y@9KR$5<8B2$J_'89)\G:1:_&H4'BC-N+RGQF43V
MN]U1Y3CT0O_HX2:]<KCW[U( K$O;F9),)NSE-L$.F9R/H+S*;CDP>KDDP.6^
M15^:;(U<BKD=:"><8CJDR "Y85GI@T@1(.Y>FB4 (_AA":_,6GPW[A<LVZSZ
M*@<@2?YB,>U(^*M'80K]6-PK+#O-DF1/X0&\2=OME6H32VF[?(ZW[:[EN%1Y
M?_I9RW-6I^#DRU-L21?%"T80!J0./"9>LQO"!Z]B$IWO9?< 4K;%9602^9#X
M&=^1+OW)I04TQ=/99S?U!V\< 5/B2X&6CPAI;!G EF\[#J]88^J8E;@B _&B
M+*E=EN.O+']YU+\_03JG4.T_4B]$F'["W)N!B7CSF+E*()'TR%:H933W;+TZ
MOL%54PYVG*0D[,"K?)@!LKH@HS>ML&@>@^5#<)."FZQ1/$@9;]*BG>S3)"5*
M5L#DW2K>GJ2"&KH E]3/1)!+YHM?M1TT?DN*2#]1<)DN@OE2%;$J%:&T.<-G
M[W"E9_7CH<L!K5SC,D= )T(5$4>!5^1!,R 6RX+R?.;\16M:KO:[W,CF#N+0
MZ'76LDBX)*K<?BK-8WV;9R7IG/7DR8E&:.^*0/OB(DG!%"!_G/3,:B'1#(<1
M6EPC.6)NIS]->5Z_VF\DG=AXQ];FG:[6G0<"XW]!2Q>/"7^H-A==G#F,%$5<
M@)3#6E$QT#'6^_O>J2\C3U)/I$A[TDCMQQR=J!?O7$A=>R'ZR(+MF0DA$3BI
M]<6,Y2K 38JB:)/RXC6*!-N5M"Z22Q'Z4>:5IC9)1ISI5KR796WWRZ_9.#ZO
MO)*DRE:._(8\1+9N67OZ0$*"/!_K$Y2!-)VD$I$,D&E\3@'TQ^V^H$ Q^8<V
M66GNS_01DQ9^.V506=IYP(FIXQ;(0D_NK_$M0ZK6HB/:B[RJ9ER9\L[#1$FN
MPC;J9=KZY?271L]L#%O0K\Q"3E&/HII+(67<D3.X^9@@)><6V(EWNW[O"WX\
MW%;SPU:KL3T7Y!-(JGWX+EG2 I<T_H[;YH](IQE!H*6Y<3]IJR].QYL@JJMP
MM=S"#X99%3R9-=5T4] Y/NWXA243D$N2PI7Z8,HT ":KSZ*:'<] PNB2)27D
MX*<(VSPXNB79Z\L;[>6Z4QPY%>W3EV&I?6[L\/8+;+8D#"46T"6GK3K*?<D\
M'>E[Y5#V:T>)=;G*!AM>Y\/HSN>*D2JJOAN@R92#@6W>0!TA*K2>Z^.X1Z8L
M6>RZU_FTV3Q/5<.-:<>(=DKLM.1 9T%RS0MCA_CDUSMU%/&]CXU""./RN@$]
M:>#&6C-:H!&\^&C2NU%DR%GB3DDUEF_*U%/N1VW5QIT81)N.6H#JU]Y?J+(\
MHC0Y"F^T,OJ1*7A,].01_*5D)4Q"11J6[(;Q)3R@#P]H0"HT&PH%TY[Y.'O;
M![7L(!^5'9,)4$][Q]TX'/[QWI%#G9U-M&<!1K.C3?A9&&"-)J%M&"!O#O(=
M)];ZDD>6/8)N/@\OS;OWS?EMG-FH$AN>.08?UIAYNHMIA7'4.A9AH]R'RG]9
M7.D1/)BFGJC_9&>TY;--+9.< ^AV=:^ #%>:SO2I\]\8H,WP G&;Z3B,.N;-
M_)W5Y?:3+*M@"9H-\)C458@G8V*DRZN'KH:;ER8<DZNIX2E>%#E[URIYF#]L
MA?_I 4%)D7+L4=H!.BN8;[3]]772^&#CS!Z6 M [*(YU- 9(6UNGH7[UVVFH
M"KV+?FZ4KLHDX%*C-(!MES?HB$+R 5?ZKD1$'N!9.BI*S<BJ7/Q\>.WG1\A]
MZ[YM"8W1G_TY>Z\'@AF@I]>@DT/PD*) :G+V&S3QX."7Q3+B,5]LY$F63>LO
M$$&D!.*:=S6"CV"S.O]YO9?X-JF+M95#4HFO7BV_\R..-\':._1*RKXBU%%X
M^$529E0P <;O;57[X(V3W\8,=,9!T6*R-4MQ=>7"+1"OR5F!C:CVH@!JTPSI
M)CH,.J;<B7#&H7@7S^_FF?@6W5#H#FG9>Q5'U*UO9UD3JZ*S^Q9ZJ2TRY?,Q
M-FD3<GH'YHCG]/'XO>X"C1>K7'5'\-/"WR!C[[@?D;C;T%%HOM>KX - FG;-
MBD[98W<9M8O^^SLY+J]QYI?*GSV0]6("QYL=ZO4>V"+!X9-T@7F:W ADHIEF
M(WP1IGC[^0;KJS<2%C7C&SNB];WUQ [-C0ZBZ^P/&)Z-QB^*CXJE@8]Y9SS&
MP^*(FO +G=61S3]@Q/ $JCM7^&3/'3URW\NFNTPP>8 7)=S[Z6M0.FD#GKW,
MQ+D#1PJ#G!\IUW]KA&6$UV&$WW%7(QZ3G?%K+2?*HMH;91(&9J^K<>E]/>N2
M^6O.L"[; Q]C9W3S!L?G&T>/VH1Z6[<T2G_7@;X;!_*::X>+<W*7!!?]G5'.
M]TI;_/DX"[(^'7\>GG01\P+"--K$F/T+_RY:P4.#S@I(S;9@#]-DW7,NM>P_
MM'6(:^];_^3]L0/;ZT/@6H5@^N&LHIF'8%&D6$') $*:O-9JI0=^&M)M:IVB
M'>X77IJ=>N4"L3%4[\V_'(-]RE\2LD-X4&IO5AF\8;TKK;#6"[+_HXR\[##3
MI+9H8( :TQ(!DR#4+K\*:BWG7PK0\SI"Z1$<,]1%ID'Z--V: 7I_:9N^:P>B
M30 %#)"L?BN: JYG@/K7; 1JR+H3YC&WCR?/GK1WJ),5S4>? PK/_Z=+/R"_
M69K R#/-@6U^ Z7>:3^=KQ4&'V%%1C% S:;,KKZ_?\P A2@]?F5-REE")C=!
M5S51;;O2=V,[_AUAD+\>38,^\3\<Q-@_/?S_HB>Y%7Y7K6> NFJG?H>TCS)
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M$M#4###]%K)9)(8/@J0QET3O ,2&O1MV5\4QVJ)TLV3?$KS>6^4ZDLX?E][
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M9[69 <OY92XROBJ^LF2K8O;!55+:AHL[&W^6B:.>":=I"@<E:CU"*C? X8I
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M>YGHPR+9,>0V\MCK428*'QO>WX*N0L7JN)B)>TI;OY&*0'[KNN!B_ 9B<!&
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MS#/XU-6_(C!M.+GRD[UN'_(\$/?CX=RPFHBJX,JM:#=SS)'I% ^^N"A'_=?
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MZ'=<O'UW!U]HCJ9D\?+*NV5L%UK"^^I\(*XL;'JZ"I\*C,4AEO3YG0#[,EH
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M7,#('XDJLWF>!\5(;[-LTR%^>N)\9F:VSW;L$5BCQ0;L$B7@!C90D)U3S2>
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M@ >&GWG#]5J)/]8E:^K&5;X[H(=FB*!P[LX=:OGZ$TE;@7:+MSYZ_CB<(8,
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MZL# N' 3/3S@M-BYK[EH:E!<!4GM!'IL_!ZE9:G=ZVIBQ9MLA\MOR!-[NLU
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M@G4)X*JK'5?2LH<CBAF+*14T3U]LJ8Q< ,^]_I:("!GJ6.*J6QWQ$MB&J(=
MKU73T/,_G.^4@]^_I8)S-O@14[V^O72=Q2,V_9#;G[W@!]9(L &[CG!"/J&&
M) 294SH>$G)S%I4%%+\]11'OE=A>DQI4^U8V:"F(:T&$<7CTXJ*0D(I AJ3Y
MU5-8[+G8_=R[4TK;:O_+.\.(_D7!/>!:O"B4H;F-HAPH7-S78CP0H^9YSDC2
M\+38^">A8DYUA4U^>,SSF7F;QB>9CE9PM,N['U8O*Z?#ILN,[3T=]S<+TH[X
M&_#W/&YIT=FT<?T67<#B5]<0_S*]NT,1B5#2%F)*TXSK&3:<-F:8S=C;C/,1
MIQ_F+H6YN<X%GA\:RC-ZY=L\;B-Q#<L&&JLD()<A%_MA5,A,19C\L:XQ0L]H
MM;9-A4IAU &^E RU-?/I4YVT",IL8]O>5@K*%Z_RPW9W=Q'/R[4V]L=]3YHZ
MNKEX;,<X&^H9X+[(EBB-!,5?7%;*2HZ0S-=6(D&3=+\>/"=V\^*.@!JB>T(R
MQ>7TR7?CLIWW"KLIF[C]L<.>=K<W6GQT2E)+IBQ?;4)M?LUZ##H>@/H8.YP[
M'>^;!S%!,DL: ]G9!W0Q=853@J^5%85NU[DE%O-,$ZLCIK)C]R4XG<&K UYE
MG,5WQX.!ZT!'!(,VY[V8932V&QTY4(1@M&7OW6LCIHUIXO1E2'%(PHN>2UT*
MP0DGB%-;U4?8 $\.3GO4*TQ6ILY@5\JNEF^B!,_OJ<?4T$K7!F)7O.KB6["(
MX2VY,[C+VIV0'TR^]/(F+>#H@,6]RR]0MVRY:)F4DJE^6F*]!\B!LZ?UU=RW
M?U3(>W87K8F>$S2MV)Y^:WW(WO'@?'V^I_E[U>M8W24?Q$.,OM\??4DC#?5F
MO,6ZZ11"<:] !VS=&<2TX''LQBAXB&6_,1IUD+HM>:)__MIF<[FD)#Z^ /H+
MJ(UVCDQJ<",*#,'IZ37)N .]1?)\FR'\<,TUS%;>_?N6HHQ5EBE;<Z-V:V:7
M<\L3GHE?^O*>E9,*M5$(?ACNJO5.(>F$>C?.9@JOL55"_ZY$@\X8M0UYC<O'
M;\G,*5B_V)\4?LPTO-/6E*'QM8ZA!==@4%5BV&]PVUL(5:\M7U):$ANDI-OC
MHA4:F!XCPG-K2P3C>W&XCE B0Q''1PN8ZF 8PQU]B?Q3(\5B35-CRK[6;8SB
MLH\B\AF5F9(/F6E/=\/*.VDOTQYHJ=JPJM(@>6H3Q9EIG1MPEH:N,3I&[.]J
MUGS4.]PC';80QSW_73/M0OC1TC6O/$S6;*A47&K$A!#6:"O@]E/MFU""%I/W
M, *O$PW+WA=VFWV^:W/KTOQP,&]JG*(=C]I1?5M=]Y/[]UT1^0X2P:&^L*K]
M7_!?T.(5&U,[WB ,0HV$SBA*RKLKLE(&4<&[>GRNSD[MTA5MM]UEFT0A$9QS
M\IE>T!A#%?(@M\TY\9>$-86-E!6YM$H^L7? 3&_2^V8@.2S:D[ M%3#ARH5[
MT86280QYN$-R-T3+=LS&E?$^<#;2PCB6ET7I^@]NGW\PURP6M:9:9FCX?<AL
M*$$$OQ9G =D-=81K[\[KG:J2,]2.=;_EF);]]D?9<,U8@Z"XP7ZK%F&'!X\K
M@B="KUVJ5Y9&P-VN2NK2-(JQ!7>B"^:"7IVAG4D?>GFE:\RR6\VPIS1JVPWE
MG0FC1-UCIS[DR01<'HEN5#V+[\/804NT#KH]=;;N^4B/M)MXA'BSN]- C-:N
M]D\$HFA$6916O4J&IJH^D,2S!>Y.W%:U%Z<!93..X5 ]"Y":LC^Q]_5E,HGO
MJX5"R+!.VDG).8-1M.85LZVZ7-$EEW4]YM?=$!=!%2TD;JOPH&:2S:O#3.\N
M06%#_9J7,R;/#<ATCQ_9W_A0^!!IMZM,@F[('?_S_!].J1#E6]#V7L] >\(7
M><I2G;$XH;\(LPX*:+BW=&".)ONA+"P]+U)PKI;L*L7/!G#%G1^D$+UEE_,0
MWL>*8P,( ?M7YH>U7L346;!>?*<Z>Q+N]5GZ?'<_6'3U$_IIEQ^J841;M? 3
M5R5.&NJF:0Q?SZ ='#H1/^U74L_G1YRN0!'YKF@WO27:6(=D;DP/O-8H&_KL
M.__CX_4?_70V:,SV+U&N^S)TF'NZ\7(.9OO[U5N-7#+&/3:+V1Q9V6@E_MQ<
MVJ>S);QT:-^:@$WRC6S@FC(?9A*Q6DNFY6BCG88.1QHKDQW$=#\P8@7&[X/1
MV/.(/6*0.C=WZ&MXY?EA-+3K]!&?+[B[976\2A1Z!.U\_!ZT>_+\3O,] _;Q
M^5<EZDRXNI_^M+]X0=U&LL\B3*HLZL*&?LGSKXW'?[JA!.DL1"PO(TJXNO@5
MO,5;&L:[@53%-^NN!",*_A%*GPTD/B<Q>9S09*XN]-CH$AM82_SI@/Y_%_SO
M@O]=\/^ @G]8S31G [\J7)H36K6Y:[IJ"_;=L$9(?B?DNOQ4O9L_TG4LTO3<
M$-Y?-&?)<07]@3F4$BP_$E'K\\L!M]58(ZOQ=3T0ZR'O"H4-Z WT#7RF-C$%
M2(8EG^&#&*NO%6]?U=W)5=$_/];A^WZE#[%DJ;[CJ/EY+S;PT 6C$\,&RG']
M*^D;V,"'EV#0<T$S-'/'BAZ3.<@&AJQ-V< &;03LHP\2(.'//U F-TPM?E.!
MWJ]>-EF]$OCK CU@+5\JV-$V"W,4 ?]=\G]=2;U3GQ0*/24-+>VO3/J.?K3
M%]W_^:"S,!2;PSR.,)$7OML<LP6_UR$?"ACJ"\6!;[#1%;JI5D6-R>3)@4Q.
M'^R[))0J4>IM;N2:+Y&1S7NC%]$!L!*^#<6#WPZ9&Q1 !+*6=-T<%M^#O9!3
M<=QE[<4O,OJ1FB?U,"H'.)8#A*H1TZ0:+&J "2Y)#2E8^?HC(%/FR$B9;=%;
MIR73Y\[B'Y1B=KM.ZV9F^0C%71&776L2G*H7M=C#W,4*A;EPFI#LT*ROK0)U
M5P"%@XH/D'SI^!8;H5-2&DV;UV^1,9O[_*+@!M>Z'=<H:FLFCMAFI#G'VU45
MI4SLL[4<//J$:$/\F*^K>28YNO/IXQ:=]5MNZGS(F.!5-NQ6T]I/TNV\^T-A
M:FI(7U%1\;+%L(^,R=O M\ %  !$@4OG%_Y3(_Z\>;&95?2+LGNO'(4:*NM=
MME.-1>]&BE[*W#/DLW&]9)&BX)IZ2(3N!O%26QL\M ] WM2 NO@#Z7>3C0:?
MI]2L.U%^+SHT99WHY5:.ZJO-;<<]J?XV?)00W%WJ]L?'/;(=8U;,0]66F_47
MQ;$21"+94J>A7O)&RWX5F=M/9>^]4O;4!6X:,^3Q'[<>CC+NKZL^_?'VQT&^
M?)E$S.+Y*E5HS9";./,X-2*\",W[(Q#>]+@UU5@R1&1 VB4T:),'ZK[XK<>C
M,NN\I*[YF9G/[D[:I(4A1]1AMF!3^IK$ENJ^;698Y6U0* IIV[7--;LVROQ:
MUNMNCF>A_#[&V58T<]\*:4JE1(46!>0>+VM/F).O#,^\*E&OT'([Z^S1\X\]
MN;:+=:4\V.MP?W, .4R*5 >+=V:K,7CT']TK/G!@4G!?TH\W@6O?T-<65$A3
MF\@E=<LS[RHXJ$O'.V6K+KE=ZU)[YA(_Y*.O=-64$'.UW?/JI/53$RX^:LX0
MYA%>&"IIL#W\:4%+JM6$YKYP9\(PQ5&EO[Y655[Z2/K*>(BQ:K,&KAV3>V'=
MG5KT)KPX#ITP,5F-X;NKM=5ZE)-N)&W@W_]N@XS/J+KX\G7-L1CMHE)=X/($
M&]B$%X-\&X2K#O552?[P('X.U+'+LG7<U^KN*AA5+FNG]$RA_E+H5F^GON *
M"3)*XL<T>58<,C?JO;L4:3/E;BTZL_/ZN>@K46M3?3\<&NJ-%ESC^_:'6&(
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MN@4NJ5'6QZTC-)2-2J<MB\\=>Y/0*CM<8,!#"-T("6#O/@"MO(ZXGU5ML'X
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M;\5WWJBJV\?U/GP=^PRA!9W>'7L %D':K]ATVJ+V_DSG$;?JA_WT?L8J=]C
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M/:1O+&U9R)0-<:5[3O/I77@YXE:,)I-$\H"[/9066>#&.8I!.DHOAEZ[(V#
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M#:^>D,",WSI,I:C]:OSW01R8!?N6,4QQNB2K&1;YC4]'3#)Y<N@"GU'3\B9
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M>&=I&6OX.WJ9"T5^LZGA&1?E'UCE9N>%#I:C.,A:Z^HH^/Y=>)>]AT/DB$D
M>]+^DUU[]CY($R1N%Y(4&='PHTV>9S(K737_FZ48VB_#BD?MY/_1WIE])9U
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M*YZ.\9HV[V ), LQ?HC]R$4R/&$C&=(!/5 ]Q-#'A)"W/Y,F)UMU[DE=<GZ
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M1XJ(-!5,L% $%5 !J9'>FP6"A@11.D@341""%.D@$#H2Z2(@TGL)""(UH81
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MC4M4)J!E'R]WOQIT,ME[55*-_=V'=]-8Q%,\:#:T>7I,BF"']PK9^L!XK7;
MG6P,#K>OQ@L%Z4B@31JQ3?K'33G6M-V#QU^<.,9'-_ZS2GYWG8 F/LU8VM.N
MPEG,,3:QWB,U[X E<(WH^J=-IH_24 6CX!Q;SQ/WO;C>.IB8F79ZO]/$/SO:
M$E%* N"G\5X?H8'F[:%P(YO"46>F.2&3S8_)#+GBU0U]</ &G8OKHMHG/F!-
M=#?U2G[1YD'&^FYZ7FFQZF!QPZ5&JXL'7H3<ZO'6/$$X<6N1;@%#E$IZLAV\
MG_20AF] Q^"<Q8OE4%A)B\%#AR+GS='ZETE5P\>T%QVT6&M/'IB3N-H(X*V=
MP<QP!R^B5"2R\1SC4Q6:Q\;SG<+QMD1(V"<K58ITN9LR0+*>EG(:J=GPVYWR
M6B,X)9,0$<#&.8HX\5+SK -FY6HN7 'OT9#J/Y/)@YI]_:#>1<VH4%*M7/_-
MYOFF[+#Q0,;JGIZG,U5M)C1-"ZLB<\;"E.[0?-=&3R160 #?^UW@:A\2K3&]
M:E"QNN$;$(F20J8N4-8=_4O*(5CVKQ:M3]LVS>MKX\TJBNHWKW7)8VT+?PAP
M5EY8";N3>ZA2<O92KL"# YO04 J7)>+S=*5P'=[I!JZA'#F#.0YCU.\_Y:E\
M76#."&4P@$ZW"18/&5-+Z'PYV&!V,)&-699[(J6^$6.+BCR)4Z2H@([HP6$0
M9PS1HKG)]K;2/FI5'5FVPS#Z/2#RC9.P5T?:]HX0UX'-.IB@&7&;Y W3)X2%
M-@MTAP8C!(A*1D^O5P^AW2*9UK>M-/-UX\8G,O3G6SU1RL&7DA*-]3T"ZDO:
MA)RL]JL1#,3[<Z!FKV?6<E_)MW"1LPLI)5=G8GA^!+7?JG:3C^]T*WT5Z%!>
M:R;V?<$V,N[-\)!<W8OBV3.*<0,F?L%PB72BTC4/J69"]/%[-S9[Q,LURGJ4
MWM3'ZWY#1QGXBL\<^ H 8 2>K<F-IGH)S3@JT+IZ^2>7062.&2'3ZY750UN1
MT><#+AL-WKY\1N?09_&,LT6WUV+3;V[DYWF45'6U-WI%%=%0.9XF%2=PCJ4T
M^Q0T0?/3E57F,K\H)V11 6=_S!C*;?S;"HD7?(,*J'?O3W5M0KUZ-4$J1"16
MJWVEB&2SC.%YL,Z\K$9AQK<'/OAP9F'N2F^Q"O_6OKX> ]]-78],?XT:#XOY
MV).&N+)2JXZZS/UG8"9B%58G2,-NSB#,_);+V$Y+2=@8)K($_=K*_+JJ>HUF
M5<6]K+P'(6<[@1M"(_9S*FO*_Y'&N/;RL!1@<.2L$%WNV9Q>378JX.1"!3;G
MV/;WN)#_?<NMPG6 C>"+H@+@TU1@^JT9XFS_"F-019#<6WH7/SY1&E#1&*LL
M4&B';(@O@PA'JJE [V]@I=??P<HK/P_+/!&"C#0?ZSE2+2QD2Y<+V9@2(*F1
MU VH (H/N?ZU)!HRDTP%-DQ5>DB\@E1 3Z0$[;9X;WW'>*EGD*A/N=*[G;1P
M>3\UAPKT1$%V%HU^O;T]8.J_E049'4.2B<U4 !$,^O7VNA;P1T2&]/\K)(P+
MJ%7Z?)00W#8L_<"LVU?@.-OT!Y_M$<K?]X_YED\%>*P+R0K\E)U;9(/-(](9
MZ=]_ILLN\!+TKR00HG 9ND]>+$F)A%S<'Q]>C/G-]$!3J< _L8\W]-?ASOSU
M-B^WY!I)%+2R"J' ;:@ YE+,K[?O,@)%*%_ZJ<#W-A!I2_K76QE7Z8-_D?Q%
M\O\]$KI/$$]!];-(1RC'5>Y"U\857"<?(P6,+0DLV&(FS%.!!%L\[_Z#,BK0
M]\EMDU#/TK^/?80H)+='0[ZYL>$4]F4N716]$BU7S'W[6%<[P'8+^@R#,RX9
M5V^!5 VOWG+!-<_L5@^09;'[ETF@QDK5$U6$#ROQA[_5&H-@GTDW(7N.^;!3
M@SL@,B^$L$T%@@_A8(@N#&M%B4+KU+DRF_QN^E<)U_N8I+^+K=5_4]:G?'R!
M\TW&HX@G("O<^WFY'20OLD%ON9?SQBCQX-@L6#SE11H58,PU2);NV8G*"8IP
M?1_[7#BRQ>";2[QA=N)=A^19GKJ+?EXE/1MUX/F?^ S16LNV B&I_D"Q\IR5
MQ N_C:0"?*Y&+/L9NP,.W'6M["TN7]FSWS-7/.[F,DT]]SEK(KL.;,!A72R)
MSA_P>Y$Z8CJ*P5WOM#"C'%OVN(#VU E[=7"1C?P^I.%,"1KYBY+6W>XA\8U3
M@:O8XJY?<-\T5F'W>'L?-&Y+X3=J2><W][>,H%<0Q?\[NOB,K)LSTVF+#,Z!
MC /) 7^\EX?!(+J>#0L-FQ)*:+)6Z?78%E)UB_3/*:L-MX\P";%_35=PD-^O
M+2OHM&8K/ ;?/XL):9 A:S?LOT#>97LR=618P\9URC2R'NF'[711AC**B!];
MGT^LKN-3M[$,_+C&6C&(2-M/%\0VP7GPXAA>,O1^.M%*N09D-5BD8N:>%31R
MMV'TK>@5<=;JRS55'OQ2W'B:]N[T(QU>W/-,G?$*2G9J[Z&#W3+Q]]P*<+6(
M]KO>6_($%E?\K%.2WB$[&/[C4K$5U_M/7 >V("L^)&XX:#\*KG@_ Z:-W89R
M+;>O6I_$FV17K=;6-Y9]T834A9M?KE3!^FV8A=NMJGR?/@IQZI;"QL1X:GAE
MPW9:'Y6,H9'O.SUFD9Q6KI?D],1-PR;4^<)WGQ[8>8^:_/[5^;]+ TI>40%W
MZ#%$YWFUMFY1MFA(*6]$@ZS;-"Y2R<QR$<5BA^?B(81\"XH2]'NY?.*+;Q13
M;>H(Z,8M<^GZ1N_>DP]NYI,0=X\R :09Q*5 L!#-N241V*A EB*,1,.']]@H
M:M!KE$_G44$5J%&2]@!"""[S 0>.E%C+DM.0ROTQ;8>Z;I1KF1>A[]/"6JVH
M>)33M_<C-Q;!1>R@ H?XB:_]L/NW-(G!."7M4GQQW*D<;)W95H#V]MLCI9T$
M?D?]+-/:.PZF(J:L\UVW/2Y;#Y,X804M4\K[263969  ;*.SI;8ESDHKWTT@
M )/$E<1AU<T5%_.ZZM5K%NWKW0M\G=_6NH%'V?]T#2;M<B!^IUQ)M:,TFH+V
MY MNEI'O4P'1&S17\6Y!S#[/X!FB62H4J]^+>KEEI 4/)Y[]KQ3W%I3,":7H
M+=10 =LYY(\K*H1HN!7-UQRF O$UQ<B1ZND](]: 3.CE)&1MB0FBI FZ(1E3
MB#F=$2%;OV?XU_$H/\?P&Z9*@9S"&X99SDZBO+P,?85"HU8/S$!&[\^@PL#G
MX#IUH^\63;2-#E8?L^I"W"F:ZS&-^YR^HF8_<]!M:_WOK<6N/DV_3E FDR#H
MZ79=C.-Z</*+)&L.W(WTKYV$,U8//>Q>?8O3)"WS7#OYO-#AKN[#$BGNB[.*
M^1?D2Z9ZPK[<ZUBHU[J!&C6\8="9#(T<#=AG.TD4P0W/J9&Y,82-M/76X4W&
MX6V& ;)97A-3C&Y?IDR=V!=O;HUJ44:(XC7:ZBB9AM#!Q)HPK'#^;#B8MBJ.
MIF8N5G*8N;Q477X6='A 1GK[(UU"QY)_20H5F$E O4^M6C$BG?W8(--O!+\_
MVQI! S@)[,P6\)R.4L8^;KNT]$\;[+KC,7END8)AQJ[WVK'/V[OQ1YV.^TH8
M96;+/-(>AT!Z_1_1_'A+G9Y# 9G_*7TZ-.EKF]XS8(5;09W_,V,4MXPB*%91
M$IJM1OU(?5M.?;@D\G.['PJ?]DY%2)=D0$S_5!_!8<)'(J,=R0#Q!2Q)E,AU
MB_N15]!('S<UH=/ -U]5';$ 4;FG=L6:VY2?_JT[NUL[%7 KTFD75L.]BZ"P
M$0MPG8VU!F11\ZD8O.K/EM,-(V/:B6?1+BB#.TW^?2L5L2)Q7("VH3!C/1E)
ME,=BQD!8A@J<5^LPIU:.F\^5)'EFCKK.UQ)'&G7E!95MK"X*QI9]<Q+KU+"@
M#4#%?C!<"\MJT)QLNC*.O2"S1KJ>/#9N7-''U>DDUF;L>"W-C(GES*,GFB!-
M<\NQJ;%6?[M["9?E7''=G"%F7%$A]-X7CW__</4.]"A" ,:+!07+DUEQT\VQ
M/P0NO$-TO!LK]S>D(TMGI4:V3_+Q=[1+5CG_9OV6Y"[56L< M8/;LH_O1'H<
ML^S*S:Z=D]/1 'T.!(L,/R@!P36)7D5$/0.BZ ,_!"_>LV#_0VXC;TNJ0/>Z
MYVOM\>XG\<Z.LC\JVA;H'5Z!LB V/^R2"#=QT 3<R^:/N<EVHC#3:YB0!4'V
M<EW@V)6NPN[HU81ZI??>QT\+*\PHA(#0.RV@@\Y38!#.>/7&Z,-NF6E#B[-P
M[K?2P8[1]AS1/ZKOJH(]8=^Y5S&E,:$40:(=P1VW%H?+;-L+#5?V'BY+]3-^
M;5]37Q]/\%<0OI1^B@I4:,P$[U[DHP]D K8%_DL&3KX<-AF.8UH])?;R3 MC
M=#-+T$5^X6<<VUQ[_\<B5MF_!:7FB7^3',U+:NI:H@)'K*/(531%^<V@L>F_
MNOUE_#Q,Y.\1Z.PZ41)#3NR^3VEMH^F ,+=5@;WC=?N#C\JW$<=HN$HYP.'G
M&116W_N"_T#_@Y)1: 5R$I(?.=(30 4RIZJ75I#.T-U3E#-4H#2-9O1T/O@,
M_JES+0S^OG_H[S=(T4;Q@]+*OUS2^B]=LM'[;QO \%/[+QL8B3F$,.+@K.X6
MBAD&T4ZY.52"BB_5KAF)1*7I>.2&G?-[:-3!=6!WCN;:TI1JH\$#MI%0PO&$
M&<8GVU\QG!0Y4-DBQWAG^(/4\_P<Q0\EVV6T>?AJ.<6#D\#Z$61#FAIF1S0Z
MS?&V[.P7@R47*4XA9*''Y<V&ECF=R ) \,OW=8EJD?(IDVN@N&#_I'9,) :-
M(O.F4([<SX/MK8W!/.'&N6'HY<NU%D@FHB_CN,"QTP>U!!UB.A=Z9-GI]"/V
MJXA2.+^/F/*=IFC&F9YF*SFSQ0;A_KZASZ?4P.=<C@>JZ:Z9C=:5*ZY;>]J$
MW7[;*32_"Q)K-<OROGTA6&'VMGE#_GG*H^S-\\G2&?6<F^R_.$Z_<YY+(@M6
M03_E*_["?4H;35/UP=SJ:$OBD774GO5/Z>H*D-@%:?5J<6_I+&'_S";U%,0P
MA ,A0I8F,N?#EK'@<(:\674/?;U0W;XU1X[VQW)[B6B0DY,X_3&F(YY2\Y-I
M@]]D\1C*D;;;G"16XF'[!Q!.SACRO0_EA 0<6S1" @["X-J;4U+/R/M>T+D^
MH%Q>V"GN6Z22NO]A+*M(0%VF*JY*Y$[T:&,F-G15#.<UFTH%R*+)C#3?X8C!
MK#-W2":V2*GUI>FP2?&ST,^-LD+UM._UB?Z<(P.<-1BMFTU:C9E3B'R4%(IT
M90LZKQ!4Z$'6J!(0<$[>6V)"GGPCU_7E].TVC?>\=/LNYRY\&/N-2U-H$(8Z
M"J?#VS7N-!PDIF"%():]7EC%*9>QU+).SCQZ)\9,EF^G&QEC+RY4+J:S1?QL
M8SQRBZ!*S,')$7OT?M9IN R)'GQ/U*=P7M=W& [;V@X1.YJIU')\'-WX:M5^
MLN:>)BL-V)3E1#2PPWH("-P0!@=JPBTB>-RNBO2C[WC<9%O9B7"*>.Q[1>)R
M5H=,Z<V+#K;\Y0GS4#ZD(UM4VG'<!\+K&2I E$84X,:Q'^HE[-_7XPBIXK77
M49?I!=Z\.R<_:[3Q-F!=(/C )\ T ]$J8/IQE9%@BVMX2E*SZGXX4W=XK>B!
MQ>ZWJ9TIJXD.^5Y/NMU^N;(U@&[!_A C0#>P^%/I-=&4U]M'/:TH5CA])1[2
MS,IL/NB.[N'^484XUU>O)OLN\S&6.#_YF+5.Q/3H9U[O2WSM"RR!UQ]GWX/P
M(L26H2SRRM?OM7^L;:C)F5@N<"M!VOPHF[(<,5>I7SGU\O#%>&.SEX?N1G3Q
M:(O<D*9K0]X59'N*4,>E)>&G"4A\Z7GYP7>E=@6+/.8O,$Y*';E90WW=SI;9
M'[J\"XKU"EY4\W]BMI:8\0K;HP*1#T@]HYFWWP\HQXR5&.#+NE6KX%W1*C&$
MF#$+HXAOJ64N*!M6T"BOC+88Q_&UXF&"'E&CA&1F 7]$E)K9=VJN926$EUS&
MGUG:T:_N7U597A@\/G)X]?OM,ST"N]WBGU\97N*9LG)+QH-6QF>GPU!E%3'/
MZ@UP.RTF5 #M%4HV5<W,)DZQ'IU'SGKOD!HF5!1!L4/7/<4D6)[)&679T,=E
M &S5<+-9605&HL4MO&=6H0?Z ]BM+C!5[TKPN##Q%O1H\Y^JQ-K>YHU *"V:
M3[=U8.PQ7&0EO*61VQ1/\IUZDS&326%<V=F7?>K1[3O+PM]EGS/>^M3SA>Y?
M"/^G'_W>B&)?0;J#QF^U6 /XX\<FB&(?44?1;HMPB%S7B=J!"GN2WD17OF9<
M9M61N)!/VDX^(2=BI%,(Q<0\MD8SB.,=N%L>%?"D LT&;,_>$PM68_8S:D6J
MCT5FJOH%I)LCYKJ_D*-WIS=-T?]RV+I+D'"26(:B \T9X;)RVI\2(JE <+V&
MI,1ER"BEOXJDX.V1YC=2T^:S0'Z]KBF,\BF^3%)#3 L?),K./'MLP$0VPOGF
MBW]]:>(L__"ZLOCLQNF6%?\3<;_4=ST?O7MU\&?K=K@9WBF0S#KC%9+&.+2&
M_J S&]JR+]ATQK62DV]-SGW-P;$V6>IX5MHU]R>A7>^N?[X,:#GB5,OQRX09
M7-(J!UN(2@K;$;(*SC&3(<6GR'F8AW-ZJ?;)[3BQJIHK29T1DV"7(\$*,ODO
MQTC^T*CS7^I(WC3W[7L;)&3Z<+W96V(.EK>U6\TZH5%8OO_0\QSO(0N)E\-V
MBD"GTX,RG9ZN5EZQ<^G,4\IXPFL2B#)*X<;QAF3$CS=::Q"119.3BXIZW:R5
MF5G:IZ(G+H:/;(R79[UJ?V7$7_8Q8>$TL:Y]$]FH!*(<$92L\09+)WGQ2K[S
M_*98]'Y 5\#PVMR*=I>_Y'$/.?CT-NK"(RH0AN"TI Q0@4I0*$7!59AOR%V#
M=R8&6*KUJ&BKRK)TZ5\2>)Z?P1]_]I21!$>K:\Z#X(/_D7QI</SS>2Y@#<Z/
M/]I.:-ROT-":8>-HE.\)TF#"+6LWA#9O=#4Q%^F;&*"+NCYG,0FH>^?QN3]S
M]..S/;P$F4$AN>%&<UZ,L!UL:%1%0>J-36QH*ZM=DV]M]E:;1>2XH#_WJOCK
M+_J?1!/M',\Y*GK:7A7_]K^9.5$^L*;\LY,4U'#PP>I)GNO:JR*F9V]^SRO@
MZK@;Y$V/RWSR]?S3".#M'Y0F6/[#.*7T0=1OGG$@CK=."20T)M>[%#:9H3L#
M@0L&+P>__B8=DS07#?X(D[TC^IE=.\DG2 RTV9WO@"L_CVE*RH0H.&=$['+B
MO/\+XB\:$*7 >3D_H-S;>=N"Z&#!YJ[\+X]0X%.R*UZ_*3(CDBA,-?1*9/.A
M(9CQ1]PRN]!%*O 2-SR*^368%G#4BK+TP6P/PX3\E PN(W]&_L,J"^.>?QBF
MK>O)/OE'16NFD'(T%=C%AU+VC_SF%LCY'XSC;ZI,[O_#5$?ZD3_%?^"_FWNZ
M3>C<%FZ"[(,/:*U_TF=PS+KL].+%USBWN.)F0I"QP?,&Q2N& %YE$3C*N#Y5
MO;<K@VE-*H PMR$_T!8V)YF&77+/_00P;)?V7Q07K6"<D4<FK?2.*0\P^7D&
M^GM!W_YF2':W21(95TG:,"-QS<\/.6.;3U!6E[=T?I."\Y.ET'] 7D$D-D(W
M%/(HD%XN*O";BLC?U% 6H/YA[/61T^B?)0%N_>/2S&+D/\I+<ATP^/61WU9,
MUOS#*+'A(<@_KN[,__X'86K-O_C_B_^_^/^+_W\#_Q0?&DA;@Q!E5R!"8&F:
M2:'O)]+-8M2;K)D:]'O"30DWR<EIE?6M-G$[F16,]Y^'^#8>*&J$%")Q4 6B
MC&D(9"814RK\=HZ-6=]VFK/>5;*W0<"E[TI4QP-#_[&G(HR*YIF,YPZ9:X<H
MM;P&A4)Q[J'D8S$_D40L930)6H%:9<WN*8"K$IT*)7,*N_,7C/$*86;UB_)"
M*/"] H[[8#][?^=FSH5 B"9D)@*#T^OF)##3J"V(H80GQ*KL5M[6Z4C?9(_!
MU8H6&.IR+WB8OG(,*792#.]S>F9-4;OYM/U>< ")Y#TZVDPZ0XS0+;(S87,*
MN?,1@M]AA1^R9G"AX#Y 3!!V;:@-E5 B+R7QYY;W+^ KOT3M:*Z)%+@N\P?T
MB$JNBM"ELU;UE[KRO^=NB"XTG"LI1\ZDO*PL)TL,C3UVGHCA.'WH*VC7AM7/
M87I=OQ>EWP3=.!>3A1&;1OZIJ0_@V*OYOUT<A5%%/\X7H!\])-\_P_+^\E?C
M?'N3H:_'[E9=D<J[0J?\Q^'23:^QY2:_J;/[:=OKS./F;KRJ509.^U4.6(+-
M8[]L^6]L2"^&IN/U+R-]^&ZKCR,&=\-*$AY.1Z!P^E:F6@9/4:7MC592QL1L
M=.M,IP$S7*.F=/!!ZA4?[F\[\>-MA$Z6%&O3^&LK)A/%9W*646,I+0TBN-!&
M(8,680'\5AK72\%]%2\- ^XW2JF2'>NK?6N+6?@.'K$JEU?E;V\#I1]OZG29
MHBH56MC"TB3P):TEP2"T5D,BK@3[+CG9,ZEXTKF2LZH%RG%XS"10U\;RXZL[
M814<Y?S,!8?F-<'3_.W*AD<UP9.YO\8FZRT(G7C3U0(LBFFL:@6)H\'<\X7]
MX$F:4[\VI5]WN /H]'(BH:ME:MSYRW2/B,&'T;V:(#KRZ?TD!#OB*P3M%"H/
MH8WZ&*@%(O#P&VZA*,]-F <?4)^L51G]D&7OGJ9V>-C8I-Z$)8LNOWB;IKK;
M:DD(D@W.A"MIK*30$YW>CKDD2T3M2/;<>*^E*Q^5T"$7UU;0)!TW0<]WA.$K
M@PQ;V#1C S_<'!TT/LO[M$B%M]QV+V"9X?E:ZZ?&^*G9,V7C#9#G:B8[N106
M\BDT40E'&,?.AX9M7S 7U!\?[3<<\IR:73+R\5-IDTCL<+'TK[L6I:\ZV1[O
M3)?WG[#@0.S%0VC$=?1)@8.ZMPT9KG:<%<Y*(/8O9@0J_=.E@_\1T3[<6:.W
M)B;&+Z3E!#-M,F=[JMS6!X<X][:+KVMLZ"MURFV>Z^P0?ZZOV[)C>P,0 NCT
M_O\:J9^/"?E)VWS!C8/L1EO87B0HA0,=OTE26D4YD;0';,J[1DCGM\<0B1^H
M  <G%1A$(1=HAF$](."HD7;V-8TWIM!>4";.X\ZMSJ7[D(H]L:VF"'(/#=N'
M4X&E'LSF"2JPTQ!##$-1"FGLG6&C\;0\M%?A.1VW/6V6.;T)N29=TD4%_N:!
MQ;\G+S!9W64<<MXA]_0?D=V$4$1I[!> J4#74RHPM;>70&&:)R%HO^(1#-FR
MMTZ6\2)J0;#'ZRN??J9,D?S&- 9\)U&B\J]&H^Y^OY#O<*E0S#<B^M&MQ 1P
M%&W>Q/XH$_W_RE48$R8,QCDUE1QT@W VB,'BAW5H:SL47;,M[V72D&"OZON^
MK4]?*>US;J%!7\4R3HIRE$(S:;4!SX= 1 G3CUZ<%,+#J@'*Z6FS[L]2G2II
ML;IKTQ)=F?TKRV^4(S5!;ZA 5=(JA/1S7UPS"&<B*,0\0PCW4P:+#-UJAC"1
MU;Q;=+)=#J],N[QA">N JJYA=T?46!*C 4K>SUZLJ%+>)B11RF\E$<LVJCZS
M_=X#0AM%@9!<W+,4TP'QW36O[#:$O[W<2,?A.G9X;CK"&=F8#<+I8HB.)8&T
M:3YTC/@=&R/;#N%4;N1]LK(NLK\0AQT2:?W(N-8)N]21ED$?2>]?)H_H-&2,
M__UFF$7>U4XJ(-DZJ[#WPX$*9,<.?U^%\>>0FK;VS79C!)"?AD ST+W;/]M+
MG-W]]Z8H[@U#N1[\:) J:8*RFB&=EUY6*DXO=Y731^I5Q*7:N C2OW90[)AO
M8>P2];4-/#BQED/27]R#KE[.I'0F"1\:BJ<"9KCMA5*/XJY2^816S][,#)NN
M*%(6,,]U]+!\,K!5*_N,N(NO1 8U")75?6TX[@96'%:QF"YW$>;#[89967EH
MQYLIR<J(^[1EOW[U)#YR)_5B<\5^GBBN?66G@/(5 P)S+V/8BI1#?4Z%%W0<
M:MUJOB=^D8?104&N6.S*9'SK_4!GNL'%$E4<<I5)?KI5D.TIA)/,I!:L<;EH
M\9XK1;@RQ>CYDBP)]IIG5D04X%D G5$2OWQO-?:,1J"B=>2<6NLZ/9R!:%=
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M^''T2U6MP6\1$E4AX@PZ5YSB7GPB<?&*:'++86@^U('KN*I6%"/<KX08V28
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MH.?"![F&QK0PUZALXPE)?<.K!V6E/L+G"*K3T5A)K"\#,MYE(3];6T&0@$D
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MJ8>.W;86,?=-:HJ=EL_[*$1*3+E69CRS]H1T9V/(<$27VT?\[+1W]M*W)<V
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M'2X*(X5W.[(:BE:Z''+YTFQ8^\3OFXZ+SRVH[EG\=96J\"6;8:5J8& U^%5
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MS+;H+\LX_><]5XH__O*>JVZL?_G.(74H^40[ U(@7YZEL 2;\*6;6L30$D^
M;"YN>;Z7XI=.-R)MH9_LRO,P(!_*=,M__KH:U>W;;^/^+5!&6$41T*V2L'FI
MEGT@E,?5T7.5EK-$J,I/1B+I"INZ>:!A_Z0C\_\V#_O/=VK_C8)'=7_<=ER#
M,B#!60#6,&(:[+?>DFJY\>N,N^E/57CM?O!2!0S(YVA/&1!_[/BMF>WW<%PD
MP?;)S#37DF-+MF/_Q<0XQ2*^*\QY4S8'S<.RY/TJ*M_VB+7*T-%V2Y94"9!M
MRS$@,Z&TZ.!IFK".:QR=4Z,=+09-PA+M P'U8O)S<)VN+]NAJZ=78E[[YND
M=D7?:"TZ< OF$ :$;<>_V67Q*J0I"'^BZ0&DT33UX'O%3325/Y3.\W6T29Z6
M3E%#MUX.,4^R/"^A&!R8>$//O:%&\EC9:X&]0V6G*9>O?CC!%7= \0@]VEG
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M/(E8U-?DSE )G59//(X)Q/IC/.ZORH/6=;U>"1)/*\\*7(%W??P-J2VA!I-
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M[Z;M]GMCMQ-_X@!SL"$;P9(_-ZU8[Y\Z\ -RRJ?_M>E." =8Z4@W';.@-7-
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M%""9=$G+RIB> X]NV1"2U?QI?W2S,\'6FEUD@<S(A9+F[AS1_4^:\>G-A>J
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M@:']0QOHWF^#NEZPTR7UX<*-%I%;,P(Y)U?/Z\5-#/9,6@M>><OMKR?]H"3
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M0C::VQ\4R6Z]]'@F2BU')YMOI"*A<\&U8 W_&0%HDL&=)QDF0P8$O\A1QZ3
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MH&E[A829>?=].ZWQJ[V:W,K*RE(/\_+R'/F:=KGM5*]4W7(%9BS_>+O[+\)
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MM077G\<;'^Q]K7W:5^*!0RWE&2=;X3\^0PY% =E$R.20$S"ID]+,H]-^JMI
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M&C3=J=N%08 #_U[E*XQZU?)W-@NT+L$"U=FN06KLUPYB*Q?:+-PI9?G$IJ1
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M\_\J!,_]KX7@:DP#TQ$:Y MS'C*A6\0 L$PVM4T#.),KC@72P.WA83O+C1A
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M38LF>ZKE&)!OE]%^UH=Y*G6D5#[2+'I>YNIQ\TN0%+G86.4K8L=CAEP/[;U
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MX#I_ 30B]@B"R4LS6NPM6+9G'D%89&9G'ALT#N ;::;I)N[U'%2.A[I,HIU
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M'FV'3[H/7+@O_*A@7?!4W4]=<\?&*2.Z4<.Q*?/84#<7;?@AIQ<'0@!G)S,
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M_R#Q*I_I&W%^A;:?:;@<&_K80SO-WZL^K2?ELGF"D P5M3&\@LD!42YXWQF
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M_WG*L5^QZX5V8,TY>363I2B#KJ&!VWR%P"/>I_1@AB/BW 2"W^\I>X(#-'.
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M %-F#))M@-"AZC$/G5VA4$K@Z48Q'C,A-E=,3XPM#NE6PTK; V+&EHNQ&&Z
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MLFQQZF:?9\.^+5K_Y3?3OY5.G3%_ X;7;^9/N;4SF]1[J]+(07U-^<XY4X!
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M3V B0S5$!85'C&)=2U=9U3MLFY(O?_[Z R>^"<D ",Q8"JA_R8CZ.W?POM8
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M5D-PHCYV'BPK1T;Q*/:J<V7I>/2#_:*)%G5/M'S'XMR[#N*M\*6(E7I0@&8
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M_G>R;EQ\R<CQ51H&Q$=I&JF3-:.0GL3W55X:LZR/M7@-D\,*MUHO_)@441U
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M9L-ZK'9V?@8PWOF%N,V#>N-%$=Y]"GD0)5/?G_F=LJ\^\T[0_'C#M39WV0E
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MK5E\DR5UG'GTH<_^B%C$/9Z).[J%JIRUQ4WSYHP7+,A%3Q&Z.SIJ#-I)$)H
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MBY!4?AST97_%RT]6,B>/SRQ9?(A0WAFH@22L8TQOFI,PJ9L2=917B%'M#K@
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M%7/#"E3-GA7&4.60B+*JA7T28$I#61FLP./,-U6AZQ_.'E5N*<7*9U__X3T
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M>1C#SM1B-"A<H!7^%17-04'V =V%,6S\5:@[5Z8T9'>QW!YL><7+#CX-GS=
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M#R((2S@,(N%YKOY7[;ONCX=3+ZY/7?QVGEJE;RXD!]EI?_#+]B:PCN6U"QZ
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M;@8#N T/M3%;WJ2>0JJ7D[#A&T]WA_.R?YJ^BMJSHG3"O7X=L\=5*%6+10N
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MF/SC]DU^ 3YF=IV$BT7=A;($#Z)Y1T:I7E=!LSRF.)\O_95W7S'Y>Z]J!?Q
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MOTE5(+(/>CT_!9W:%[+6\[DBI&RS1-5JMUC7U)%J/A7<-6[6)/_V?"M7@%9
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M_7'O_7%_S)JU9L^>/;-GWO=YGCW[?3?M>0];X,K)"/>-"[+WN2/5JJR;C^7
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M27O8U>8R^@3L*"!=@5R^:E2#'?'2OR>>W?X^GO^//(<7632H/;2.3>3S4GX
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M8"NI@H0^_1L3[P+WQ7^TA> O5!ZUD?PY[7>K^<$@4J7D<\RZ)ZX,?K00# X
M\W5[DTO1QO)OOUPBEKO !%S, [@G^R>T?B@96+(.2L?PNXX$"QCKSYRAJ$6'
MFY#1G00F5!4:DT7N-Q@ZA*EV6P7CQIO>5Y1&95807W>WOY)^6<52EGHFC"4'
MH<#:GSWNT,T )2Y9(U=75[Q; ):3"+7HGK67?YXF'\WI>'[]TC"OP75" FSC
M#0'!3^4BZ7XLK?EE+"62AQU/;7#:[N^1F54UI-"<(CQ2IRQ!+ [&U].8R!Q]
MR=XF\OI_'FAF^>]H/[2AB.2Z\G5W/X-6B\2Y(S\E %&T7MI]6A.MC@$2C#.
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M2.,W>J9_\QZAJN=NF+2@KKT5%J^CN+RZ-"+#B9.\RM9B#PQJVO*.B6+>P,4
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MJ*\(6TG0'O\XGM:NO.^\PNV7/;G/S96IOZ[-?L797I=DF1'&>Y'CVK-;O%V
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M;:6_^#VPGNX61G6+/&)RF=,:[YY,\YFR?9G)K\;1V"Q([0]\<"A>%]GRY((
MR;K,6M<%;O6J2Z:%'TW 2>[_#TR+^[^X=1OLC].2$&#ZHANW)Q?0@>?*P7UO
MRL42+F4MN2G=ES[WN'-0AB]5?8HSWB8N\R3+(=-<^;J0']61/_,"F,"G!*6K
MHH"D!3I'.@-TJ<N.Z<S<&"!RQ!^(.2BF:+.+HKT.;5ZY?QL(P14)+__2OS@D
MX>+N>9EM7N?UQ3=A5D<5([;*]N3>:_R?33;W_[?_C01]C/G_ 5!+ P04
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M&3*CPM.(0AV #=#T^QEUM3;+JRO0#=+@;^##H[!$&L-9]'4_K2E9 1O"'B\
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M(,M+[07H>&V%(N[58T30(B92DJB\<#"EU_M<I5Y#BW,@T5'T IPV>]/O^[T
MOJ#;6?JOPE(EMTZ=[Z4S.NYKYK! 2)K+7Q,=Z/<&QKW=UK7BZP,?E;4S;F5<
MJ.(F=-MOU>#:;N/.2-Z?F8=23E^NU=P-.\=F\(KD6*")^/1ZU?R;&K@37>IH
M8TS?94@4_XW;#*!V#.4<R';@74&M-+G5?@,,,#,HNGI2+CR_7<]8>CHU=30
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MJ19P)4CLO0HVPEI:'G4I;&UIVMDI7FIY/Z2G7&9BUYR>9;^P1ZD,\A,^TY,
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MH:L;6")I ]N0V@ZNI.>B_P:^;Z*:XC '?G$V1^*%V<7B^&YU,8A>XQ35TE:
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M44M^!*XF_32^A/7]K\+.8W8I PYYH193>([;W8>O4O(#<&<5@V6Z]<-@>A?
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ML*6[*[>3J"4,Z(I_8%N!J(8(''D1,?C$"%;_0OL=Y#,FSGI?9RS%[=D=>B@
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M1AW'TA*D'4'O)J$OTYW4H.]=7]9%JB_R"TM76]QEF,& 6YQ$3>%8Z%+C]W^
M-ME%^[MUGAM>1VR?-99P:>S_EE;VC>5@([C,^7=H[WU%(6^4MK>-GM1,3*#*
MI:#);]9DCY_ O=6>Q?JK@S6IT>@1WT42Y4\3F6CDZ4E6]*/ADNJ<<WZ\\=[&
MXV_<N-)%X1T]US>]GT?ZQ;>:[K[O!C]59^V3+%Y0682W-+>Z;E#P/)X;C6*@
MJ]C?+?C37HH\'(C3LJ'T?NFBI_BU:(GSWE2>MJ!NWS7HFK:!YT\XJIEWC7]^
M\]; 0;F]_*WP]0=Y_"*ZC#=0DZLOF.ZWOJ@+7'E_"GIK8I^AU_QR=''*GO\
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M($W^!\"<.7 >X8*YLJ]_)1)2;X9_/TJ2>%:D#UJ#"<;0>)GZ;S.[]BF9*9)
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M. ^4MT3G(O L[.E27\\Z>PUVC'Q18(7J^V@40W"OK)#_ZATU%I&2?@1V-;4
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MB*^I25.#C4L9.  -RCTP&:E0]4K^+T"F?ZFLK?!0V8N=6PD5K#E%HIC<S'1
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M<O\DPX#R6=7KV]GA/+@!&?='0O\\#H0'^IK'@F%7>68FCWA7$K&9IP(8KS5
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MI<..91JMK^1P!88?3=1Q0GLU[N=SF 2ETU/VMH/8!#TE#I86^BS.$50G\"^
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M<+GQ?35"&QGCFBT4$53OQ&&M/,Z>*[<_L?=)7A-C^G,H8)+X*U"[SHF#.FA
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M_'SI]I%^B?3Y%1'%[WSPMHN?--Q90A)DR4!2VDU!/PB7FXLT+8D',^XG\0I
M/7>P'JY2_UZZBDYY3O/]I:"^%:$!A;[,FBZC[M%1]6V3$+(Y$I@+8RT&)]C?
M=B%-?:Z\Q)P:'B?!!MS8'!.<<L6**34'EZ,#7#\&$-EH-KV0RT_B%*7B_VF#
M7E_VXMYS41$UD0[,KR:.PNJ2>9=6"&E7K__9D'=L$JN1+FTLK4O1>N/> A(H
M?3[E(/*+3XJY,DBZ39G)!Z=<"7 Y, XATRV>RMGG<J%T?'V:>A>QP@MSG Y<
M*Z-YM>LM%$V]?05"TQRJW#^TR8]:56YCF-=J%7Q%2W!!VA@2;,&??V)H@1YV
M$["]*[J;#?ZA?U:8:W=#/,C_\\;L:>-K583$%+.?8.'JDC85 RR>-KC'A5,)
M!;!,U.'HQ1/L*)GF?7>PDFOVD.,#^..IBH$&VOU+>MPK9.W]IOJ+K2,](,Q6
M'^+3(M%EZ*QQ2G:1JGDH;CL/5_Q>@>:7N\>/9P'+[1_)#=.:/14?FS[?\0\(
MFJ8O=2UPMY.F-K<GXM[+70>A\6D-&Q$/P3/N\=+!5<K?9@E.$O)'3]PH-J?5
M'ZR)1O!-.A8"+@N+;6LK[DD_*T;(#V5L;U?A#9FCL,,HV-8%)UP3NWM \]'V
MTBIS/ 'UTIZW,ON9J58F$DL$4WQ #;5@YK7X;KR"-5T4-T&D/AVM*-V8&DM!
M3\3C[OX^WW[$"-_PL;QEM597OJLMZ])^W.G9T>@;>W!> MJNE6D"0$<7;P/T
M1!@L7.S'T1?T3>N^IR2.Q/5@'>F_\UL2=+XVA<_N0(W][6_P\.-$$Y*R_+1T
MH=+Q_NP(C"J'<-^COIZU?K];Z*9<>81%D</4I[9I*_738>G^*[W5L.%7 DIS
M%W[RAKYYMV&ZUG1YU3HUEKEH:6L+P?<BGQCL<[&1J8.1A4M@PPL]KN3+EC;T
MV2,K:5.FC:_'G"ML.K8P3DZ<O,$^KMW'Y[1<NE77V3YED1 E#WX5&9$LZ0.F
M=Q-,Q*8=X;96^;;:'UQY%4>^Z:-Q[,46NF;?X\OM]@D8Y!1NKA^/4BN] M]7
M%JX/I/SH_7!2E("A70#]5RZR9=N\V1Q(NK1#M:GXEB?6."8L?F1-22ZQG;]G
M0CC6\D2$IK-IQD'!T]6_KH?5S%-$#AR5*$OBB. B>WV/C&2PC#^[?E)C77-\
M<,!@#KU0%YM:^;[)E-7O)/?KR/LI]F/-(G?YG^;U H[1-WIDDRC(L()(5$,K
M2HA:<*?IP-#<3W<QTTYIV]:W\WM1:$91^.JF299!K7&<SME.P&'BHO4L\X,;
M;N%4NZ;8ARV8[YMPQ3-IIO[F)4COEM=)84?!+*0,U"&-@4)QS_=E31O4TX5!
MA>%[S&^IG3OSS#058NJ@@(/,!-<P>0-,Q@X9R<)H;UM?TW&;?"%I7S&C*Y.H
MLL+09AAW6H7#HI)MNR(N?I-OU@(DKR"V'>EG*9%JL!/7#:84D_J3>"&1*[@*
M38[JVF!#G,JE,/!ZY&*/@3K.646QVFIQH4Y@&+WKDZ( 3Q\F];W(%7PUC2P0
M-"2$DPY$]!(^Q%5<KV^,F:K'8;-HL.-K;\<N0:4NT$#H=_R31.4[$.<R0]8<
M6VM7_H8O:Q&!Q1<76-B)K>'.X78![;K.MNFF&SQURI$*\<2.#,&I8IZL3_9K
ML(DQAW#"C'Q/[PLZU!02FR]!WI@DBFM4ZJNI2$@(XDA(,X'\2S\7/UXAQ!Z]
M)T[23HGY'5OK1JS<0AGRJY*"<  Z^0T,61;(.+AWE#)Y!539=)J?6XN]MW>6
M[&<XF.N\I9TL$O(H]1S6]&0X8H(Y8M+K4IT,-_VA.VO<CM@M(1-?2HTP%Q"T
MS+#E;D%\N>B"61;7@Y_"1Z:_^7+ -E&*-](@]QM]C#&^1+X !J^JB%DKO5)(
M/B6<S.B322Z.I;!1?0AHMUC)"$>4&9QLV98Y'7=@K<XO&+>I*F]<=MVKB6E#
M3\:(+4QBV +%%L]$DU82?KK9;8RBNU$W3^!I%6?,W'XQ)QU$@D#$0',/&Y5X
MO.<BI2#"=SINGAQBT:1H$2ST>UM[[_J()-AU0V::N%=%F];_!*]<7'M/;4I]
M4/KD;23Y)L98?$!)%$LO4;'1GU%8GY5@0D5Q9XDWP^85H!TJA"C(-X,/X[CZ
M[<A<I;Y43J9_*U(<?_NCKRPD9DAL!' 1L3,*^5N[2(S,,*&A^?)Q[:WVU=+N
M)C9*(0; Z'W:H/T.]289N1#'Z*]([+D->D-TQ2Q3;!,HUMN,+KM;B]@6^U'=
M7N2$/CZIMK-CEAMJB593).!Q'[^O$/%IFN1JZ\M 74,==7."NH[DL#M;;&'X
MC,R$4^NQ&/''S1."E=R9S4\0$]N&]U['1)!//WXV7YP-FPW(_0*[]Y1OX 0(
MBGD0POHO-G_-$KO_FWO!]YW\IX/X'@N/"@MJ6CMH["L5Q\PTG@P3"[TPK4J8
M6)1;\V1T?6WN_<'<=33UWBXRR[%0(2K!VUI2)<&M3-=T8("<8<XXUH&&@=GC
MQ(Z5&AGQ<8OHTA=6'0_SQ:I<=<TF^R_F1R95Y9.E!Z$;P=3@O@*>@I%TJT0[
M#06+%>A-/X2#Z;+">K)IO_0WT29PH,-0N($@,Q6ZIS[J<\>H,AK6('M9(Z_E
M2 W*P&X0=FSX\0"7&"BYJ;CLO;FYN6.)TL7"S?BAH!@*Q-!A1@^FT16*-/Z/
M_V/1%4ZK(X*-XT%CXU -9%1"G+$'A1(7:U;8G]W&JHI;=VE.BJ50UB&;72CW
MO<*W:(_3,#J1=1^-;T P,CSY',R@X(;VALUBTT-27(UPE;C,4 [5>P=!WY"!
M]9:[<A+RTK(3DJ)[HGM$Z]T40JO :%/L=K'[FVXDSRJO+4V%E$M)BE001X$?
M1EDNIG IP0I"BVU8. <7.G>0U(XPRJD8[E_0 %3_+TUEX=>]NS[FHW+X<:5Y
M:]".[!RN*=C4J8=,)"^0;=J ]Q5 U35\!?)" EZ!SP6OP&Y#P(^4Q5?@*'?S
M%=@L%?US#OC2X.\&7!8VO@(/]'_7WYTHOPA*/S'8![Q$8;P"SP^)KT#<%%*=
MZO_)Q1I'_,0NE=JW[!')%#M, WS K5I"W[.%S+7K<]C_WK_?N5CY1V4Z_!93
MOZ['M&,;S*#>=%;E#8!FW.>IG&O8:='3\^^_2&X%KB97WKR(Z= ]^S>_A(B1
M]WUW\V>P)KR(+V3Y3\^ZXT?L*M_C^(F_ D:K\<\$\ZU:G[E? 0AA'\4M1LLK
M,&TO!LKY]PI-Q^:6XU.BENCI@>&A 40,076A$86[DN#ZA4F;-7N#-N$],= D
M4H#N*?*C^I/FNZOU%45[>EI^2+X3)A_U7UX\P?HB4)"Z0C:6KKX=?"<#O9"G
MQWUG8:02H:8;NJ)+3)G--XE?[GDE^+XQ?,,\ZL3+K"'N5E,L9"CR@0"].['G
M7M-Y:[Z3K?OVP7:Y_D33DW9B0%&$@IVRCZ49.%>%P@9B'7YZ!;9UK*=I<I8=
MJRA]?3_4>[+W,J1P3\R\SP?6LJ7H80?CG\1+K#;(FS-D9--MV[\::6]K;8YB
M;IDA4>**=Y]P+9)95^ZN,M%:.;#P,% V0)ELU\4&*5+AQPCW_7CU:B:FQ&B;
M>2HQ-_5J@V<LO?+#=YC"KFOX8T-@AH[[30V]$$<>'L['G\\\")L9W#V+ORDS
M6FN"H)I.2#9[<!/T<+BS_0_?%L^W6CM4K=S7)6;T!O*Q)7',B0=-N+*+&O/_
MQ!=WP'K._);YEKZ@V_[.*\&_CF_@X'K@[-"1\MU:5%TV_*S&/:N!;21'@*N?
MJ4F[=K%$7'%\>\B@CP-D2UZ1\WK"VAUM]<CMC\'?L ?-8)D>(/(K0_/+=]#*
MIH>!^DE-Y;>U!#[G5@AXWL:G8]NY+577*GG[5Q63/]O47NT1:.J$Z V6*(DL
MVMIBY.E*D=.E4YZT;MZX+O+U\!&#YJPOBS\HTJXJ/2J>2B,<KC37!T^T2W@K
M.-^]*XOQ19UOO52,72A_EWO'"ROK3FHO5L(4>%DT;Y"%_(^9O<-7B"/R7J$^
M%GD/H:EU6K'"&J)\\B07?EF/['@A6>O]AM-^VH@=*74ZUBO!_4*)?3.RN&%A
M>7Q4+PZ</NY'KE%]BT)$]A&KOY+FZ.:42FD>.AO[5(5H97[PD9LD,TH$A4R*
MANE=&H;S8!!*U^B>+N=G\SO09B^#,>/,[;L%39DUYTRA/E-(AO\E1P$4I17J
MYL^R)U6:X@Z6AUA (92[$ W36*I(ZEA\:C%\=2G8H"D8I?\;LNJ_,XY&%OR?
M<;5-YLK-QZ<6K7IGU./W\27/1T]EB--LL4=HPBWUNC^;KHO'^$'%Q6I* >B>
M5<%1P&'^Y5ID4:_M;>B8C^SLG?W/0%Y_OF-5+,R-1)Z*5(*# =NEJJ6PMY+7
MM]CYM:-2_&<H1!<"-O1PT-K+D%7MU569:2Z=KP1,(<QQ8Y!14*B]B8295*?@
MH[,&FYM@ZVY'8[.6IMNYL[W;Q,@E5YQ<\J&3_2 (E@C]=U5*%# 0+^-;+FS
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MBX]$)LHE!KJ_JBC%[U^>+?25U(XQ-TG"5MGVY%!LL?.@ V'Z"C>>&[@Z@E3
M++=#.][@\$^RJDF9].Y(E,%86[Y;]E5AQ?2MAC1CFE1]-0T3)H(3NG=F?\L]
M(<S#N2DW>6KK6XM'^0&PMKAOJ_9\A 2H:?L/A>%',6+54\^)@XV!A;_5 =BB
M)2O^H73$R$EY_)Y^"QU@J//*OM;5_EEQ3OFNZ0 !8IX08?HV_RHH/MG,L'1H
MI_GMS%EN0H<3@@D8_D(8[/]SLQVT(/)MV^KB()P>2F2/)T$4D>BL-42)/['
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MX/V&3_%$32#I5YRR?SYOIF5D24JY@5IKP#7]%3TQ4(8(#^9=1MFHM]OM'4&
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MT>&.4PMJ(G#7V[KT65#*WV$:G/U55,^$,=:,XU_K1#JJRBGYUG73UWXRUT1
MX_&XU+E0TM2=.=%>ZTY.B7@963!^+F;>X_(V>W9]O+9W?1Q]QOC/^AM$/<Q>
MI^'?X(<I) Z1]O+"[%)W>U=W)MTL,9FZ%81PA"\CU&;^(:[F*C@I)\L#3#XL
M3NM>X0,3>*UQ#"Q%4''A\L&6TAA6-)CG@^-3S57I1GO:GXJ"+Y.>A]XYO**=
M%I8]#ZW]2K<JG;\((SPSX!U)7 >(2D4?@%RT_Q:S/_Y[&?Z_](8[XSI<;T-?
M@02"R+]YW/X5R)U"JOVW1K'D8_ZQ_#\%P/^0_!W^%0Y4D.C^?;"NYOT7^/PG
MAVB+O(V3GMV&\F6K(LR]D079:$<Q1RD!>Y#8)5"F\[BMJA@H-#UK_.M<5:4]
M:\]<-= ,J=AW9-' TTB>8MWB+ #$UL2.,"57T:PHOT_;G\%W*5:&1BF4J ?C
M!KV'A4&(2AQZ>:./3ZF.J4>_)@:_"T52/K""L27MD_5VMT4(RVH;<Z A]_S:
MC_WA.Q>B467L$EJ,:\N#QC@>3'\_>:DY2P?N<6%L]C>6.0:'L2-37^\AE7W-
M?&C+(%!<4I8"L>%E<R9ZM%F56V#^8.U,,&,>P(T(::9(=3@@VB7#\/RE@BB5
M"-]T=:(Q1GMMVFKL &;>I/H@]&:8--ITMMCF8&'GP!'5BJ!&VAMUE9GA<YWV
M1 $,&H ,HQU^V;JB;'>5?G&4BRF 9J]!S&S7/[X^1MCCN68'$0J+D]@C&W1)
MD2B%NG@<EI9@Q.6[FOJ#!U7?2!81-,/*$MZM'E &8C$#RMWQ.A?TN8@#6@-A
M75=PHCKN_R\ S__/0.S_*O8_)#RH5X\?U28=CSHL>I%KM5AH30KME= 5^:JG
MT\.-#<9WB&63DNS/%Z5A5-\&:T-(9:FO>%,.'9",9 :4E9A*E$%'\2:+5%7-
ME8M++R/V9F_2:MLM4V.75R>5DA6%4-_TJAR] BO$.">F*C=^V=^[;CQ,/;<S
M'W?*;38Q3>8NV!RZUK+]5KY\_R+OV,4CHA*3S[K=@LV5((X'\YWN2V719=9!
M9S&%")_]0;+ZW+=U(KMRN"'*4GA-CNV<2&HU^=)&]=F=NN::OX PRK"BM;WF
MO"][?47W2,TSM>+U-Z*0N>9&LNSR8H^3#ML[[N=R.NS1[LZ*=.Q6NCK[L=Q4
M'(2H+L2,N1W]^D.R,6V,4R;05H\QZ(LH>>+O;P57V' 5E^KMZ F6]3_4L>-<
M:4S*<P)M(\<[[&"5X!LH4UAQ:/>Z7*^%,%_K,HN:)XZ_H1R.*>(D+2:[9F*]
MZ29<R5EU:,1P-Y^K^H#2R?+N_?Z'_HZF&!$M#CK/,5'4S_&7YV[EY0RO0,-;
MQWJ;CS;D>AK!8%J9#[YXB()B ]*&RCZ OO0.?NF\VR@&G5^E2%D*US!+0["0
M<7/H9[RZA/S2$R^>[Q5_,A2GBL+1\IUI^D8F$G1U.V;P##M6/^'B6996>;!%
M+*ILZL O#-[J%Y6YR]@KYFZ 4F@4,EJ)3>,$;](7%YYXO7TK5T]U-(J:2$(U
M)JW&6;YGQK_!WO1TV0KFQ/R<%\AYX>>PF,TRY38.ND_AG<I(8_T\" [^,!*(
M%X-PXC(HJ 2#[ZA]A=F,%6TZU6!+2AHAX-UEZLXEG0!>;L NSI;6\8C>^L(M
M.$YBZSMH]6N4V!Y6P)4*DAR=F,V/%.-9;"M".%?MITC>6GAJ73S!K)B(6/_&
MK_!NSSP0B=(=,9#!^D6T^7N\<EL"3:::[OJPNRTCURBIF)A3Q7=6)&$I)2G!
M^=HK+#%;K0MJWV4U26\\:7,FCE@Q%E;8PU'2P/6IS%T>V<^DJ^*VEH[V)7+E
MCN;>=C\9';T-MC!FWD"&J/E>/HW+;X]Y0H[.\>=K<Y1K=!$?]8NS\$J GB4R
MN29Q864]%<35/Z,RCT[U3;R:=?=H3INFC5"C+Z.M:/CP&-U. NGC,R_4UIX/
M^%6%/)6_</45+GMLFF9DP86R$]V$!P ZE(\,9:BT81)Y[2A]U^#8)X9]14\2
MWM.CTCIA0\T.D9/(;B20([SB43GB;L6_*YWY]]#,KERV9RWD[ X&;YD5RGK5
M<M,+VRF@@EA[=1#X49EC;9S+AO1E J+;+HAG5(4:E,RH3+E+1-=H,/4D:[R#
MGZ+(I]>!+*,;T>P6IX>+.4")N$>>')_W!X<[5E[A^\N4]4$CH2*'5>#-7E9R
M6CC6" P(\W,C;[@0Y0O%_&\,\9^4CDV,I<WU3>\N@U$$1R[L6B?!IL=BN/*[
MXXA,T4OHBQ@TF>'$'KHRO>-KV%(%6&G#U*C\U-E)U;N5./947X5G1[E_VJ5$
MVE+K>9=PCI@.;(GU")G"^T1-=O[QQ[B E"X+_YST+"?3X&7?-PU(11W-R33"
M]B:>M(EB Y2MF%G/V,[L&N7Y]Y/-@KN_@&2B8BHITA)_5 O6]P.VRKNQF"M/
MRZ/<)R-7@\S?+1)'@C9)U:0'YDTA/4*6F9_>^+V_?.*=M)HQX"YUN4V+F]#\
M*. >@]W"[-Q-9A.VV?N8T=359&_%FEJZ-N@98,?RV3/9XV+IL4O2),HY)&Z@
M4G++F&R,*\#*<G219H%C[_=&A=#WSE7/C=MCL3>R5VB]QY:6+C1M"?J#3/T@
M#RAWZ =G2D9$\8^+(N%9ME=PO:FJ:W+-4+"*SG/-,$O'EVI,YTY.$>-LOI_]
MJK5_/C,7-24^RGQ/2!V.IR9^E+^8W'@ASWZ9A_^.GMLRNU67H^81QX)GK:TE
M!H[$[\M2=J-@.Q4CF=Q=1V62;LF6;T'5D[:['+5^.U*U2__.U',,"1[3ZA4(
MO9-XQ[%6OEX_[+9@:],$)7[:)S:[OFJG=/&J&#6,"*:O?!K-(-J/5FGJM&RH
MY4"!!R=4H#73.1\*^7P\N,0[+FDJ-BZO( D^2;3![DA9G?Y0^V7EG7ZO$)M>
M?"' )?XGTM;?&&VCHDY?7U^OL.&=1YT@MVK7U+Z4S"[Q!+\P4WGG_-FOQT<T
MP31BFN^0_)!]&NUD3Z/LP"V091539,YVS*Q5TX.M+3:A?)J#SJ^EG6T26=[$
M-TBD6*9S%$I,RCOO<KQ+_WB@";_;.%%4/N>0M11B1 Z6-+YII0MJJ)GL!'12
M!U=@Q=%+6<9>K"#3+.=FD(Z6I?(AB6 )6.3UJ=MQ'1'VJ:?R-+6;L:B-;AO6
MH]!XRD-TOL.+;(&%3]D(*=-GM%/NDK.'3;-27P]T'?D-F/= #GI\_/S#IT-E
MA!3HZ8+O+0M/%:T=6:'<Y4$T-<E9,"9$9+WP*?RG@PKNN9A=/PUFS^S.'"YH
MS(,?M+;#;G%Y9>^XCK!*?Y<1BKR;MD^;'6])-W:GR>MU=+B6!7^!<2K+A>*1
M*XNKG721QJM?^EKA*GU\)J.6#^S(+T)M(3X;P>3ZLR#@A6LKJ$^@**B!8Y-N
MF:DXM_!BHD?<FM3F0*8+"=_="*0-^")@>M)&5IC<N;XG4..2BB.V_]$1'J>Y
MA!J=;X6?KY*,J_]!I+J$):N@GA"BG^L9-",8&(%IZL+^AZ[YNB+:$$8DNPTO
MQ:?Z02-#Z$:>><J!D#S@83.)??5\>+"3+JR+XOUVK!1#?LJ$%<O\PEJ&<#,J
M:;UL1TC0("K71B#:*T"LK_OGO$,8E"[<857S[O0T$93H'1I<6T+!A>YVAZ_8
MX5TA$NFZ$^W_=OY)$+ZB8^+'@4SR+7?9N_,3E!4E)X%%1<?MH6]7%M^J.LJ9
M]'O0Y=]\$/4P71^RNUL_$M 4I>M=K3X[C44E\\Z[W+OACK5@"4I6S_"5JKO8
MEJ7[(WM8"7SL_)/LZ;@C7T[J*X^6X>5P?CZ#XS3JSIZLWIQG% [G*2R@:5KY
M)UYI"B-ODWOU8FT0WNG'3$,<HD=@;N:BL._E"6GTN,0MVGQS1_KMQO6,L0-*
M$P=CU68'+RS,T&YUH]952G*9C<YFN/G,ZHBO;JN9;PCAUUHLAD#F5F+XJSGW
M7#2XP1<**SNP[*%'ES4N,G3E/975$E.I"B<R,R>6778R37$<-]/J[X;P';LA
M,RT+6T^M8K.)JW^<J&?W(5]3QR#M-I6;:QB74)19T],5WIM-Q)SF3D60Q^:Z
M#FHNYM%9W/YU*VOJ\%#;,O.K.,463=R!0.R,"+AVN _^R==-_@NFN/A)_/*B
M8'A?7Q'/1;=SS%5/MT-UF 2]5<,(9G63C#Y^AS!"9^;@0#XCVNM\BQ"LIS-,
M*HM#I3[%N9\$12(;JC+L_8[YTQT+TQK'*^J^3Z/-;6%:NP"6GXJ+=9'Y7O +
M"!.IR_=,>DM^&6V\Y&0A]0YG"4-D2;'X9=]TK6+@P^9-[0H2@M@9/9S#87^*
M1KJ=YNSR23DH:-CP[%Y^H/PN;8YM1'C28+DBY6J_LJFQ)+K45$!!(R5Q519=
MX5IN-@4 N#*WG8"?VK&7;1^+EI>;&NH&42=B\?N+TU C9?@CT9["G,/ 35R:
MU'^\C.O2$3H;6FZX'^5Q4U-$S,S$D-<TO?8.A;VH2W,QZ\]3"7WXVV;/O[2X
MT=)7JW_KF1!Q#I;>UQ;!OT*XJ!>IMBS17:49R'!CV="59L,++7%  8*Y@H6M
M[3IX?(O^D/F)6E8JI%KCQ/(@QOO2:F6&T=7P@2XY)O%S\KTL#2XW4LV+M$Y2
M7+J;G1LF6(2*KKM,J<#U/ST%O?D&N6%\!SY3ME\>?&U>N#[F&(!S>)G*RN=D
M)_X4 WAR]'[6/Y5;U639'O77N9C8082NT_J:QQ9 T  />U6H.-^QNI!RWHG
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M!@ZS.&22TN-4@\=6N=:*8,4_.5W>)IQ/VRQT@OH+9CM7JA#]D^L$/9Q+'O2
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MGBBB3:_<XC*?#4J^[.,?-37[$F:G-K&G$//\M1;GV,0WF_8(4/W+^9!E1V6
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MYXM+<\1::OH5N<NE3TZ>MAA*5Y'Q509=[="5-J%1P]TU[%*Q6DI(?7\XAO<
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M"FA=J&D*<7QZE,=&JBF -#%R?3.^%DX4[#M&.W ]L_8MO#<$@C5+@6B^&YL
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M-1(';ZNHX3.5\"IL1)IUT;(J9\LF3D8$A)<AH(XM@E%S++#@J6RBM# ;]2^
M@*O>6%F9\$"$LQ"*KLQ;GL!1GY@O+Q0=+)A0C$'' ?!Y=$B78>4[0+#6X@VJ
M=@-Z&*U<)^ACNPN?IZL?31<E5B WF5M#E[H!?RXSYU/N*CDD5>\R'&.8$XL7
M*Z.#Y%9S]GK5LK=_EM"SN0,?9CG<?JN5WEU,/8P<&U3TUOP%V!3H[.SR>F.3
MY*$QX,%<I6A_C;Y6Y@&@)*C9ET%_@F\M9"$!#MS1CJ[4PTL*I5V;)=(TVR;8
M, ZIE'9C88XN%L9!AOOVUMW6YB69CI -P0QG=IUIO>$YEU5I6RO+K(KD.GH/
M7)5,LRL:/( O.F51CCN4J:_MNOR77 XO:%=':\ HSNG]3<-<ZO 8V/U%=VD7
M#XB:8+@UT="?2[-]CO.)!3=@<7]CJ;%J!_[-BK,OP"T+P F\18O\=>=J\> 9
MN:O\FV.])4,>[@NMZ=F18Y?LU7--0S,CSE8PEZ)-="_5T^.MV#F&MW /1Q1J
ML>PG:O:Y0OEJY<1<1$)MM)Q &'%J\W#OG%Z6,"XZNRFC%3V#7G866LB?M*8H
MT>F87)C_Y:'.50Q4>:J=T6'(TY/D[<V:FJ'1&QRNP9X=\JU3@O% T48!8Y$#
MUQ=M?\JG<7>%=W7,8:UHZ3'78V^!5A'7RDP)7-?A\YC8KC!YK]W6J*YGASM7
MO?KI*OY_-\24AG;2F\E%DA9=S@7FSY='W"*Q2H=^)'YD_@7Z8)TY4E,DH4%L
MO<&$'?IP#]7MB=&>I^M<H.@[]QC.]2#\0MLW[*\^9ZF-^N 3? H).E;S5^H6
MG:WU7;)N@;:@),OF_-@3V/:1R,&E(VC%XM=Q'G!F;D-)FZ.G"$PQ<A0>&FC3
M3G,K>:*H %.&I@50JGKSR%U@-:98ON%1I+(4=6Z(<PZT0T.V+SKLCI$AS2_I
M40I5MWBB;=E%<7UFX@<3Y6OE#\X;<<N+WP3]EJYZ/7OLSB%I?.[16L8XO=0%
M=?"G=&&*5-;6,1--=JJXPC/)V%!,F-ZXB>#?LW+:=Q+[&MN,KJ0*@'",$CC=
M[/-#^,W(HH79<Z\&#UB%KZDHH";CHB.>S=*I0=::!^+SP-=;2+SQ*O--?Z%^
M,J3<6%L[W)U15Y> E9M'M>%HRTXTB;EO&[8+?Z(30"1N%4]>#;'#'0R_-64;
MUB/87*V6:G5T?W=F8\@.%+U#F_G]O^=;:XF#3\04/Y[")\((U:SR!E1>YQ:+
ME'Y?V]=?_JTXSU[A*:CHH\M?S!DZOZ%8:E/:HSE/!^R4/[E_25B0*[>;1,9\
MG#SY;-/0?*DQ/+!+\OEG,J1#0U_(]+5C7@,\6YQUY'/Z!Y^""/&_@*1>/NZ+
MK7O\W7NO_<PY>$Z0.Q;3],Z<^_?*L#2[FSGN)>0]*#3_8@2A'R6XEON394.+
M3Y^13+=F>-*N9K]ZF+Y'CA5HG?;1:QN&46P :'X6;4GMW0(UU$]#!N*A/"(Q
MY\'RE_(>/S^+?G?K]]FL-/3*T)^#L\W\NLI0Y']D*X(G[)[LY_,V9TKT:3EB
ME#((:'F)ZL7V?C.@#$OEGY:&DOP+"M6\-)-H*;*M$,8$WZU8I0;+C2Q+V5DH
MG?PL1%>EK47(!;EB4%>O,L"UT]RX_O#*68JDPL^V@K.X0O8GV,"_K3*"<L2?
M7RB6X87=:(C%]_ZM(!BHV-!K6B?VD?92=_)-_=2U=P*5]]MF7F4<$!_=]Q8I
MJK:( 9\94ZP^YL)-[\KB2PA\83-B4[LK1H>!8J_=-<=^%'%F4L%U(YY=5='E
M7KA/-"#0ZFSP?2<MGSQV%-+KU]YIVP;X-"G!N'R0/E:8V6S<&'GB$!ZW9'R?
MJ+#C.*)(.QDJZ@4\83/M,F%K.8?4K<'A7P4_X_=&'@V)60D*#F=(?0K*ABLH
MW/FX&:[P/D_=,+8B&IL<(DAQ_8LHOB/Z]X":NNA[A0:_GAA\K3>'GF1+5A;@
MHRE%"X6A>4%6(R_7F/4;A,AS,;QZ^@\W#$?(20=7L%#2CY//;QR<#L)D>"8X
MA6_X[4T$5?D&$+0TZ=."#1Y#+$NR9["C@TAY$:+OXS[5)7#);W/(DX:?]B(5
MUTM1C3I(\HHBKP].@2X5(9<[$9]IQ7_62Q(PI1-P?9KI&PFP9$[=9933XP6-
M)X0D#@X_LZ4#8$L#R**"9D8?QQ@'IO&"!FBM0QUE;K!J)K=L@L]596H/[1LU
MPOW:92I]#DY()>W< 5(>UR)9XF+;28%^;[7)E^[;0W\R-#>#QF7&!.R\(C^M
M:F-L=9GC_$8VFO"Z,K^'EM84'UR[E%'*>>+H2'MPL"N';9W\?&GFA &P1 8"
MQ44W?2<V#L<<+Z;5]-Y$)\$1[9><4?<_!'2B<Y%8XBX^D=,27+/U8S)4' $*
M#8B$$R3XF!;Y>[@P7_68:D<>7S0Z1!5^YVE-%[C6XSJ<[1HV=L4=ZK\*CB<H
M[5KJ]^X3OE/0G>7::)N_]G5(X^ H"I[D@*@H47Y8F)+0V]ZJ[B1!(0AY\G?>
M5/V(PQ8C@N2JUXO:3I@ZG2 ,EEJD1PH*2?QAE23VDVT\NZDK68KA7?45%R%G
MSD*>CB1__1K]]O6;\ &5R*:-*C0"7'M2,D%/#5;F3(1N38&HW$@5&Q=&V %P
MXF5E+,:B\I;HQ"L3.0>WJ1Y<)\;JEW840M;),*>/"BINN;CD7QB-.L+'L]U:
M;!I$:J;Z1T:7T>;'>""/(6*9YV/*7+'N@M-5\$-Q_/>MDM9\_1<9%77#X4LF
M'U0;D9ABI.A;<% '@5^6ZK6A[V#^3  B1U,Y"$-".; "C7H[F&^B=%\EM=,G
M?7\>B9?=0")!UY:V[153"MY4@$Q02ARW*+(D%$3?YF*Z$T2XZ!UZQA5E024R
M(.+E\N;N"-O+67U]!K9+2T\&8&G1^6[)G BLP3*O3R*D>(S116G>T#;94MB;
M4' +#2.X,].C0I6K2\0C9Q.BK)^ H[_JBK'HV8FSA+F%%6J9.(ZR]3I-*$A
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MT*Y>O[@)"BB7=A.@&G$ZM18H>(L9KL4;2+'$KBB&B\_--S0!0*=E2I>W0^*
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M4:&I8J-(#X?!AAT26N9B=I%J_A<0N$5R5WX,.9Y:I;*S#.9+BF% T=H# IR
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MC^Q6%LR<)*P^7=->_W [E _S8FR @6Q=+N3>ALFHF1!09W\IR+Z2+EI<$N.
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M7?:B 2_%@0?O<O$UZ;"6\03?]5TB%3$S9:%0^$8XR$O=&&O=+S>0&PL <#9
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M?<P7'O.,%HAE#LCY5KZ'8%Q2&'OB:*BML'@NY,IKXR?CQW<1&#6%D44G=-D
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M'P<DX,%7H!X.1^J0S@V1P_X)CU>B),OU>8ZV1<OCWJ4X==2H[JY*0R&)A\\
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M]#G,7S<<)QW *[B1;#I%.VW]2K%.@B:DHPX\Q:FJ@$PK[2SD3Z\J-B[14#D
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M@NE%;663SNJF];(+2PI(1Q=T*$D>W>%W\]SB$5!^\P@X9UF_?VO*WQ<)]BJ
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M0AS<A-WR(Y_=5,V/V9<R2S%_/+($.3?T\BX('^I14DU2A]PJMOUD;1%W(DH
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M9OE^*ZK51+'SZL8K)!J[*)*C,UMVW#AN "O':DV>DHI]?>66B<COFAWV",
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M3CX\ B0> 639?ZSZ8]4?J_Y8]<>J/U;]L>I_VBI-GP,R0X511<4Y+8@7=ZO
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M(?,+01E%52E=Z94#/)GV(J3+#J&33Z'-]/TS[=X    +\!\\3Q0QM4QZ+V/
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M'.:89G 71DZG](AB!@)#IFDOSH58]R(%H_$=I^1:.W!+U_&G#<L%! B\-HF
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MPMW#$)=!=&FYME _MG'*N#V[<<:1CR]I6 !$VS'.?J#:']U-OP5O?6Y?^*Z
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MN^/HN>]GD>U"$\-]G%0U@HTS)R;7>*EVT %K$D\ >F((<KYQ+[!#VVG+SW3
M *O3PLH=OWR4N_O;F\ .%^S#EQN1*.(:9'V/LTU;3HTM6W':&\\VHA1YC1;
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MA"2_#Y_R.VO7/_64^M.3V[]Z,XV9_5Q7_2X?)>.8H'3)+4JR^GJRY]V[Q >
M7_/=N1UO:&K3:27D2#YI_87@BI^AF[H8EHQGM\4PO8'_FV8)V<WL3RB#G!?P
MH3*'SV6=W4O52;M,O\8ZS! ;00\ W_BA+%-\(4[>)W9B<JG-];J_>21NCV!%
M[])OQ_A&&*;8%YZAQ9PZ;3G%BKDM/^.["Y'1=#S]KDXNOX>-?2C0\P (HD]A
M:_X.Z7^+N(J0T"_<GZ>.+1K@^"X>B68>%=E2ONV:(@W51;%OFE)#=,25.8T#
ME%7X15/V0KF&KG69/?1BMN,$<M7>SR$(0K?NY"]OZ$0&O/VJ4US/OG=V645B
M]P*"IOQ=<VS0+7KNV9H03J%5%X:@3Z"6.B7 -G/("+!E/X!Z_PBWCYZB$1X0
M=GSNHT^M06^@I&<VLKV=Y7'CC6;X;Q6I_T_0C?.?SCU[\DOZZ+C[G/I2[)]J
M'F3H![K=_%[84ORCSN'?$F+A6VK7Q+ZR#P"SE?@[\M^M>OZ"#X!$B@&&2_R6
M!\ O!QG:W)Z-:[8? 0L_NR<[F3HV-IU0R7K21[NF>R:)_Q-<#/+_,R![QT\?
M (S<I/==*X\.M,:BAO8N7WH;\WO PDK OB#:'^4KA9G41/_]FW\W=_Q?96J8
M\L]2GT,;_:?"$<Z)>ZP'P*A0R'W7YWOW@__QPO^_@[/4ZSF>4PE=:,W3)6,5
M^^:_0A/;/Q0U4-^&CH/"F3T(MSG0N[YW9 YTP[_92O%-NWV3L)5.KIS@#[FD
M#'!^]@2PM7N[N#>3IC'?J(;KJ_S+WJD17TM_,FDGORD>:U>+>?/Z_9MMCJ/]
M3AOT>8X:T7F4>]&1-,'IA=Z)>S:W0W7J\J8A4]$</Y91-:Y%RY2DP$;44C?B
MN*BX6SC2NO"PK6BMP>9*VCQ4[PWE$WYEO"PB2!Y!4]0PXO/.4/;FG=7EC!K/
M[OJ8K;DSVO+8EY"080T3PWSDU(!'VCJQ%TH9JZ%MJ]QHD9)9G[L^/O/%%-5I
M7&X"L%'#2#M\X(Y"O2.'\MC]6=C<Q&5[&2.]2G?JT^M%TICCUW0JPOVPL!0?
M3PO:9<<J"U"I=)JUCZ<C"=7B.2!8<<H^"G"\7RW\ ("9A!>M@H07$.N&JP<^
MGC+[[2?HM"\BL*Z#1H[B.F -]AVFUIZP3]!K;EYNWHF,]?)5IL 1< *VQ=\G
MBLR+9S;H^=]K.T1@RM+/#LXV%N6<FT;%>VKX UF7G?6=574E)\7<JLT9* \,
MR!9B>$_=\74@#;>E,XI6VI]C,QE9 ")O_, R]$%REC;4VQD['4FC!8=BMF]>
M-?\J3\.PY@P3ZH,,#RPG^;YKAJ-RF.AI9B;RTGE^OESW_;+EN M50#)HR- 7
MR;DLAT<>=SS_?I!HY^DI-G@WSQ1HT%-LV'2A#02XB&]EC,RAP$Z52)%!XF76
M^[2*@TM^B=0KSATU<O44<,CL=,C!(0?Z-$>-R+1[X-4Z6O"IUF^5G=VOEGR<
M6&$N3*.V2J+<J\Y>59W,PY<&]W7S!B9IY4;+7%6X=DJ VU=F_/[V>_3($TD;
M]*KO'1Y.$:[[IGC'[G2T=LN94\Z(Z#55QGL3!@Q1W<V_9Q<'$Q[-.5)-#?%J
MT;<T>LF:70I)DGQFI@U,+QCK8Q<UAFG_RM YD VK('C?A/?C5C_K>%[M/\3U
M1?J 'G)$9;3E?#3_P\WIV1HHEXIDE:W,PHD^QG=-"DYY.;YK#?Z0PFYK].I8
MACY7SFMC8,W%#U<'_O7 U9.NW0[#2,Y^(OTKVED*@X]D>*=).,SQV^5-:\O,
M!<BP\R4Q&&PA\;*>,I)!+':1T9)T)(]@.6J/%=&4&M*_;F"DNHQ@L-1+4<)M
MX+,>I<3!GA30EF)"UIWVT9-GW \-*4>'!"917KTE_%G [X(-?$UY&@4X*JUA
M15#$\E+HP>F_3X/(G5<E1UKJ%K5/L/7ZXKGUPC S=Z9J[([<IB(R)._":MU=
M\7<SEJ6D5C"W/UG&T!Z_QMA[_>BX+M2!AG(NWKSQE8U^.BNJF1_FSI=.F6PK
M[]>P99WS+(\9<V3V@(WJR)KJ0Q,&^&#V9+J__><T]2@J]L6J1BI3B5?,/Z1#
M 9YNNM^0O ,WE>N<<W]*$!@&]R$@Z[VF4NYYUK /\0EU<'^CG#O)6-M>A*%\
MAK)7X>R%C6![>L<W=Z6JIA5Q:_2L[2>RVW'#Q1SH[=]; X@@OWVEP6)2(57&
M*ROR+#F'\VL&+$:69WK6Z,EQ*:8ZR,3O!\S*=Q,7&Y=%M2T-Y#].^0E>Y5G2
M#3.C,QBI S_).3=WD[HA3UCKPM_/LV?0?,R!]SJT_Y%=<"9Q39"1""1XY8<O
M#66]6"^ KZBT=;7E'$*7'6:FGGO:O^^QS/%6!SK)@;U+!JH$U.:<JKC/UW0U
M5%[#;F!CJQ(>>RWFBMNN66Z]Y]4@F%I,SDE_?],-W^_8L#)7W,[U'.'T I80
M'&%9$O 5Y#AY3AU8^4L/WFX $64)/P9WZ- D'X>[';ZQ],IVV>HV<37Y7&#'
M0,3C3S>XQ>E$JN!Q1%NO7&*T)$^6)&+F?!22Q>.C#JS[9>+C %LQ=M6!RVVV
MS559SD&SYV>>X)'PE_QD'<4X9CSND0XUJD/F?]\P696EJ_Z>:$ 5NC;;(Y$)
MIF3GZ<ER7'86RU6U06_ZWG+'#&/++3_4T7&QS2C.$<+DMI#<1F-N!5CO/(]_
MO6U-Q6"@;!K1Y!U7X@HJLED>*G"R/WZ6UC2_V=\IRRK+]<CC6BXF !Z"NMF0
MM[!W-X.37<M=V:Z?K4NFA'FH\6M[J0,P2L!23J7H]"D^:LC<(I.UQ6'AS J]
MY4/"G:7UM94O81Z2 ,8D@16F0'%OSGAIXH9ZF.CYZ\K&%XY5U1*9X7& 7P,M
M5(G?Z$ES2G+MC$F'A+L$E1CK9]R_G1]]2235L!D -_$75F"M$KB&Q!4T MS/
M=0GAXWJ='3.-W Q:V2>\#89+7#F>HK;J#"F1)][Q?>W_,9<G<_Y3FX\/W;]X
M\#Q"\__6\A/]#[_];^6B_8@25$07XP/@A\/P?;3=:J4T=<!(-(SP%FLU8+\I
MCT#MW],@$Z=_?_[W_WEHV/\M.O:&7[J9,B#5!C4#AF,<+RG4EOD8GU/>X-6.
M7M(W[L\M,2NI%T94AY?_&!%$&T)6R,PU2M,BWVHU!"K9EBB+&TM=T*"_#.H5
ME23\,%LCB"_O%)WAT9&Z>3!M&^]X=FI4&?HMJ%ETWQO6_I(#?;A1^@DR:JO/
M1* V:M!@2W-^8JW<:T1D<!>]7;1GT^VUD-.P%/F\NS%DU4:*/G7V(Q9KO'&X
MAM[74MQV7[/MK91]-?1FLL,Y=2R12'N>"P8LNV5?@(H7^!,7!_\S\3HB,3@_
MB+TG!_\'_"2HN&-9LJBK+O6PF?3EBV0/T>NA@+?&?L_0=C,8@MS9X(11@ISG
MAN*QJC<P&U.(F7;3'XN&'/Z.N)9R4AOZ5PCZ%.@IOIT!BYA[3IH$+]B?9T;V
MY4"[_ !ML$+-^XMR#O01E,9F/"DD<X"BBTV/J;%KEB72#:1KLZA:NA*MZ!J4
M!,% 3&]5L0]JS^77P:\B[:'DWOO<YI?KYO7^=SC'&+3"LUD6"T)'C<E@:"SY
MD7&T8<ML?IIFZ)MAY\VDEH.@669)L PN-)N<EP!IK3K#-,3]Z:.Y=&1;O3^7
M$@H43D\V]SQWZ,P4XNYN:*QY1L5]K#(F;R6;]<,>56A)G$7/.6N31T (+0ZM
MMDFT*]", ZE(V7X]N"1=PPUOEB'P_Y08DCCDX^^$F %1!X\7]6Y6^+E,Z@5X
M@KE7P=>:M"%GS<RTM,&<K=\#):)6>DQ8I@5S@8?D901%9?M63F(_?SX3>Z\V
M%K?Z)&\K1_IE+7NHA$*U&FS-^P&@&C=TJC&3J58_.]C7;H&>!C[;3N";<CV8
M*O\E0V_["8IOQ>W9XSIA1X[/JYRT?/&EXMMJ?S-ZCM>)@":$4 VA$ *+[Z>@
M)C&VK5T55='D;%!G-E<U$/A+FKMWG+Q_K@Z,5]AD(,H-#N_?_4VJ$_=GE0O_
M9<*F4CM-T)#B584),WR^M?K(P#3J,_Q\BGV)>N;T?;06T3@EP:#Q9TUT:U%F
MJ=SPBL</D?/:5%&$N/3=RD_+Q95\KN0I=+N-?3LEL$6;_K3'(FCCHLJ/5!DA
M=#4HC52Z<" 3/!(HIODHZY)4E[T9N'CB)8%G0;O;21T%@$HQ[1OL5@1 *]8(
M)CG+W%9.&T;JQDI;*!E)_,!Q E$5^?O40S5;L88#.4PS!;,.UK,/@/J">MMY
M'3<6<BO.H=?,B,L:N?*K2_*VHB_S(C\JYV?+E)CMH>$ES]"V37$$E8<0DD<F
M8_7+$-#$K+T1;9A58OHW!O5"P@*<<\((:KJ-2 G<<EMA-)6Y_>)7$X&#QH94
MQ]DM5;'L"K,-G!BU,\=,C4UO%./X@I+G<K5.[(X!7A7[]TSSC;GH=B+>[(MA
M27^K5AU<:?Y@$G'BT;M\A//+O^RJVJ0SU)]#^<9$8E />'2;IV<1'1-A!*.Q
MX 6*TMTNE#TR/&.H-([18(UMLUC\E^K*W3H=MDL'VVIB4T<IQ2MZFHV\JMPH
M ZPR& /^DN&!,,@+C)5/UO]FYN63*!J)VF%G:>H3CCS"%_5PJ_9J9+S6G--Y
MIAK^TIJMINWN\KQ[2I$U!M A\,60?P?:QV+X5,R%*98>DOQ(KKFI,?B=4J.&
M1TPLB;"LWO!$"V)AM@ER*?8/4U2"\I(<BNVV)1VXV#5=:6#,\M!H\;VU:<=F
M', >MZ:+8#^T.TG<O+/;,(3C3PPF51K(??FQSB!$F+J#K=&[E_MAH>11*RQO
M1*(Z)&$/ )*I0AOXH8XW7$%I?<?B5CR4>0^8Q#^ 6,390%I_MZ.G@Y.%I97+
M/.\(+>*E=+>WDO\TEB1&;.S^#&TG<;^+&]YPS_9CQDVQT5#%"F:8Z5/@EGB-
MS]A+PNDB<WD4[T_''NAN2(B/I'G?I-WFQZP5=XCH#\5I'V^EB1C!C*#<BTLY
M%%3'-'Y/T3)3PQCAF*1(]\R:BE61;'M9/A9!L %%F>"'OVGXH46;,%XZY1M_
MIOAGXLN'!.<!SQJ+1W/=\<7W*D*&]X ^,>26[">L*KB*?M;$+19HR,IJ\K8F
M(P_?=%#J> KK)+DFG]GZV-V2 >2A)#-K?[JL1F62#9K9SR-D@S>'5$-_N[G_
MEF!UQ4O%$##M:IH9J*SH9S&,UP12 M -I("SOFJ;=;ZO;TA,; - UO%:<<?/
MN#YXUS%\2SR^$S!)E -X?:0G7,B\)U4C5#,K^U2U.N'I5!:Y8)<JJFUYNR8#
M1)063TM\@DER]J]3SS4HNAU)\D!,8"CCPF#M2(_8"%&,>).4HX_J0#*H$^&A
MF&E4Q^=2XZ6:Y-)5^<O"MEPA;4/&3<3HZ9'17IB$>(7-.A]UAX%$#N7T\^;$
MTV/+.1U(D4-)BKKJ- $!9-/CP*16<:RZR/CM"TK&F! 9>C]X\;+MG\9NX@D:
M^;;U M:?V/W L='E *T;W7S-E^4<VNKE6 !T ([!_\Z<X#\3_K6R:J%VX9^R
M4X!+UG_46"G^(R=E\W\UP_RS2*O&_D7D@.U_2HR0[3X _KG_&O 2M]=M/@F7
M/90'?"8XH@^4[&',D3STYD!/G;X@)+&C3D'I:MF^P<6=JE?>,1RA5ELKV%%R
M 6X,,YX7P;NC*QM5:!0H/'\U%7@Z4?D^QY[YBC=&0^/I?NV::U<+'?D<K8'@
M5*+)2_ZX'OHU=OP2(J]0.L(,%PK__$E0&K^#TS&UCN672HGX$//SA.O:-!9W
M.L-_C(R@H&>>X78G_#'E1VV$]?%3L#95U[X5.HZJ/!IC5E3G/_I+"A<\^;G4
M96)9DD3DU/F54)R3L6'RK=\/EYO*K'B=K)W8:%@3K>)T6/49QLT5-8%&92:+
M9,N0G#&?4^ 1N?"894O.D$V!R9]!;'2$(%H!]UJ'@&$_2WF=$9_>QP< %8Y>
M$/)) ,[/^$%OVF:^E>)\&HDD[*^A#NU3[[AC\^/-5-7(8MEJR!MAA'B9G#Y-
M<51%/N$^GK)/A<\ 52UXM#G9M5,:&16?^'WY;L661]AN==-W(B;_W-5X@!?6
M \6B-XAMQ?R@#:V=[[(XK(U(F('Y+EA$##I,]>>YI"LUH8+*=R8'.H<W,Z(>
MA9\SY#EPR>0P-JVS\' *Z%;%>$I@RGYO9F#ZO"<2M\ZIQXQM;W$89628&2OP
M:,V(O&D7I(M63&S!$)>3P\,'P(=F,3SR+GOA"MZ4EUEUKRW-TS&]>D8_/$9\
M?F"8"O7\Y/J)\1MBS+&TH+G4OX#AM2$7+UH"KR(U(MNDC6C*$^55RR?D(L^5
MJ-"^X;WH!6*$3+AF>"3B=U5 FYM %>WN/D?Q4C"Z4(.WR4._5Y(FXH#/KAT#
MZCO4R[ZKN7.NK0<%F%U.6JC+TW]V*; " ,MT_O"[RM" JO7U#T">?J7]3)(#
M"86)0_*7!#U,I:-6-(JOCQHRW*38?UDWYNQ*RC.\7$MDMQJ[_C",0TF<(OH'
ME%(;["=^2ZK5VM * AE.*%D]Q14?W/UYR[*(9OX*>X2.05*T/.VS>QK"0M9"
M)$UR,OM,"9?S??XLEWI,4*!W7(@D!WK;;..Q@':&HOW)EZ2A_+%GEJQJ\FB!
M8[=Q+U)-F&>$:+KKEDT5N KY9-">R'2^YZ/T]5Q6L80D]9U<F41R_4Y5<C-^
M@_D-#]/CE3W&Y1Z+'_[G??+IC:9(O.6F\F8#"$$J_V+E&R Q/YD5,1Z ,KXS
M9$A AKKM-,:>^X^UBMB]<(?25JAJGWKSM_)#RMC*'L<1C,20 V.ZM9W.T,(T
M75>65_+\)WL G+^1;'KW] ?WM Y2ARHZ\X8VNU\,11='^<G3//@:-G^8>:U=
M5)\.$"U.?3=2*&VHL/,@A[RED,?#^;'\=,2, #S$#\G#H<Z-:9@05Z0.3K=\
M*R9#G)\DD/H9&-Q*B9^3=5FQ\/AG*[>:O:I_.)+^C"07L?Y\L@+@#DJ<?%VM
M"?NKT0TO+F436%\Q,%D1ZH0V\8V"249)VY\!K!TI'=71AI\TD&HTS7;H>I6O
M<0T-J]<'.3BF C_3X&46O*;2],2B.DH^D*$Y [5]-##RSC1]>RGJS)QBZ)R0
M$P0>E>K/R%N&M\Z[02H+V>:W)UE)WHTLR6$X]Q#/MV8J\G#Q_!%:R:1)F54M
M\'D=/FI^>?0*C=6F9V22-H=?8AT\88B0JT=6;\F+?9C:"0&W+HOH;>!TM[L&
MOA$63I)4,_F*5E,!R5A?M+G26:CU"X/=5>UE4NEHX%6=Y3P ^'F9:][/-BP(
MCJ\81G]SG)9SR)48P[/BPD/U!G(.2UQ6XJ9+-W9#*9D_9*S\:2MF;X*T-+]P
M>D4;%)QWW$] (/<109_IY>D'XW,"L8S-+[OE&-3<(&AG!"/$2=0MZ+?F \7\
MQ ?$="I$@R?_2*Q(],3$A";?CE'BCX]L6[IPBBLA!'&A#FP/ -TV[=:."*+2
M+PVQ,=FE><G#>; *-3_"" FEO*YTLG[<%X4YNY[-D $;<[>SR4TI*RNMYM*E
MY.4ZMU<W'/#)@M*5R=2R(B6[J>UZ&B_E OP>O%*S0NLYM%5UK/LTF _HRX*3
MHU/>_61#AUY^6N"3;^;V/MDG_70N8 ,^2+12QA!HL%,NF$)OA_])F# +@$KO
M2>NJ6-Q%KXJ3NSO9?9&#@Y^U70Z+\M 2*/V#M-6[OSK"6NU[SQ'!$ E+[94[
M87P%A=\GF]U=OXO:0*]920TBYLI5"=$T/)V/DZ< C]N*RETW>9%7\8JM - P
MZ:\23Q\?GB76D )"@"ED7XGNI>5\E;ME:^.,DVP[<7<:[]<AR?Z8,&80 )Q%
M7>-<O#!,[DEX7WXRIFSII$0<$HK2]7H !.KH!$%2Q08,_%/ 8'!^!$N27&NS
MY2V:IG"IAT:"RP:G98S[\#.T69N;J,-EE<ZS_)B1;@G+[:%-Z-?;, Q_,@,G
MTOT?)HV%S8C*,L;(28(!UU_ZB$;#Q%[1W7SX%]4N>J6U]W[5,)_!-Z^T65.V
M->*&081#K:'9]BCB,HC=[M"NL8&L*W:@82L%+[.H/OJ6XVP+GSVJ8X\R#[\]
MUE=MJU30IF:[.8Y28I1946!/U-Z>:\PY[XD+WT(-F>= 1O9]CN!( ]2>O:O3
MT&$!^V<YGN-27X+KF?=5*1>WHQG"S<KLS/X7+'*W=WF2Q?[OT7H%Y 2;+?R=
MB+.*4)9W1@>,8VVL)H5CDHA\2!&U_T1/:&6#W;!QCJVNL6WV#:D7=7U_N'%/
M"CMCW%'R'.U?@XSP"+>JEYNR7AXD#CF?Y.1=RNYV<0A^;YXYOZY^7HF#]!S4
ML+FD2+3Y*Q,V_R+?W3/KY*\^V=!=H9>?3TC46O#_0=Q9?D7YQ?UZ$*2[AY:6
M[FXE1[I39&BD&1HE!.D8NI&NH8>A!>GN&D*ZNU'0X^\YZ[P\KY]U_P7[7M]U
M?:[/O?;>]R]Z@H<$BR -SG"*1F7IID.7*RS"MU&[<05//:GQZV7>RKIR5"9Y
M;0<+Y&T*;_S\RCE5487RVXQ27LS4 T?B1@"T(/S<MW?OD7>%#I"8<1DC,E%4
MYX^7I(-F9]Y#@S.MTAP#?P%RB&GAJ(\\5.S;[1%;"\R\W!V"[UABO]#DANBK
MQ>;YTABJ_)J/;RQU)%P2FFE;D9%')$E4 &Q2/$\7@MD:+ED3RE>9R7VFQYF@
M)/9B'N@J&)1BM.ZS^6J0GY%>56Q);.W:S!Z1)D(&/NMZ,E.56&P.&/'!B](^
MCE[G7Y'"3VY-GO9U*VN/']QZB/@YMN<&K.E-:FE+FJC0\\N/1---7&">7(A1
M=US6-]2CPW$1,YC8VGS^)]M)68#5MLN(;*?*PV:6W*[5V*,_IG$%*/$B]Y.;
MZ]4/V;HMTT^RGD'V]4('8#WB4$.NHXY@^3^\)MU4<=NCF^JF1LW0M1&-Y-/P
MB]@1D5T_SG87-W\[6B?#0?(9"U^%JW7VW:3<36JKB1._BAQPTH ?+3LJK]$E
M':((>92&R >+)AU"?YJ:F7*^?,34 5+FT#0D#4]*\YO3ID<*=2J=()$67,EH
M/!0.U',TY I*--;QADQ)1C*,%_.IZ6'P2["SN_#:>/+ )->,F=HV!C9P5$3\
M@/.-0>C;2X*O.\T(KKKG@L B[**1#9(EXI< \Z]]$OH#!5Q,;7\!*K8VBO;+
M;U(G%.HIK?A\T6Z$>K:"2(<]0O\(.*<B/5 8^>+J$?^T8Q5<^RFU?V7MB H^
M^)6MM6.NK).B@GLW?^F+EG$^=P_:R5J/I)]GGJ9:NT@N[Q.G*_$*K#@/TK]0
MN&X4>Y8,Z<L0._)H&2SO!WB]Z4=B_8R3QS)SUHIKD_,,#0.Z]^QZSL ^NQQ^
M!:FKNJ2>TIP:*MJR-"A-%=B)HX&!E,(*5[,^\5ZJX:W\O1^\O_UP^]($P+UC
M=AG<-F(]UIYEA H%Q." <FV/3RF25OSBB#U&],@8T%U$"97WY6@_FMRE\J3S
M%/,6FJJH&ELGGEPM07#Q,:7B":2BXP)5B^&Q")@7&!$5VJA.,N#A#Z!\H7H:
M[&GV5F0QP+5VS"3N%-;U_>7VX]U#EJ_!,HFOHOX:O*[[Y>3PK#!LRW1N?FL&
M@B>R=7ZR0+%Y9HV <UV&D92[Q7_UGND50PM6/96CY:*Z2_>T=2EJUWQM:^J]
MBMV@,D:FG1);P9(>*AF==:S;V) XZ"ZFBJ8NTHTE21JL@?'MP^,BF:<-39M2
M4>7R3T>J:I@/6&CEU)NX[EV--T?AF:3@K'@W695#.6O5]FA MDH-U82T@/7O
M-PI#L7M&\5-&N#D$UV'!.%2&T=RW:YP:78@6T'L9B'*TGBV7"KB.3GQ;?,?-
M2?[I34EIR7/^'>S^5=_'I($)H@2Y,11L/QIBB466$M?TWB[*)B.[WXH1A5$>
M<22H1#@,XD.'Y[-)QR86E-^_*H<TF2N(;\Y]6A91#1E9]8,V<D5O6(92VN6)
M8_R#9OT6+?L18^^I48L#KAJ5"/:$8"JNTLPJ'<HDF<)HG_N;ES=M)3\*U)5,
MC5Y\X^KQ9]='J^]F"T&V&O,*<QM[E;6WS>4]0TQ]6F:A8\PBE:S 4=)5.<K]
MS]+^MDWJG=4B]Y[OS=8=%HF.[@60YF]P^'64!..*R1B20OD"/.5HX? QP[1A
M=U3RN &]5([/3$/5SZYZZ>^H?%(B_P(<NZ*7$7;A'W<2/G'4?*U5E8Y/Q:^.
MPR\+;$B)51CN!,L&5NP*E. 3*'1K;V789-BOZ[G\%C:B;:Z0U".!!KT$J(M&
MWXCQ4 &%,7N+\_2^.I'%(9Q[ZR@ME,09JQTE]K)+0#2B/I*V22 NE3BF5%I3
MQU#W\UA#?NXOWR]"'R9>.?Z!]&6%<?C9>7V)P)8[S\']1&9+W335H5V^>I0T
M5O]>WL7Y[ O7T8O7>$ ._!DL+I3CENUO!?C-KXGMH483VG,"^5H.\RJ.S>V[
M:$-59&VKDAWO*@GW6RDG1SPDXI\=3:F'(-0X 2L> SB1"T:CKW7T(Y0QDGH*
M\ ,4+X-2%OY8% 51K66OQ'PB##?3.*1J1(&KHKAAH>VOP^$$__J*_N#RN:O.
M:V^,#Z&!<#;JG& %7HRT[HU%K@42MEYU*U)XHIDJQ(]!'KC:MR:N&U\65QQ@
M5=@>#>(E>@CAO557&,!Y)%:)%0$):-)#(PU9121##!X]IT(Q6(,E<7(#0(U=
M\2,!?:85WJ21+\9ZAK'=,-Y5[!<,"@T%*A=KEC^'<AX@-]J5 !A.$L^[>'$E
M$?ARXI0RJ4E%#HR#?1-)47EB0I(@(Q=;S<SFCM;A[L<6'>69UK\ _,/-FS5J
MI3FXLP'G*-#*MD%$C11$XC)Q2:Y&C+76GKB:DP4X\,JG-,JP4]?X(]0"^IT=
M>/)*V\!'I;>.6B^1XIPHZX!"N]&ZW=TM^^,2K(>-3AN;<O_/"_E?5!O$1V*!
MK[?,J=1%SD_O$5FA/03+.<_EPYQ?+)<&Q %07YR\#&&9U@\^KE6F]D=4*D]O
MT P6=7@5^;;'P7^>F&N?T+0P_!%\G05MQ 0,91DT%R+;XD^5X?G_4FP_DZ'M
M<2MA' (5B3WY<X&+;KCJ#JI=75_R];_;?A<VT1Y-_"'VE<OG-9H<2/=QK"$5
MC'NA*_UUN:-)"D[1>M&JF4FU=E']EW SI8ZGLK"\L"Y[U!KXI5),  0/WO6-
M>E@DL"@"YQ4J,R=1!(,= TTLO=K'=:XIV)Y]R1S80!77@X;?:(G?3!*,-<0$
MY836M<7H7:2'>\5P@KYT1H" YKBXA6B159)I ZMD.BB3XQT!L\YP3J,F>C*'
M.+ [R]K:\Y4BL6EC3.'8")_<X/N4G5B4Y) P.=KFHEJ'++UAO-TIU5Q0Y#25
M,E*B7A\M_%Y*)TX))R9._!2"XQUZ:)ZDYWK=;19:C8\N<3_NZ6^=?Q%S+&IG
M1$+?9&)2;:B*,U0-3G!23L7 \#9"7?P,W"N8.N'9[)K:@\[8,T+/M5J-,C'Y
ME%]QA7R]@.*[+^5X%^#'$Y =^!@2]N!_HVX:(Q?!7@%&#IDOK;33]^;\UB/T
M_:Z>;3+7M <&ULN=,W%:7O2W6X)=:Z6K\'&PBA[ Q2NPZA@!<^,A,%'NR*>%
MV$%:98_/5/45*\+KM5NY;/=)DY6'%;15I,XU@:UZ3TN#:+'7J_Y3Z+#:R _-
M,]5G<+]8W9_H6=20N-QY@E?>Y<RG.NT)[_)+C!-T;18+X3X$SD'.^TB95<L:
MT8I?$0; _7-_[)ZYVFH7KU-.H^B[8XVY\"H_ K+&=YB2/GT'I&'7[-2^'^,Q
MJ_C5?2J/_E &5+DVKLL[WB.2"!ZM)NG3")^-L^EOQWYIH2,B;U6]G%_L:X43
M[<2XD%V'I:$B%M*U+LF32\S\*-*CH5^N@63 $;;[;'M)P[#A[HV%]W'[QDT&
M,XRJ-EV=]@N4VU'9LAUF4+ENP M59C<.:J>#0.G:XWW=Z WJE2\MB$SN=6TN
M*V;UX')9@0;$Z.(>&J0 ;[3SLUJ]J:?T"?B4/Y,!*UV0?04:XF%ZSOONMDJ$
M*KRTPAYAH%L]!37TN S%QV2XPI0B]*L1[<W2GR\MVLR'&W<H4>/)AS;LG_RQ
MGFIX)8V"J;;]G'QHNDX;H>(J)=\EHABDGBO*@XJ*:Y:@G?-'O #;1Z*YDZ>U
MRN2PJO11PO_M"@]9KYHQ".S[D?>=G0-LG$E;':Q8/[>M%"_9[KNOYU()?&/Y
M!S)>^Y4;[DKI=.5(9)X!=$[5=V&)?JW4FZAOQ/E'O*9(,V]]:YAN022>C%58
M*7(0X< 97(R++W8W(%: *R:L#C:8OZ7T>O0Z=@J2V3 =INW39&X(K.QO@6#B
MGXE]W):9MY4E-09M5301M4_$DR5_6NBQ,B,[C']A)]XS_L&W(4C&SRZ(A[/_
M4KWEZI1N':EHY[IIZ-QNPFO>5PX\<'Q>]GVR@U"GAY\W96P@4I3Z _O]5*F#
MNYG\\^Q1-7A)#AI_<N?X7#;!7D7AXP^ZSY-=-B$P@CW[67Y&-X& NQ';6F^A
MY"M\R#[%J=TA2NU)W1"SS$R7#IRR!]OU@3UN"^'FX&[G51R?N)2F\$N$/=)(
MQ&\;R-K,_3'#Q'<4TNC2VI;NHK6G_UO($CQGQW1=@->I;#;K51KERA,J5=#
M6"5)1FN*C=4]-'P@:(SXPXIH7/1*=&64<-Z-Z]M,=+TV-B',YH>N2KI)_"$;
M[R=;SZY$FJ_]_'DX969_EUA\@:PND'#EI3Y38O]DJ?SN>M4@+[FHWZ;&U\WT
MN71K 4_F$1H0Z2W0!.WN)FIR%N,"=&]H82BUW:4@08[Y+I'&KSEFZ@<6,%QF
M"%XU#DCL1]M\CVS*KG)JCSPG92D$\J!%#TWS8(UR KHMZ=PG.%/:FEI#SP+V
MFO) ($VBYTJC&<;^0I$>T<J0-.P3ZMCGV56]K&K7+:=GG2!6H G]"6<VD^#
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M0D/4 C,HBG2#YD*PD$/-(8TS<VQE-)8M.!APYI2F2;C&&O)<F!6?7>'2T8S
M<T;M(QG+9()86H-;,,YC?<B<WL^5@%IOZJ)VQHO7S,CWW:S9"X+X]J](4;[3
M1 FI<KG44@>/C'A0TGVA@KA+&%3 #OTIOM:<&PPW_?[F_'%*F1K+\AJ@9[4;
MZ9I1HS0=>Z$AWE[L))%7Y1> U3D+J_G@8/A;!F0HJ(!*&#\X1CVW01,.V ?<
M%^!GJ8(C7R?-H_)IMVPSW]";!+GY<_\IP0AO>KP%<O-F.>M_4+AHUA7%+6F8
M\%#6/XS%AW-1_%H+_QGKRM8!;XGN#QS:O*)U^[%&*S?V%>>(?YAYQXX49?;H
MUSO_\7)XWI;O:<:?7^S1(1+W2LPD3?<]&.LUP\QN ]:I"V*+5?S=]''6ZX[7
MW;^P!Y+VM?-'$NO8[*^8DYGR]5 /L_:<SV\#I''Z$/ZQ"Z*'+X\+?]R=43"4
MW>=V6?A:K#>A_)PVVYR#Y.KJS<%NOM8CPC03Y28A.".VZ5:MJ$XU\RAS=GO[
M4N[C[%*:E8ZS]E,.4R8KTK?PL70\-Q@#PM<ZCA* ?4Z=^55[Z:X'<,)>G4!P
M9&AX8:$86/=<.7((*_:5UTM&,>)#@PI4BPWW3 I_^O.YT<A,<[\'(QWH*K*Q
M);1=Y2'VI @P*FSQE?K@_Q.9N#)J4ZWN:LVS$<!.QS?HKE,"$O_H)J\[-#3@
M?V-!WY6N72?*6['DB#D>#IT@C^2MK.,99'C&O"G <^1,HTJ/A--JFB)FOS=^
MB]%H,0*+$DEF#D>+B^2(+8?^!03D%<6+1RSV(?,0D&+%$D4G5]J[W+M#YE:#
MQ/X(+:V7-L./]2O?9/I0:PO_I?OIL_>V8MLE6:'17X#=F[T.;U?JS-)H 7E7
M06^R2!TY9(#U+]5RW]*[%:V( 1S[TF2]MT&,[VAAW0)^'9=U@4]@II"A OP2
MF[BU:7/CJ> C?+4=:[O9Z"#W7_G1Z+&_9BD_%J5QMCO9[R7?.TXRV_N,K,<D
M/_!P5/K.'"A7R+NZESG>DU\H2WD>'O2_:#P)NHP I]"+H-I\_5: ?Q0]-E6S
MTS6K.'ID(!':3IN\_!:L((W)\Q3VSZ##/=T=D7E)%;Z-6G,N&RT-=3@,H6+F
MIL]J#970'=[O-,EY$O^=+?#DKCA&ZB&]VK[?!38O)I=T)*V\/;B;>.(=,XI"
M/WF]Z;^/A#TDZ'V?_=ZP-6L5JGI>JUAC-S&'_IK>!\WN)<J@>]* !T 8+[?]
M/<MAE/J(TC37UW(%>88@M80AO=L?/WT']I"_[OJ.?I'!![(B&V+J]-;>:8EC
M2G6#S?B DH]LL]EIZZ_FX>,:U$$LSMS.NS.GMP0R1ZRIB2-F'SF GC_B/?C#
M%ID M!"R@012QWN^P^:%A06'\M7W9D9F0%$A[2:UG;:-4'FL1.G+I(5*1SK1
M/&20*H7>U&;RN^>5E55H@X5*.? N\"^@74=C.O$I["'8AT)D:MUDW,DM5(55
M*?ZM-%"EASY5F@BL^%:KL@B TDTV*K\%JCHG5'2BG<\-[XC";;Y<6VE4]8W]
MEC&P,B\/Y(SE1[.^C![I? AE$+V/*C\X=+5QN_@W&D/+;9E@YYKN<VJ--V3F
M90SX?ANH4^PU)NJZ?119>0C7,EH)RJ9E,NT:1C_<G1]09S'(RBA]]G^C6,9:
M4N78-AGN^M$%=GK*>TJW/02E\!RS[^/'1]ELV8[WG\)P4M1:<)7I*1EUOUN1
M9&QY?MX8<X)*Q(WF?TB:X$Q]#UR/8S*$DMB4FRU-?DP:QI;2'FMHJ!%)8U$9
MQ=V)_XH,ELP:A?Y8P+.!F+8O4RG(3+K23,30*(Z$$@*P;#DZ5:4C) P<%N#<
M3+H!SC:G;%^6U .A)C^F4XA(\;\(-I\QZQ#0$I E5)@[+9I\_GK.VY^P?'9+
M+8Y+J#1RM^PV@I/VZAF?S$\(Y:>>#R%LO*E._!6S0EQ\"Q/9Y,.>NA(OOE 6
M9,[[C"U84D"0&+><#[MANU;:0T!LPN&]UD(-W&>&J[0N/@!DO]?>GK:VAB-N
M69GT%2WHARJ7>])B'?IN:K$W.?F".SF_:5_]*W!R. #W]Z7VX2\OB8^ZRB@>
MK"W0343.TT1_O'2#8VE(Y7BE\2I..91S%/05WF(TS&[N?OVON+[4('BWU0@+
M5/5Q+SMTV/DA+)F]UY@G15N?$>,WANX95^Z>_ 1:");PYXS]"_B2;.J*+QM=
M!"(IX1#N;N3_GK.PG?O']@0=*>J\$K]\KAE]KXNX;*Z5NK\[+5DYG#*C3,,8
M4EBD1/ILB(X.#S*@_).F$_8:$K7+T;6U0W6>;T4362DA>*E%>P'F(\8^(E?T
M!0:/AFB_#7WDB.2=\1K:>BD5?1PH\;,S=O+[KF]9(T^_1?O9J72G?73]=!H2
M+!,VN_IKD6V+GFRX<'UL^JA-+PIU@%[S*K,,J8+!0X_MQ_RB*Z^U*M')<)&.
MHW76NJV^T<BZSSM9;L\IHSG46GD=74"EVV! _ YPZ,@OQ>UV=\P!3-)'\O5Z
M5#"_4-;",NBYDTE-K77T\?8X7)#P_^$*P1I3N0X=)JX4;$S$Y YN065BCG?*
MR#?IO/C3O@5ZUG:VSOJI4:^R+M5/TUZ2JY<(^DB=C9'<S88,EGZ1R5S_H[T8
MHLC,8[1AG8/R 'WISN\[<6K3#@_=!RWR*'Y!N.'Q$7U5*!@8[1R>V)"G9,/E
MSVI&KC;X^KGFW:O-)]7"/KQG74X"<TO9^W!*$AZW,XDQA"3]=TWV"*C:"5%F
MV#;3'VIRV-#QFJQ/8]+CH  Q1HD&E%3&FY69&S4/,)FO\1HU?05V<6DJ/]_-
M,\J2BUUZJ8!AMB_E.4!@ C@NK[&0)5R5C4 >'=VKS[H4MD-GC&M(FUB2E@5B
M6E77F@A%K>VZ.,G_ OJH:JHV:=5 H&/%O)$_DG:M$< 78\5]W>7KV.X,:,2>
M8<=R=.&*[LBR:+OZ^73E9,/ICRX?X*K[K1T*Q$I6/09B3]V?OT!]:*PADR^_
M1D/P@KQ:A$J:$'E[2-.8J%*#++$^U]U-@,U::V-84O>D> %^L_AFYJY*B;)]
MOG6($7%<L%L0/J;8#6-QS?N>2:][&6;1"BHS/*.J1S^DNRL 5W (#>"^(C9<
M8JYI,?]>.U_ESV0\<L*/>SMZ3]2NU7>"?@\7#>S&(>:2>5> GQ>]X]RA7.&T
MV*QMO[6POG[\+OXO8*(MJH3_S$K$V< L+V<'C%%+UKAYJA9DJ'9=4Q3'8Y7G
MY/#%>,E"'(AE=AV&8*#++, #[D<L8+&UI#)&"'-=J?3HRQVI2K]4M7#^]*O7
MUW3P.Y*B^9Y(<9^QV*TM\:==Y%-);EV+K ^MJO@^V:QRQ=$=56<L596Q<.>5
MBKYE7"ILC>+33'^D>]SJIA^M^ 9J46$+GN3@WI6ZP,$1U=M$1\%!XL.+9A=+
M8WRB3$1B'W%[NOV II3GC&_ROS "SR9K1&.Q=728OO^Y[Q@:O](BW1P6O\VT
M'BQR4$/UN__> !FWGH,<"'/R+!L(!?MB!Y4:R#TH7J,H]KS/2-_)$]N[38B%
M.CE5K92_%2D"Q>@%>[8,C/A4W-K8#-*OFP".#FK(/U-:L/Q<XA&F)5#K;(9'
M@Y+\58G?';<4XATIQ L,2ON[&U0_:58ZI9OHF9B)-%^N.VS],N8A*[[JLBP!
M& "E-N@D2$[E:,/)1ARZF%JS]K6AO\Y&7C9<9SF+GISP@..PD+]C-D, -%\&
MQ=#+'63$ MK'.<?GA *^S.6\:FP*''<T!O'LK;^Y07[2[Q%"6=.56GKZR>G_
MF.WS<5+L,,??@"(*GIW+:DH:[>0DZ;?<MWCOUI2D($>M%SP:MRR5!G"^9:QR
MI'J</JNQ:XM >CH5">\D*V2;*,#N]:!N977#Q_]@9VP701YGD\HDT#74RT>]
M@K;AG_/"_<11;4N8?#&B9-.S,IM"%4+89ZHT9/F9\7U*FNVZQ-.21:[X5M-[
MPB]=^E='$I(FH]YU<>*FH@J"K#VLIP^3DM$?#W\*H1R0&FA\K]0L[7$@R]$>
M#@CP:*[#4EVJEK<:CW<C,]J #(A-.$8?4:U254S7E-4Y5<78MC2U@^ST'H%O
MJ@;W2)(Z55ZU3B(8J W\X](*640,W<PP<P9?1?4Z?YBC\:DHRZ,V]?O7/E2^
MQ8$ZH'SZ^C30?]4S]R$0 =J0)ET#X9PUAA==%;W^PMZ"ER;NTBIE-].Z)G\;
M<;'81U1NL3*)JRK!H8Q38?";ZZTSR]++'ED>":CG!#OJS.ND49KI*$:(ES10
M0_[)Z06MLG'3@M>*L^:).GXAK3Y#7.KIFN'_3&UPKYB%LH;O4$+?HD/9(9VI
M U(=/I4-F5LXN6"JSC;@0RW7669C:>U!39:C'9<7SNVX)[\>)>YH/C$AE^U6
MX5!YPJ*/TUUPW9_IX"]WY&"$;BU,J';W8(Z5FY9ZQB:\'VA(-UPXJ1'*A LW
M.*FKZ0?WXWYL,)5\;3-*_FI :?;'E:<<K2)9?^]6D$-3!>0U0\-K[FV'.X,>
M(\'1_8S4M2LY"RP&W,N<Z^@IJ@@$N,KT,/UJ2>-^:L39Y57(MEXJNG<;A94\
M6DZHS"'EN1PM"]F _%;G>^V&.>;ZV4+3.)ZU_AV=",F:]&1L0B4E%,GO*YK^
MR\V+GYN$VT&F]#P@5:Y/*UQEXM@[F,'_9)J8_@$/X/R_=&.#_EPUP[S7*$SF
M@.3E'#=N, UM-9_[^;A)83#?J5>GY8IT6DF5Z2JR"0__ (:K*Z(D2KZNY'Y0
MQ#9;HM-PT?4-YR &4KDR[%K491F-(\L[1J?[5A2ZGR-JB6$A3GFHXUO"4S\2
MK[496B>IV6EYT,62K!]$9+(,_C,S@WRN>UR2CW2F\9#U][LKP#BD8BTII#PY
MA5![SS!Y@$--=6SBL-@L$\4H@1NIS/CBQPH/UKSASD*:\$M79@&_]??K5[O&
M_+&7N2W'ZTVWM!J+:@C5LY]64M,_6HZ,U[0_X]:-&ZK;X'?ZE0WO#N)U5E.\
ML U$OZ;2'_SSACX7(&LR8V@TV_\]9TJ=ID**I !MD)'/YB-=$5/2*C%'25Y<
MX*\^D]+:SWAC"Y="!I<K*QE@]:75/@HKHU/4&L DS5YSWMMX0::V2A3HF!O&
MMEIUS;>4T&)K0E\AE#=O9V7KFP*"9,>O.Q*5GML]H9KO\DTF6R]NQQ;;1I6#
MB$T<Z_P\!J;(O3[SCN+"6G#!&&C>Q^,N3=/,,=0CT>?W>G4ONT(;FSH_\(XC
M1YC"OW5 ETF_\S;2//L=RF')1+.9 P.?/MMJ- 9-WF9$;0]:R/P)N*G,LHVJ
M.#AI3O//K9^!ZASB-H>7O.4R&J 1H]P)5H-BP%Q4I;1.KVW>KKJU9^#F.QJF
MB458)VGAG[C+4?K0 4D._/>R[SJ_(VL%'_,L FOYY0[SW!,<V_W*@,(QTGKB
MW':N4E9D%M;7(G2MVW3OCPV?#CK..<<T!8'++79T+443,1-7@7/7[KG9$2?^
M6\&O#[YJ.Q./PYWSD7B$3N%R $.I5,J;"5GLR8:+#I&VO8IR5?$LZGF.M+$,
MHS<H>QO[N;MZ^26N-^4S6T F >;I!GP<SA<8VW(T\^EAGT8W[:9_:ON50GWW
MH(?;C_FCUDC,2>LX"O'3?,>I(+H=WXAM[= S%D1[LPK/*U\0__*>LXUE+_VQ
M.!I=;D6@:.6JD[_EG W(=S/G+(318XR$C?KY,FP0YC@JI,7N4*(RE_/B!#"Y
M+4<YNMG=AA]3\EPENQSW<=TN_4_C"&JS[X3TY;FA,$SP-Q@$'1V_0G0X?W<Y
M<8:X9-)Z;]5(72HBQE))_'Z<68K2.QJSQ+-P,U4"!$ TEEKH2D7%%L/5RI4.
MZ5.F9IAX'57N+C;*ZBLA (E$^<E FGESV1]Q-G19M>52YW;EFH$3TP ;@>J"
ML+ !W.+]E8*:L,FO'KQ9V<5 ^1:;KP@8YSBI-48J*934Q5(@2*8)!:0X*]L@
M-&VW]]B29BQZNG*_8S<@X.\RN&D6_W5S#:1]4>5P[0BB2X>XB^>A-\MX]PJF
M*09UOW2%,*.+2?.O18$=J(23WD4+C! P';%?%UYWY M+S0@VNJTEF&FAT[31
M%3F7KZ\>('/(*P)_J&[ES8V1RWWS*:5U4ZO<H8F-_;4'VP_EKA%RYE6/.%.!
M]O\%^#&QV[;$A1 7>?U^');IK"J!^EH-9G*P:DRW!N_/%!?@B@>*0!^::3U/
MN8C%@D56Q!SD(,:">=^8(0.2"6KQHV_G;BIV8C3G3M/5H;ME5VQ-O,P!2^V5
M+6Y\JE8"9<!STPC?MZ5,7)^LXOI%<4..HVO+'+W;8%5F)L-MPE"5>%^&H@;Z
M7@[[%]*2[WZ_W*MPWW?]'335LH*@YB=UWZZ5/;K.DYAW!BFW9>M_U9]U98)W
MJKS#9_TR2E.?W/("]34:3:+\F:\XS+XTVNLG:13C/E )S;;<B:K)WS:APD()
MG.7$:<S&=[YSJK,D/> N!^S]4?U+?Y6"8MWF]'3',%V4D0O=?EV S%"*9VE>
MF6TQ:[W5>!VI"$\3*V/:\6/BJ0R:(TIZB#8J(5:DID&'X%+(S#T%RPT-'["C
MIGW&7#4OK1(^^T;8]?VW.+&IJ9][WY3(PXJ#+9</A/D*0&-5\J].>6JUS15_
MGX.KV*2>L-83]3B"X]ZD2 ;S#,KR2ETGS=+<A(0PO\"B52ZQZ:D>9(67&ZON
M#I)5NTF,O#_/%+W\"XC_TX22;K=I^G!ZTXYS:B$)DU2W7V<F7V%)*J)GO5^7
M!P3[:FF@:YHAS0FT6A>KX=Q*?Q;TZP4HB=>G^@;]4Q^7VJT!_@ !.>EZ4P&0
MP%HOU5L8215%XG!H,1C (SZA.4MWLWRV%6[S0F5L>N#]Z*I@]Z0:H*?YHG/,
M@']IM/SMW<*OT'734\2K;N),;/YU^>/88 DO89LG6:ZL^)IQ"'#VUNAN$B7R
M,:2CGD[_WA*OP$WO>KWF %GHV*8>M[R4;(8<=)OZ.JQ^1+!(<UOE(TID8@IR
M%W2.%^8:7-+"D'3=[-2NN?&#X-F^WIXIYB56M <+_#G<'H7N[_5Z R#;2>'Y
M/^X%Y6'&?P'V;YM-8DLA[QN3F36\]_=^1KQ/N0SV.^XW=R54N*<2320[O64X
MW1.T+(P<C>>T$"<VZDMJ:Z.++6/X(X02+A)5OG)DB/"7*7E9^9/,;ZL%+HC"
MH)4]B]_"HB^/P10<Y'$JVDMXZ&-B5F<FR1)7?/?@GI9:XKN6DV\VH,'_9%YO
MJ@VB&>YZ3:PX(5"-66;] EU)4UZ.YNG7IZ)2G.22%JBSLEZ\ VVB%6:DXJ>R
M_#3!!&\:=T/X,]-O3Y6 5WSA'4.[RJ\[WS!5U>P.K;9J)R4EF9C.V>W1T- %
MS(*S7H?PJ\2C]'!T;_S20D<SH:MN*_[5U 9O?"]=WAQG,!8)1KFW<\ULN9\<
M/YPELU.<MIL]OZ55N#H"UIS'?K(,125U)"3D*\E(GF3.\[VI@$A_X+)N4/GB
M*70?Y;@ARW^&ZWF[76+_.!WUUL+*[XN=[6;./]*+'=-*&B>;7[[-^E1"FZ49
M6/YVH=3,"DF?)YOIYL>4VQLRB"$IX1JQ,>/*5=R<^D7$__.2C@B0V46W!5$[
M>KC>C%O_%=/:?)^!QT_L6$O=6[U=U9:Q%0+1Z;+7$NBF\]MYH2&Y37N FO\9
M^WV<S+YR\_P,+=5N\1K%<E2>D =H .K:C<'\0B^18)9X_4&!<YG'+J P71ZL
M+J.7\$=*P;)F.L^CEWO6[<<-V53'I3(CTW_QJI_QXJ<:G6^1^CD'!TKN6#>N
M_Q3ZRY_AZOMW7^("P:VM+:%'K\$QS^_J.8+=5%>Q+)2_,:W7]+O6QACW(=-R
M%ME<H<-6FR08>ZNE.J9,4[$!"]^2T#Y]@&#%GDU2WH[C,$I9*4*LF5Z%# TN
M! MX25.9\Y@K[.WMB=?4[I. =GIWE8K9M>$>FHI 9JBZ8>O%K/E/QRW3C!7U
M^6]$JRL9"1F4K&-59]W;M'I7$O/S\PN:A&_*WA*K%#<%) ET^1G^TQ?I7P9I
M2J>MP'\DHKFRI\H=NT,UG"]L;ZY/M8UCA/-+-;#_:(KK"(O=QZ9@1CTU,4G+
M?/[F6:J^[_?Y0]MO#9']SV<[[R#;S[:>IX:]KR<PQ3:N9S*N>^G&KPK/Q=3'
MT,_+8 "KT<(C R1\]RZI?&4%=FG8$K$W-]9E52YW#)\+U=<C])SRJCZLAAA+
M!?BY@P-(B5E3G:B!I[%)H$RV29244#[,_6]2GEG'#8*QL;?]=H[(;[-=_0W"
MR?]M4A<=CVMOG#R4(^7JX&EV+E5QI3*&\=BU9RDEH/NQ&.+Z/Q7Q=N\'8W2^
MGA:6E%;ZM:TR=UH0\4M>J&X5"6Q6;7IM_6H1B"V [[>/;!+.U1:"L?XZ^>@'
M@UFW&($VNOK9CN,EYH>8KV%;*;$4<DLW0P6XZDYOYH1;7W8LWE641A5F6R%)
M)%(LEXA=NX=IO7=0$_Q!YB2ZLSQEYJ*ZS>HR 6DM?)KVUKZCS?N8/7.64)4A
ML<E/J9X*"R1&,UQGJ\JDBT2/>2J!B0+*BW#[?\861:WR_XPMF-W$0=:F8[Y&
MZO0GDH2KW7M[M$^53N+Z7G %9EL6X>+,U2%-F_H$DDD ('X*MT(RI>KBKB+0
MZ%.(AI^<BDNYIIM@Q$,1BKLI?$._H@%CBUY^$.OZ@( OH7LC!^8*,_U[KRRK
M6VR&AGKSOA"Z!1@X^6KL;4+8.N;)5<]WFU.7N>^*/X$B4 S=Q<10DX_\#LW9
M\@DRZA\K.AOT?7!S_+%KLDJ*LYK:K(;PYK29QSJ;ZRUE:8K<Y<C.FXQJ;^U=
M60/[TGS($_!_=C5D#(M/4EY=/OPV$+LH+6.6,"^9:($:.Z03J6/#2I=9B/)3
M5%:&I'P GI/PCW&V[!JY+R]  :-3[L1#M/JA:4P^0!HZ]W&>S$KJ1V%AWP7A
MAG:GP+/?W8S-VX?WW]4 YCX@B8D$Z6@-!A_VX5?J/<9& E ! 8&BV.AOK#&5
M/ 7"(&FU&>I'2R.>7J1@+[M./R5O!E!EM?><)NQFX I$4Q_%!/&2BM!-_$PU
M'O3A,^+$Z^"MQZ"GL]2>?N#&P#2/V.TUP:X<_K104M&R*HG&(@7)NWL*DH;3
M:V8PU$T"/QB_&Q]NL-CKCGRH/#:AX!H5R$U;X:N71,/_9Z$_F$\'""I@>,JZ
M\!G8C!-B*4'(K;9=\LO[7BY! ^8\RB0+5?!;%U1! ![ 8_^':/ZR9D$-C.I
M0RWCTUC@)98X/Y;HM@O^ZNG$NL2UB>Z!QW M*(BVCW'F:)J;!U;\I=Y+]Y5Y
M-:7S7X!1]P[=/%RUTSMM521V9[\$8&6/-*@M88'G9,$Z)W(_YIF@-S%ZR_%]
MR_^T&B^.,R&IWTET^]IKFZ>R4#**-2F- >-L>]W[]: NPD6SQO%8DUB"Z?\U
MASRXA;G.#*W!3W4_0&N>:"I%\QP'?M ?2 &^]W[/_<S2D82U28?6X3V"UZOW
M)#-#L.NJY'ZCYO/RA-BD__?R _^(JG)3X?GGVB5GEYDC]NTFQH_?AG1?>?#G
M%;,/;2&D_J_W\\6>K HFF.FZ6*C ;*"4"ZKZ.(R"I[AR&R0KQW*DPK!7M[SU
MD\X>W+4?2Z]AN_;WY2QJ#0T[-FKU-$1+^]%#KAB3 :RU,F65F79SEJ%\EF&C
MIM[A:].)Y"[A(3V3#'=B5!19XS^<VKQ3/Z;],-X*B$(:$PQ%#Y7HX5<'3DC@
M<]HG%C$'2Q^@<JROO#>R-<W5U82J9W^P/P'*N9[S">0\H]";C/VS)K6M+=!*
M]LJ#^MKJG4<KHIE_X&5'H9Q(&G.C!P[)+(V[N9"GXNL/-)&[&M1.J&$']L:%
M?O^L&#A[SFZI]JP(<&L[3-#(-FZJ6Z!C[1R#'A[:SKR[$@ $I@T-G FX=1-K
MTBS<A1>HEGVV,U-GOW:^*:^V8.BP<5.="/*%?9?A2MHK53AC<MOP?V8WWO(-
MW$VEXK+SM53Z)^_CPYNJ6VGK>Q-_6-H17:WML9,N%E+O3#GT^,116BR59[-T
M-\5W9B#9#G!^EHDR#X3%YZ3PN'DPX.7:2!CAMO@@\-R<$423%$7\UGY2"1=3
M-@Y+2$>PVH,I1<RR&G_V((@=%5V=1-]<$6*JKC;#^<B]L'XB720D$&[+KO 8
MDA)W(G,Y)/M.U:?PYZB/386I(Z%BI>F/*1#3"GFTM1762]10/CVB:_=)LX61
M29*1::[R&;9UK>ZD6[(0FRV[=F<NX0:&SM;V\/B_@)97/"A/WI^ !3B?Z*=9
MI].UG&*V_81OE]M\KNY>LA"IA20/#@\6,'C&9B5L/FNLF][,0'QAW+PE#KG,
M< $IGI^! RO=0*FGGCI5F?EI%RV4H?TR:7MF7.N0//$"W"#1WN9?ZC?$R%8C
MAMGM^GABP7 %%<GVO"".B:32SS:FF@2Y>X\(W=5]%_X]E<GX3@18^M*0*>\U
MF)>F_$#@7W]$9Q?\0;8T2FGTX&'TX5-7"LK$VH/%WAXOH0F> G/# EE&!8)5
MI=A^1L#'%5!#(M8M+NUD\%O-=$U3H\/!.T8D\3' \[L_Z8#GH-G\7A;SUPD'
M;:L!GS0 ^%AE]D>27RT'U^>?7("G U02I6F(.96D$R8<Y.=5]:&!?:=)QBW6
MK=SZ9[P8<&7JD_!GG5G9)KO9XNO [_7F.#G.$T],-1*7]]?YCATSC#5[$%3@
ML'1EZ;?*Y<.V=[]RKL*<T)PY)0*7 =;;BR4 .\W"(SXG"O^(_Y+XN>E52_2_
M)"Z9]_YJ7E-,6_ "7[[[4 F^^0VVZI ,\@8'&-!]6GIH2?"05/+;((\C^(1"
M>PPQ-G_#B:X[%9;U(>\5WY>14!T!$K=5Y9E@_AHO<P5NVVW=&6%,[O4C(5!D
MC7/L4+\ V0"MBIB85*(<+<><B5X,3+%BU(-.O_$W9^5@$_\J9=W.=IGF0ME7
MO:9\O=;9HF11D8,$QM\R)^#%,RKS_R%G6@ "&<?EC@OA.B/Z;$"*DB#[E5=8
MV@!Y;-@)S\/19H_F#- EX4O")CPQ;Q#)"\9-)/BH]TLDO=K!P=F!I\K5LVR%
M+2T$ACTQ@DXJ>+Z2-*"BG>-=A5-==O>\D,^6EMCC@#>4T84B(!63\!0A*S'C
M1RPV%G]4C@[B[T;]1Q\(*$ACDTSH=Y687H2QP=%\*2X^?ZS$-LV%9\Y==<![
M-.0;JV:!U6'AVCOM65JU8&/58<L R 8X^G ^=4Z@SH:)(2S12=1B05=A!GD)
MVVU-]A\DZQ#[R5G?K3^Y]2EX"MWH8@_F[E<\7G[LKDF7*9I-I>BPFQD_\&X(
ME.>V%DSKNV,5Q/NOSGJD_?^^Q=2:+#5T(K[/GI[#=O!<W:E&J?VK ,K7%3KV
M)6N[0PEUF\UU8C(1P>Q._IIW\&I.VI[FUN9<%^Y]G';KF*21>S1R-/<>J7BX
MQ:!2.U7//-QTJ<8E#=45NP<E6BPITK:;JZ^1S"SG1GO0[)CK4BC/9"3BG0N2
MTHZNY:;LS(RDQ1(B_D^^O*0%?U/+S][4\^;>2?IN7(N<_H3+30BXYQBHGX>?
MN6Q?DE4>$;&DP:E==%W>):E,<QGC=;QHD7./W;FMB5#=_.KZK]MOAZ]V6__6
M9YU;#E0E3]W%J[6_E['U>VEN2/D7$/(I!8!HLUL1EA:XGEB^ ]+>.4\\3S>
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MMS=WW@\U*D1^,;%H0Y5R*2VPLK_FSU :B9=Y+D,D0)_,%8Q+DJRR$+P5O%6
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M2>$AB$QF" XK<GYEC;/<F5R;/4<!$'+[C2'J(=OH('>NHK)2<@0]LUUOXW*
M7E?]<0=7!TD,I5<:+IP3,XC1EW"Q1YV ,AMZ9F,=\AC_;C1W:@$341"/KQO+
M,+PZX2:W<_IDWA'C4VZDHSGU%X"UPUOBL].U0/+CBK:^.Q*9\T]^&+Y1"92<
M!0)OZQ1?EH*F&$.6$J=:2CLG7K+?:_17A*7Q55L:[+.<CTQ5V:-^/3M2":P
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MK:"%DR;0JH(46WWJ\>!>SR75C]B^77[ V%OB"7?F5*;!1(&&Y")9V.1L*70
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MZLUSB<MMV3OSMU2('XTPFF]@HVA"!77/9VIEAA@V(H^/DOS-7QVFK8>Y^]J
MP<[%DQ>31)O#UK;A[] E-</0VR[<X92_UP^;;KB-3^=F3KB<!^HUA]@8QCB#
M?-36N8-KR ]Y_I5-G3RQ!HJ9R*-LT##.N[^ 7XU_ =.0Y:/_L= ;X$_T9^:J
ML."_EG@#_O.(^9_S/V>6]';_CYDF@%O0_]PE?1D4TG6A:O'OCM2@3#]Y /$*
MH])'7VM/I6E26ZO@'$_&N3*<(V%/*LF]T2T5&=?7<K28:.4O"'[;OXA)15"
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M.N/65]H;E?7'_H7!DV[!2!!):@)"*$V.6$L5S.FJM"W%/CQ*G(7/[8M4\4=
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MDC_6Q2@9Z.AT0O04<SZ9]MZ5'8&(EAF.6 ZGY-T6XO-::1=U $H"#4PG ^-
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MAE?>4:,R9?R2G;IX>E?UM"=FYW,RVLD8+3]Q.AY=?H5W9%^^LE^/-J^9TK?
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M7J)K*.KK#=W5??EHYU:)6W.Z(5ZS-U/;0GN7,'92KT"V Z;1'6#",\BB3?-
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M^I8_Y(??WOBO\RO09>IZ6N7;>'5S\ Y%PL7;&.$M9U(BO5V#*;:3N+Y#C>J
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M1YH%=9E8[S[J_61Y#Z*;IKC3Z@AY^'SWU%0!E[(D&%9H)"YUW+$8B\%+,Z&
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M:;MMPI][/0XL"1D1A?MW44_9$!N"X\>$"K/EG@$-8X\,+A%LS3LF)-*/S%J
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MO@;1Q/D1@A0*N +7P6E%K@L;C"\.[4I?O1)X3K J(3 '/#'=.'Z3,C#[BZ7
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MBY-MXZS  -DZ<U *^++MV[OE^%I\<P]W@IR\%/9Q(T>OV[SW E!+ 0(4 Q0
M   ( &6 F%J\H*LT;\D! '-[$@ 1              "  0    !B8W)X+3(P
M,C4P-#(T+FAT;5!+ 0(4 Q0    ( &6 F%J#I]Q<U@(  #,)   1
M      "  9[) 0!B8W)X+3(P,C4P-#(T+GAS9%!+ 0(4 Q0    ( &6 F%KF
MO11RI (  %<)   5              "  :/, 0!B8W)X+3(P,C4P-#(T7V1E
M9BYX;6Q02P$"% ,4    " !E@)A:(_D&I^-2  #35@  %
M@ %ZSP$ 8F-R>"TR,#(U,#0R-%]G,2YJ<&=02P$"% ,4    " !E@)A:TO]R
M<%23 0#0"P( %               @ &/(@( 8F-R>"TR,#(U,#0R-%]G,BYJ
M<&=02P$"% ,4    " !E@)A:XGP*%HM$ 0 8PP$ %               @ $5
MM@, 8F-R>"TR,#(U,#0R-%]G,RYJ<&=02P$"% ,4    " !E@)A:DVI\A/!K
M 0!LZ@$ %               @ '2^@0 8F-R>"TR,#(U,#0R-%]G-"YJ<&=0
M2P$"% ,4    " !E@)A:J^=R_5+] 0 A7P( %               @ 'T9@8
M8F-R>"TR,#(U,#0R-%]G-2YJ<&=02P$"% ,4    " !E@)A:QYW#+R%< 0#T
MO@$ %               @ %X9 @ 8F-R>"TR,#(U,#0R-%]G-BYJ<&=02P$"
M% ,4    " !E@)A:"(G7E)X"  "R"@  %0              @ '+P D 8F-R
M>"TR,#(U,#0R-%]L86(N>&UL4$L! A0#%     @ 98"86K8Z%_H[ @  P 4
M !4              ( !G,,) &)C<G@M,C R-3 T,C1?<')E+GAM;%!+!08
1    "P + -,"   *Q@D    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>bcrx-20250424_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bcrx="http://biocryst.com/20250424"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bcrx-20250424.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="c-1" id="f-2">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-3">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-4">0000882796</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">BIOCRYST PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-5">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c-1" id="f-6">&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants all equity incentive awards based on the fair market value as of the date of grant. The exercise price for stock option grants and similar awards is determined by reference to the last quoted price per share on the Nasdaq Global Select Market at the close of business on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally grants annual equity awards to employees in mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees. Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company did not take material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c-1" id="f-8">&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally grants annual equity awards to employees in mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees. Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company did not take material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="c-1" id="f-7">&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally grants annual equity awards to employees in mid-December and, in 2024, on the last business day of the month of hire for newly-hired employees. Starting in March 2025, the Company began granting inducement awards to newly-hired employees on the first business day following the end of the month of hire. The Company may also consider and approve interim or mid-year grants, from time to time based on business needs, and it may change its equity grant practices in the future. Additionally, eligible employees may enroll to purchase shares under the ESPP during six-month purchase intervals using payroll deductions accumulated during the applicable accumulation period. During 2024, the Company did not take material nonpublic information into account when determining the timing and terms of equity awards and did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. No stock options were granted to any Named Executive Officers in 2024 during any period beginning four business days before and ending one business day after the filing of a Form 10-Q or Form 10-K or the filing or furnishing of a Form 8-K that discloses material nonpublic information.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c-1" id="f-9">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c-1" id="f-10">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c-1" id="f-11">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-12">&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#x201c;compensation actually paid&#x201d; and certain financial performance of the Company. For further information concerning the Company&#x2019;s pay-for-performance philosophy and how the Company aligns executive compensation with the Company&#x2019;s performance, refer to the &#x201c;Compensation Discussion and Analysis&#x201d; section above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value of Initial Fixed $100 &lt;br/&gt;Investment Based On:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Actually&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Paid to PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;NEOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Actually&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Paid to Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stockholder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Return&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Peer&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Group&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stockholder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Return&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Income&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($ in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ORLADEYO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($ in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,317,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,979,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,368,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,160,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;217.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(88,881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;434,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,777,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,691,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,963,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,232,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(226,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;323,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,982,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,009,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,568,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,452,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;332.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;153.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(247,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;249,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,061,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,053,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,523,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,254,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;401.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;137.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(184,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,034,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,853,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,353,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,630,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(182,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amount of &#x201c;compensation actually paid&#x201d; to Mr. Stonehouse and the average &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Mr. Stonehouse 2024&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Non-PEO NEOs &lt;br/&gt;2024&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8,317,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,368,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(Less), value of &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6,678,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,274,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6,818,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,322,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,507,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;520,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,013,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;224,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;10,979,333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;4,160,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the average of the amounts reported for the Company&#x2019;s named executive officers (referred to as &#x201c;NEOs&#x201d; in this section) as a group (excluding Mr. Stonehouse) in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2024 and 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#x2019;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#x2019;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#x2019;s former Chief Business Officer; and (iv) for 2020 Thomas R. Staab II, the Company&#x2019;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#x201c;2023 Summary Compensation Table,&#x201d; &#x201c;2022 Summary Compensation Table,&#x201d; &#x201c;2021 Summary Compensation Table&#x201d; and &#x201c;2020 Summary Compensation Table&#x201d; in our proxy statements for our 2024, 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2023, 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on December&#160;31, 2019 and the closing share price of our Common Stock at the end of each fiscal year shown. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The dollar amounts reported represent the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#x201c;Company-Selected Measure,&#x201d; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#x201c;Pay Versus Performance&#x201d; table) used to link &#x201c;compensation actually paid&#x201d; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month.&lt;/span&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-13" unitRef="usd">8317286</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-14" unitRef="usd">10979333</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-15" unitRef="usd">3368257</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-16" unitRef="usd">4160611</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-17" unitRef="usd">217.97</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-18" unitRef="usd">172.62</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-19" unitRef="usd">-88881000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-3" id="f-20" unitRef="usd">434090000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-21" unitRef="usd">4777778</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-22" unitRef="usd">-3691891</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-23" unitRef="usd">1963725</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-24" unitRef="usd">-1232421</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-25" unitRef="usd">173.62</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-26" unitRef="usd">159.01</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-3" id="f-27" unitRef="usd">-226539000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-2" decimals="-3" id="f-28" unitRef="usd">323812000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-29" unitRef="usd">6982994</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-30" unitRef="usd">4009070</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-31" unitRef="usd">2568935</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-32" unitRef="usd">1452633</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-33" unitRef="usd">332.75</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-34" unitRef="usd">153.08</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">-247116000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">249689000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-37" unitRef="usd">7061225</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-38" unitRef="usd">17053230</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-39" unitRef="usd">4523739</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-40" unitRef="usd">7254142</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-41" unitRef="usd">401.45</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-42" unitRef="usd">137.47</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">-184062000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">121865000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-5" decimals="0" id="f-45" unitRef="usd">6034941</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-5" decimals="0" id="f-46" unitRef="usd">10853629</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-5" decimals="0" id="f-47" unitRef="usd">2353552</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-5" decimals="0" id="f-48" unitRef="usd">3630213</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-49" unitRef="usd">215.94</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-50" unitRef="usd">110.52</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-51" unitRef="usd">-182814000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-5" decimals="-3" id="f-52" unitRef="usd">133000</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-53">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year.&lt;/span&gt;These amounts represent the average of the amounts reported for the Company&#x2019;s named executive officers (referred to as &#x201c;NEOs&#x201d; in this section) as a group (excluding Mr. Stonehouse) in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2024 and 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#x2019;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#x2019;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#x2019;s former Chief Business Officer; and (iv) for 2020 Thomas R. Staab II, the Company&#x2019;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#x201c;2023 Summary Compensation Table,&#x201d; &#x201c;2022 Summary Compensation Table,&#x201d; &#x201c;2021 Summary Compensation Table&#x201d; and &#x201c;2020 Summary Compensation Table&#x201d; in our proxy statements for our 2024, 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2023, 2022, 2021 and 2020, respectively.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-1" id="f-54">Jon P. Stonehouse</ecd:PeoName>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-56">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amount of &#x201c;compensation actually paid&#x201d; to Mr. Stonehouse and the average &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;div style="margin-top:3pt;padding-left:20pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Mr. Stonehouse 2024&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Non-PEO NEOs &lt;br/&gt;2024&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8,317,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,368,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(Less), value of &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6,678,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,274,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6,818,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,322,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,507,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;520,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,013,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;224,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;10,979,333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;4,160,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-55">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amount of &#x201c;compensation actually paid&#x201d; to Mr. Stonehouse and the average &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;div style="margin-top:3pt;padding-left:20pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.114%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Mr. Stonehouse 2024&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Non-PEO NEOs &lt;br/&gt;2024&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8,317,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,368,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(Less), value of &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6,678,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,274,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6,818,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,322,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,507,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;520,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,013,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;224,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;10,979,333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;4,160,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-57" unitRef="usd">8317286</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-58" unitRef="usd">3368257</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-59" unitRef="usd">-6678053</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-60" unitRef="usd">-2274445</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-61" unitRef="usd">6818576</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-62" unitRef="usd">2322304</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-63" unitRef="usd">1507716</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-64" unitRef="usd">520381</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-65" unitRef="usd">1013808</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-66" unitRef="usd">224114</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-67" unitRef="usd">10979333</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-68" unitRef="usd">4160611</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-69">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on December&#160;31, 2019 and the closing share price of our Common Stock at the end of each fiscal year shown. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The dollar amounts reported represent the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable year.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#x201c;Company-Selected Measure,&#x201d; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#x201c;Pay Versus Performance&#x201d; table) used to link &#x201c;compensation actually paid&#x201d; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have &lt;/span&gt;selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in more detail in the &#x201c;Compensation Discussion and Analysis&#x201d; section above, the Company&#x2019;s executive compensation program reflects a variable-pay-for-performance philosophy. It is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Company&#x2019;s primary objectives for our executive compensation program are described on page &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i08dd44edc832493d888aecb8122c7631_37" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;27&lt;/a&gt;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Compensation Discussion and Analysis,&#x201d; and the pre-established corporate objectives used to determine the variable component of executive compensation for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (i.e., cash bonus under the AIP and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; long-term equity grants) are described on page &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id9ea9e013d6740e696bf1d820d021d58_26709" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;31&lt;/a&gt;&lt;/span&gt;. While the Company uses several performance measures to align executive compensation with Company performance, not all of those Company measures are presented in the &#x201c;Pay Versus Performance&#x201d; table above. Further, not all of the Company&#x2019;s performance measures are &#x201c;financial performance measures&#x201d; as defined above in note 7 to the &#x201c;Pay Versus Performance&#x201d; table. For example, as a growing commercial-stage biotechnology company with the goal of developing first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, some of our performance measures relate to developments in the Company&#x2019;s product pipeline and to building a robust and adaptable organization. The Company generally seeks to incentivize long-term performance of the Company as a whole and, therefore, does not specifically align the Company&#x2019;s performance measures with &#x201c;compensation actually paid&#x201d; (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year, which can be impacted in large part by changes in stock price. The Compensation Committee does not consider the information presented in this &#x201c;Pay Versus Performance&#x201d; section when making determinations regarding executive compensation.</ecd:Additional402vDisclosureTextBlock>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c-1" id="f-70">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.&lt;/span&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-72">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid, Cumulative TSR, and Peer Group TSR &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6343" src="bcrx-20250424_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-71">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid, Cumulative TSR, and Peer Group TSR &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6343" src="bcrx-20250424_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-73">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid and Net Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6385" src="bcrx-20250424_g3.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-74">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid and ORLADEYO Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6433" src="bcrx-20250424_g4.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-75">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Measures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As disclosed above under &#x201c;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table,&#x201d; the Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the &#x201c;Pay Versus Performance&#x201d; table. These performance measures include the pre-established corporate objectives for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as described in the &#x201c;Compensation Discussion and Analysis&#x201d; section, and reflect the Company&#x2019;s variable pay-for-performance philosophy. As a growing company that engages heavily in research and development, the majority of our corporate objectives were not &#x201c;financial performance measures,&#x201d; as defined by SEC rules. However, they did include one financial performance measure for ORLADEYO sales. Accordingly, the most important financial performance measure used by the Company to link executive &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s NEOs, for the most recently completed fiscal year, to the Company&#x2019;s performance is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;ORLADEYO sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span id="i830655254dc8407a904e56626902ed14_7756"&gt;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to our financial performance measure, the Company views stock price as a key driver of value for all of our equity awards and, in particular, the stock options, which have no value unless the stock price appreciates from the date of grant.&lt;/span&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
